# num of genes	num of total genes	Log of odds ratio	P-value	Adjusted p-value	GO term ID	GO term name	GO type
11	11	3.3218233202	-	9.65e-12	GO:0060968	regulation of gene silencing	BP
5	5	3.3218233202	-	9.94e-06	GO:0055012	ventricular cardiac muscle cell differentiation	BP
5	5	3.3218233202	-	9.94e-06	GO:0014031	mesenchymal cell development	BP
5	5	3.3218233202	-	9.94e-06	GO:0010606	positive regulation of cytoplasmic mRNA processing body assembly	BP
4	4	3.3218233202	-	9.96e-05	GO:0030578	PML body organization	BP
4	4	3.3218233202	-	9.96e-05	GO:0060534	trachea cartilage development	BP
4	4	3.3218233202	-	9.96e-05	GO:0003219	cardiac right ventricle formation	BP
3	3	3.3218233202	-	9.98e-04	GO:0070562	regulation of vitamin D receptor signaling pathway	BP
3	3	3.3218233202	-	9.98e-04	GO:2000074	regulation of type B pancreatic cell development	BP
3	3	3.3218233202	-	9.98e-04	GO:0055098	response to low-density lipoprotein particle stimulus	BP
3	3	3.3218233202	-	9.98e-04	GO:0060745	mammary gland branching involved in pregnancy	BP
3	3	3.3218233202	-	9.98e-04	GO:0045604	regulation of epidermal cell differentiation	BP
3	3	3.3218233202	-	9.98e-04	GO:0072539	T-helper 17 cell differentiation	BP
3	3	3.3218233202	-	9.98e-04	GO:0070141	response to UV-A	BP
3	3	3.3218233202	-	9.98e-04	GO:0010871	negative regulation of receptor biosynthetic process	BP
3	3	3.3218233202	-	9.98e-04	GO:0097039	protein linear polyubiquitination	BP
3	3	3.3218233202	-	9.98e-04	GO:1990785	response to water-immersion restraint stress	BP
3	3	3.3218233202	-	9.98e-04	GO:0061198	fungiform papilla formation	BP
3	3	3.3218233202	-	9.98e-04	GO:0051097	negative regulation of helicase activity	BP
3	3	3.3218233202	-	9.98e-04	GO:0002265	astrocyte activation involved in immune response	BP
3	3	3.3218233202	-	9.98e-04	GO:0046886	positive regulation of hormone biosynthetic process	BP
3	3	3.3218233202	-	9.98e-04	GO:0019065	receptor-mediated endocytosis of virus by host cell	BP
3	3	3.3218233202	-	9.98e-04	GO:0018076	N-terminal peptidyl-lysine acetylation	BP
3	3	3.3218233202	-	9.98e-04	GO:0002068	glandular epithelial cell development	BP
3	3	3.3218233202	-	9.98e-04	GO:0031281	positive regulation of cyclase activity	BP
2	2	3.3218233202	-	9.99e-03	GO:0060260	regulation of transcription initiation from RNA polymerase II promoter	BP
2	2	3.3218233202	-	9.99e-03	GO:0003207	cardiac chamber formation	BP
2	2	3.3218233202	-	9.99e-03	GO:0090402	oncogene-induced cell senescence	BP
2	2	3.3218233202	-	9.99e-03	GO:0061325	cell proliferation involved in outflow tract morphogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:0017055	negative regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
2	2	3.3218233202	-	9.99e-03	GO:0014740	negative regulation of muscle hyperplasia	BP
2	2	3.3218233202	-	9.99e-03	GO:0097252	oligodendrocyte apoptotic process	BP
2	2	3.3218233202	-	9.99e-03	GO:2001055	positive regulation of mesenchymal cell apoptotic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0008050	female courtship behavior	BP
2	2	3.3218233202	-	9.99e-03	GO:0072182	regulation of nephron tubule epithelial cell differentiation	BP
2	2	3.3218233202	-	9.99e-03	GO:0090427	activation of meiosis	BP
2	2	3.3218233202	-	9.99e-03	GO:2000077	negative regulation of type B pancreatic cell development	BP
2	2	3.3218233202	-	9.99e-03	GO:1905167	positive regulation of lysosomal protein catabolic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0055092	sterol homeostasis	BP
2	2	3.3218233202	-	9.99e-03	GO:0051563	smooth endoplasmic reticulum calcium ion homeostasis	BP
2	2	3.3218233202	-	9.99e-03	GO:0036315	cellular response to sterol	BP
2	2	3.3218233202	-	9.99e-03	GO:0023035	CD40 signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0046642	negative regulation of alpha-beta T cell proliferation	BP
2	2	3.3218233202	-	9.99e-03	GO:0034971	histone H3-R17 methylation	BP
2	2	3.3218233202	-	9.99e-03	GO:0034970	histone H3-R2 methylation	BP
2	2	3.3218233202	-	9.99e-03	GO:0032916	positive regulation of transforming growth factor beta3 production	BP
2	2	3.3218233202	-	9.99e-03	GO:0035947	regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter	BP
2	2	3.3218233202	-	9.99e-03	GO:2000327	positive regulation of ligand-dependent nuclear receptor transcription coactivator activity	BP
2	2	3.3218233202	-	9.99e-03	GO:0010725	regulation of primitive erythrocyte differentiation	BP
2	2	3.3218233202	-	9.99e-03	GO:1905906	regulation of amyloid fibril formation	BP
2	2	3.3218233202	-	9.99e-03	GO:0032425	positive regulation of mismatch repair	BP
2	2	3.3218233202	-	9.99e-03	GO:0071174	mitotic spindle checkpoint	BP
2	2	3.3218233202	-	9.99e-03	GO:0061145	lung smooth muscle development	BP
2	2	3.3218233202	-	9.99e-03	GO:0090042	tubulin deacetylation	BP
2	2	3.3218233202	-	9.99e-03	GO:0048145	regulation of fibroblast proliferation	BP
2	2	3.3218233202	-	9.99e-03	GO:1901558	response to metformin	BP
2	2	3.3218233202	-	9.99e-03	GO:0036369	transcription factor catabolic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0033032	regulation of myeloid cell apoptotic process	BP
2	2	3.3218233202	-	9.99e-03	GO:2000824	negative regulation of androgen receptor activity	BP
2	2	3.3218233202	-	9.99e-03	GO:2001178	positive regulation of mediator complex assembly	BP
2	2	3.3218233202	-	9.99e-03	GO:2001038	regulation of cellular response to drug	BP
2	2	3.3218233202	-	9.99e-03	GO:0003220	left ventricular cardiac muscle tissue morphogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:0033127	regulation of histone phosphorylation	BP
2	2	3.3218233202	-	9.99e-03	GO:0035408	histone H3-T6 phosphorylation	BP
2	2	3.3218233202	-	9.99e-03	GO:0061308	cardiac neural crest cell development involved in heart development	BP
2	2	3.3218233202	-	9.99e-03	GO:0090035	positive regulation of chaperone-mediated protein complex assembly	BP
2	2	3.3218233202	-	9.99e-03	GO:1904017	cellular response to Thyroglobulin triiodothyronine	BP
2	2	3.3218233202	-	9.99e-03	GO:1902170	cellular response to reactive nitrogen species	BP
2	2	3.3218233202	-	9.99e-03	GO:2000707	positive regulation of dense core granule biogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:0048340	paraxial mesoderm morphogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:0044839	cell cycle G2/M phase transition	BP
2	2	3.3218233202	-	9.99e-03	GO:2000017	positive regulation of determination of dorsal identity	BP
2	2	3.3218233202	-	9.99e-03	GO:0003057	regulation of the force of heart contraction by chemical signal	BP
2	2	3.3218233202	-	9.99e-03	GO:0030221	basophil differentiation	BP
2	2	3.3218233202	-	9.99e-03	GO:0060577	pulmonary vein morphogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:1902728	positive regulation of growth factor dependent skeletal muscle satellite cell proliferation	BP
2	2	3.3218233202	-	9.99e-03	GO:0007070	negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle	BP
2	2	3.3218233202	-	9.99e-03	GO:0002268	follicular dendritic cell differentiation	BP
2	2	3.3218233202	-	9.99e-03	GO:0038183	bile acid signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0060532	bronchus cartilage development	BP
2	2	3.3218233202	-	9.99e-03	GO:0090107	regulation of high-density lipoprotein particle assembly	BP
2	2	3.3218233202	-	9.99e-03	GO:1904674	positive regulation of somatic stem cell population maintenance	BP
2	2	3.3218233202	-	9.99e-03	GO:0060251	regulation of glial cell proliferation	BP
2	2	3.3218233202	-	9.99e-03	GO:1902595	regulation of DNA replication origin binding	BP
2	2	3.3218233202	-	9.99e-03	GO:0021514	ventral spinal cord interneuron differentiation	BP
2	2	3.3218233202	-	9.99e-03	GO:0003218	cardiac left ventricle formation	BP
2	2	3.3218233202	-	9.99e-03	GO:1990791	dorsal root ganglion development	BP
2	2	3.3218233202	-	9.99e-03	GO:0060977	coronary vasculature morphogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:0003160	endocardium morphogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:0003162	atrioventricular node development	BP
2	2	3.3218233202	-	9.99e-03	GO:0072368	regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter	BP
2	2	3.3218233202	-	9.99e-03	GO:0010559	regulation of glycoprotein biosynthetic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0060849	regulation of transcription involved in lymphatic endothelial cell fate commitment	BP
2	2	3.3218233202	-	9.99e-03	GO:0044027	hypermethylation of CpG island	BP
2	2	3.3218233202	-	9.99e-03	GO:0035854	eosinophil fate commitment	BP
2	2	3.3218233202	-	9.99e-03	GO:0086098	angiotensin-activated signaling pathway involved in heart process	BP
2	2	3.3218233202	-	9.99e-03	GO:0021897	forebrain astrocyte development	BP
2	2	3.3218233202	-	9.99e-03	GO:0071888	macrophage apoptotic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0060713	labyrinthine layer morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0090340	positive regulation of secretion of lysosomal enzymes	BP
1	1	3.3218233202	-	1.00e-01	GO:0006591	ornithine metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0099641	anterograde axonal protein transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0002458	peripheral T cell tolerance induction	BP
1	1	3.3218233202	-	1.00e-01	GO:0061670	evoked neurotransmitter secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0090341	negative regulation of secretion of lysosomal enzymes	BP
1	1	3.3218233202	-	1.00e-01	GO:1903533	regulation of protein targeting	BP
1	1	3.3218233202	-	1.00e-01	GO:0002333	transitional one stage B cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000108	positive regulation of leukocyte apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:2000103	positive regulation of mammary stem cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0050812	regulation of acyl-CoA biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0061085	regulation of histone H3-K27 methylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0046671	negative regulation of retinal cell programmed cell death	BP
1	1	3.3218233202	-	1.00e-01	GO:1903988	ferrous iron export across plasma membrane	BP
1	1	3.3218233202	-	1.00e-01	GO:0007344	pronuclear fusion	BP
1	1	3.3218233202	-	1.00e-01	GO:0071357	cellular response to type I interferon	BP
1	1	3.3218233202	-	1.00e-01	GO:0071351	cellular response to interleukin-18	BP
1	1	3.3218233202	-	1.00e-01	GO:0086018	SA node cell to atrial cardiac muscle cell signaling	BP
1	1	3.3218233202	-	1.00e-01	GO:1904899	positive regulation of hepatic stellate cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1902396	protein localization to bicellular tight junction	BP
1	1	3.3218233202	-	1.00e-01	GO:1902253	regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	1	3.3218233202	-	1.00e-01	GO:1902251	negative regulation of erythrocyte apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0051238	sequestering of metal ion	BP
1	1	3.3218233202	-	1.00e-01	GO:0010714	positive regulation of collagen metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0046824	positive regulation of nucleocytoplasmic transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0019677	NAD catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0019676	ammonia assimilation cycle	BP
1	1	3.3218233202	-	1.00e-01	GO:1901135	carbohydrate derivative metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0061326	renal tubule development	BP
1	1	3.3218233202	-	1.00e-01	GO:0061324	canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1903285	positive regulation of hydrogen peroxide catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1903284	positive regulation of glutathione peroxidase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0072615	interleukin-17 secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0051729	germline cell cycle switching, mitotic to meiotic cell cycle	BP
1	1	3.3218233202	-	1.00e-01	GO:2001229	negative regulation of response to gamma radiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0086052	membrane repolarization during SA node cell action potential	BP
1	1	3.3218233202	-	1.00e-01	GO:0034670	chemotaxis to arachidonic acid	BP
1	1	3.3218233202	-	1.00e-01	GO:1903002	positive regulation of lipid transport across blood brain barrier	BP
1	1	3.3218233202	-	1.00e-01	GO:0071387	cellular response to cortisol stimulus	BP
1	1	3.3218233202	-	1.00e-01	GO:0010522	regulation of calcium ion transport into cytosol	BP
1	1	3.3218233202	-	1.00e-01	GO:1904246	negative regulation of polynucleotide adenylyltransferase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0035790	platelet-derived growth factor receptor-alpha signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0042265	peptidyl-asparagine hydroxylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0003171	atrioventricular valve development	BP
1	1	3.3218233202	-	1.00e-01	GO:0003175	tricuspid valve development	BP
1	1	3.3218233202	-	1.00e-01	GO:0031935	regulation of chromatin silencing	BP
1	1	3.3218233202	-	1.00e-01	GO:2000723	negative regulation of cardiac vascular smooth muscle cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0038097	positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0045898	regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0070446	negative regulation of oligodendrocyte progenitor proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1901994	negative regulation of meiotic cell cycle phase transition	BP
1	1	3.3218233202	-	1.00e-01	GO:0060345	spleen trabecula formation	BP
1	1	3.3218233202	-	1.00e-01	GO:0043063	intercellular bridge organization	BP
1	1	3.3218233202	-	1.00e-01	GO:2000564	regulation of CD8-positive, alpha-beta T cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1904206	positive regulation of skeletal muscle hypertrophy	BP
1	1	3.3218233202	-	1.00e-01	GO:0042197	halogenated hydrocarbon metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0033184	positive regulation of histone ubiquitination	BP
1	1	3.3218233202	-	1.00e-01	GO:0031052	chromosome breakage	BP
1	1	3.3218233202	-	1.00e-01	GO:0031056	regulation of histone modification	BP
1	1	3.3218233202	-	1.00e-01	GO:1903788	positive regulation of glutathione biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0010021	amylopectin biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0032776	DNA methylation on cytosine	BP
1	1	3.3218233202	-	1.00e-01	GO:0043610	regulation of carbohydrate utilization	BP
1	1	3.3218233202	-	1.00e-01	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	1	3.3218233202	-	1.00e-01	GO:0003131	mesodermal-endodermal cell signaling	BP
1	1	3.3218233202	-	1.00e-01	GO:0003138	primary heart field specification	BP
1	1	3.3218233202	-	1.00e-01	GO:0044648	histone H3-K4 dimethylation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000764	positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:2000763	positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0061736	engulfment of target by autophagosome	BP
1	1	3.3218233202	-	1.00e-01	GO:1904998	negative regulation of leukocyte adhesion to arterial endothelial cell	BP
1	1	3.3218233202	-	1.00e-01	GO:1904992	positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1990859	cellular response to endothelin	BP
1	1	3.3218233202	-	1.00e-01	GO:0070407	oxidation-dependent protein catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0002840	regulation of T cell mediated immune response to tumor cell	BP
1	1	3.3218233202	-	1.00e-01	GO:0035711	T-helper 1 cell activation	BP
1	1	3.3218233202	-	1.00e-01	GO:0060594	mammary gland specification	BP
1	1	3.3218233202	-	1.00e-01	GO:0035037	sperm entry	BP
1	1	3.3218233202	-	1.00e-01	GO:0043371	negative regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0043375	CD8-positive, alpha-beta T cell lineage commitment	BP
1	1	3.3218233202	-	1.00e-01	GO:0032072	regulation of restriction endodeoxyribonuclease activity	BP
1	1	3.3218233202	-	1.00e-01	GO:1904404	response to formaldehyde	BP
1	1	3.3218233202	-	1.00e-01	GO:0090096	positive regulation of metanephric cap mesenchymal cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1901628	positive regulation of postsynaptic membrane organization	BP
1	1	3.3218233202	-	1.00e-01	GO:0035505	positive regulation of myosin light chain kinase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0043990	histone H2A-S1 phosphorylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0003032	detection of oxygen	BP
1	1	3.3218233202	-	1.00e-01	GO:0060552	positive regulation of fructose 1,6-bisphosphate metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0060550	positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0060558	regulation of calcidiol 1-monooxygenase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:1904828	positive regulation of hydrogen sulfide biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0072141	renal interstitial fibroblast development	BP
1	1	3.3218233202	-	1.00e-01	GO:0018885	carbon tetrachloride metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1990774	tumor necrosis factor secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0000117	regulation of transcription involved in G2/M transition of mitotic cell cycle	BP
1	1	3.3218233202	-	1.00e-01	GO:1900134	negative regulation of renin secretion into blood stream	BP
1	1	3.3218233202	-	1.00e-01	GO:0051695	actin filament uncapping	BP
1	1	3.3218233202	-	1.00e-01	GO:1904793	regulation of euchromatin binding	BP
1	1	3.3218233202	-	1.00e-01	GO:0060517	epithelial cell proliferation involved in prostatic bud elongation	BP
1	1	3.3218233202	-	1.00e-01	GO:0097698	telomere maintenance via base-excision repair	BP
1	1	3.3218233202	-	1.00e-01	GO:0097343	ripoptosome assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0021881	Wnt-activated signaling pathway involved in forebrain neuron fate commitment	BP
1	1	3.3218233202	-	1.00e-01	GO:0051248	negative regulation of protein metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0051249	regulation of lymphocyte activation	BP
1	1	3.3218233202	-	1.00e-01	GO:0010768	negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	1	3.3218233202	-	1.00e-01	GO:0010481	epidermal cell division	BP
1	1	3.3218233202	-	1.00e-01	GO:2000173	negative regulation of branching morphogenesis of a nerve	BP
1	1	3.3218233202	-	1.00e-01	GO:0097101	blood vessel endothelial cell fate specification	BP
1	1	3.3218233202	-	1.00e-01	GO:0060709	glycogen cell differentiation involved in embryonic placenta development	BP
1	1	3.3218233202	-	1.00e-01	GO:0060700	regulation of ribonuclease activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0051866	general adaptation syndrome	BP
1	1	3.3218233202	-	1.00e-01	GO:1903376	regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1905000	regulation of membrane repolarization during atrial cardiac muscle cell action potential	BP
1	1	3.3218233202	-	1.00e-01	GO:2000612	regulation of thyroid-stimulating hormone secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0021572	rhombomere 6 development	BP
1	1	3.3218233202	-	1.00e-01	GO:0071301	cellular response to vitamin B1	BP
1	1	3.3218233202	-	1.00e-01	GO:0051651	maintenance of location in cell	BP
1	1	3.3218233202	-	1.00e-01	GO:0033233	regulation of protein sumoylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0048561	establishment of animal organ orientation	BP
1	1	3.3218233202	-	1.00e-01	GO:0086027	AV node cell to bundle of His cell signaling	BP
1	1	3.3218233202	-	1.00e-01	GO:0006117	acetaldehyde metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0003270	Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0006580	ethanolamine metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0006582	melanin metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0006638	neutral lipid metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0000296	spermine transport	BP
1	1	3.3218233202	-	1.00e-01	GO:1990442	intrinsic apoptotic signaling pathway in response to nitrosative stress	BP
1	1	3.3218233202	-	1.00e-01	GO:0035627	ceramide transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0035624	receptor transactivation	BP
1	1	3.3218233202	-	1.00e-01	GO:0036164	cell-abiotic substrate adhesion	BP
1	1	3.3218233202	-	1.00e-01	GO:0001743	optic placode formation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000794	regulation of epithelial cell proliferation involved in lung morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:2000793	cell proliferation involved in heart valve development	BP
1	1	3.3218233202	-	1.00e-01	GO:2000864	regulation of estradiol secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:1902068	regulation of sphingolipid mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0019089	transmission of virus	BP
1	1	3.3218233202	-	1.00e-01	GO:2000655	negative regulation of cellular response to testosterone stimulus	BP
1	1	3.3218233202	-	1.00e-01	GO:2000657	negative regulation of apolipoprotein binding	BP
1	1	3.3218233202	-	1.00e-01	GO:1904797	negative regulation of core promoter binding	BP
1	1	3.3218233202	-	1.00e-01	GO:0043402	glucocorticoid mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0061144	alveolar secondary septum development	BP
1	1	3.3218233202	-	1.00e-01	GO:0003144	embryonic heart tube formation	BP
1	1	3.3218233202	-	1.00e-01	GO:0072431	signal transduction involved in mitotic G1 DNA damage checkpoint	BP
1	1	3.3218233202	-	1.00e-01	GO:0003433	chondrocyte development involved in endochondral bone morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0010877	lipid transport involved in lipid storage	BP
1	1	3.3218233202	-	1.00e-01	GO:0036211	protein modification process	BP
1	1	3.3218233202	-	1.00e-01	GO:0099551	trans-synaptic signaling by neuropeptide, modulating synaptic transmission	BP
1	1	3.3218233202	-	1.00e-01	GO:0019478	D-amino acid catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0000433	negative regulation of transcription from RNA polymerase II promoter by glucose	BP
1	1	3.3218233202	-	1.00e-01	GO:0045685	regulation of glial cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0032462	regulation of protein homooligomerization	BP
1	1	3.3218233202	-	1.00e-01	GO:0060784	regulation of cell proliferation involved in tissue homeostasis	BP
1	1	3.3218233202	-	1.00e-01	GO:0072386	plus-end-directed organelle transport along microtubule	BP
1	1	3.3218233202	-	1.00e-01	GO:2001250	positive regulation of ammonia assimilation cycle	BP
1	1	3.3218233202	-	1.00e-01	GO:0072308	negative regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0090049	regulation of cell migration involved in sprouting angiogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0038161	prolactin signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0007440	foregut morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0060375	regulation of mast cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0001080	nitrogen catabolite activation of transcription from RNA polymerase II promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:1903034	regulation of response to wounding	BP
1	1	3.3218233202	-	1.00e-01	GO:0002509	central tolerance induction to self antigen	BP
1	1	3.3218233202	-	1.00e-01	GO:0061106	negative regulation of stomach neuroendocrine cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061107	seminal vesicle development	BP
1	1	3.3218233202	-	1.00e-01	GO:1903755	positive regulation of SUMO transferase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0044330	canonical Wnt signaling pathway involved in positive regulation of wound healing	BP
1	1	3.3218233202	-	1.00e-01	GO:0035409	histone H3-Y41 phosphorylation	BP
1	1	3.3218233202	-	1.00e-01	GO:1901189	positive regulation of ephrin receptor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1901186	positive regulation of ERBB signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0016046	detection of fungus	BP
1	1	3.3218233202	-	1.00e-01	GO:0070105	positive regulation of interleukin-6-mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:2001040	positive regulation of cellular response to drug	BP
1	1	3.3218233202	-	1.00e-01	GO:0014038	regulation of Schwann cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0043062	extracellular structure organization	BP
1	1	3.3218233202	-	1.00e-01	GO:1902303	negative regulation of potassium ion export	BP
1	1	3.3218233202	-	1.00e-01	GO:1904213	negative regulation of iodide transmembrane transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0043603	cellular amide metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0046725	negative regulation by virus of viral protein levels in host cell	BP
1	1	3.3218233202	-	1.00e-01	GO:2000753	positive regulation of glucosylceramide catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:2000755	positive regulation of sphingomyelin catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0086050	membrane repolarization during bundle of His cell action potential	BP
1	1	3.3218233202	-	1.00e-01	GO:0045844	positive regulation of striated muscle tissue development	BP
1	1	3.3218233202	-	1.00e-01	GO:0072303	positive regulation of glomerular metanephric mesangial cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061889	negative regulation of astrocyte activation	BP
1	1	3.3218233202	-	1.00e-01	GO:0070430	positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:2000256	positive regulation of male germ cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0060823	canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation	BP
1	1	3.3218233202	-	1.00e-01	GO:0048790	maintenance of presynaptic active zone structure	BP
1	1	3.3218233202	-	1.00e-01	GO:1905860	positive regulation of heparan sulfate proteoglycan binding	BP
1	1	3.3218233202	-	1.00e-01	GO:0002637	regulation of immunoglobulin production	BP
1	1	3.3218233202	-	1.00e-01	GO:0035042	fertilization, exchange of chromosomal proteins	BP
1	1	3.3218233202	-	1.00e-01	GO:0042766	nucleosome mobilization	BP
1	1	3.3218233202	-	1.00e-01	GO:0072110	glomerular mesangial cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0038002	endocrine signaling	BP
1	1	3.3218233202	-	1.00e-01	GO:0098759	cellular response to interleukin-8	BP
1	1	3.3218233202	-	1.00e-01	GO:0090085	regulation of protein deubiquitination	BP
1	1	3.3218233202	-	1.00e-01	GO:0061847	response to cholecystokinin	BP
1	1	3.3218233202	-	1.00e-01	GO:2000213	positive regulation of glutamate metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1904353	regulation of telomere capping	BP
1	1	3.3218233202	-	1.00e-01	GO:0061026	cardiac muscle tissue regeneration	BP
1	1	3.3218233202	-	1.00e-01	GO:0050703	interleukin-1 alpha secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0001544	initiation of primordial ovarian follicle growth	BP
1	1	3.3218233202	-	1.00e-01	GO:0001543	ovarian follicle rupture	BP
1	1	3.3218233202	-	1.00e-01	GO:1904168	negative regulation of thyroid hormone receptor activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0002778	antibacterial peptide production	BP
1	1	3.3218233202	-	1.00e-01	GO:1903464	negative regulation of mitotic cell cycle DNA replication	BP
1	1	3.3218233202	-	1.00e-01	GO:0010986	positive regulation of lipoprotein particle clearance	BP
1	1	3.3218233202	-	1.00e-01	GO:1905281	positive regulation of retrograde transport, endosome to Golgi	BP
1	1	3.3218233202	-	1.00e-01	GO:1903815	negative regulation of collecting lymphatic vessel constriction	BP
1	1	3.3218233202	-	1.00e-01	GO:0061550	cranial ganglion development	BP
1	1	3.3218233202	-	1.00e-01	GO:0009956	radial pattern formation	BP
1	1	3.3218233202	-	1.00e-01	GO:0048753	pigment granule organization	BP
1	1	3.3218233202	-	1.00e-01	GO:0070926	regulation of ATP:ADP antiporter activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0031441	negative regulation of mRNA 3'-end processing	BP
1	1	3.3218233202	-	1.00e-01	GO:0051595	response to methylglyoxal	BP
1	1	3.3218233202	-	1.00e-01	GO:0060730	regulation of intestinal epithelial structure maintenance	BP
1	1	3.3218233202	-	1.00e-01	GO:2001286	regulation of caveolin-mediated endocytosis	BP
1	1	3.3218233202	-	1.00e-01	GO:1905695	positive regulation of phosphatidic acid biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1905031	regulation of membrane repolarization during cardiac muscle cell action potential	BP
1	1	3.3218233202	-	1.00e-01	GO:0045407	positive regulation of interleukin-5 biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0034255	regulation of urea metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0050975	sensory perception of touch	BP
1	1	3.3218233202	-	1.00e-01	GO:0051622	negative regulation of norepinephrine uptake	BP
1	1	3.3218233202	-	1.00e-01	GO:0070846	Hsp90 deacetylation	BP
1	1	3.3218233202	-	1.00e-01	GO:1905208	negative regulation of cardiocyte differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0098749	cerebellar neuron development	BP
1	1	3.3218233202	-	1.00e-01	GO:0098746	fast, calcium ion-dependent exocytosis of neurotransmitter	BP
1	1	3.3218233202	-	1.00e-01	GO:0014805	smooth muscle adaptation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000410	regulation of thymocyte migration	BP
1	1	3.3218233202	-	1.00e-01	GO:0003205	cardiac chamber development	BP
1	1	3.3218233202	-	1.00e-01	GO:0035978	histone H2A-S139 phosphorylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0001923	B-1 B cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:1904501	positive regulation of chromatin-mediated maintenance of transcription	BP
1	1	3.3218233202	-	1.00e-01	GO:0030421	defecation	BP
1	1	3.3218233202	-	1.00e-01	GO:0003409	optic cup structural organization	BP
1	1	3.3218233202	-	1.00e-01	GO:0001710	mesodermal cell fate commitment	BP
1	1	3.3218233202	-	1.00e-01	GO:0036138	peptidyl-histidine hydroxylation	BP
1	1	3.3218233202	-	1.00e-01	GO:1900169	regulation of glucocorticoid mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1900163	positive regulation of phospholipid scramblase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0010905	negative regulation of UDP-glucose catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0070060	'de novo' actin filament nucleation	BP
1	1	3.3218233202	-	1.00e-01	GO:0086030	adrenergic receptor signaling pathway involved in cardiac muscle relaxation	BP
1	1	3.3218233202	-	1.00e-01	GO:0072010	glomerular epithelium development	BP
1	1	3.3218233202	-	1.00e-01	GO:0090132	epithelium migration	BP
1	1	3.3218233202	-	1.00e-01	GO:0043380	regulation of memory T cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0030656	regulation of vitamin metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0045014	negative regulation of transcription by glucose	BP
1	1	3.3218233202	-	1.00e-01	GO:0090425	acinar cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000317	negative regulation of T-helper 17 type immune response	BP
1	1	3.3218233202	-	1.00e-01	GO:0006343	establishment of chromatin silencing	BP
1	1	3.3218233202	-	1.00e-01	GO:0060127	prolactin secreting cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:2001031	positive regulation of cellular glucuronidation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000872	positive regulation of progesterone secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:1902073	positive regulation of hypoxia-inducible factor-1alpha signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1900085	negative regulation of peptidyl-tyrosine autophosphorylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0045932	negative regulation of muscle contraction	BP
1	1	3.3218233202	-	1.00e-01	GO:0086072	AV node cell-bundle of His cell adhesion involved in cell communication	BP
1	1	3.3218233202	-	1.00e-01	GO:0003226	right ventricular compact myocardium morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0002572	pro-T cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:1905890	regulation of cellular response to very-low-density lipoprotein particle stimulus	BP
1	1	3.3218233202	-	1.00e-01	GO:0021872	forebrain generation of neurons	BP
1	1	3.3218233202	-	1.00e-01	GO:0021870	Cajal-Retzius cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0002683	negative regulation of immune system process	BP
1	1	3.3218233202	-	1.00e-01	GO:0007499	ectoderm and mesoderm interaction	BP
1	1	3.3218233202	-	1.00e-01	GO:0100057	regulation of phenotypic switching by transcription from RNA polymerase II promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:0043012	regulation of fusion of sperm to egg plasma membrane	BP
1	1	3.3218233202	-	1.00e-01	GO:1902038	positive regulation of hematopoietic stem cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0042659	regulation of cell fate specification	BP
1	1	3.3218233202	-	1.00e-01	GO:0032848	negative regulation of cellular pH reduction	BP
1	1	3.3218233202	-	1.00e-01	GO:0060367	sagittal suture morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0060366	lambdoid suture morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0045977	positive regulation of mitotic cell cycle, embryonic	BP
1	1	3.3218233202	-	1.00e-01	GO:2000097	regulation of smooth muscle cell-matrix adhesion	BP
1	1	3.3218233202	-	1.00e-01	GO:0001840	neural plate development	BP
1	1	3.3218233202	-	1.00e-01	GO:0046016	positive regulation of transcription by glucose	BP
1	1	3.3218233202	-	1.00e-01	GO:1904268	positive regulation of Schwann cell chemotaxis	BP
1	1	3.3218233202	-	1.00e-01	GO:0061114	branching involved in pancreas morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:1903766	positive regulation of potassium ion export across plasma membrane	BP
1	1	3.3218233202	-	1.00e-01	GO:0044329	canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion	BP
1	1	3.3218233202	-	1.00e-01	GO:0044328	canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration	BP
1	1	3.3218233202	-	1.00e-01	GO:1902415	regulation of mRNA binding	BP
1	1	3.3218233202	-	1.00e-01	GO:2000979	positive regulation of forebrain neuron differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000977	regulation of forebrain neuron differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000971	negative regulation of detection of glucose	BP
1	1	3.3218233202	-	1.00e-01	GO:0099509	regulation of presynaptic cytosolic calcium ion concentration	BP
1	1	3.3218233202	-	1.00e-01	GO:1905337	positive regulation of aggrephagy	BP
1	1	3.3218233202	-	1.00e-01	GO:0071471	cellular response to non-ionic osmotic stress	BP
1	1	3.3218233202	-	1.00e-01	GO:2000703	negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061753	substrate localization to autophagosome	BP
1	1	3.3218233202	-	1.00e-01	GO:0031279	regulation of cyclase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0035622	intrahepatic bile duct development	BP
1	1	3.3218233202	-	1.00e-01	GO:0098597	observational learning	BP
1	1	3.3218233202	-	1.00e-01	GO:1905524	negative regulation of protein autoubiquitination	BP
1	1	3.3218233202	-	1.00e-01	GO:0003185	sinoatrial valve morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0060873	anterior semicircular canal development	BP
1	1	3.3218233202	-	1.00e-01	GO:0060872	semicircular canal development	BP
1	1	3.3218233202	-	1.00e-01	GO:0060875	lateral semicircular canal development	BP
1	1	3.3218233202	-	1.00e-01	GO:0046223	aflatoxin catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0048621	post-embryonic digestive tract morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0031644	regulation of neurological system process	BP
1	1	3.3218233202	-	1.00e-01	GO:1905643	positive regulation of DNA methylation	BP
1	1	3.3218233202	-	1.00e-01	GO:1905642	negative regulation of DNA methylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0001806	type IV hypersensitivity	BP
1	1	3.3218233202	-	1.00e-01	GO:1904197	positive regulation of granulosa cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1904193	negative regulation of cholangiocyte apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1904227	negative regulation of glycogen synthase activity, transferring glucose-1-phosphate	BP
1	1	3.3218233202	-	1.00e-01	GO:1904056	positive regulation of cholangiocyte proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0071206	establishment of protein localization to juxtaparanode region of axon	BP
1	1	3.3218233202	-	1.00e-01	GO:0060479	lung cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0046521	sphingoid catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0045870	positive regulation of single stranded viral RNA replication via double stranded DNA intermediate	BP
1	1	3.3218233202	-	1.00e-01	GO:1901978	positive regulation of cell cycle checkpoint	BP
1	1	3.3218233202	-	1.00e-01	GO:1901976	regulation of cell cycle checkpoint	BP
1	1	3.3218233202	-	1.00e-01	GO:0007529	establishment of synaptic specificity at neuromuscular junction	BP
1	1	3.3218233202	-	1.00e-01	GO:1905855	positive regulation of heparan sulfate binding	BP
1	1	3.3218233202	-	1.00e-01	GO:0070194	synaptonemal complex disassembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0035883	enteroendocrine cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0060004	reflex	BP
1	1	3.3218233202	-	1.00e-01	GO:2000191	regulation of fatty acid transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0051541	elastin metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0019102	male somatic sex determination	BP
1	1	3.3218233202	-	1.00e-01	GO:2000227	negative regulation of pancreatic A cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0043954	cellular component maintenance	BP
1	1	3.3218233202	-	1.00e-01	GO:1900117	regulation of execution phase of apoptosis	BP
1	1	3.3218233202	-	1.00e-01	GO:0060768	regulation of epithelial cell proliferation involved in prostate gland development	BP
1	1	3.3218233202	-	1.00e-01	GO:0002194	hepatocyte cell migration	BP
1	1	3.3218233202	-	1.00e-01	GO:2000050	regulation of non-canonical Wnt signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0060578	superior vena cava morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:1904800	negative regulation of neuron remodeling	BP
1	1	3.3218233202	-	1.00e-01	GO:0060681	branch elongation involved in ureteric bud branching	BP
1	1	3.3218233202	-	1.00e-01	GO:0071538	SH2 domain-mediated complex assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0016479	negative regulation of transcription from RNA polymerase I promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:1904635	positive regulation of glomerular visceral epithelial cell apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0072163	mesonephric epithelium development	BP
1	1	3.3218233202	-	1.00e-01	GO:0060217	hemangioblast cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:1901291	negative regulation of double-strand break repair via single-strand annealing	BP
1	1	3.3218233202	-	1.00e-01	GO:0090494	dopamine uptake	BP
1	1	3.3218233202	-	1.00e-01	GO:0051582	positive regulation of neurotransmitter uptake	BP
1	1	3.3218233202	-	1.00e-01	GO:0051585	negative regulation of dopamine uptake involved in synaptic transmission	BP
1	1	3.3218233202	-	1.00e-01	GO:1905689	positive regulation of diacylglycerol kinase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0038185	intracellular bile acid receptor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0090108	positive regulation of high-density lipoprotein particle assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0044111	development involved in symbiotic interaction	BP
1	1	3.3218233202	-	1.00e-01	GO:0003251	positive regulation of cell proliferation involved in heart valve morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0035967	cellular response to topologically incorrect protein	BP
1	1	3.3218233202	-	1.00e-01	GO:0032606	type I interferon production	BP
1	1	3.3218233202	-	1.00e-01	GO:1904677	positive regulation of somatic stem cell division	BP
1	1	3.3218233202	-	1.00e-01	GO:1901835	positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA	BP
1	1	3.3218233202	-	1.00e-01	GO:1904531	positive regulation of actin filament binding	BP
1	1	3.3218233202	-	1.00e-01	GO:0061395	positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance	BP
1	1	3.3218233202	-	1.00e-01	GO:0061394	regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance	BP
1	1	3.3218233202	-	1.00e-01	GO:0007403	glial cell fate determination	BP
1	1	3.3218233202	-	1.00e-01	GO:2000808	negative regulation of synaptic vesicle clustering	BP
1	1	3.3218233202	-	1.00e-01	GO:2000806	positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled	BP
1	1	3.3218233202	-	1.00e-01	GO:2000802	positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation	BP
1	1	3.3218233202	-	1.00e-01	GO:0030844	positive regulation of intermediate filament depolymerization	BP
1	1	3.3218233202	-	1.00e-01	GO:0050820	positive regulation of coagulation	BP
1	1	3.3218233202	-	1.00e-01	GO:0021515	cell differentiation in spinal cord	BP
1	1	3.3218233202	-	1.00e-01	GO:1905274	regulation of modification of postsynaptic actin cytoskeleton	BP
1	1	3.3218233202	-	1.00e-01	GO:0003213	cardiac right atrium morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0070512	positive regulation of histone H4-K20 methylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0043397	regulation of corticotropin-releasing hormone secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:1990654	sebum secreting cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1901297	positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment	BP
1	1	3.3218233202	-	1.00e-01	GO:0001971	negative regulation of activation of membrane attack complex	BP
1	1	3.3218233202	-	1.00e-01	GO:1905920	positive regulation of CoA-transferase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0000415	negative regulation of histone H3-K36 methylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0000414	regulation of histone H3-K36 methylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0000416	positive regulation of histone H3-K36 methylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0072599	establishment of protein localization to endoplasmic reticulum	BP
1	1	3.3218233202	-	1.00e-01	GO:0050865	regulation of cell activation	BP
1	1	3.3218233202	-	1.00e-01	GO:0002154	thyroid hormone mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0051884	regulation of timing of anagen	BP
1	1	3.3218233202	-	1.00e-01	GO:0061445	endocardial cushion cell fate commitment	BP
1	1	3.3218233202	-	1.00e-01	GO:1903010	regulation of bone development	BP
1	1	3.3218233202	-	1.00e-01	GO:0002561	basophil degranulation	BP
1	1	3.3218233202	-	1.00e-01	GO:0010517	regulation of phospholipase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0097090	presynaptic membrane organization	BP
1	1	3.3218233202	-	1.00e-01	GO:1903489	positive regulation of lactation	BP
1	1	3.3218233202	-	1.00e-01	GO:0043969	histone H2B acetylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0019627	urea metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0052547	regulation of peptidase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:1905344	prostaglandin catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1905341	negative regulation of protein localization to kinetochore	BP
1	1	3.3218233202	-	1.00e-01	GO:2000734	negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000739	regulation of mesenchymal stem cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0071440	regulation of histone H3-K14 acetylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0071441	negative regulation of histone H3-K14 acetylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061767	negative regulation of lung blood pressure	BP
1	1	3.3218233202	-	1.00e-01	GO:0010990	regulation of SMAD protein complex assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0072362	regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:0072363	regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:0072366	regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:0072365	regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:1902988	neurofibrillary tangle assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0098974	postsynaptic actin cytoskeleton organization	BP
1	1	3.3218233202	-	1.00e-01	GO:0010045	response to nickel cation	BP
1	1	3.3218233202	-	1.00e-01	GO:0051341	regulation of oxidoreductase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0045083	negative regulation of interleukin-12 biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0010034	response to acetate	BP
1	1	3.3218233202	-	1.00e-01	GO:1902426	deactivation of mitotic spindle assembly checkpoint	BP
1	1	3.3218233202	-	1.00e-01	GO:0032769	negative regulation of monooxygenase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0071873	response to norepinephrine	BP
1	1	3.3218233202	-	1.00e-01	GO:0071250	cellular response to nitrite	BP
1	1	3.3218233202	-	1.00e-01	GO:1904681	response to 3-methylcholanthrene	BP
1	1	3.3218233202	-	1.00e-01	GO:0070845	polyubiquitinated misfolded protein transport	BP
1	1	3.3218233202	-	1.00e-01	GO:1905305	negative regulation of cardiac myofibril assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0100002	negative regulation of protein kinase activity by protein phosphorylation	BP
1	1	3.3218233202	-	1.00e-01	GO:1901534	positive regulation of hematopoietic progenitor cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0000435	positive regulation of transcription from RNA polymerase II promoter by galactose	BP
1	1	3.3218233202	-	1.00e-01	GO:0043049	otic placode formation	BP
1	1	3.3218233202	-	1.00e-01	GO:0048370	lateral mesoderm formation	BP
1	1	3.3218233202	-	1.00e-01	GO:0032298	positive regulation of DNA-dependent DNA replication initiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0060844	arterial endothelial cell fate commitment	BP
1	1	3.3218233202	-	1.00e-01	GO:0060843	venous endothelial cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0098930	axonal transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0002875	negative regulation of chronic inflammatory response to antigenic stimulus	BP
1	1	3.3218233202	-	1.00e-01	GO:0045713	low-density lipoprotein particle receptor biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1904237	positive regulation of substrate-dependent cell migration, cell attachment to substrate	BP
1	1	3.3218233202	-	1.00e-01	GO:0034377	plasma lipoprotein particle assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0071211	protein targeting to vacuole involved in autophagy	BP
1	1	3.3218233202	-	1.00e-01	GO:1902870	negative regulation of amacrine cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:1902691	respiratory basal cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0003322	pancreatic A cell development	BP
1	1	3.3218233202	-	1.00e-01	GO:0018910	benzene metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0051531	NFAT protein import into nucleus	BP
1	1	3.3218233202	-	1.00e-01	GO:0060806	negative regulation of cell differentiation involved in embryonic placenta development	BP
1	1	3.3218233202	-	1.00e-01	GO:1901630	negative regulation of presynaptic membrane organization	BP
1	1	3.3218233202	-	1.00e-01	GO:0097198	histone H3-K36 trimethylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061040	female gonad morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0061046	regulation of branching involved in lung morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0007538	primary sex determination	BP
1	1	3.3218233202	-	1.00e-01	GO:2000683	regulation of cellular response to X-ray	BP
1	1	3.3218233202	-	1.00e-01	GO:2000685	positive regulation of cellular response to X-ray	BP
1	1	3.3218233202	-	1.00e-01	GO:0070377	negative regulation of ERK5 cascade	BP
1	1	3.3218233202	-	1.00e-01	GO:0072286	metanephric connecting tubule development	BP
1	1	3.3218233202	-	1.00e-01	GO:0061535	glutamate secretion, neurotransmission	BP
1	1	3.3218233202	-	1.00e-01	GO:0061534	gamma-aminobutyric acid secretion, neurotransmission	BP
1	1	3.3218233202	-	1.00e-01	GO:0014048	regulation of glutamate secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0032048	cardiolipin metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0035898	parathyroid hormone secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0060010	Sertoli cell fate commitment	BP
1	1	3.3218233202	-	1.00e-01	GO:2000184	positive regulation of progesterone biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0051570	regulation of histone H3-K9 methylation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000230	negative regulation of pancreatic stellate cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1901674	regulation of histone H3-K27 acetylation	BP
1	1	3.3218233202	-	1.00e-01	GO:1901675	negative regulation of histone H3-K27 acetylation	BP
1	1	3.3218233202	-	1.00e-01	GO:1900100	positive regulation of plasma cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0036306	embryonic heart tube elongation	BP
1	1	3.3218233202	-	1.00e-01	GO:0045799	positive regulation of chromatin assembly or disassembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0032535	regulation of cellular component size	BP
1	1	3.3218233202	-	1.00e-01	GO:0060566	positive regulation of DNA-templated transcription, termination	BP
1	1	3.3218233202	-	1.00e-01	GO:0060695	negative regulation of cholesterol transporter activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0060694	regulation of cholesterol transporter activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0060697	positive regulation of phospholipid catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0060691	epithelial cell maturation involved in salivary gland development	BP
1	1	3.3218233202	-	1.00e-01	GO:0022018	lateral ganglionic eminence cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0071529	cementum mineralization	BP
1	1	3.3218233202	-	1.00e-01	GO:1901475	pyruvate transmembrane transport	BP
1	1	3.3218233202	-	1.00e-01	GO:1903839	positive regulation of mRNA 3'-UTR binding	BP
1	1	3.3218233202	-	1.00e-01	GO:0010232	vascular transport	BP
1	1	3.3218233202	-	1.00e-01	GO:1901860	positive regulation of mitochondrial DNA metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1901863	positive regulation of muscle tissue development	BP
1	1	3.3218233202	-	1.00e-01	GO:0021894	cerebral cortex GABAergic interneuron development	BP
1	1	3.3218233202	-	1.00e-01	GO:0021763	subthalamic nucleus development	BP
1	1	3.3218233202	-	1.00e-01	GO:0033567	DNA replication, Okazaki fragment processing	BP
1	1	3.3218233202	-	1.00e-01	GO:0052047	interaction with other organism via secreted substance involved in symbiotic interaction	BP
1	1	3.3218233202	-	1.00e-01	GO:0009444	pyruvate oxidation	BP
1	1	3.3218233202	-	1.00e-01	GO:0002270	plasmacytoid dendritic cell activation	BP
1	1	3.3218233202	-	1.00e-01	GO:1902544	regulation of DNA N-glycosylase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:2000607	negative regulation of cell proliferation involved in mesonephros development	BP
1	1	3.3218233202	-	1.00e-01	GO:0007388	posterior compartment specification	BP
1	1	3.3218233202	-	1.00e-01	GO:0007387	anterior compartment pattern formation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061433	cellular response to caloric restriction	BP
1	1	3.3218233202	-	1.00e-01	GO:0060520	activation of prostate induction by androgen receptor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0045992	negative regulation of embryonic development	BP
1	1	3.3218233202	-	1.00e-01	GO:1905223	epicardium morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:1905224	clathrin-coated pit assembly	BP
7	7	3.3218233202	-	9.87e-08	GO:0004887	thyroid hormone receptor activity	MF
5	5	3.3218233202	-	9.94e-06	GO:0003708	retinoic acid receptor activity	MF
4	4	3.3218233202	-	9.96e-05	GO:0030375	thyroid hormone receptor coactivator activity	MF
3	3	3.3218233202	-	9.98e-04	GO:0045309	protein phosphorylated amino acid binding	MF
3	3	3.3218233202	-	9.98e-04	GO:0070644	vitamin D response element binding	MF
3	3	3.3218233202	-	9.98e-04	GO:0019826	oxygen sensor activity	MF
3	3	3.3218233202	-	9.98e-04	GO:0001161	intronic transcription regulatory region sequence-specific DNA binding	MF
3	3	3.3218233202	-	9.98e-04	GO:0008384	IkappaB kinase activity	MF
3	3	3.3218233202	-	9.98e-04	GO:0004886	9-cis retinoic acid receptor activity	MF
3	3	3.3218233202	-	9.98e-04	GO:0050692	DBD domain binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0004666	prostaglandin-endoperoxide synthase activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0098531	transcription factor activity, direct ligand regulated sequence-specific DNA binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0038052	RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0031701	angiotensin receptor binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0032810	sterol response element binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0034212	peptide N-acetyltransferase activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0004874	aryl hydrocarbon receptor activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0042610	CD8 receptor binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0035403	histone kinase activity (H3-T6 specific)	MF
2	2	3.3218233202	-	9.99e-03	GO:0016890	site-specific endodeoxyribonuclease activity, specific for altered base	MF
2	2	3.3218233202	-	9.99e-03	GO:0034988	Fc-gamma receptor I complex binding	MF
2	2	3.3218233202	-	9.99e-03	GO:1990837	sequence-specific double-stranded DNA binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0035014	phosphatidylinositol 3-kinase regulator activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0001225	RNA polymerase II transcription coactivator binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0042903	tubulin deacetylase activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0050682	AF-2 domain binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0031762	follicle-stimulating hormone receptor binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0001025	RNA polymerase III transcription factor binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0031691	alpha-1A adrenergic receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:1990450	linear polyubiquitin binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0050649	testosterone 6-beta-hydroxylase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005477	pyruvate secondary active transmembrane transporter activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0008545	JUN kinase kinase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0052725	inositol-1,3,4-trisphosphate 6-kinase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0015068	glycine amidinotransferase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0016248	channel inhibitor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004955	prostaglandin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0038051	glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0001010	transcription factor activity, sequence-specific DNA binding transcription factor recruiting	MF
1	1	3.3218233202	-	1.00e-01	GO:0035033	histone deacetylase regulator activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0061507	cyclic-GMP-AMP binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0035501	MH1 domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0043997	histone acetyltransferase activity (H4-K12 specific)	MF
1	1	3.3218233202	-	1.00e-01	GO:0008434	calcitriol receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0036317	tyrosyl-RNA phosphodiesterase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0008116	prostaglandin-I synthase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0070853	myosin VI binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0070260	5'-tyrosyl-DNA phosphodiesterase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0016653	oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor	MF
1	1	3.3218233202	-	1.00e-01	GO:0036468	L-dopa decarboxylase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0001069	regulatory region RNA binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0070539	linoleic acid binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0001128	RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly	MF
1	1	3.3218233202	-	1.00e-01	GO:0061663	NEDD8 ligase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0016615	malate dehydrogenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0016231	beta-N-acetylglucosaminidase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0044377	RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending	MF
1	1	3.3218233202	-	1.00e-01	GO:0031962	mineralocorticoid receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0060175	brain-derived neurotrophic factor-activated receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0102798	heptaldehyde:oxygen oxidoreductase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0102797	geranial:oxygen oxidoreductase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0044213	intronic transcription regulatory region DNA binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0102113	hypoxia-inducible factor-asparagine oxygenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0097655	serpin family protein binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0035438	cyclic-di-GMP binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0000210	NAD+ diphosphatase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0035401	histone kinase activity (H3-Y41 specific)	MF
1	1	3.3218233202	-	1.00e-01	GO:0071855	neuropeptide receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0033780	taurochenodeoxycholate 6alpha-hydroxylase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0030504	inorganic diphosphate transmembrane transporter activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0000250	lanosterol synthase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005018	platelet-derived growth factor alpha-receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004058	aromatic-L-amino-acid decarboxylase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:1902122	chenodeoxycholic acid binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0030273	melanin-concentrating hormone receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0001587	Gq/11-coupled serotonin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0047402	protein-glucosylgalactosylhydroxylysine glucosidase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0008445	D-aspartate oxidase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:1990188	euchromatin binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0050429	calcium-dependent phospholipase C activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0031859	platelet activating factor receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0046970	NAD-dependent histone deacetylase activity (H4-K16 specific)	MF
1	1	3.3218233202	-	1.00e-01	GO:0033204	ribonuclease P RNA binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0008106	alcohol dehydrogenase (NADP+) activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004361	glutaryl-CoA dehydrogenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0052726	inositol-1,3,4-trisphosphate 5-kinase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0030616	transforming growth factor beta receptor, common-partner cytoplasmic mediator activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004607	phosphatidylcholine-sterol O-acyltransferase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0061656	SUMO conjugating enzyme activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0036139	peptidyl-histidine dioxygenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0043739	G/U mismatch-specific uracil-DNA glycosylase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0047127	thiomorpholine-carboxylate dehydrogenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0043924	suramin binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0001133	RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0004876	complement component C3a receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0050591	quinine 3-monooxygenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0102166	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0102167	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0071820	N-box binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0031896	V2 vasopressin receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0032841	calcitonin binding	MF
1	1	3.3218233202	-	1.00e-01	GO:1990444	F-box domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0004729	oxygen-dependent protoporphyrinogen oxidase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004728	signal transducer, downstream of receptor, with protein tyrosine phosphatase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0070320	inward rectifier potassium channel inhibitor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0047638	albendazole monooxygenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0000990	transcription factor activity, core RNA polymerase binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0001226	RNA polymerase II transcription corepressor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0004883	glucocorticoid receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0001034	RNA polymerase III transcription factor activity, sequence-specific DNA binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0001595	angiotensin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0070361	mitochondrial light strand promoter anti-sense binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0070362	mitochondrial heavy strand promoter anti-sense binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0051427	hormone receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0034593	phosphatidylinositol bisphosphate phosphatase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0034040	lipid-transporting ATPase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0070975	FHA domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0070974	POU domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0070976	TIR domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0030226	apolipoprotein receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0047323	[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0047325	inositol tetrakisphosphate 1-kinase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0086087	voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization	MF
1	1	3.3218233202	-	1.00e-01	GO:0086082	cell adhesive protein binding involved in AV node cell-bundle of His cell communication	MF
1	1	3.3218233202	-	1.00e-01	GO:0102571	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0015126	canalicular bile acid transmembrane transporter activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0050683	AF-1 domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0052835	inositol-3,4,6-trisphosphate 1-kinase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0052830	inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0052831	inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0038186	lithocholic acid receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0008829	dCTP deaminase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005133	interferon-gamma receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0036140	peptidyl-asparagine 3-dioxygenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0016639	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	MF
1	1	3.3218233202	-	1.00e-01	GO:0016964	alpha-2 macroglobulin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0102320	1,8-cineole 2-exo-monooxygenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0032093	SAM domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0008554	sodium-exporting ATPase activity, phosphorylative mechanism	MF
1	1	3.3218233202	-	1.00e-01	GO:0002153	steroid receptor RNA activator RNA binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0036403	arachidonate 8(S)-lipoxygenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004925	prolactin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0035642	histone methyltransferase activity (H3-R17 specific)	MF
1	1	3.3218233202	-	1.00e-01	GO:0010858	calcium-dependent protein kinase regulator activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0010855	adenylate cyclase inhibitor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0003908	methylated-DNA-[protein]-cysteine S-methyltransferase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0032448	DNA hairpin binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0035258	steroid hormone receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0098973	structural constituent of postsynaptic actin cytoskeleton	MF
1	1	3.3218233202	-	1.00e-01	GO:0099530	G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential	MF
1	1	3.3218233202	-	1.00e-01	GO:0019969	interleukin-10 binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0017168	5-oxoprolinase (ATP-hydrolyzing) activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0001642	group III metabotropic glutamate receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0050104	L-gulonate 3-dehydrogenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:1902121	lithocholic acid binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0035851	Krueppel-associated box domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0034039	8-oxo-7,8-dihydroguanine DNA N-glycosylase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0046911	metal chelating activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0070611	histone methyltransferase activity (H3-R2 specific)	MF
1	1	3.3218233202	-	1.00e-01	GO:0070612	histone methyltransferase activity (H2A-R3 specific)	MF
1	1	3.3218233202	-	1.00e-01	GO:0070615	nucleosome-dependent ATPase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0086090	voltage-gated potassium channel activity involved in SA node cell action potential repolarization	MF
1	1	3.3218233202	-	1.00e-01	GO:0097689	iron channel activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0052825	inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005140	interleukin-9 receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0005141	interleukin-10 receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0035594	ganglioside binding	MF
1	1	3.3218233202	-	1.00e-01	GO:1902098	calcitriol binding	MF
34	36	3.23936116001	-	1.33e-11	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	MF
15	16	3.22871391581	-	3.99e-11	GO:0046965	retinoid X receptor binding	MF
9	10	3.16982022676	-	8.90e-09	GO:0000338	protein deneddylation	BP
35	39	3.16570411828	-	9.37e-11	GO:0030522	intracellular receptor signaling pathway	BP
16	18	3.15189831876	-	4.79e-12	GO:0045653	negative regulation of megakaryocyte differentiation	BP
24	27	3.15189831876	-	2.90e-11	GO:0032200	telomere organization	BP
6	7	3.09943089886	-	6.34e-06	GO:0010870	positive regulation of receptor biosynthetic process	BP
6	7	3.09943089886	-	6.34e-06	GO:2000144	positive regulation of DNA-templated transcription, initiation	BP
5	6	3.05878891437	-	9.94e-06	GO:0010887	negative regulation of cholesterol storage	BP
5	6	3.05878891437	-	5.47e-05	GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
5	6	3.05878891437	-	5.47e-05	GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress	BP
5	6	3.05878891437	-	5.47e-05	GO:0060536	cartilage morphogenesis	BP
5	6	3.05878891437	-	5.47e-05	GO:0045084	positive regulation of interleukin-12 biosynthetic process	BP
5	6	3.05878891437	-	5.47e-05	GO:0050693	LBD domain binding	MF
44	53	3.05333448428	-	3.77e-11	GO:0003707	steroid hormone receptor activity	MF
26	32	3.02226303834	-	1.08e-10	GO:0006335	DNA replication-dependent nucleosome assembly	BP
30	37	3.01926055018	-	1.33e-11	GO:0000183	chromatin silencing at rDNA	BP
12	15	2.99989522531	-	3.27e-10	GO:0042809	vitamin D receptor binding	MF
4	5	2.99989522531	-	9.96e-05	GO:0060509	Type I pneumocyte differentiation	BP
4	5	2.99989522531	-	4.58e-04	GO:0060850	regulation of transcription involved in cell fate commitment	BP
4	5	2.99989522531	-	4.58e-04	GO:0070345	negative regulation of fat cell proliferation	BP
4	5	2.99989522531	-	4.58e-04	GO:0043550	regulation of lipid kinase activity	BP
4	5	2.99989522531	-	4.58e-04	GO:0051573	negative regulation of histone H3-K9 methylation	BP
8	10	2.99989522531	-	3.67e-07	GO:0033558	protein deacetylase activity	MF
8	10	2.99989522531	-	3.67e-07	GO:0042975	peroxisome proliferator activated receptor binding	MF
4	5	2.99989522531	-	4.58e-04	GO:0000975	regulatory region DNA binding	MF
4	5	2.99989522531	-	4.58e-04	GO:0051525	NFAT protein binding	MF
4	5	2.99989522531	-	4.58e-04	GO:0030235	nitric-oxide synthase regulator activity	MF
4	5	2.99989522531	-	4.58e-04	GO:0000988	transcription factor activity, protein binding	MF
41	53	2.95145487026	-	3.77e-11	GO:0043401	steroid hormone mediated signaling pathway	BP
16	21	2.92950589742	-	2.83e-11	GO:0016922	ligand-dependent nuclear receptor binding	MF
18	24	2.90678582092	-	3.12e-11	GO:0051403	stress-activated MAPK cascade	BP
12	16	2.90678582092	-	1.19e-09	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	BP
3	4	2.90678582092	-	9.98e-04	GO:0048550	negative regulation of pinocytosis	BP
3	4	2.90678582092	-	9.98e-04	GO:2001141	regulation of RNA biosynthetic process	BP
3	4	2.90678582092	-	9.98e-04	GO:0030641	regulation of cellular pH	BP
3	4	2.90678582092	-	9.98e-04	GO:0090309	positive regulation of methylation-dependent chromatin silencing	BP
3	4	2.90678582092	-	3.69e-03	GO:0090400	stress-induced premature senescence	BP
3	4	2.90678582092	-	3.69e-03	GO:0042159	lipoprotein catabolic process	BP
3	4	2.90678582092	-	3.69e-03	GO:0014044	Schwann cell development	BP
3	4	2.90678582092	-	3.69e-03	GO:0097300	programmed necrotic cell death	BP
3	4	2.90678582092	-	3.69e-03	GO:0061428	negative regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
3	4	2.90678582092	-	3.69e-03	GO:0035948	positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter	BP
3	4	2.90678582092	-	3.69e-03	GO:0045064	T-helper 2 cell differentiation	BP
3	4	2.90678582092	-	3.69e-03	GO:0002326	B cell lineage commitment	BP
3	4	2.90678582092	-	3.69e-03	GO:0060336	negative regulation of interferon-gamma-mediated signaling pathway	BP
3	4	2.90678582092	-	3.69e-03	GO:0007258	JUN phosphorylation	BP
3	4	2.90678582092	-	3.69e-03	GO:0032375	negative regulation of cholesterol transport	BP
3	4	2.90678582092	-	3.69e-03	GO:0098815	modulation of excitatory postsynaptic potential	BP
3	4	2.90678582092	-	3.69e-03	GO:0090170	regulation of Golgi inheritance	BP
3	4	2.90678582092	-	3.69e-03	GO:0061419	positive regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
3	4	2.90678582092	-	3.69e-03	GO:0003266	regulation of secondary heart field cardioblast proliferation	BP
3	4	2.90678582092	-	3.69e-03	GO:0006344	maintenance of chromatin silencing	BP
3	4	2.90678582092	-	3.69e-03	GO:0051098	regulation of binding	BP
3	4	2.90678582092	-	3.69e-03	GO:0060574	intestinal epithelial cell maturation	BP
3	4	2.90678582092	-	3.69e-03	GO:1904637	cellular response to ionomycin	BP
3	4	2.90678582092	-	3.69e-03	GO:0010957	negative regulation of vitamin D biosynthetic process	BP
3	4	2.90678582092	-	3.69e-03	GO:0003253	cardiac neural crest cell migration involved in outflow tract morphogenesis	BP
3	4	2.90678582092	-	3.69e-03	GO:0050798	activated T cell proliferation	BP
3	4	2.90678582092	-	3.69e-03	GO:0033158	regulation of protein import into nucleus, translocation	BP
3	4	2.90678582092	-	3.69e-03	GO:0060018	astrocyte fate commitment	BP
3	4	2.90678582092	-	3.69e-03	GO:0060528	secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development	BP
3	4	2.90678582092	-	3.69e-03	GO:0032909	regulation of transforming growth factor beta2 production	BP
9	12	2.90678582092	-	1.62e-07	GO:0042974	retinoic acid receptor binding	MF
3	4	2.90678582092	-	9.98e-04	GO:0034875	caffeine oxidase activity	MF
3	4	2.90678582092	-	9.98e-04	GO:0044323	retinoic acid-responsive element binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0001012	RNA polymerase II regulatory region DNA binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0070851	growth factor receptor binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0034056	estrogen response element binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0004971	AMPA glutamate receptor activity	MF
3	4	2.90678582092	-	3.69e-03	GO:0071535	RING-like zinc finger domain binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0043125	ErbB-3 class receptor binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0009008	DNA-methyltransferase activity	MF
3	4	2.90678582092	-	3.69e-03	GO:0004698	calcium-dependent protein kinase C activity	MF
3	4	2.90678582092	-	3.69e-03	GO:0044020	histone methyltransferase activity (H4-R3 specific)	MF
50	67	2.89959031952	-	4.04e-11	GO:0045652	regulation of megakaryocyte differentiation	BP
17	23	2.88572420539	-	1.15e-11	GO:0043044	ATP-dependent chromatin remodeling	BP
19	26	2.8693111155	-	1.18e-11	GO:0035035	histone acetyltransferase binding	MF
8	11	2.86239170156	-	3.67e-07	GO:0006476	protein deacetylation	BP
24	33	2.86239170156	-	1.08e-10	GO:0001104	RNA polymerase II transcription cofactor activity	MF
8	11	2.86239170156	-	1.23e-06	GO:0032041	NAD-dependent histone deacetylase activity (H3-K14 specific)	MF
8	11	2.86239170156	-	1.23e-06	GO:0070411	I-SMAD binding	MF
5	7	2.83639649303	-	1.76e-04	GO:0071499	cellular response to laminar fluid shear stress	BP
5	7	2.83639649303	-	1.76e-04	GO:0099565	chemical synaptic transmission, postsynaptic	BP
20	28	2.83639649303	-	6.70e-11	GO:0046966	thyroid hormone receptor binding	MF
32	45	2.82997022387	-	2.06e-11	GO:0031492	nucleosomal DNA binding	MF
30	43	2.80244916111	-	1.05e-10	GO:1904837	beta-catenin-TCF complex assembly	BP
34	49	2.79457631734	-	3.77e-11	GO:0045814	negative regulation of gene expression, epigenetic	BP
9	13	2.7913086035	-	4.81e-07	GO:0035259	glucocorticoid receptor binding	MF
11	16	2.78125493884	-	2.64e-09	GO:0048384	retinoic acid receptor signaling pathway	BP
11	16	2.78125493884	-	2.62e-08	GO:0030518	intracellular steroid hormone receptor signaling pathway	BP
13	19	2.7743355249	-	1.45e-09	GO:0051568	histone H3-K4 methylation	BP
15	22	2.76928229717	-	8.06e-11	GO:0035257	nuclear hormone receptor binding	MF
20	30	2.73686081948	-	2.41e-11	GO:0006352	DNA-templated transcription, initiation	BP
12	18	2.73686081948	-	1.00e-08	GO:0006337	nucleosome disassembly	BP
10	15	2.73686081948	-	1.82e-07	GO:0043923	positive regulation by host of viral transcription	BP
10	15	2.73686081948	-	1.82e-07	GO:2000679	positive regulation of transcription regulatory region DNA binding	BP
6	9	2.73686081948	-	2.32e-05	GO:0003208	cardiac ventricle morphogenesis	BP
4	6	2.73686081948	-	9.96e-05	GO:0009913	epidermal cell differentiation	BP
4	6	2.73686081948	-	4.58e-04	GO:0061469	regulation of type B pancreatic cell proliferation	BP
4	6	2.73686081948	-	1.27e-03	GO:0046321	positive regulation of fatty acid oxidation	BP
4	6	2.73686081948	-	1.27e-03	GO:1904798	positive regulation of core promoter binding	BP
4	6	2.73686081948	-	1.27e-03	GO:0003180	aortic valve morphogenesis	BP
4	6	2.73686081948	-	1.27e-03	GO:1903026	negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding	BP
4	6	2.73686081948	-	1.27e-03	GO:0071156	regulation of cell cycle arrest	BP
4	6	2.73686081948	-	1.27e-03	GO:0071218	cellular response to misfolded protein	BP
4	6	2.73686081948	-	1.27e-03	GO:0060440	trachea formation	BP
2	3	2.73686081948	-	9.99e-03	GO:1990418	response to insulin-like growth factor stimulus	BP
2	3	2.73686081948	-	9.99e-03	GO:0032732	positive regulation of interleukin-1 production	BP
2	3	2.73686081948	-	9.99e-03	GO:0001547	antral ovarian follicle growth	BP
2	3	2.73686081948	-	9.99e-03	GO:1903691	positive regulation of wound healing, spreading of epidermal cells	BP
2	3	2.73686081948	-	9.99e-03	GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	BP
2	3	2.73686081948	-	9.99e-03	GO:0060164	regulation of timing of neuron differentiation	BP
2	3	2.73686081948	-	9.99e-03	GO:0043585	nose morphogenesis	BP
2	3	2.73686081948	-	9.99e-03	GO:1900114	positive regulation of histone H3-K9 trimethylation	BP
2	3	2.73686081948	-	9.99e-03	GO:0060769	positive regulation of epithelial cell proliferation involved in prostate gland development	BP
2	3	2.73686081948	-	9.99e-03	GO:0010956	negative regulation of calcidiol 1-monooxygenase activity	BP
2	3	2.73686081948	-	9.99e-03	GO:2000381	negative regulation of mesoderm development	BP
2	3	2.73686081948	-	9.99e-03	GO:1901536	negative regulation of DNA demethylation	BP
2	3	2.73686081948	-	9.99e-03	GO:0071930	negative regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
2	3	2.73686081948	-	9.99e-03	GO:0071393	cellular response to progesterone stimulus	BP
2	3	2.73686081948	-	2.80e-02	GO:0034770	histone H4-K20 methylation	BP
2	3	2.73686081948	-	2.80e-02	GO:0055005	ventricular cardiac myofibril assembly	BP
2	3	2.73686081948	-	2.80e-02	GO:1902661	positive regulation of glucose mediated signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:1903984	positive regulation of TRAIL-activated apoptotic signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:0043415	positive regulation of skeletal muscle tissue regeneration	BP
2	3	2.73686081948	-	2.80e-02	GO:0006499	N-terminal protein myristoylation	BP
2	3	2.73686081948	-	2.80e-02	GO:1904030	negative regulation of cyclin-dependent protein kinase activity	BP
2	3	2.73686081948	-	2.80e-02	GO:0031937	positive regulation of chromatin silencing	BP
2	3	2.73686081948	-	2.80e-02	GO:0098904	regulation of AV node cell action potential	BP
2	3	2.73686081948	-	2.80e-02	GO:0098903	regulation of membrane repolarization during action potential	BP
2	3	2.73686081948	-	2.80e-02	GO:0046985	positive regulation of hemoglobin biosynthetic process	BP
2	3	2.73686081948	-	2.80e-02	GO:0061138	morphogenesis of a branching epithelium	BP
2	3	2.73686081948	-	2.80e-02	GO:0033590	response to cobalamin	BP
2	3	2.73686081948	-	2.80e-02	GO:0097720	calcineurin-mediated signaling	BP
2	3	2.73686081948	-	2.80e-02	GO:0060559	positive regulation of calcidiol 1-monooxygenase activity	BP
2	3	2.73686081948	-	2.80e-02	GO:0097061	dendritic spine organization	BP
2	3	2.73686081948	-	2.80e-02	GO:1901896	positive regulation of calcium-transporting ATPase activity	BP
2	3	2.73686081948	-	2.80e-02	GO:0089700	protein kinase D signaling	BP
2	3	2.73686081948	-	2.80e-02	GO:0072574	hepatocyte proliferation	BP
2	3	2.73686081948	-	2.80e-02	GO:0060748	tertiary branching involved in mammary gland duct morphogenesis	BP
2	3	2.73686081948	-	2.80e-02	GO:0021775	smoothened signaling pathway involved in ventral spinal cord interneuron specification	BP
2	3	2.73686081948	-	2.80e-02	GO:0021776	smoothened signaling pathway involved in spinal cord motor neuron cell fate specification	BP
2	3	2.73686081948	-	2.80e-02	GO:0045608	negative regulation of auditory receptor cell differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:2000820	negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:2000611	positive regulation of thyroid hormone generation	BP
2	3	2.73686081948	-	2.80e-02	GO:0070537	histone H2A K63-linked deubiquitination	BP
2	3	2.73686081948	-	2.80e-02	GO:0022898	regulation of transmembrane transporter activity	BP
2	3	2.73686081948	-	2.80e-02	GO:0045061	thymic T cell selection	BP
2	3	2.73686081948	-	2.80e-02	GO:2000138	positive regulation of cell proliferation involved in heart morphogenesis	BP
2	3	2.73686081948	-	2.80e-02	GO:0045925	positive regulation of female receptivity	BP
2	3	2.73686081948	-	2.80e-02	GO:0090258	negative regulation of mitochondrial fission	BP
2	3	2.73686081948	-	2.80e-02	GO:0035986	senescence-associated heterochromatin focus assembly	BP
2	3	2.73686081948	-	2.80e-02	GO:0000432	positive regulation of transcription from RNA polymerase II promoter by glucose	BP
2	3	2.73686081948	-	2.80e-02	GO:0090043	regulation of tubulin deacetylation	BP
2	3	2.73686081948	-	2.80e-02	GO:0038163	thrombopoietin-mediated signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:0046890	regulation of lipid biosynthetic process	BP
2	3	2.73686081948	-	2.80e-02	GO:1901026	ripoptosome assembly involved in necroptotic process	BP
2	3	2.73686081948	-	2.80e-02	GO:0031063	regulation of histone deacetylation	BP
2	3	2.73686081948	-	2.80e-02	GO:0019218	regulation of steroid metabolic process	BP
2	3	2.73686081948	-	2.80e-02	GO:1903421	regulation of synaptic vesicle recycling	BP
2	3	2.73686081948	-	2.80e-02	GO:0009912	auditory receptor cell fate commitment	BP
2	3	2.73686081948	-	2.80e-02	GO:0003340	negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
2	3	2.73686081948	-	2.80e-02	GO:0061614	pri-miRNA transcription from RNA polymerase II promoter	BP
2	3	2.73686081948	-	2.80e-02	GO:1902952	positive regulation of dendritic spine maintenance	BP
2	3	2.73686081948	-	2.80e-02	GO:0001922	B-1 B cell homeostasis	BP
2	3	2.73686081948	-	2.80e-02	GO:0072014	proximal tubule development	BP
2	3	2.73686081948	-	2.80e-02	GO:0032651	regulation of interleukin-1 beta production	BP
2	3	2.73686081948	-	2.80e-02	GO:0035633	maintenance of permeability of blood-brain barrier	BP
2	3	2.73686081948	-	2.80e-02	GO:0003199	endocardial cushion to mesenchymal transition involved in heart valve formation	BP
2	3	2.73686081948	-	2.80e-02	GO:0000189	MAPK import into nucleus	BP
2	3	2.73686081948	-	2.80e-02	GO:0032692	negative regulation of interleukin-1 production	BP
2	3	2.73686081948	-	2.80e-02	GO:1903721	positive regulation of I-kappaB phosphorylation	BP
2	3	2.73686081948	-	2.80e-02	GO:0060948	cardiac vascular smooth muscle cell development	BP
2	3	2.73686081948	-	2.80e-02	GO:0061309	cardiac neural crest cell development involved in outflow tract morphogenesis	BP
2	3	2.73686081948	-	2.80e-02	GO:1903025	regulation of RNA polymerase II regulatory region sequence-specific DNA binding	BP
2	3	2.73686081948	-	2.80e-02	GO:2000974	negative regulation of pro-B cell differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:0010829	negative regulation of glucose transport	BP
2	3	2.73686081948	-	2.80e-02	GO:0060297	regulation of sarcomere organization	BP
2	3	2.73686081948	-	2.80e-02	GO:0007176	regulation of epidermal growth factor-activated receptor activity	BP
2	3	2.73686081948	-	2.80e-02	GO:2000466	negative regulation of glycogen (starch) synthase activity	BP
2	3	2.73686081948	-	2.80e-02	GO:0035054	embryonic heart tube anterior/posterior pattern specification	BP
2	3	2.73686081948	-	2.80e-02	GO:0035880	embryonic nail plate morphogenesis	BP
2	3	2.73686081948	-	2.80e-02	GO:0043504	mitochondrial DNA repair	BP
2	3	2.73686081948	-	2.80e-02	GO:0035359	negative regulation of peroxisome proliferator activated receptor signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:0060729	intestinal epithelial structure maintenance	BP
2	3	2.73686081948	-	2.80e-02	GO:0003256	regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:2000345	regulation of hepatocyte proliferation	BP
2	3	2.73686081948	-	2.80e-02	GO:2000348	regulation of CD40 signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:2000111	positive regulation of macrophage apoptotic process	BP
2	3	2.73686081948	-	2.80e-02	GO:2001184	positive regulation of interleukin-12 secretion	BP
2	3	2.73686081948	-	2.80e-02	GO:2000630	positive regulation of miRNA metabolic process	BP
2	3	2.73686081948	-	2.80e-02	GO:0033152	immunoglobulin V(D)J recombination	BP
2	3	2.73686081948	-	2.80e-02	GO:0002520	immune system development	BP
2	3	2.73686081948	-	2.80e-02	GO:0071871	response to epinephrine	BP
2	3	2.73686081948	-	2.80e-02	GO:0010810	regulation of cell-substrate adhesion	BP
2	3	2.73686081948	-	2.80e-02	GO:0071409	cellular response to cycloheximide	BP
2	3	2.73686081948	-	2.80e-02	GO:0021697	cerebellar cortex formation	BP
2	3	2.73686081948	-	2.80e-02	GO:0034370	triglyceride-rich lipoprotein particle remodeling	BP
2	3	2.73686081948	-	2.80e-02	GO:1900222	negative regulation of amyloid-beta clearance	BP
2	3	2.73686081948	-	2.80e-02	GO:2000278	regulation of DNA biosynthetic process	BP
2	3	2.73686081948	-	2.80e-02	GO:0010621	negative regulation of transcription by transcription factor localization	BP
2	3	2.73686081948	-	2.80e-02	GO:0051572	negative regulation of histone H3-K4 methylation	BP
2	3	2.73686081948	-	2.80e-02	GO:0072717	cellular response to actinomycin D	BP
2	3	2.73686081948	-	2.80e-02	GO:0061577	calcium ion transmembrane transport via high voltage-gated calcium channel	BP
2	3	2.73686081948	-	2.80e-02	GO:1904645	response to amyloid-beta	BP
2	3	2.73686081948	-	2.80e-02	GO:2000297	negative regulation of synapse maturation	BP
2	3	2.73686081948	-	2.80e-02	GO:0090116	C-5 methylation of cytosine	BP
12	18	2.73686081948	-	1.19e-09	GO:0001190	transcriptional activator activity, RNA polymerase II transcription factor binding	MF
6	9	2.73686081948	-	6.37e-05	GO:0003680	AT DNA binding	MF
4	6	2.73686081948	-	1.27e-03	GO:0001221	transcription cofactor binding	MF
4	6	2.73686081948	-	1.27e-03	GO:0048273	mitogen-activated protein kinase p38 binding	MF
2	3	2.73686081948	-	9.99e-03	GO:0030369	ICAM-3 receptor activity	MF
2	3	2.73686081948	-	9.99e-03	GO:0050473	arachidonate 15-lipoxygenase activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0050816	phosphothreonine residue binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0086056	voltage-gated calcium channel activity involved in AV node cell action potential	MF
2	3	2.73686081948	-	2.80e-02	GO:0001093	TFIIB-class transcription factor binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0004705	JUN kinase activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0061628	H3K27me3 modified histone binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0019166	trans-2-enoyl-CoA reductase (NADPH) activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0035939	microsatellite binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0003886	DNA (cytosine-5-)-methyltransferase activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0097472	cyclin-dependent protein kinase activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0045322	unmethylated CpG binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0070095	fructose-6-phosphate binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0004882	androgen receptor activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0043120	tumor necrosis factor binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0043398	HLH domain binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0004699	calcium-independent protein kinase C activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0031692	alpha-1B adrenergic receptor binding	MF
17	26	2.70884644331	-	1.18e-11	GO:0006336	DNA replication-independent nucleosome assembly	BP
15	23	2.70515195975	-	2.10e-10	GO:0000715	nucleotide-excision repair, DNA damage recognition	BP
11	17	2.69379209759	-	6.75e-08	GO:0042800	histone methyltransferase activity (H3-K4 specific)	MF
9	14	2.68439339959	-	4.81e-07	GO:0033147	negative regulation of intracellular estrogen receptor signaling pathway	BP
9	14	2.68439339959	-	1.23e-06	GO:0000983	transcription factor activity, RNA polymerase II core promoter sequence-specific	MF
7	11	2.66974662362	-	2.96e-06	GO:2000188	regulation of cholesterol homeostasis	BP
7	11	2.66974662362	-	9.01e-06	GO:0006473	protein acetylation	BP
7	11	2.66974662362	-	9.01e-06	GO:0030850	prostate gland development	BP
7	11	2.66974662362	-	2.26e-05	GO:0004707	MAP kinase activity	MF
5	8	2.64375141509	-	1.76e-04	GO:0060020	Bergmann glial cell differentiation	BP
5	8	2.64375141509	-	1.76e-04	GO:0035357	peroxisome proliferator activated receptor signaling pathway	BP
5	8	2.64375141509	-	4.29e-04	GO:0045348	positive regulation of MHC class II biosynthetic process	BP
5	8	2.64375141509	-	4.29e-04	GO:0018026	peptidyl-lysine monomethylation	BP
5	8	2.64375141509	-	4.29e-04	GO:0033598	mammary gland epithelial cell proliferation	BP
5	8	2.64375141509	-	4.29e-04	GO:0042753	positive regulation of circadian rhythm	BP
5	8	2.64375141509	-	4.29e-04	GO:0085020	protein K6-linked ubiquitination	BP
16	26	2.62138360206	-	1.85e-10	GO:0016233	telomere capping	BP
8	13	2.62138360206	-	1.23e-06	GO:0061029	eyelid development in camera-type eye	BP
8	13	2.62138360206	-	3.36e-06	GO:0010745	negative regulation of macrophage derived foam cell differentiation	BP
8	13	2.62138360206	-	3.36e-06	GO:2000273	positive regulation of receptor activity	BP
8	13	2.62138360206	-	3.36e-06	GO:0004535	poly(A)-specific ribonuclease activity	MF
27	44	2.61727920373	-	3.26e-11	GO:0051290	protein heterotetramerization	BP
92	150	2.61656658576	-	6.06e-11	GO:0006367	transcription initiation from RNA polymerase II promoter	BP
28	46	2.6056162862	-	2.06e-11	GO:0030521	androgen receptor signaling pathway	BP
12	20	2.58485772603	-	5.61e-08	GO:0070932	histone H3 deacetylation	BP
9	15	2.58485772603	-	2.79e-06	GO:0051571	positive regulation of histone H3-K4 methylation	BP
6	10	2.58485772603	-	6.37e-05	GO:1902894	negative regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
6	10	2.58485772603	-	1.46e-04	GO:0033148	positive regulation of intracellular estrogen receptor signaling pathway	BP
6	10	2.58485772603	-	1.46e-04	GO:0051247	positive regulation of protein metabolic process	BP
6	10	2.58485772603	-	1.46e-04	GO:0033235	positive regulation of protein sumoylation	BP
6	10	2.58485772603	-	1.46e-04	GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	BP
6	10	2.58485772603	-	1.46e-04	GO:0035067	negative regulation of histone acetylation	BP
3	5	2.58485772603	-	3.69e-03	GO:0045347	negative regulation of MHC class II biosynthetic process	BP
3	5	2.58485772603	-	3.69e-03	GO:0071557	histone H3-K27 demethylation	BP
3	5	2.58485772603	-	3.69e-03	GO:0003417	growth plate cartilage development	BP
3	5	2.58485772603	-	3.69e-03	GO:0072602	interleukin-4 secretion	BP
3	5	2.58485772603	-	3.69e-03	GO:0050996	positive regulation of lipid catabolic process	BP
3	5	2.58485772603	-	3.69e-03	GO:0043045	DNA methylation involved in embryo development	BP
3	5	2.58485772603	-	8.55e-03	GO:0007262	STAT protein import into nucleus	BP
3	5	2.58485772603	-	8.55e-03	GO:0036016	cellular response to interleukin-3	BP
3	5	2.58485772603	-	8.55e-03	GO:0018027	peptidyl-lysine dimethylation	BP
3	5	2.58485772603	-	8.55e-03	GO:0061734	parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization	BP
3	5	2.58485772603	-	8.55e-03	GO:0042158	lipoprotein biosynthetic process	BP
3	5	2.58485772603	-	8.55e-03	GO:0071599	otic vesicle development	BP
3	5	2.58485772603	-	8.55e-03	GO:1902749	regulation of cell cycle G2/M phase transition	BP
3	5	2.58485772603	-	8.55e-03	GO:0045063	T-helper 1 cell differentiation	BP
3	5	2.58485772603	-	8.55e-03	GO:0033132	negative regulation of glucokinase activity	BP
3	5	2.58485772603	-	8.55e-03	GO:0050847	progesterone receptor signaling pathway	BP
3	5	2.58485772603	-	8.55e-03	GO:0002634	regulation of germinal center formation	BP
3	5	2.58485772603	-	8.55e-03	GO:0030854	positive regulation of granulocyte differentiation	BP
3	5	2.58485772603	-	8.55e-03	GO:0072584	caveolin-mediated endocytosis	BP
3	5	2.58485772603	-	8.55e-03	GO:0071376	cellular response to corticotropin-releasing hormone stimulus	BP
3	5	2.58485772603	-	8.55e-03	GO:0090240	positive regulation of histone H4 acetylation	BP
3	5	2.58485772603	-	8.55e-03	GO:0010828	positive regulation of glucose transport	BP
3	5	2.58485772603	-	8.55e-03	GO:0038033	positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	BP
3	5	2.58485772603	-	8.55e-03	GO:0051583	dopamine uptake involved in synaptic transmission	BP
3	5	2.58485772603	-	8.55e-03	GO:0021861	forebrain radial glial cell differentiation	BP
3	5	2.58485772603	-	8.55e-03	GO:0051534	negative regulation of NFAT protein import into nucleus	BP
3	5	2.58485772603	-	8.55e-03	GO:0035519	protein K29-linked ubiquitination	BP
3	5	2.58485772603	-	8.55e-03	GO:0010626	negative regulation of Schwann cell proliferation	BP
3	5	2.58485772603	-	8.55e-03	GO:0042501	serine phosphorylation of STAT protein	BP
9	15	2.58485772603	-	1.23e-06	GO:0035326	enhancer binding	MF
9	15	2.58485772603	-	2.79e-06	GO:0004697	protein kinase C activity	MF
3	5	2.58485772603	-	3.69e-03	GO:0071558	histone demethylase activity (H3-K27 specific)	MF
3	5	2.58485772603	-	3.69e-03	GO:0061665	SUMO ligase activity	MF
3	5	2.58485772603	-	8.55e-03	GO:0030284	estrogen receptor activity	MF
3	5	2.58485772603	-	8.55e-03	GO:0010385	double-stranded methylated DNA binding	MF
3	5	2.58485772603	-	8.55e-03	GO:0046974	histone methyltransferase activity (H3-K9 specific)	MF
3	5	2.58485772603	-	8.55e-03	GO:0030618	transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity	MF
3	5	2.58485772603	-	8.55e-03	GO:0005231	excitatory extracellular ligand-gated ion channel activity	MF
3	5	2.58485772603	-	8.55e-03	GO:0043426	MRF binding	MF
29	49	2.56509447121	-	6.33e-11	GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	MF
13	22	2.5628314197	-	3.75e-09	GO:0030520	intracellular estrogen receptor signaling pathway	BP
10	17	2.55628857384	-	1.82e-07	GO:0021542	dentate gyrus development	BP
10	17	2.55628857384	-	1.82e-07	GO:0071375	cellular response to peptide hormone stimulus	BP
10	17	2.55628857384	-	1.82e-07	GO:0000987	core promoter proximal region sequence-specific DNA binding	MF
7	12	2.54421574154	-	4.96e-05	GO:0035635	entry of bacterium into host cell	BP
7	12	2.54421574154	-	4.96e-05	GO:0003198	epithelial to mesenchymal transition involved in endocardial cushion formation	BP
7	12	2.54421574154	-	4.96e-05	GO:0033160	positive regulation of protein import into nucleus, translocation	BP
25	43	2.53941475527	-	1.05e-10	GO:0050681	androgen receptor binding	MF
8	14	2.51446839814	-	1.23e-06	GO:0010875	positive regulation of cholesterol efflux	BP
8	14	2.51446839814	-	7.97e-06	GO:1903351	cellular response to dopamine	BP
8	14	2.51446839814	-	1.70e-05	GO:0060644	mammary gland epithelial cell differentiation	BP
4	7	2.51446839814	-	4.58e-04	GO:0060740	prostate gland epithelium morphogenesis	BP
4	7	2.51446839814	-	1.27e-03	GO:0071455	cellular response to hyperoxia	BP
4	7	2.51446839814	-	1.27e-03	GO:2000617	positive regulation of histone H3-K9 acetylation	BP
4	7	2.51446839814	-	1.27e-03	GO:0034983	peptidyl-lysine deacetylation	BP
4	7	2.51446839814	-	1.27e-03	GO:0034372	very-low-density lipoprotein particle remodeling	BP
4	7	2.51446839814	-	1.27e-03	GO:0051574	positive regulation of histone H3-K9 methylation	BP
4	7	2.51446839814	-	2.72e-03	GO:2000641	regulation of early endosome to late endosome transport	BP
4	7	2.51446839814	-	2.72e-03	GO:0019919	peptidyl-arginine methylation, to asymmetrical-dimethyl arginine	BP
4	7	2.51446839814	-	2.72e-03	GO:0042921	glucocorticoid receptor signaling pathway	BP
4	7	2.51446839814	-	2.72e-03	GO:0016458	gene silencing	BP
4	7	2.51446839814	-	2.72e-03	GO:0044321	response to leptin	BP
4	7	2.51446839814	-	2.72e-03	GO:0033601	positive regulation of mammary gland epithelial cell proliferation	BP
16	28	2.51446839814	-	4.12e-10	GO:0033613	activating transcription factor binding	MF
4	7	2.51446839814	-	1.27e-03	GO:0015280	ligand-gated sodium channel activity	MF
4	7	2.51446839814	-	2.72e-03	GO:0035242	protein-arginine omega-N asymmetric methyltransferase activity	MF
4	7	2.51446839814	-	2.72e-03	GO:0008469	histone-arginine N-methyltransferase activity	MF
9	16	2.49174832164	-	2.79e-06	GO:0016571	histone methylation	BP
10	18	2.47382641365	-	4.41e-07	GO:0042789	mRNA transcription from RNA polymerase II promoter	BP
5	9	2.47382641365	-	1.76e-04	GO:0003143	embryonic heart tube morphogenesis	BP
5	9	2.47382641365	-	8.86e-04	GO:0051146	striated muscle cell differentiation	BP
5	9	2.47382641365	-	8.86e-04	GO:0010944	negative regulation of transcription by competitive promoter binding	BP
40	72	2.47382641365	-	2.22e-11	GO:0000980	RNA polymerase II distal enhancer sequence-specific DNA binding	MF
5	9	2.47382641365	-	8.86e-04	GO:0017162	aryl hydrocarbon receptor binding	MF
11	20	2.45932684395	-	6.89e-07	GO:1902895	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
6	11	2.44735420229	-	1.46e-04	GO:2000036	regulation of stem cell population maintenance	BP
6	11	2.44735420229	-	2.93e-04	GO:0043276	anoikis	BP
6	11	2.44735420229	-	2.93e-04	GO:0031065	positive regulation of histone deacetylation	BP
6	11	2.44735420229	-	2.93e-04	GO:0060544	regulation of necroptotic process	BP
6	11	2.44735420229	-	1.46e-04	GO:0016407	acetyltransferase activity	MF
6	11	2.44735420229	-	2.93e-04	GO:0070410	co-SMAD binding	MF
14	26	2.42873852412	-	2.85e-08	GO:0043388	positive regulation of DNA binding	BP
7	13	2.42873852412	-	2.26e-05	GO:0051145	smooth muscle cell differentiation	BP
7	13	2.42873852412	-	9.82e-05	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	BP
21	39	2.42873852412	-	2.63e-11	GO:0001102	RNA polymerase II activating transcription factor binding	MF
57	106	2.4267928798	-	2.97e-11	GO:0042826	histone deacetylase binding	MF
153	286	2.41933982612	-	6.72e-11	GO:0008134	transcription factor binding	MF
8	15	2.41493272459	-	1.70e-05	GO:0001076	transcription factor activity, RNA polymerase II transcription factor binding	MF
8	15	2.41493272459	-	3.31e-05	GO:0070742	C2H2 zinc finger domain binding	MF
33	62	2.41202112917	-	4.76e-11	GO:0045815	positive regulation of gene expression, epigenetic	BP
9	17	2.40428548039	-	1.13e-05	GO:0035994	response to muscle stretch	BP
9	17	2.40428548039	-	5.81e-06	GO:0001223	transcription coactivator binding	MF
21	40	2.39221264809	-	2.63e-11	GO:0018024	histone-lysine N-methyltransferase activity	MF
12	23	2.38322386487	-	2.38e-07	GO:0070412	R-SMAD binding	MF
25	48	2.38071700925	-	1.05e-10	GO:0000976	transcription regulatory region sequence-specific DNA binding	MF
13	25	2.37840684857	-	1.99e-08	GO:0045648	positive regulation of erythrocyte differentiation	BP
32	62	2.36762700981	-	8.54e-11	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	BP
18	35	2.3624653047	-	7.75e-10	GO:0070491	repressing transcription factor binding	MF
19	37	2.36029746802	-	2.69e-10	GO:0070888	E-box binding	MF
21	41	2.35658873836	-	9.37e-11	GO:0030331	estrogen receptor binding	MF
24	47	2.35219696924	-	3.65e-11	GO:0001046	core promoter sequence-specific DNA binding	MF
30	59	2.34607086645	-	5.99e-11	GO:0031490	chromatin DNA binding	MF
34	67	2.34319697099	-	2.64e-11	GO:0001047	core promoter binding	MF
27	54	2.3218233202	-	6.33e-11	GO:0006325	chromatin organization	BP
9	18	2.3218233202	-	1.13e-05	GO:0001892	embryonic placenta development	BP
7	14	2.3218233202	-	4.96e-05	GO:0031641	regulation of myelination	BP
7	14	2.3218233202	-	4.96e-05	GO:2000678	negative regulation of transcription regulatory region DNA binding	BP
5	10	2.3218233202	-	1.76e-04	GO:0048935	peripheral nervous system neuron development	BP
6	12	2.3218233202	-	2.93e-04	GO:0071498	cellular response to fluid shear stress	BP
6	12	2.3218233202	-	2.93e-04	GO:0060766	negative regulation of androgen receptor signaling pathway	BP
5	10	2.3218233202	-	4.29e-04	GO:0048096	chromatin-mediated maintenance of transcription	BP
5	10	2.3218233202	-	4.29e-04	GO:0060411	cardiac septum morphogenesis	BP
6	12	2.3218233202	-	5.37e-04	GO:0043149	stress fiber assembly	BP
5	10	2.3218233202	-	8.86e-04	GO:0000288	nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	BP
5	10	2.3218233202	-	8.86e-04	GO:0006515	misfolded or incompletely synthesized protein catabolic process	BP
5	10	2.3218233202	-	8.86e-04	GO:0003181	atrioventricular valve morphogenesis	BP
5	10	2.3218233202	-	8.86e-04	GO:0010954	positive regulation of protein processing	BP
5	10	2.3218233202	-	8.86e-04	GO:0034378	chylomicron assembly	BP
5	10	2.3218233202	-	8.86e-04	GO:0048715	negative regulation of oligodendrocyte differentiation	BP
3	6	2.3218233202	-	9.98e-04	GO:0016098	monoterpenoid metabolic process	BP
4	8	2.3218233202	-	1.27e-03	GO:0060736	prostate gland growth	BP
4	8	2.3218233202	-	1.27e-03	GO:0051152	positive regulation of smooth muscle cell differentiation	BP
5	10	2.3218233202	-	1.63e-03	GO:0031571	mitotic G1 DNA damage checkpoint	BP
5	10	2.3218233202	-	1.63e-03	GO:0042416	dopamine biosynthetic process	BP
5	10	2.3218233202	-	1.63e-03	GO:0051775	response to redox state	BP
4	8	2.3218233202	-	2.72e-03	GO:0034382	chylomicron remnant clearance	BP
4	8	2.3218233202	-	2.72e-03	GO:0003139	secondary heart field specification	BP
4	8	2.3218233202	-	2.72e-03	GO:0034393	positive regulation of smooth muscle cell apoptotic process	BP
4	8	2.3218233202	-	2.72e-03	GO:0001542	ovulation from ovarian follicle	BP
4	8	2.3218233202	-	2.72e-03	GO:0007183	SMAD protein complex assembly	BP
3	6	2.3218233202	-	3.69e-03	GO:0010694	positive regulation of alkaline phosphatase activity	BP
4	8	2.3218233202	-	5.01e-03	GO:0071550	death-inducing signaling complex assembly	BP
4	8	2.3218233202	-	5.01e-03	GO:0051569	regulation of histone H3-K4 methylation	BP
4	8	2.3218233202	-	5.01e-03	GO:0002467	germinal center formation	BP
4	8	2.3218233202	-	5.01e-03	GO:0045647	negative regulation of erythrocyte differentiation	BP
4	8	2.3218233202	-	5.01e-03	GO:0048143	astrocyte activation	BP
4	8	2.3218233202	-	5.01e-03	GO:0033129	positive regulation of histone phosphorylation	BP
4	8	2.3218233202	-	5.01e-03	GO:1901838	positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	BP
4	8	2.3218233202	-	5.01e-03	GO:1990000	amyloid fibril formation	BP
4	8	2.3218233202	-	5.01e-03	GO:2000774	positive regulation of cellular senescence	BP
4	8	2.3218233202	-	5.01e-03	GO:2000020	positive regulation of male gonad development	BP
3	6	2.3218233202	-	8.55e-03	GO:0034447	very-low-density lipoprotein particle clearance	BP
3	6	2.3218233202	-	8.55e-03	GO:0038092	nodal signaling pathway	BP
3	6	2.3218233202	-	8.55e-03	GO:0060992	response to fungicide	BP
3	6	2.3218233202	-	8.55e-03	GO:0002320	lymphoid progenitor cell differentiation	BP
3	6	2.3218233202	-	8.55e-03	GO:0046533	negative regulation of photoreceptor cell differentiation	BP
3	6	2.3218233202	-	8.55e-03	GO:0003406	retinal pigment epithelium development	BP
3	6	2.3218233202	-	8.55e-03	GO:0032792	negative regulation of CREB transcription factor activity	BP
3	6	2.3218233202	-	8.55e-03	GO:0032808	lacrimal gland development	BP
2	4	2.3218233202	-	9.99e-03	GO:0090403	oxidative stress-induced premature senescence	BP
2	4	2.3218233202	-	9.99e-03	GO:0042481	regulation of odontogenesis	BP
2	4	2.3218233202	-	9.99e-03	GO:0050994	regulation of lipid catabolic process	BP
3	6	2.3218233202	-	1.58e-02	GO:0051271	negative regulation of cellular component movement	BP
3	6	2.3218233202	-	1.58e-02	GO:0051101	regulation of DNA binding	BP
3	6	2.3218233202	-	1.58e-02	GO:0051444	negative regulation of ubiquitin-protein transferase activity	BP
3	6	2.3218233202	-	1.58e-02	GO:0090647	modulation of age-related behavioral decline	BP
3	6	2.3218233202	-	1.58e-02	GO:0010265	SCF complex assembly	BP
3	6	2.3218233202	-	1.58e-02	GO:2000288	positive regulation of myoblast proliferation	BP
3	6	2.3218233202	-	1.58e-02	GO:0060789	hair follicle placode formation	BP
3	6	2.3218233202	-	1.58e-02	GO:0051902	negative regulation of mitochondrial depolarization	BP
3	6	2.3218233202	-	1.58e-02	GO:0014033	neural crest cell differentiation	BP
3	6	2.3218233202	-	1.58e-02	GO:1903799	negative regulation of production of miRNAs involved in gene silencing by miRNA	BP
3	6	2.3218233202	-	1.58e-02	GO:1903140	regulation of establishment of endothelial barrier	BP
3	6	2.3218233202	-	1.58e-02	GO:1902231	positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
3	6	2.3218233202	-	1.58e-02	GO:0035897	proteolysis in other organism	BP
3	6	2.3218233202	-	1.58e-02	GO:1901016	regulation of potassium ion transmembrane transporter activity	BP
3	6	2.3218233202	-	1.58e-02	GO:0048667	cell morphogenesis involved in neuron differentiation	BP
3	6	2.3218233202	-	1.58e-02	GO:1900113	negative regulation of histone H3-K9 trimethylation	BP
3	6	2.3218233202	-	1.58e-02	GO:0006333	chromatin assembly or disassembly	BP
3	6	2.3218233202	-	1.58e-02	GO:0097242	amyloid-beta clearance	BP
3	6	2.3218233202	-	1.58e-02	GO:0061312	BMP signaling pathway involved in heart development	BP
3	6	2.3218233202	-	1.58e-02	GO:0051346	negative regulation of hydrolase activity	BP
3	6	2.3218233202	-	1.58e-02	GO:0038066	p38MAPK cascade	BP
3	6	2.3218233202	-	1.58e-02	GO:0043985	histone H4-R3 methylation	BP
2	4	2.3218233202	-	2.80e-02	GO:0060965	negative regulation of gene silencing by miRNA	BP
2	4	2.3218233202	-	2.80e-02	GO:0031936	negative regulation of chromatin silencing	BP
2	4	2.3218233202	-	2.80e-02	GO:0009987	cellular process	BP
2	4	2.3218233202	-	2.80e-02	GO:0070384	Harderian gland development	BP
2	4	2.3218233202	-	2.80e-02	GO:0060742	epithelial cell differentiation involved in prostate gland development	BP
2	4	2.3218233202	-	2.80e-02	GO:0070857	regulation of bile acid biosynthetic process	BP
2	4	2.3218233202	-	2.80e-02	GO:0070858	negative regulation of bile acid biosynthetic process	BP
2	4	2.3218233202	-	2.80e-02	GO:0034103	regulation of tissue remodeling	BP
2	4	2.3218233202	-	2.80e-02	GO:0007290	spermatid nucleus elongation	BP
2	4	2.3218233202	-	2.80e-02	GO:0071466	cellular response to xenobiotic stimulus	BP
2	4	2.3218233202	-	2.80e-02	GO:0072221	metanephric distal convoluted tubule development	BP
2	4	2.3218233202	-	2.80e-02	GO:2000757	negative regulation of peptidyl-lysine acetylation	BP
2	4	2.3218233202	-	2.80e-02	GO:0035886	vascular smooth muscle cell differentiation	BP
2	4	2.3218233202	-	2.80e-02	GO:0060571	morphogenesis of an epithelial fold	BP
2	4	2.3218233202	-	2.80e-02	GO:0035112	genitalia morphogenesis	BP
2	4	2.3218233202	-	2.80e-02	GO:0003257	positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation	BP
2	4	2.3218233202	-	5.23e-02	GO:0060263	regulation of respiratory burst	BP
2	4	2.3218233202	-	5.23e-02	GO:1902219	negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress	BP
2	4	2.3218233202	-	5.23e-02	GO:0071359	cellular response to dsRNA	BP
2	4	2.3218233202	-	5.23e-02	GO:0043201	response to leucine	BP
2	4	2.3218233202	-	5.23e-02	GO:0010523	negative regulation of calcium ion transport into cytosol	BP
2	4	2.3218233202	-	5.23e-02	GO:0003170	heart valve development	BP
2	4	2.3218233202	-	5.23e-02	GO:0046545	development of primary female sexual characteristics	BP
2	4	2.3218233202	-	5.23e-02	GO:0032369	negative regulation of lipid transport	BP
2	4	2.3218233202	-	5.23e-02	GO:0060669	embryonic placenta morphogenesis	BP
2	4	2.3218233202	-	5.23e-02	GO:1901203	positive regulation of extracellular matrix assembly	BP
2	4	2.3218233202	-	5.23e-02	GO:0071922	regulation of cohesin loading	BP
2	4	2.3218233202	-	5.23e-02	GO:0014042	positive regulation of neuron maturation	BP
2	4	2.3218233202	-	5.23e-02	GO:0032079	positive regulation of endodeoxyribonuclease activity	BP
2	4	2.3218233202	-	5.23e-02	GO:0042345	regulation of NF-kappaB import into nucleus	BP
2	4	2.3218233202	-	5.23e-02	GO:0051567	histone H3-K9 methylation	BP
2	4	2.3218233202	-	5.23e-02	GO:0002248	connective tissue replacement involved in inflammatory response wound healing	BP
2	4	2.3218233202	-	5.23e-02	GO:0045415	negative regulation of interleukin-8 biosynthetic process	BP
2	4	2.3218233202	-	5.23e-02	GO:0098779	positive regulation of mitophagy in response to mitochondrial depolarization	BP
2	4	2.3218233202	-	5.23e-02	GO:0060708	spongiotrophoblast differentiation	BP
2	4	2.3218233202	-	5.23e-02	GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:0007210	serotonin receptor signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:0010724	regulation of definitive erythrocyte differentiation	BP
2	4	2.3218233202	-	5.23e-02	GO:0007296	vitellogenesis	BP
2	4	2.3218233202	-	5.23e-02	GO:0042063	gliogenesis	BP
2	4	2.3218233202	-	5.23e-02	GO:0032376	positive regulation of cholesterol transport	BP
2	4	2.3218233202	-	5.23e-02	GO:0009750	response to fructose	BP
2	4	2.3218233202	-	5.23e-02	GO:1905867	epididymis development	BP
2	4	2.3218233202	-	5.23e-02	GO:0030035	microspike assembly	BP
2	4	2.3218233202	-	5.23e-02	GO:0060033	anatomical structure regression	BP
2	4	2.3218233202	-	5.23e-02	GO:0018393	internal peptidyl-lysine acetylation	BP
2	4	2.3218233202	-	5.23e-02	GO:0018394	peptidyl-lysine acetylation	BP
2	4	2.3218233202	-	5.23e-02	GO:0030910	olfactory placode formation	BP
2	4	2.3218233202	-	5.23e-02	GO:1990182	exosomal secretion	BP
2	4	2.3218233202	-	5.23e-02	GO:0070849	response to epidermal growth factor	BP
2	4	2.3218233202	-	5.23e-02	GO:0042992	negative regulation of transcription factor import into nucleus	BP
2	4	2.3218233202	-	5.23e-02	GO:0048386	positive regulation of retinoic acid receptor signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:1901797	negative regulation of signal transduction by p53 class mediator	BP
2	4	2.3218233202	-	5.23e-02	GO:1905244	regulation of modification of synaptic structure	BP
2	4	2.3218233202	-	5.23e-02	GO:0032925	regulation of activin receptor signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:0006642	triglyceride mobilization	BP
2	4	2.3218233202	-	5.23e-02	GO:2000664	positive regulation of interleukin-5 secretion	BP
2	4	2.3218233202	-	5.23e-02	GO:0060364	frontal suture morphogenesis	BP
2	4	2.3218233202	-	5.23e-02	GO:0018216	peptidyl-arginine methylation	BP
2	4	2.3218233202	-	5.23e-02	GO:0060430	lung saccule development	BP
2	4	2.3218233202	-	5.23e-02	GO:0010822	positive regulation of mitochondrion organization	BP
2	4	2.3218233202	-	5.23e-02	GO:0033600	negative regulation of mammary gland epithelial cell proliferation	BP
2	4	2.3218233202	-	5.23e-02	GO:0032042	mitochondrial DNA metabolic process	BP
2	4	2.3218233202	-	5.23e-02	GO:0043353	enucleate erythrocyte differentiation	BP
2	4	2.3218233202	-	5.23e-02	GO:0045833	negative regulation of lipid metabolic process	BP
2	4	2.3218233202	-	5.23e-02	GO:0010463	mesenchymal cell proliferation	BP
2	4	2.3218233202	-	5.23e-02	GO:0070836	caveola assembly	BP
2	4	2.3218233202	-	5.23e-02	GO:0021943	formation of radial glial scaffolds	BP
2	4	2.3218233202	-	5.23e-02	GO:0014878	response to electrical stimulus involved in regulation of muscle adaptation	BP
2	4	2.3218233202	-	5.23e-02	GO:0010748	negative regulation of plasma membrane long-chain fatty acid transport	BP
2	4	2.3218233202	-	5.23e-02	GO:0002051	osteoblast fate commitment	BP
2	4	2.3218233202	-	5.23e-02	GO:0032095	regulation of response to food	BP
2	4	2.3218233202	-	5.23e-02	GO:0010513	positive regulation of phosphatidylinositol biosynthetic process	BP
2	4	2.3218233202	-	5.23e-02	GO:0060355	positive regulation of cell adhesion molecule production	BP
2	4	2.3218233202	-	5.23e-02	GO:0014904	myotube cell development	BP
2	4	2.3218233202	-	5.23e-02	GO:0060842	arterial endothelial cell differentiation	BP
2	4	2.3218233202	-	5.23e-02	GO:0048679	regulation of axon regeneration	BP
2	4	2.3218233202	-	5.23e-02	GO:0072289	metanephric nephron tubule formation	BP
2	4	2.3218233202	-	5.23e-02	GO:2000189	positive regulation of cholesterol homeostasis	BP
2	4	2.3218233202	-	5.23e-02	GO:0060750	epithelial cell proliferation involved in mammary gland duct elongation	BP
2	4	2.3218233202	-	5.23e-02	GO:0051385	response to mineralocorticoid	BP
2	4	2.3218233202	-	5.23e-02	GO:0006990	positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response	BP
2	4	2.3218233202	-	5.23e-02	GO:0035910	ascending aorta morphogenesis	BP
2	4	2.3218233202	-	5.23e-02	GO:0021764	amygdala development	BP
2	4	2.3218233202	-	5.23e-02	GO:0010499	proteasomal ubiquitin-independent protein catabolic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0097152	mesenchymal cell apoptotic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0072079	nephron tubule formation	BP
1	2	2.3218233202	-	1.00e-01	GO:0070564	positive regulation of vitamin D receptor signaling pathway	BP
1	2	2.3218233202	-	1.00e-01	GO:0070171	negative regulation of tooth mineralization	BP
1	2	2.3218233202	-	1.00e-01	GO:1904762	positive regulation of myofibroblast differentiation	BP
1	2	2.3218233202	-	1.00e-01	GO:0032823	regulation of natural killer cell differentiation	BP
1	2	2.3218233202	-	1.00e-01	GO:0045720	negative regulation of integrin biosynthetic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0044381	glucose import in response to insulin stimulus	BP
1	2	2.3218233202	-	1.00e-01	GO:0033594	response to hydroxyisoflavone	BP
1	2	2.3218233202	-	1.00e-01	GO:0009786	regulation of asymmetric cell division	BP
1	2	2.3218233202	-	1.00e-01	GO:1903860	negative regulation of dendrite extension	BP
1	2	2.3218233202	-	1.00e-01	GO:1901899	positive regulation of relaxation of cardiac muscle	BP
1	2	2.3218233202	-	1.00e-01	GO:1901857	positive regulation of cellular respiration	BP
1	2	2.3218233202	-	1.00e-01	GO:0021882	regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment	BP
1	2	2.3218233202	-	1.00e-01	GO:0003415	chondrocyte hypertrophy	BP
1	2	2.3218233202	-	1.00e-01	GO:0007423	sensory organ development	BP
1	2	2.3218233202	-	1.00e-01	GO:0086029	Purkinje myocyte to ventricular cardiac muscle cell signaling	BP
1	2	2.3218233202	-	1.00e-01	GO:0099558	maintenance of synapse structure	BP
1	2	2.3218233202	-	1.00e-01	GO:0072190	ureter urothelium development	BP
1	2	2.3218233202	-	1.00e-01	GO:0030505	inorganic diphosphate transport	BP
1	2	2.3218233202	-	1.00e-01	GO:0035574	histone H4-K20 demethylation	BP
1	2	2.3218233202	-	1.00e-01	GO:0051136	regulation of NK T cell differentiation	BP
1	2	2.3218233202	-	1.00e-01	GO:0060460	left lung morphogenesis	BP
1	2	2.3218233202	-	1.00e-01	GO:0060738	epithelial-mesenchymal signaling involved in prostate gland development	BP
1	2	2.3218233202	-	1.00e-01	GO:1905206	positive regulation of hydrogen peroxide-induced cell death	BP
1	2	2.3218233202	-	1.00e-01	GO:0090362	positive regulation of platelet-derived growth factor production	BP
1	2	2.3218233202	-	1.00e-01	GO:0060900	embryonic camera-type eye formation	BP
1	2	2.3218233202	-	1.00e-01	GO:0010730	negative regulation of hydrogen peroxide biosynthetic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0060123	regulation of growth hormone secretion	BP
1	2	2.3218233202	-	1.00e-01	GO:0002684	positive regulation of immune system process	BP
1	2	2.3218233202	-	1.00e-01	GO:1902995	positive regulation of phospholipid efflux	BP
1	2	2.3218233202	-	1.00e-01	GO:0045976	negative regulation of mitotic cell cycle, embryonic	BP
1	2	2.3218233202	-	1.00e-01	GO:0021623	oculomotor nerve formation	BP
1	2	2.3218233202	-	1.00e-01	GO:0009063	cellular amino acid catabolic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0021985	neurohypophysis development	BP
1	2	2.3218233202	-	1.00e-01	GO:0042942	D-serine transport	BP
1	2	2.3218233202	-	1.00e-01	GO:0033082	regulation of extrathymic T cell differentiation	BP
1	2	2.3218233202	-	1.00e-01	GO:0097536	thymus epithelium morphogenesis	BP
1	2	2.3218233202	-	1.00e-01	GO:0006448	regulation of translational elongation	BP
1	2	2.3218233202	-	1.00e-01	GO:0030222	eosinophil differentiation	BP
1	2	2.3218233202	-	1.00e-01	GO:0072554	blood vessel lumenization	BP
1	2	2.3218233202	-	1.00e-01	GO:1900111	positive regulation of histone H3-K9 dimethylation	BP
1	2	2.3218233202	-	1.00e-01	GO:0001554	luteolysis	BP
1	2	2.3218233202	-	1.00e-01	GO:0014835	myoblast differentiation involved in skeletal muscle regeneration	BP
1	2	2.3218233202	-	1.00e-01	GO:1904639	cellular response to resveratrol	BP
1	2	2.3218233202	-	1.00e-01	GO:0035358	regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	2	2.3218233202	-	1.00e-01	GO:0021551	central nervous system morphogenesis	BP
1	2	2.3218233202	-	1.00e-01	GO:0021557	oculomotor nerve development	BP
1	2	2.3218233202	-	1.00e-01	GO:0021558	trochlear nerve development	BP
1	2	2.3218233202	-	1.00e-01	GO:0034165	positive regulation of toll-like receptor 9 signaling pathway	BP
1	2	2.3218233202	-	1.00e-01	GO:1903053	regulation of extracellular matrix organization	BP
1	2	2.3218233202	-	1.00e-01	GO:0009115	xanthine catabolic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0042595	behavioral response to starvation	BP
1	2	2.3218233202	-	1.00e-01	GO:0090187	positive regulation of pancreatic juice secretion	BP
1	2	2.3218233202	-	1.00e-01	GO:1903979	negative regulation of microglial cell activation	BP
1	2	2.3218233202	-	1.00e-01	GO:0032370	positive regulation of lipid transport	BP
1	2	2.3218233202	-	1.00e-01	GO:0031658	negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
1	2	2.3218233202	-	1.00e-01	GO:1902871	positive regulation of amacrine cell differentiation	BP
1	2	2.3218233202	-	1.00e-01	GO:1900224	positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	BP
1	2	2.3218233202	-	1.00e-01	GO:0035063	nuclear speck organization	BP
1	2	2.3218233202	-	1.00e-01	GO:0072560	type B pancreatic cell maturation	BP
1	2	2.3218233202	-	1.00e-01	GO:0009405	pathogenesis	BP
1	2	2.3218233202	-	1.00e-01	GO:0097681	double-strand break repair via alternative nonhomologous end joining	BP
1	2	2.3218233202	-	1.00e-01	GO:0021893	cerebral cortex GABAergic interneuron fate commitment	BP
1	2	2.3218233202	-	1.00e-01	GO:2000143	negative regulation of DNA-templated transcription, initiation	BP
1	2	2.3218233202	-	1.00e-01	GO:0002017	regulation of blood volume by renal aldosterone	BP
1	2	2.3218233202	-	1.00e-01	GO:0003241	growth involved in heart morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:1904528	positive regulation of microtubule binding	BP
1	2	2.3218233202	-	1.90e-01	GO:0045659	negative regulation of neutrophil differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0071109	superior temporal gyrus development	BP
1	2	2.3218233202	-	1.90e-01	GO:0097154	GABAergic neuron differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0006127	glycerophosphate shuttle	BP
1	2	2.3218233202	-	1.90e-01	GO:0070563	negative regulation of vitamin D receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:1902257	negative regulation of apoptotic process involved in outflow tract morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:2000628	regulation of miRNA metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0060928	atrioventricular node cell development	BP
1	2	2.3218233202	-	1.90e-01	GO:1904562	phosphatidylinositol 5-phosphate metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0001776	leukocyte homeostasis	BP
1	2	2.3218233202	-	1.90e-01	GO:0010652	positive regulation of cell communication by chemical coupling	BP
1	2	2.3218233202	-	1.90e-01	GO:0044565	dendritic cell proliferation	BP
1	2	2.3218233202	-	1.90e-01	GO:1904761	negative regulation of myofibroblast differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0060302	negative regulation of cytokine activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0042264	peptidyl-aspartic acid hydroxylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0021855	hypothalamus cell migration	BP
1	2	2.3218233202	-	1.90e-01	GO:0071453	cellular response to oxygen levels	BP
1	2	2.3218233202	-	1.90e-01	GO:0048320	axial mesoderm formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0038156	interleukin-3-mediated signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0043241	protein complex disassembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0098907	regulation of SA node cell action potential	BP
1	2	2.3218233202	-	1.90e-01	GO:0032368	regulation of lipid transport	BP
1	2	2.3218233202	-	1.90e-01	GO:0001869	negative regulation of complement activation, lectin pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0071650	negative regulation of chemokine (C-C motif) ligand 5 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0008627	intrinsic apoptotic signaling pathway in response to osmotic stress	BP
1	2	2.3218233202	-	1.90e-01	GO:0071417	cellular response to organonitrogen compound	BP
1	2	2.3218233202	-	1.90e-01	GO:0044818	mitotic G2/M transition checkpoint	BP
1	2	2.3218233202	-	1.90e-01	GO:0006742	NADP catabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:1905665	positive regulation of calcium ion import across plasma membrane	BP
1	2	2.3218233202	-	1.90e-01	GO:1905664	regulation of calcium ion import across plasma membrane	BP
1	2	2.3218233202	-	1.90e-01	GO:0010611	regulation of cardiac muscle hypertrophy	BP
1	2	2.3218233202	-	1.90e-01	GO:0071929	alpha-tubulin acetylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0021681	cerebellar granular layer development	BP
1	2	2.3218233202	-	1.90e-01	GO:0060599	lateral sprouting involved in mammary gland duct morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0097026	dendritic cell dendrite assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0060621	negative regulation of cholesterol import	BP
1	2	2.3218233202	-	1.90e-01	GO:0002032	desensitization of G-protein coupled receptor protein signaling pathway by arrestin	BP
1	2	2.3218233202	-	1.90e-01	GO:0007208	phospholipase C-activating serotonin receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0051445	regulation of meiotic cell cycle	BP
1	2	2.3218233202	-	1.90e-01	GO:0043370	regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0014041	regulation of neuron maturation	BP
1	2	2.3218233202	-	1.90e-01	GO:0014040	positive regulation of Schwann cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0032071	regulation of endodeoxyribonuclease activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0060025	regulation of synaptic activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0045819	positive regulation of glycogen catabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0061032	visceral serous pericardium development	BP
1	2	2.3218233202	-	1.90e-01	GO:0098989	NMDA selective glutamate receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:1902530	positive regulation of protein linear polyubiquitination	BP
1	2	2.3218233202	-	1.90e-01	GO:0036353	histone H2A-K119 monoubiquitination	BP
1	2	2.3218233202	-	1.90e-01	GO:0060557	positive regulation of vitamin D biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0065001	specification of axis polarity	BP
1	2	2.3218233202	-	1.90e-01	GO:0048259	regulation of receptor-mediated endocytosis	BP
1	2	2.3218233202	-	1.90e-01	GO:0043335	protein unfolding	BP
1	2	2.3218233202	-	1.90e-01	GO:0043331	response to dsRNA	BP
1	2	2.3218233202	-	1.90e-01	GO:0050432	catecholamine secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:1905426	positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:2000594	positive regulation of metanephric DCT cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:1900275	negative regulation of phospholipase C activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0046168	glycerol-3-phosphate catabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0048210	Golgi vesicle fusion to target membrane	BP
1	2	2.3218233202	-	1.90e-01	GO:1902746	regulation of lens fiber cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0090169	regulation of spindle assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0032957	inositol trisphosphate metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0010767	regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	2	2.3218233202	-	1.90e-01	GO:0036294	cellular response to decreased oxygen levels	BP
1	2	2.3218233202	-	1.90e-01	GO:0097107	postsynaptic density assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0035585	calcium-mediated signaling using extracellular calcium source	BP
1	2	2.3218233202	-	1.90e-01	GO:0007638	mechanosensory behavior	BP
1	2	2.3218233202	-	1.90e-01	GO:2000615	regulation of histone H3-K9 acetylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0021571	rhombomere 5 development	BP
1	2	2.3218233202	-	1.90e-01	GO:0072160	nephron tubule epithelial cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0071306	cellular response to vitamin E	BP
1	2	2.3218233202	-	1.90e-01	GO:0051650	establishment of vesicle localization	BP
1	2	2.3218233202	-	1.90e-01	GO:0086023	adrenergic receptor signaling pathway involved in heart process	BP
1	2	2.3218233202	-	1.90e-01	GO:0032915	positive regulation of transforming growth factor beta2 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0031393	negative regulation of prostaglandin biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0010727	negative regulation of hydrogen peroxide metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0003188	heart valve formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0034391	regulation of smooth muscle cell apoptotic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0034395	regulation of transcription from RNA polymerase II promoter in response to iron	BP
1	2	2.3218233202	-	1.90e-01	GO:1905908	positive regulation of amyloid fibril formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0032429	regulation of phospholipase A2 activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0045645	positive regulation of eosinophil differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0030862	positive regulation of polarized epithelial cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0010934	macrophage cytokine production	BP
1	2	2.3218233202	-	1.90e-01	GO:0046605	regulation of centrosome cycle	BP
1	2	2.3218233202	-	1.90e-01	GO:0048069	eye pigmentation	BP
1	2	2.3218233202	-	1.90e-01	GO:0072053	renal inner medulla development	BP
1	2	2.3218233202	-	1.90e-01	GO:0072054	renal outer medulla development	BP
1	2	2.3218233202	-	1.90e-01	GO:0086067	AV node cell to bundle of His cell communication	BP
1	2	2.3218233202	-	1.90e-01	GO:0071624	positive regulation of granulocyte chemotaxis	BP
1	2	2.3218233202	-	1.90e-01	GO:0045023	G0 to G1 transition	BP
1	2	2.3218233202	-	1.90e-01	GO:1905719	protein localization to perinuclear region of cytoplasm	BP
1	2	2.3218233202	-	1.90e-01	GO:0046831	regulation of RNA export from nucleus	BP
1	2	2.3218233202	-	1.90e-01	GO:0046833	positive regulation of RNA export from nucleus	BP
1	2	2.3218233202	-	1.90e-01	GO:0035669	TRAM-dependent toll-like receptor 4 signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0010874	regulation of cholesterol efflux	BP
1	2	2.3218233202	-	1.90e-01	GO:0099553	trans-synaptic signaling by endocannabinoid, modulating synaptic transmission	BP
1	2	2.3218233202	-	1.90e-01	GO:1905366	negative regulation of intralumenal vesicle formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0045355	negative regulation of interferon-alpha biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0000430	regulation of transcription from RNA polymerase II promoter by glucose	BP
1	2	2.3218233202	-	1.90e-01	GO:0045684	positive regulation of epidermis development	BP
1	2	2.3218233202	-	1.90e-01	GO:0030821	negative regulation of cAMP catabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0072305	negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0090045	positive regulation of deacetylase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0019046	release from viral latency	BP
1	2	2.3218233202	-	1.90e-01	GO:0019049	evasion or tolerance of host defenses by virus	BP
1	2	2.3218233202	-	1.90e-01	GO:1900078	positive regulation of cellular response to insulin stimulus	BP
1	2	2.3218233202	-	1.90e-01	GO:0045963	negative regulation of dopamine metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:1903038	negative regulation of leukocyte cell-cell adhesion	BP
1	2	2.3218233202	-	1.90e-01	GO:0048822	enucleate erythrocyte development	BP
1	2	2.3218233202	-	1.90e-01	GO:1903758	negative regulation of transcription from RNA polymerase II promoter by histone modification	BP
1	2	2.3218233202	-	1.90e-01	GO:0044334	canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition	BP
1	2	2.3218233202	-	1.90e-01	GO:0051284	positive regulation of sequestering of calcium ion	BP
1	2	2.3218233202	-	1.90e-01	GO:0021849	neuroblast division in subventricular zone	BP
1	2	2.3218233202	-	1.90e-01	GO:0070101	positive regulation of chemokine-mediated signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0072197	ureter morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0044869	negative regulation by host of viral exo-alpha-sialidase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0044860	protein localization to plasma membrane raft	BP
1	2	2.3218233202	-	1.90e-01	GO:0030997	regulation of centriole-centriole cohesion	BP
1	2	2.3218233202	-	1.90e-01	GO:0006542	glutamine biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0031061	negative regulation of histone methylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0035026	leading edge cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0035022	positive regulation of Rac protein signal transduction	BP
1	2	2.3218233202	-	1.90e-01	GO:1904049	negative regulation of spontaneous neurotransmitter secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:1903894	regulation of IRE1-mediated unfolded protein response	BP
1	2	2.3218233202	-	1.90e-01	GO:0086100	endothelin receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0007518	myoblast fate determination	BP
1	2	2.3218233202	-	1.90e-01	GO:0003062	regulation of heart rate by chemical signal	BP
1	2	2.3218233202	-	1.90e-01	GO:0003064	regulation of heart rate by hormone	BP
1	2	2.3218233202	-	1.90e-01	GO:0061188	negative regulation of chromatin silencing at rDNA	BP
1	2	2.3218233202	-	1.90e-01	GO:0060632	regulation of microtubule-based movement	BP
1	2	2.3218233202	-	1.90e-01	GO:0032701	negative regulation of interleukin-18 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0032707	negative regulation of interleukin-23 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0060032	notochord regression	BP
1	2	2.3218233202	-	1.90e-01	GO:1903382	negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0072738	cellular response to diamide	BP
1	2	2.3218233202	-	1.90e-01	GO:0060545	positive regulation of necroptotic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0060988	lipid tube assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0031444	slow-twitch skeletal muscle fiber contraction	BP
1	2	2.3218233202	-	1.90e-01	GO:2001288	positive regulation of caveolin-mediated endocytosis	BP
1	2	2.3218233202	-	1.90e-01	GO:0036493	positive regulation of translation in response to endoplasmic reticulum stress	BP
1	2	2.3218233202	-	1.90e-01	GO:0002730	regulation of dendritic cell cytokine production	BP
1	2	2.3218233202	-	1.90e-01	GO:0060502	epithelial cell proliferation involved in lung morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:1902957	negative regulation of mitochondrial electron transport, NADH to ubiquinone	BP
1	2	2.3218233202	-	1.90e-01	GO:0022037	metencephalon development	BP
1	2	2.3218233202	-	1.90e-01	GO:0014806	smooth muscle hyperplasia	BP
1	2	2.3218233202	-	1.90e-01	GO:0071506	cellular response to mycophenolic acid	BP
1	2	2.3218233202	-	1.90e-01	GO:0032615	interleukin-12 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0006601	creatine biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0045054	constitutive secretory pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0055025	positive regulation of cardiac muscle tissue development	BP
1	2	2.3218233202	-	1.90e-01	GO:0051252	regulation of RNA metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0001927	exocyst assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0003404	optic vesicle morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0048710	regulation of astrocyte differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0001712	ectodermal cell fate commitment	BP
1	2	2.3218233202	-	1.90e-01	GO:0010902	positive regulation of very-low-density lipoprotein particle remodeling	BP
1	2	2.3218233202	-	1.90e-01	GO:1903305	regulation of regulated secretory pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0002296	T-helper 1 cell lineage commitment	BP
1	2	2.3218233202	-	1.90e-01	GO:2000620	positive regulation of histone H4-K16 acetylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0052314	phytoalexin metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0090288	negative regulation of cellular response to growth factor stimulus	BP
1	2	2.3218233202	-	1.90e-01	GO:0046098	guanine metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0035441	cell migration involved in vasculogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0007206	phospholipase C-activating G-protein coupled glutamate receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0003195	tricuspid valve formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0003193	pulmonary valve formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0071163	DNA replication preinitiation complex assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0046619	optic placode formation involved in camera-type eye formation	BP
1	2	2.3218233202	-	1.90e-01	GO:2001202	negative regulation of transforming growth factor-beta secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0090071	negative regulation of ribosome biogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0071379	cellular response to prostaglandin stimulus	BP
1	2	2.3218233202	-	1.90e-01	GO:2000663	negative regulation of interleukin-5 secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:2000666	negative regulation of interleukin-13 secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0090241	negative regulation of histone H4 acetylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0014889	muscle atrophy	BP
1	2	2.3218233202	-	1.90e-01	GO:0001172	transcription, RNA-templated	BP
1	2	2.3218233202	-	1.90e-01	GO:0035407	histone H3-T11 phosphorylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0061153	trachea gland development	BP
1	2	2.3218233202	-	1.90e-01	GO:0021873	forebrain neuroblast division	BP
1	2	2.3218233202	-	1.90e-01	GO:0003156	regulation of animal organ formation	BP
1	2	2.3218233202	-	1.90e-01	GO:1904582	positive regulation of intracellular mRNA localization	BP
1	2	2.3218233202	-	1.90e-01	GO:0031959	mineralocorticoid receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0044324	regulation of transcription involved in anterior/posterior axis specification	BP
1	2	2.3218233202	-	1.90e-01	GO:0044091	membrane biogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0038179	neurotrophin signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0090209	negative regulation of triglyceride metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:1903027	regulation of opsonization	BP
1	2	2.3218233202	-	1.90e-01	GO:0002537	nitric oxide production involved in inflammatory response	BP
1	2	2.3218233202	-	1.90e-01	GO:2000397	positive regulation of ubiquitin-dependent endocytosis	BP
1	2	2.3218233202	-	1.90e-01	GO:2000978	negative regulation of forebrain neuron differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0060435	bronchiole development	BP
1	2	2.3218233202	-	1.90e-01	GO:0002643	regulation of tolerance induction	BP
1	2	2.3218233202	-	1.90e-01	GO:1903223	positive regulation of oxidative stress-induced neuron death	BP
1	2	2.3218233202	-	1.90e-01	GO:1902172	regulation of keratinocyte apoptotic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0071478	cellular response to radiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0035802	adrenal cortex formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0060086	circadian temperature homeostasis	BP
1	2	2.3218233202	-	1.90e-01	GO:0044871	negative regulation by host of viral glycoprotein metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0032805	positive regulation of low-density lipoprotein particle receptor catabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0021986	habenula development	BP
1	2	2.3218233202	-	1.90e-01	GO:1990051	activation of protein kinase C activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0051124	synaptic growth at neuromuscular junction	BP
1	2	2.3218233202	-	1.90e-01	GO:1904057	negative regulation of sensory perception of pain	BP
1	2	2.3218233202	-	1.90e-01	GO:0016577	histone demethylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0045872	positive regulation of rhodopsin gene expression	BP
1	2	2.3218233202	-	1.90e-01	GO:1900215	negative regulation of apoptotic process involved in metanephric collecting duct development	BP
1	2	2.3218233202	-	1.90e-01	GO:1900218	negative regulation of apoptotic process involved in metanephric nephron tubule development	BP
1	2	2.3218233202	-	1.90e-01	GO:0072318	clathrin coat disassembly	BP
1	2	2.3218233202	-	1.90e-01	GO:1904209	positive regulation of chemokine (C-C motif) ligand 2 secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0070427	nucleotide-binding oligomerization domain containing 1 signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0033604	negative regulation of catecholamine secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0048669	collateral sprouting in absence of injury	BP
1	2	2.3218233202	-	1.90e-01	GO:1905606	regulation of presynapse assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0007521	muscle cell fate determination	BP
1	2	2.3218233202	-	1.90e-01	GO:0071900	regulation of protein serine/threonine kinase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:2000016	negative regulation of determination of dorsal identity	BP
1	2	2.3218233202	-	1.90e-01	GO:0006808	regulation of nitrogen utilization	BP
1	2	2.3218233202	-	1.90e-01	GO:0033044	regulation of chromosome organization	BP
1	2	2.3218233202	-	1.90e-01	GO:1903849	positive regulation of aorta morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0035051	cardiocyte differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:1905448	positive regulation of mitochondrial ATP synthesis coupled electron transport	BP
1	2	2.3218233202	-	1.90e-01	GO:0003430	growth plate cartilage chondrocyte growth	BP
1	2	2.3218233202	-	1.90e-01	GO:0043503	skeletal muscle fiber adaptation	BP
1	2	2.3218233202	-	1.90e-01	GO:0045161	neuronal ion channel clustering	BP
1	2	2.3218233202	-	1.90e-01	GO:0051548	negative regulation of keratinocyte migration	BP
1	2	2.3218233202	-	1.90e-01	GO:0019100	male germ-line sex determination	BP
1	2	2.3218233202	-	1.90e-01	GO:1900110	negative regulation of histone H3-K9 dimethylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0060764	cell-cell signaling involved in mammary gland development	BP
1	2	2.3218233202	-	1.90e-01	GO:0036337	Fas signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0072708	response to sorbitol	BP
1	2	2.3218233202	-	1.90e-01	GO:0072709	cellular response to sorbitol	BP
1	2	2.3218233202	-	1.90e-01	GO:0021599	abducens nerve formation	BP
1	2	2.3218233202	-	1.90e-01	GO:1902722	positive regulation of prolactin secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0090149	mitochondrial membrane fission	BP
1	2	2.3218233202	-	1.90e-01	GO:0044154	histone H3-K14 acetylation	BP
1	2	2.3218233202	-	1.90e-01	GO:2000426	negative regulation of apoptotic cell clearance	BP
1	2	2.3218233202	-	1.90e-01	GO:1901407	regulation of phosphorylation of RNA polymerase II C-terminal domain	BP
1	2	2.3218233202	-	1.90e-01	GO:0035922	foramen ovale closure	BP
1	2	2.3218233202	-	1.90e-01	GO:0043313	regulation of neutrophil degranulation	BP
1	2	2.3218233202	-	1.90e-01	GO:0032227	negative regulation of synaptic transmission, dopaminergic	BP
1	2	2.3218233202	-	1.90e-01	GO:0045624	positive regulation of T-helper cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0031134	sister chromatid biorientation	BP
1	2	2.3218233202	-	1.90e-01	GO:0034243	regulation of transcription elongation from RNA polymerase II promoter	BP
1	2	2.3218233202	-	1.90e-01	GO:0032972	regulation of muscle filament sliding speed	BP
1	2	2.3218233202	-	1.90e-01	GO:0000720	pyrimidine dimer repair by nucleotide-excision repair	BP
1	2	2.3218233202	-	1.90e-01	GO:2000342	negative regulation of chemokine (C-X-C motif) ligand 2 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0035397	helper T cell enhancement of adaptive immune response	BP
1	2	2.3218233202	-	1.90e-01	GO:0061647	histone H3-K9 modification	BP
1	2	2.3218233202	-	1.90e-01	GO:0051012	microtubule sliding	BP
1	2	2.3218233202	-	1.90e-01	GO:0016185	synaptic vesicle budding from presynaptic endocytic zone membrane	BP
1	2	2.3218233202	-	1.90e-01	GO:1900195	positive regulation of oocyte maturation	BP
1	2	2.3218233202	-	1.90e-01	GO:0071322	cellular response to carbohydrate stimulus	BP
1	2	2.3218233202	-	1.90e-01	GO:0086001	cardiac muscle cell action potential	BP
1	2	2.3218233202	-	1.90e-01	GO:0051598	meiotic recombination checkpoint	BP
1	2	2.3218233202	-	1.90e-01	GO:0034728	nucleosome organization	BP
1	2	2.3218233202	-	1.90e-01	GO:0034721	histone H3-K4 demethylation, trimethyl-H3-K4-specific	BP
1	2	2.3218233202	-	1.90e-01	GO:0046068	cGMP metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0001976	neurological system process involved in regulation of systemic arterial blood pressure	BP
1	2	2.3218233202	-	1.90e-01	GO:2000309	positive regulation of tumor necrosis factor (ligand) superfamily member 11 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0014733	regulation of skeletal muscle adaptation	BP
1	2	2.3218233202	-	1.90e-01	GO:0014736	negative regulation of muscle atrophy	BP
1	2	2.3218233202	-	1.90e-01	GO:0002302	CD8-positive, alpha-beta T cell differentiation involved in immune response	BP
1	2	2.3218233202	-	1.90e-01	GO:2001023	regulation of response to drug	BP
1	2	2.3218233202	-	1.90e-01	GO:0034124	regulation of MyD88-dependent toll-like receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:2000845	positive regulation of testosterone secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0050867	positive regulation of cell activation	BP
1	2	2.3218233202	-	1.90e-01	GO:0043970	histone H3-K9 acetylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0043217	myelin maintenance	BP
1	2	2.3218233202	-	1.90e-01	GO:1903016	negative regulation of exo-alpha-sialidase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:1903019	negative regulation of glycoprotein metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0033484	nitric oxide homeostasis	BP
1	2	2.3218233202	-	1.90e-01	GO:1990619	histone H3-K9 deacetylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0061162	establishment of monopolar cell polarity	BP
1	2	2.3218233202	-	1.90e-01	GO:0031086	nuclear-transcribed mRNA catabolic process, deadenylation-independent decay	BP
1	2	2.3218233202	-	1.90e-01	GO:1902283	negative regulation of primary amine oxidase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0060978	angiogenesis involved in coronary vascular morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0003166	bundle of His development	BP
1	2	2.3218233202	-	1.90e-01	GO:0003169	coronary vein morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0031943	regulation of glucocorticoid metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0043006	activation of phospholipase A2 activity by calcium-mediated signaling	BP
1	2	2.3218233202	-	1.90e-01	GO:0048332	mesoderm morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0072369	regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter	BP
1	2	2.3218233202	-	1.90e-01	GO:0032834	positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response	BP
1	2	2.3218233202	-	1.90e-01	GO:0006711	estrogen catabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0003290	atrial septum secundum morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0061290	canonical Wnt signaling pathway involved in metanephric kidney development	BP
1	2	2.3218233202	-	1.90e-01	GO:0045082	positive regulation of interleukin-10 biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0018205	peptidyl-lysine modification	BP
1	2	2.3218233202	-	1.90e-01	GO:0032762	mast cell cytokine production	BP
1	2	2.3218233202	-	1.90e-01	GO:0032764	negative regulation of mast cell cytokine production	BP
1	2	2.3218233202	-	1.90e-01	GO:0071874	cellular response to norepinephrine stimulus	BP
1	2	2.3218233202	-	1.90e-01	GO:0071879	positive regulation of adrenergic receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0014015	positive regulation of gliogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0014908	myotube differentiation involved in skeletal muscle regeneration	BP
1	2	2.3218233202	-	1.90e-01	GO:2000779	regulation of double-strand break repair	BP
1	2	2.3218233202	-	1.90e-01	GO:2000777	positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia	BP
1	2	2.3218233202	-	1.90e-01	GO:1901532	regulation of hematopoietic progenitor cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0039003	pronephric field specification	BP
1	2	2.3218233202	-	1.90e-01	GO:0006286	base-excision repair, base-free sugar-phosphate removal	BP
1	2	2.3218233202	-	1.90e-01	GO:0006285	base-excision repair, AP site formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0048638	regulation of developmental growth	BP
1	2	2.3218233202	-	1.90e-01	GO:0052651	monoacylglycerol catabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0006568	tryptophan metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0060443	mammary gland morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:1905477	positive regulation of protein localization to membrane	BP
1	2	2.3218233202	-	1.90e-01	GO:0003329	pancreatic PP cell fate commitment	BP
1	2	2.3218233202	-	1.90e-01	GO:0003326	pancreatic A cell fate commitment	BP
1	2	2.3218233202	-	1.90e-01	GO:1900221	regulation of amyloid-beta clearance	BP
1	2	2.3218233202	-	1.90e-01	GO:0060717	chorion development	BP
1	2	2.3218233202	-	1.90e-01	GO:2000276	negative regulation of oxidative phosphorylation uncoupler activity	BP
1	2	2.3218233202	-	1.90e-01	GO:1904379	protein localization to cytosolic proteasome complex involved in ERAD pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0035511	oxidative DNA demethylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0050725	positive regulation of interleukin-1 beta biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0036344	platelet morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0070375	ERK5 cascade	BP
1	2	2.3218233202	-	1.90e-01	GO:0035728	response to hepatocyte growth factor	BP
1	2	2.3218233202	-	1.90e-01	GO:0097050	type B pancreatic cell apoptotic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0032986	protein-DNA complex disassembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0010899	regulation of phosphatidylcholine catabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0072134	nephrogenic mesenchyme morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0043516	regulation of DNA damage response, signal transduction by p53 class mediator	BP
1	2	2.3218233202	-	1.90e-01	GO:0019858	cytosine metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0046331	lateral inhibition	BP
1	2	2.3218233202	-	1.90e-01	GO:2000182	regulation of progesterone biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:1904338	regulation of dopaminergic neuron differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0036304	umbilical cord morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0086097	phospholipase C-activating angiotensin-activated signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0070828	heterochromatin organization	BP
1	2	2.3218233202	-	1.90e-01	GO:1902750	negative regulation of cell cycle G2/M phase transition	BP
1	2	2.3218233202	-	1.90e-01	GO:0072179	nephric duct formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0003420	regulation of growth plate cartilage chondrocyte proliferation	BP
1	2	2.3218233202	-	1.90e-01	GO:0039692	single stranded viral RNA replication via double stranded DNA intermediate	BP
1	2	2.3218233202	-	1.90e-01	GO:0033561	regulation of water loss via skin	BP
1	2	2.3218233202	-	1.90e-01	GO:0002711	positive regulation of T cell mediated immunity	BP
1	2	2.3218233202	-	1.90e-01	GO:0038194	thyroid-stimulating hormone signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0060529	squamous basal epithelial stem cell differentiation involved in prostate gland acinus development	BP
1	2	2.3218233202	-	1.90e-01	GO:0045994	positive regulation of translational initiation by iron	BP
1	2	2.3218233202	-	1.90e-01	GO:0006163	purine nucleotide metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0072033	renal vesicle formation	BP
1	2	2.3218233202	-	1.90e-01	GO:1902938	regulation of intracellular calcium activated chloride channel activity	BP
15	30	2.3218233202	-	1.86e-08	GO:0001205	transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding	MF
12	24	2.3218233202	-	8.22e-07	GO:0043425	bHLH transcription factor binding	MF
8	16	2.3218233202	-	1.70e-05	GO:0019789	SUMO transferase activity	MF
7	14	2.3218233202	-	4.96e-05	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
6	12	2.3218233202	-	5.37e-04	GO:0000989	transcription factor activity, transcription factor binding	MF
5	10	2.3218233202	-	8.86e-04	GO:0016274	protein-arginine N-methyltransferase activity	MF
5	10	2.3218233202	-	1.63e-03	GO:0070016	armadillo repeat domain binding	MF
4	8	2.3218233202	-	5.01e-03	GO:0070878	primary miRNA binding	MF
3	6	2.3218233202	-	1.58e-02	GO:0019870	potassium channel inhibitor activity	MF
3	6	2.3218233202	-	1.58e-02	GO:0097371	MDM2/MDM4 family protein binding	MF
3	6	2.3218233202	-	1.58e-02	GO:0032453	histone demethylase activity (H3-K4 specific)	MF
3	6	2.3218233202	-	1.58e-02	GO:0071253	connexin binding	MF
2	4	2.3218233202	-	2.80e-02	GO:0030229	very-low-density lipoprotein particle receptor activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0016361	activin receptor activity, type I	MF
2	4	2.3218233202	-	5.23e-02	GO:0050815	phosphoserine residue binding	MF
2	4	2.3218233202	-	5.23e-02	GO:0031014	troponin T binding	MF
2	4	2.3218233202	-	5.23e-02	GO:0005025	transforming growth factor beta receptor activity, type I	MF
2	4	2.3218233202	-	5.23e-02	GO:0034186	apolipoprotein A-I binding	MF
2	4	2.3218233202	-	5.23e-02	GO:0035173	histone kinase activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0001129	RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly	MF
2	4	2.3218233202	-	5.23e-02	GO:0004677	DNA-dependent protein kinase activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0030546	receptor activator activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0034191	apolipoprotein A-I receptor binding	MF
2	4	2.3218233202	-	5.23e-02	GO:0017136	NAD-dependent histone deacetylase activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0008853	exodeoxyribonuclease III activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0034648	histone demethylase activity (H3-dimethyl-K4 specific)	MF
2	4	2.3218233202	-	5.23e-02	GO:0004176	ATP-dependent peptidase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0017050	D-erythro-sphingosine kinase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0034188	apolipoprotein A-I receptor activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0030549	acetylcholine receptor activator activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0016903	oxidoreductase activity, acting on the aldehyde or oxo group of donors	MF
1	2	2.3218233202	-	1.00e-01	GO:0035575	histone demethylase activity (H4-K20 specific)	MF
1	2	2.3218233202	-	1.00e-01	GO:0034437	glycoprotein transporter activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0008481	sphinganine kinase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0052741	(R)-limonene 6-monooxygenase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0016811	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides	MF
1	2	2.3218233202	-	1.00e-01	GO:0030343	vitamin D3 25-hydroxylase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:1903763	gap junction channel activity involved in cell communication by electrical coupling	MF
1	2	2.3218233202	-	1.00e-01	GO:0018675	(S)-limonene 6-monooxygenase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0018676	(S)-limonene 7-monooxygenase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0004103	choline kinase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0090556	phosphatidylserine-translocating ATPase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0038181	bile acid receptor activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0004031	aldehyde oxidase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0046811	histone deacetylase inhibitor activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0001567	cholesterol 25-hydroxylase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004996	thyroid-stimulating hormone receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0099609	microtubule lateral binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0086059	voltage-gated calcium channel activity involved SA node cell action potential	MF
1	2	2.3218233202	-	1.90e-01	GO:0019912	cyclin-dependent protein kinase activating kinase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0033142	progesterone receptor binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0004912	interleukin-3 receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0001632	leukotriene B4 receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0061733	peptide-lysine-N-acetyltransferase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0015432	bile acid-exporting ATPase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0016165	linoleate 13S-lipoxygenase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0035034	histone acetyltransferase regulator activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0008311	double-stranded DNA 3'-5' exodeoxyribonuclease activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0035500	MH2 domain binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0036505	prosaposin receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0098770	FBXO family protein binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0061629	RNA polymerase II sequence-specific DNA binding transcription factor binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0008534	oxidized purine nucleobase lesion DNA N-glycosylase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0034189	very-low-density lipoprotein particle binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0047710	bis(5'-adenosyl)-triphosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0070576	vitamin D 24-hydroxylase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0016005	phospholipase A2 activator activity	MF
1	2	2.3218233202	-	1.90e-01	GO:1990404	protein ADP-ribosylase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0003968	RNA-directed 5'-3' RNA polymerase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0051717	inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0008263	pyrimidine-specific mismatch base pair DNA N-glycosylase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004906	interferon-gamma receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0008670	2,4-dienoyl-CoA reductase (NADPH) activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0019002	GMP binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0015235	cobalamin transporter activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0003845	11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0008309	double-stranded DNA exodeoxyribonuclease activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0033549	MAP kinase phosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004367	glycerol-3-phosphate dehydrogenase [NAD+] activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004368	glycerol-3-phosphate dehydrogenase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0030617	transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0005128	erythropoietin receptor binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0016641	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	MF
1	2	2.3218233202	-	1.90e-01	GO:0001134	transcription factor activity, transcription factor recruiting	MF
1	2	2.3218233202	-	1.90e-01	GO:0010736	serum response element binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0086075	gap junction channel activity involved in cardiac conduction electrical coupling	MF
1	2	2.3218233202	-	1.90e-01	GO:0035402	histone kinase activity (H3-T11 specific)	MF
1	2	2.3218233202	-	1.90e-01	GO:0005330	dopamine:sodium symporter activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0061752	telomeric repeat-containing RNA binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0001071	nucleic acid binding transcription factor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0005006	epidermal growth factor-activated receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0000171	ribonuclease MRP activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0008170	N-methyltransferase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004105	choline-phosphate cytidylyltransferase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004356	glutamate-ammonia ligase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0018479	benzaldehyde dehydrogenase (NAD+) activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0022839	ion gated channel activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0005174	CD40 receptor binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0004723	calcium-dependent protein serine/threonine phosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0046969	NAD-dependent histone deacetylase activity (H3-K9 specific)	MF
1	2	2.3218233202	-	1.90e-01	GO:0017002	activin-activated receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0001147	transcription termination site sequence-specific DNA binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0004692	cGMP-dependent protein kinase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0034647	histone demethylase activity (H3-trimethyl-K4 specific)	MF
1	2	2.3218233202	-	1.90e-01	GO:0017129	triglyceride binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0004962	endothelin receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0070080	titin Z domain binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0001640	adenylate cyclase inhibiting G-protein coupled glutamate receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0008798	beta-aspartyl-peptidase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0005072	transforming growth factor beta receptor, cytoplasmic mediator activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0008160	protein tyrosine phosphatase activator activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0015114	phosphate ion transmembrane transporter activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0038025	reelin receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:1990763	arrestin family protein binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0051800	phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0008124	4-alpha-hydroxytetrahydrobiopterin dehydratase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0071886	1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0016427	tRNA (cytosine) methyltransferase activity	MF
29	59	2.29716126597	-	5.99e-11	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	MF
24	49	2.29207597681	-	3.65e-11	GO:0001085	RNA polymerase II transcription factor binding	MF
120	245	2.29207597681	-	9.17e-11	GO:0003713	transcription coactivator activity	MF
32	66	2.27742920084	-	3.05e-11	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
15	31	2.27451760542	-	9.89e-09	GO:1990841	promoter-specific chromatin binding	MF
20	42	2.25143399231	-	5.20e-10	GO:0034080	CENP-A containing nucleosome assembly	BP
10	21	2.25143399231	-	1.22e-05	GO:0043393	regulation of protein binding	BP
29	61	2.24906697777	-	8.54e-11	GO:0007249	I-kappaB kinase/NF-kappaB signaling	BP
19	40	2.24782273876	-	1.49e-09	GO:0004407	histone deacetylase activity	MF
18	38	2.2438208082	-	1.41e-09	GO:0001105	RNA polymerase II transcription coactivator activity	MF
33	70	2.23693442261	-	6.13e-11	GO:0002039	p53 binding	MF
8	17	2.23436047895	-	1.04e-04	GO:0051123	RNA polymerase II transcriptional preinitiation complex assembly	BP
15	32	2.22871391581	-	1.01e-07	GO:0010803	regulation of tumor necrosis factor-mediated signaling pathway	BP
14	30	2.22228764665	-	9.76e-08	GO:0000289	nuclear-transcribed mRNA poly(A) tail shortening	BP
7	15	2.22228764665	-	4.96e-05	GO:0010832	negative regulation of myotube differentiation	BP
7	15	2.22228764665	-	4.96e-05	GO:0034968	histone lysine methylation	BP
7	15	2.22228764665	-	1.79e-04	GO:1904646	cellular response to amyloid-beta	BP
13	28	2.21490811628	-	2.83e-07	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	BP
6	13	2.20634610278	-	1.46e-04	GO:2000773	negative regulation of cellular senescence	BP
6	13	2.20634610278	-	9.14e-04	GO:0001829	trophectodermal cell differentiation	BP
6	13	2.20634610278	-	2.93e-04	GO:0032454	histone demethylase activity (H3-K9 specific)	MF
45	98	2.19896657242	-	1.05e-10	GO:1902036	regulation of hematopoietic stem cell differentiation	BP
11	24	2.19629243812	-	7.01e-06	GO:0070423	nucleotide-binding oligomerization domain containing signaling pathway	BP
11	24	2.19629243812	-	7.01e-06	GO:1901216	positive regulation of neuron death	BP
10	22	2.18431979645	-	2.03e-05	GO:0006306	DNA methylation	BP
5	11	2.18431979645	-	1.63e-03	GO:1990440	positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
5	11	2.18431979645	-	1.63e-03	GO:0060213	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	BP
5	11	2.18431979645	-	1.63e-03	GO:0045945	positive regulation of transcription from RNA polymerase III promoter	BP
5	11	2.18431979645	-	2.74e-03	GO:1901653	cellular response to peptide	BP
5	11	2.18431979645	-	2.74e-03	GO:0045667	regulation of osteoblast differentiation	BP
5	11	2.18431979645	-	2.74e-03	GO:0060444	branching involved in mammary gland duct morphogenesis	BP
10	22	2.18431979645	-	9.76e-07	GO:0001158	enhancer sequence-specific DNA binding	MF
5	11	2.18431979645	-	2.74e-03	GO:0043560	insulin receptor substrate binding	MF
24	53	2.17886536636	-	2.21e-11	GO:0048511	rhythmic process	BP
28	62	2.17498193187	-	8.54e-11	GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	BP
25	56	2.15832458792	-	2.22e-11	GO:0003712	transcription cofactor activity	MF
28	63	2.15189831876	-	4.76e-11	GO:0006303	double-strand break repair via nonhomologous end joining	BP
12	27	2.15189831876	-	2.42e-06	GO:0043392	negative regulation of DNA binding	BP
8	18	2.15189831876	-	3.31e-05	GO:0060324	face development	BP
8	18	2.15189831876	-	1.04e-04	GO:0035066	positive regulation of histone acetylation	BP
4	9	2.15189831876	-	1.27e-03	GO:0048617	embryonic foregut morphogenesis	BP
4	9	2.15189831876	-	2.72e-03	GO:0061072	iris morphogenesis	BP
4	9	2.15189831876	-	2.72e-03	GO:0060039	pericardium development	BP
4	9	2.15189831876	-	2.72e-03	GO:0071374	cellular response to parathyroid hormone stimulus	BP
4	9	2.15189831876	-	2.72e-03	GO:0061314	Notch signaling involved in heart development	BP
4	9	2.15189831876	-	2.72e-03	GO:0034371	chylomicron remodeling	BP
4	9	2.15189831876	-	5.01e-03	GO:0003197	endocardial cushion development	BP
4	9	2.15189831876	-	5.01e-03	GO:0051974	negative regulation of telomerase activity	BP
4	9	2.15189831876	-	5.01e-03	GO:0048660	regulation of smooth muscle cell proliferation	BP
4	9	2.15189831876	-	5.01e-03	GO:0002726	positive regulation of T cell cytokine production	BP
4	9	2.15189831876	-	8.31e-03	GO:0034384	high-density lipoprotein particle clearance	BP
4	9	2.15189831876	-	8.31e-03	GO:0007196	adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway	BP
4	9	2.15189831876	-	8.31e-03	GO:0034405	response to fluid shear stress	BP
4	9	2.15189831876	-	8.31e-03	GO:0008354	germ cell migration	BP
4	9	2.15189831876	-	8.31e-03	GO:0043068	positive regulation of programmed cell death	BP
4	9	2.15189831876	-	8.31e-03	GO:0033762	response to glucagon	BP
4	9	2.15189831876	-	8.31e-03	GO:0070933	histone H4 deacetylation	BP
4	9	2.15189831876	-	8.31e-03	GO:0032000	positive regulation of fatty acid beta-oxidation	BP
4	9	2.15189831876	-	8.31e-03	GO:0032183	SUMO binding	MF
11	25	2.13739874906	-	1.32e-06	GO:0046329	negative regulation of JNK cascade	BP
36	82	2.13419631703	-	3.17e-11	GO:0006338	chromatin remodeling	BP
18	41	2.13419631703	-	2.48e-09	GO:0004402	histone acetyltransferase activity	MF
7	16	2.12917824226	-	9.82e-05	GO:0048714	positive regulation of oligodendrocyte differentiation	BP
7	16	2.12917824226	-	1.79e-04	GO:0003222	ventricular trabecula myocardium morphogenesis	BP
7	16	2.12917824226	-	3.08e-04	GO:0060749	mammary gland alveolus development	BP
7	16	2.12917824226	-	3.08e-04	GO:0035162	embryonic hemopoiesis	BP
7	16	2.12917824226	-	5.00e-04	GO:0003203	endocardial cushion morphogenesis	BP
7	16	2.12917824226	-	3.08e-04	GO:0031435	mitogen-activated protein kinase kinase kinase binding	MF
10	23	2.12018945903	-	3.27e-05	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	BP
6	14	2.09943089886	-	5.37e-04	GO:0060065	uterus development	BP
6	14	2.09943089886	-	5.37e-04	GO:0033169	histone H3-K9 demethylation	BP
6	14	2.09943089886	-	9.14e-04	GO:0014912	negative regulation of smooth muscle cell migration	BP
6	14	2.09943089886	-	9.14e-04	GO:0040029	regulation of gene expression, epigenetic	BP
6	14	2.09943089886	-	9.14e-04	GO:0060441	epithelial tube branching involved in lung morphogenesis	BP
6	14	2.09943089886	-	1.46e-03	GO:0042993	positive regulation of transcription factor import into nucleus	BP
3	7	2.09943089886	-	3.69e-03	GO:0035356	cellular triglyceride homeostasis	BP
3	7	2.09943089886	-	8.55e-03	GO:0048646	anatomical structure formation involved in morphogenesis	BP
3	7	2.09943089886	-	8.55e-03	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	BP
3	7	2.09943089886	-	8.55e-03	GO:0036302	atrioventricular canal development	BP
3	7	2.09943089886	-	1.58e-02	GO:0045656	negative regulation of monocyte differentiation	BP
3	7	2.09943089886	-	1.58e-02	GO:0045722	positive regulation of gluconeogenesis	BP
3	7	2.09943089886	-	1.58e-02	GO:2000650	negative regulation of sodium ion transmembrane transporter activity	BP
3	7	2.09943089886	-	1.58e-02	GO:0061154	endothelial tube morphogenesis	BP
3	7	2.09943089886	-	1.58e-02	GO:2001028	positive regulation of endothelial cell chemotaxis	BP
3	7	2.09943089886	-	1.58e-02	GO:1903214	regulation of protein targeting to mitochondrion	BP
3	7	2.09943089886	-	1.58e-02	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	BP
3	7	2.09943089886	-	1.58e-02	GO:0060017	parathyroid gland development	BP
3	7	2.09943089886	-	1.58e-02	GO:0045617	negative regulation of keratinocyte differentiation	BP
3	7	2.09943089886	-	2.57e-02	GO:0007221	positive regulation of transcription of Notch receptor target	BP
3	7	2.09943089886	-	2.57e-02	GO:0090050	positive regulation of cell migration involved in sprouting angiogenesis	BP
3	7	2.09943089886	-	2.57e-02	GO:0002741	positive regulation of cytokine secretion involved in immune response	BP
3	7	2.09943089886	-	2.57e-02	GO:2000171	negative regulation of dendrite development	BP
3	7	2.09943089886	-	2.57e-02	GO:0007253	cytoplasmic sequestering of NF-kappaB	BP
3	7	2.09943089886	-	2.57e-02	GO:0034351	negative regulation of glial cell apoptotic process	BP
3	7	2.09943089886	-	2.57e-02	GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway	BP
3	7	2.09943089886	-	2.57e-02	GO:1903599	positive regulation of autophagy of mitochondrion	BP
3	7	2.09943089886	-	2.57e-02	GO:0034616	response to laminar fluid shear stress	BP
3	7	2.09943089886	-	2.57e-02	GO:0060290	transdifferentiation	BP
3	7	2.09943089886	-	2.57e-02	GO:0035520	monoubiquitinated protein deubiquitination	BP
3	7	2.09943089886	-	2.57e-02	GO:0031642	negative regulation of myelination	BP
3	7	2.09943089886	-	2.57e-02	GO:0010742	macrophage derived foam cell differentiation	BP
3	7	2.09943089886	-	2.57e-02	GO:0032873	negative regulation of stress-activated MAPK cascade	BP
3	7	2.09943089886	-	2.57e-02	GO:0043983	histone H4-K12 acetylation	BP
3	7	2.09943089886	-	2.57e-02	GO:0035065	regulation of histone acetylation	BP
90	210	2.09943089886	-	5.05e-11	GO:0044212	transcription regulatory region DNA binding	MF
15	35	2.09943089886	-	4.35e-07	GO:0001784	phosphotyrosine residue binding	MF
12	28	2.09943089886	-	6.31e-06	GO:0097718	disordered domain specific binding	MF
12	28	2.09943089886	-	6.31e-06	GO:0051059	NF-kappaB binding	MF
3	7	2.09943089886	-	1.58e-02	GO:0070324	thyroid hormone binding	MF
3	7	2.09943089886	-	2.57e-02	GO:0004970	ionotropic glutamate receptor activity	MF
3	7	2.09943089886	-	2.57e-02	GO:0004691	cAMP-dependent protein kinase activity	MF
34	80	2.08735806656	-	2.72e-11	GO:0008013	beta-catenin binding	MF
11	26	2.0808152207	-	2.39e-06	GO:0016573	histone acetylation	BP
8	19	2.07389580676	-	1.23e-06	GO:0023019	signal transduction involved in regulation of gene expression	BP
8	19	2.07389580676	-	6.05e-05	GO:0030220	platelet formation	BP
8	19	2.07389580676	-	1.04e-04	GO:0014911	positive regulation of smooth muscle cell migration	BP
8	19	2.07389580676	-	2.70e-04	GO:0043011	myeloid dendritic cell differentiation	BP
20	48	2.05878891437	-	9.39e-09	GO:0043525	positive regulation of neuron apoptotic process	BP
5	12	2.05878891437	-	8.86e-04	GO:0033700	phospholipid efflux	BP
5	12	2.05878891437	-	2.74e-03	GO:0060707	trophoblast giant cell differentiation	BP
5	12	2.05878891437	-	2.74e-03	GO:0003215	cardiac right ventricle morphogenesis	BP
5	12	2.05878891437	-	4.31e-03	GO:0055093	response to hyperoxia	BP
5	12	2.05878891437	-	4.31e-03	GO:0007252	I-kappaB phosphorylation	BP
5	12	2.05878891437	-	4.31e-03	GO:0016578	histone deubiquitination	BP
5	12	2.05878891437	-	4.31e-03	GO:0042994	cytoplasmic sequestering of transcription factor	BP
5	12	2.05878891437	-	4.31e-03	GO:0045820	negative regulation of glycolytic process	BP
5	12	2.05878891437	-	4.31e-03	GO:0004861	cyclin-dependent protein serine/threonine kinase inhibitor activity	MF
12	29	2.04880482579	-	9.79e-06	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	BP
7	17	2.04171540101	-	4.96e-05	GO:0044030	regulation of DNA methylation	BP
7	17	2.04171540101	-	3.08e-04	GO:0043691	reverse cholesterol transport	BP
7	17	2.04171540101	-	5.00e-04	GO:0033189	response to vitamin A	BP
7	17	2.04171540101	-	9.82e-05	GO:0008301	DNA binding, bending	MF
11	27	2.02636743667	-	2.76e-05	GO:0045931	positive regulation of mitotic cell cycle	BP
17	42	2.01696873867	-	1.33e-07	GO:0043966	histone H3 acetylation	BP
110	272	2.01572019248	-	7.95e-11	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
19	47	2.01516198197	-	3.99e-08	GO:0007254	JNK cascade	BP
6	15	1.99989522531	-	5.37e-04	GO:0045618	positive regulation of keratinocyte differentiation	BP
6	15	1.99989522531	-	1.46e-03	GO:0032743	positive regulation of interleukin-2 production	BP
6	15	1.99989522531	-	1.46e-03	GO:0060397	JAK-STAT cascade involved in growth hormone signaling pathway	BP
12	30	1.99989522531	-	2.42e-06	GO:0004693	cyclin-dependent protein serine/threonine kinase activity	MF
6	15	1.99989522531	-	2.24e-03	GO:0004708	MAP kinase kinase activity	MF
22	55	1.99989522531	-	2.85e-09	GO:0032922	circadian regulation of gene expression	BP
8	20	1.99989522531	-	1.71e-04	GO:0010971	positive regulation of G2/M transition of mitotic cell cycle	BP
4	10	1.99989522531	-	2.72e-03	GO:0045598	regulation of fat cell differentiation	BP
4	10	1.99989522531	-	5.01e-03	GO:0003300	cardiac muscle hypertrophy	BP
4	10	1.99989522531	-	5.01e-03	GO:0043267	negative regulation of potassium ion transport	BP
4	10	1.99989522531	-	8.31e-03	GO:0042770	signal transduction in response to DNA damage	BP
4	10	1.99989522531	-	8.31e-03	GO:0060674	placenta blood vessel development	BP
4	10	1.99989522531	-	8.31e-03	GO:0006307	DNA dealkylation involved in DNA repair	BP
4	10	1.99989522531	-	8.31e-03	GO:0034115	negative regulation of heterotypic cell-cell adhesion	BP
4	10	1.99989522531	-	8.31e-03	GO:0003214	cardiac left ventricle morphogenesis	BP
4	10	1.99989522531	-	8.31e-03	GO:2001022	positive regulation of response to DNA damage stimulus	BP
2	5	1.99989522531	-	9.99e-03	GO:1902807	negative regulation of cell cycle G1/S phase transition	BP
4	10	1.99989522531	-	1.28e-02	GO:0051272	positive regulation of cellular component movement	BP
4	10	1.99989522531	-	1.28e-02	GO:1902237	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
4	10	1.99989522531	-	1.28e-02	GO:0033327	Leydig cell differentiation	BP
4	10	1.99989522531	-	1.28e-02	GO:0016572	histone phosphorylation	BP
4	10	1.99989522531	-	1.28e-02	GO:0060487	lung epithelial cell differentiation	BP
4	10	1.99989522531	-	1.28e-02	GO:0031000	response to caffeine	BP
2	5	1.99989522531	-	2.80e-02	GO:2001016	positive regulation of skeletal muscle cell differentiation	BP
2	5	1.99989522531	-	2.80e-02	GO:0061743	motor learning	BP
2	5	1.99989522531	-	2.80e-02	GO:0002322	B cell proliferation involved in immune response	BP
2	5	1.99989522531	-	5.23e-02	GO:0048733	sebaceous gland development	BP
2	5	1.99989522531	-	5.23e-02	GO:1905050	positive regulation of metallopeptidase activity	BP
2	5	1.99989522531	-	5.23e-02	GO:0009299	mRNA transcription	BP
2	5	1.99989522531	-	5.23e-02	GO:0010793	regulation of mRNA export from nucleus	BP
2	5	1.99989522531	-	5.23e-02	GO:0043374	CD8-positive, alpha-beta T cell differentiation	BP
2	5	1.99989522531	-	5.23e-02	GO:1904179	positive regulation of adipose tissue development	BP
2	5	1.99989522531	-	5.23e-02	GO:0031113	regulation of microtubule polymerization	BP
2	5	1.99989522531	-	5.23e-02	GO:0048562	embryonic organ morphogenesis	BP
2	5	1.99989522531	-	5.23e-02	GO:0060956	endocardial cell differentiation	BP
2	5	1.99989522531	-	5.23e-02	GO:0048311	mitochondrion distribution	BP
2	5	1.99989522531	-	5.23e-02	GO:0019217	regulation of fatty acid metabolic process	BP
2	5	1.99989522531	-	5.23e-02	GO:2000987	positive regulation of behavioral fear response	BP
2	5	1.99989522531	-	5.23e-02	GO:0048752	semicircular canal morphogenesis	BP
2	5	1.99989522531	-	5.23e-02	GO:1901300	positive regulation of hydrogen peroxide-mediated programmed cell death	BP
2	5	1.99989522531	-	5.23e-02	GO:0051122	hepoxilin biosynthetic process	BP
2	5	1.99989522531	-	5.23e-02	GO:0035881	amacrine cell differentiation	BP
2	5	1.99989522531	-	5.23e-02	GO:0002155	regulation of thyroid hormone mediated signaling pathway	BP
2	5	1.99989522531	-	5.23e-02	GO:1901727	positive regulation of histone deacetylase activity	BP
2	5	1.99989522531	-	5.23e-02	GO:0086045	membrane depolarization during AV node cell action potential	BP
2	5	1.99989522531	-	5.23e-02	GO:0045542	positive regulation of cholesterol biosynthetic process	BP
2	5	1.99989522531	-	5.23e-02	GO:0043367	CD4-positive, alpha-beta T cell differentiation	BP
2	5	1.99989522531	-	5.23e-02	GO:1900223	positive regulation of amyloid-beta clearance	BP
2	5	1.99989522531	-	8.14e-02	GO:0042541	hemoglobin biosynthetic process	BP
2	5	1.99989522531	-	8.14e-02	GO:0072655	establishment of protein localization to mitochondrion	BP
2	5	1.99989522531	-	8.14e-02	GO:0010715	regulation of extracellular matrix disassembly	BP
2	5	1.99989522531	-	8.14e-02	GO:0051891	positive regulation of cardioblast differentiation	BP
2	5	1.99989522531	-	8.14e-02	GO:0042634	regulation of hair cycle	BP
2	5	1.99989522531	-	8.14e-02	GO:0003289	atrial septum primum morphogenesis	BP
2	5	1.99989522531	-	8.14e-02	GO:0034349	glial cell apoptotic process	BP
2	5	1.99989522531	-	8.14e-02	GO:0031622	positive regulation of fever generation	BP
2	5	1.99989522531	-	8.14e-02	GO:0036091	positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
2	5	1.99989522531	-	8.14e-02	GO:0033599	regulation of mammary gland epithelial cell proliferation	BP
2	5	1.99989522531	-	8.14e-02	GO:0050920	regulation of chemotaxis	BP
2	5	1.99989522531	-	8.14e-02	GO:0065004	protein-DNA complex assembly	BP
2	5	1.99989522531	-	8.14e-02	GO:0050882	voluntary musculoskeletal movement	BP
2	5	1.99989522531	-	8.14e-02	GO:0060744	mammary gland branching involved in thelarche	BP
2	5	1.99989522531	-	8.14e-02	GO:1905007	positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	BP
2	5	1.99989522531	-	8.14e-02	GO:1902262	apoptotic process involved in blood vessel morphogenesis	BP
2	5	1.99989522531	-	8.14e-02	GO:0031536	positive regulation of exit from mitosis	BP
2	5	1.99989522531	-	8.14e-02	GO:1990441	negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
2	5	1.99989522531	-	8.14e-02	GO:0045646	regulation of erythrocyte differentiation	BP
2	5	1.99989522531	-	8.14e-02	GO:1904714	regulation of chaperone-mediated autophagy	BP
2	5	1.99989522531	-	8.14e-02	GO:0060179	male mating behavior	BP
2	5	1.99989522531	-	8.14e-02	GO:0010830	regulation of myotube differentiation	BP
2	5	1.99989522531	-	8.14e-02	GO:0046578	regulation of Ras protein signal transduction	BP
2	5	1.99989522531	-	8.14e-02	GO:0010310	regulation of hydrogen peroxide metabolic process	BP
2	5	1.99989522531	-	8.14e-02	GO:0032747	positive regulation of interleukin-23 production	BP
2	5	1.99989522531	-	8.14e-02	GO:0045843	negative regulation of striated muscle tissue development	BP
2	5	1.99989522531	-	8.14e-02	GO:0051081	nuclear envelope disassembly	BP
2	5	1.99989522531	-	8.14e-02	GO:0016202	regulation of striated muscle tissue development	BP
2	5	1.99989522531	-	8.14e-02	GO:0042699	follicle-stimulating hormone signaling pathway	BP
2	5	1.99989522531	-	8.14e-02	GO:0070842	aggresome assembly	BP
2	5	1.99989522531	-	8.14e-02	GO:0071504	cellular response to heparin	BP
2	5	1.99989522531	-	8.14e-02	GO:0034197	triglyceride transport	BP
2	5	1.99989522531	-	8.14e-02	GO:1903307	positive regulation of regulated secretory pathway	BP
2	5	1.99989522531	-	8.14e-02	GO:0071332	cellular response to fructose stimulus	BP
2	5	1.99989522531	-	8.14e-02	GO:1902035	positive regulation of hematopoietic stem cell proliferation	BP
2	5	1.99989522531	-	8.14e-02	GO:0071864	positive regulation of cell proliferation in bone marrow	BP
2	5	1.99989522531	-	8.14e-02	GO:0048341	paraxial mesoderm formation	BP
2	5	1.99989522531	-	8.14e-02	GO:0030262	apoptotic nuclear changes	BP
2	5	1.99989522531	-	8.14e-02	GO:0032269	negative regulation of cellular protein metabolic process	BP
2	5	1.99989522531	-	8.14e-02	GO:0051546	keratinocyte migration	BP
2	5	1.99989522531	-	8.14e-02	GO:0060761	negative regulation of response to cytokine stimulus	BP
2	5	1.99989522531	-	8.14e-02	GO:0090335	regulation of brown fat cell differentiation	BP
2	5	1.99989522531	-	8.14e-02	GO:0032489	regulation of Cdc42 protein signal transduction	BP
2	5	1.99989522531	-	8.14e-02	GO:0007610	behavior	BP
2	5	1.99989522531	-	8.14e-02	GO:1902083	negative regulation of peptidyl-cysteine S-nitrosylation	BP
2	5	1.99989522531	-	8.14e-02	GO:0002260	lymphocyte homeostasis	BP
2	5	1.99989522531	-	8.14e-02	GO:1904885	beta-catenin destruction complex assembly	BP
2	5	1.99989522531	-	8.14e-02	GO:0060157	urinary bladder development	BP
2	5	1.99989522531	-	8.14e-02	GO:0034121	regulation of toll-like receptor signaling pathway	BP
2	5	1.99989522531	-	8.14e-02	GO:2000535	regulation of entry of bacterium into host cell	BP
2	5	1.99989522531	-	8.14e-02	GO:0033153	T cell receptor V(D)J recombination	BP
2	5	1.99989522531	-	8.14e-02	GO:0044314	protein K27-linked ubiquitination	BP
2	5	1.99989522531	-	8.14e-02	GO:0010994	free ubiquitin chain polymerization	BP
2	5	1.99989522531	-	8.14e-02	GO:0010991	negative regulation of SMAD protein complex assembly	BP
2	5	1.99989522531	-	8.14e-02	GO:0071681	cellular response to indole-3-methanol	BP
2	5	1.99989522531	-	8.14e-02	GO:0042976	activation of Janus kinase activity	BP
2	5	1.99989522531	-	8.14e-02	GO:0010891	negative regulation of sequestering of triglyceride	BP
2	5	1.99989522531	-	8.14e-02	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	BP
2	5	1.99989522531	-	8.14e-02	GO:0051023	regulation of immunoglobulin secretion	BP
10	25	1.99989522531	-	5.10e-05	GO:0030332	cyclin binding	MF
4	10	1.99989522531	-	8.31e-03	GO:0001222	transcription corepressor binding	MF
4	10	1.99989522531	-	8.31e-03	GO:0016504	peptidase activator activity	MF
4	10	1.99989522531	-	1.28e-02	GO:0048156	tau protein binding	MF
4	10	1.99989522531	-	1.28e-02	GO:1990782	protein tyrosine kinase binding	MF
2	5	1.99989522531	-	5.23e-02	GO:0101020	estrogen 16-alpha-hydroxylase activity	MF
2	5	1.99989522531	-	5.23e-02	GO:0034979	NAD-dependent protein deacetylase activity	MF
2	5	1.99989522531	-	5.23e-02	GO:0071813	lipoprotein particle binding	MF
2	5	1.99989522531	-	5.23e-02	GO:0019871	sodium channel inhibitor activity	MF
2	5	1.99989522531	-	5.23e-02	GO:0070513	death domain binding	MF
2	5	1.99989522531	-	5.23e-02	GO:0004920	interleukin-10 receptor activity	MF
2	5	1.99989522531	-	5.23e-02	GO:0051575	5'-deoxyribose-5-phosphate lyase activity	MF
2	5	1.99989522531	-	8.14e-02	GO:0044388	small protein activating enzyme binding	MF
2	5	1.99989522531	-	8.14e-02	GO:0097100	supercoiled DNA binding	MF
2	5	1.99989522531	-	8.14e-02	GO:0004532	exoribonuclease activity	MF
2	5	1.99989522531	-	8.14e-02	GO:0032184	SUMO polymer binding	MF
2	5	1.99989522531	-	8.14e-02	GO:0008142	oxysterol binding	MF
2	5	1.99989522531	-	8.14e-02	GO:0046976	histone methyltransferase activity (H3-K27 specific)	MF
2	5	1.99989522531	-	8.14e-02	GO:0042799	histone methyltransferase activity (H4-K20 specific)	MF
2	5	1.99989522531	-	8.14e-02	GO:0071532	ankyrin repeat binding	MF
2	5	1.99989522531	-	8.14e-02	GO:0004844	uracil DNA N-glycosylase activity	MF
2	5	1.99989522531	-	8.14e-02	GO:0019966	interleukin-1 binding	MF
19	48	1.98478833292	-	1.70e-08	GO:0042752	regulation of circadian rhythm	BP
17	43	1.98302140675	-	3.38e-08	GO:0048538	thymus development	BP
203	516	1.97593198196	-	1.72e-10	GO:0045893	positive regulation of transcription, DNA-templated	BP
11	28	1.97390001678	-	4.17e-06	GO:0035116	embryonic hindlimb morphogenesis	BP
11	28	1.97390001678	-	7.01e-06	GO:0048863	stem cell differentiation	BP
11	28	1.97390001678	-	4.13e-05	GO:0010332	response to gamma radiation	BP
11	28	1.97390001678	-	1.32e-06	GO:0005496	steroid binding	MF
78	199	1.97060091852	-	5.97e-11	GO:0003714	transcription corepressor activity	MF
9	23	1.96818636559	-	3.55e-05	GO:0009954	proximal/distal pattern formation	BP
56	144	1.95925324082	-	6.25e-11	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
7	18	1.95925324082	-	7.77e-04	GO:0070577	lysine-acetylated histone binding	MF
12	31	1.95258951054	-	6.31e-06	GO:0034614	cellular response to reactive oxygen species	BP
12	31	1.95258951054	-	9.79e-06	GO:0071276	cellular response to cadmium ion	BP
139	360	1.9489112966	-	1.31e-10	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	MF
5	13	1.94331169695	-	1.63e-03	GO:0034380	high-density lipoprotein particle assembly	BP
5	13	1.94331169695	-	2.74e-03	GO:0048546	digestive tract morphogenesis	BP
5	13	1.94331169695	-	2.74e-03	GO:0071391	cellular response to estrogen stimulus	BP
5	13	1.94331169695	-	4.31e-03	GO:0042692	muscle cell differentiation	BP
5	13	1.94331169695	-	6.43e-03	GO:0097296	activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
5	13	1.94331169695	-	6.43e-03	GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
5	13	1.94331169695	-	6.43e-03	GO:2000573	positive regulation of DNA biosynthetic process	BP
5	13	1.94331169695	-	6.43e-03	GO:0035729	cellular response to hepatocyte growth factor stimulus	BP
5	13	1.94331169695	-	6.43e-03	GO:0002756	MyD88-independent toll-like receptor signaling pathway	BP
5	13	1.94331169695	-	6.43e-03	GO:1904264	ubiquitin protein ligase activity involved in ERAD pathway	MF
5	13	1.94331169695	-	6.43e-03	GO:0034450	ubiquitin-ubiquitin ligase activity	MF
51	133	1.93896622667	-	5.22e-11	GO:1901796	regulation of signal transduction by p53 class mediator	BP
8	21	1.92950589742	-	1.71e-04	GO:0048844	artery morphogenesis	BP
8	21	1.92950589742	-	1.71e-04	GO:0007492	endoderm development	BP
11	29	1.92327394371	-	6.06e-05	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
17	45	1.91743306512	-	2.06e-08	GO:0035914	skeletal muscle cell differentiation	BP
40	106	1.91583096053	-	5.54e-11	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	BP
12	32	1.90678582092	-	9.79e-06	GO:0071479	cellular response to ionizing radiation	BP
9	24	1.90678582092	-	2.05e-05	GO:0030878	thyroid gland development	BP
12	32	1.90678582092	-	3.20e-05	GO:1990090	cellular response to nerve growth factor stimulus	BP
9	24	1.90678582092	-	5.88e-05	GO:0055088	lipid homeostasis	BP
6	16	1.90678582092	-	1.46e-03	GO:0070498	interleukin-1-mediated signaling pathway	BP
6	16	1.90678582092	-	2.24e-03	GO:2000811	negative regulation of anoikis	BP
3	8	1.90678582092	-	1.58e-02	GO:0030828	positive regulation of cGMP biosynthetic process	BP
3	8	1.90678582092	-	1.58e-02	GO:0001763	morphogenesis of a branching structure	BP
3	8	1.90678582092	-	2.57e-02	GO:0055001	muscle cell development	BP
3	8	1.90678582092	-	2.57e-02	GO:0045410	positive regulation of interleukin-6 biosynthetic process	BP
3	8	1.90678582092	-	2.57e-02	GO:0032330	regulation of chondrocyte differentiation	BP
3	8	1.90678582092	-	2.57e-02	GO:1901380	negative regulation of potassium ion transmembrane transport	BP
3	8	1.90678582092	-	2.57e-02	GO:0060982	coronary artery morphogenesis	BP
3	8	1.90678582092	-	2.57e-02	GO:0000076	DNA replication checkpoint	BP
3	8	1.90678582092	-	2.57e-02	GO:1901017	negative regulation of potassium ion transmembrane transporter activity	BP
3	8	1.90678582092	-	2.57e-02	GO:0015889	cobalamin transport	BP
3	8	1.90678582092	-	2.57e-02	GO:1901409	positive regulation of phosphorylation of RNA polymerase II C-terminal domain	BP
3	8	1.90678582092	-	2.57e-02	GO:0035912	dorsal aorta morphogenesis	BP
3	8	1.90678582092	-	2.57e-02	GO:0071316	cellular response to nicotine	BP
3	8	1.90678582092	-	3.81e-02	GO:0033173	calcineurin-NFAT signaling cascade	BP
3	8	1.90678582092	-	3.81e-02	GO:0035234	ectopic germ cell programmed cell death	BP
3	8	1.90678582092	-	3.81e-02	GO:0010544	negative regulation of platelet activation	BP
3	8	1.90678582092	-	3.81e-02	GO:2000587	negative regulation of platelet-derived growth factor receptor-beta signaling pathway	BP
3	8	1.90678582092	-	3.81e-02	GO:0035457	cellular response to interferon-alpha	BP
3	8	1.90678582092	-	3.81e-02	GO:1900119	positive regulation of execution phase of apoptosis	BP
3	8	1.90678582092	-	3.81e-02	GO:0060396	growth hormone receptor signaling pathway	BP
3	8	1.90678582092	-	3.81e-02	GO:0034720	histone H3-K4 demethylation	BP
3	8	1.90678582092	-	3.81e-02	GO:0021795	cerebral cortex cell migration	BP
3	8	1.90678582092	-	3.81e-02	GO:0032872	regulation of stress-activated MAPK cascade	BP
3	8	1.90678582092	-	3.81e-02	GO:0050891	multicellular organismal water homeostasis	BP
6	16	1.90678582092	-	3.28e-03	GO:0008353	RNA polymerase II carboxy-terminal domain kinase activity	MF
3	8	1.90678582092	-	8.55e-03	GO:0019213	deacetylase activity	MF
3	8	1.90678582092	-	2.57e-02	GO:0017151	DEAD/H-box RNA helicase binding	MF
3	8	1.90678582092	-	3.81e-02	GO:0008140	cAMP response element binding protein binding	MF
3	8	1.90678582092	-	3.81e-02	GO:0001135	transcription factor activity, RNA polymerase II transcription factor recruiting	MF
16	43	1.8955585655	-	8.36e-07	GO:1901215	negative regulation of neuron death	BP
13	35	1.8929800214	-	5.32e-06	GO:0045787	positive regulation of cell cycle	BP
17	46	1.88572420539	-	2.03e-07	GO:0046332	SMAD binding	MF
48	130	1.88441800789	-	5.75e-11	GO:0042393	histone binding	MF
14	38	1.88125072882	-	4.28e-06	GO:0038128	ERBB2 signaling pathway	BP
7	19	1.88125072882	-	1.79e-04	GO:0002052	positive regulation of neuroblast proliferation	BP
7	19	1.88125072882	-	1.16e-03	GO:0030099	myeloid cell differentiation	BP
15	41	1.87116191119	-	1.03e-06	GO:0010718	positive regulation of epithelial to mesenchymal transition	BP
78	214	1.86575855266	-	7.16e-11	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	MF
4	11	1.86239170156	-	2.72e-03	GO:0042551	neuron maturation	BP
4	11	1.86239170156	-	5.01e-03	GO:0030857	negative regulation of epithelial cell differentiation	BP
4	11	1.86239170156	-	5.01e-03	GO:0043586	tongue development	BP
4	11	1.86239170156	-	8.31e-03	GO:0030278	regulation of ossification	BP
4	11	1.86239170156	-	8.31e-03	GO:0032703	negative regulation of interleukin-2 production	BP
4	11	1.86239170156	-	8.31e-03	GO:0001893	maternal placenta development	BP
4	11	1.86239170156	-	8.31e-03	GO:0010867	positive regulation of triglyceride biosynthetic process	BP
4	11	1.86239170156	-	1.28e-02	GO:0060272	embryonic skeletal joint morphogenesis	BP
4	11	1.86239170156	-	1.28e-02	GO:0055015	ventricular cardiac muscle cell development	BP
4	11	1.86239170156	-	1.28e-02	GO:0042445	hormone metabolic process	BP
4	11	1.86239170156	-	1.28e-02	GO:0019068	virion assembly	BP
4	11	1.86239170156	-	1.85e-02	GO:0010884	positive regulation of lipid storage	BP
4	11	1.86239170156	-	1.85e-02	GO:0003279	cardiac septum development	BP
4	11	1.86239170156	-	1.85e-02	GO:0045637	regulation of myeloid cell differentiation	BP
4	11	1.86239170156	-	1.85e-02	GO:0048712	negative regulation of astrocyte differentiation	BP
4	11	1.86239170156	-	1.85e-02	GO:0000302	response to reactive oxygen species	BP
4	11	1.86239170156	-	1.85e-02	GO:0032727	positive regulation of interferon-alpha production	BP
4	11	1.86239170156	-	8.31e-03	GO:0001206	transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
4	11	1.86239170156	-	1.28e-02	GO:0042054	histone methyltransferase activity	MF
4	11	1.86239170156	-	1.85e-02	GO:0008066	glutamate receptor activity	MF
41	113	1.8591963624	-	5.54e-11	GO:0006334	nucleosome assembly	BP
25	69	1.8571550532	-	6.90e-10	GO:0018107	peptidyl-threonine phosphorylation	BP
17	47	1.85469730977	-	6.56e-07	GO:0016575	histone deacetylation	BP
48	133	1.85150338542	-	5.05e-11	GO:0001078	transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
9	25	1.84789213187	-	3.16e-04	GO:0071889	14-3-3 protein binding	MF
29	81	1.83995431244	-	2.51e-10	GO:0060964	regulation of gene silencing by miRNA	BP
5	14	1.83639649303	-	2.74e-03	GO:0003407	neural retina development	BP
5	14	1.83639649303	-	2.74e-03	GO:0061045	negative regulation of wound healing	BP
5	14	1.83639649303	-	4.31e-03	GO:1900153	positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	BP
5	14	1.83639649303	-	4.31e-03	GO:0042325	regulation of phosphorylation	BP
5	14	1.83639649303	-	6.43e-03	GO:0001678	cellular glucose homeostasis	BP
5	14	1.83639649303	-	9.20e-03	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	BP
5	14	1.83639649303	-	9.20e-03	GO:0042953	lipoprotein transport	BP
5	14	1.83639649303	-	9.20e-03	GO:0043518	negative regulation of DNA damage response, signal transduction by p53 class mediator	BP
5	14	1.83639649303	-	6.43e-03	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	MF
5	14	1.83639649303	-	9.20e-03	GO:0031434	mitogen-activated protein kinase kinase binding	MF
5	14	1.83639649303	-	9.20e-03	GO:1990381	ubiquitin-specific protease binding	MF
5	14	1.83639649303	-	9.20e-03	GO:0070063	RNA polymerase binding	MF
11	31	1.82705862845	-	2.76e-05	GO:0060412	ventricular septum morphogenesis	BP
11	31	1.82705862845	-	1.23e-04	GO:0031663	lipopolysaccharide-mediated signaling pathway	BP
6	17	1.81932297967	-	9.14e-04	GO:0001953	negative regulation of cell-matrix adhesion	BP
6	17	1.81932297967	-	1.46e-03	GO:0061178	regulation of insulin secretion involved in cellular response to glucose stimulus	BP
6	17	1.81932297967	-	2.24e-03	GO:0001702	gastrulation with mouth forming second	BP
6	17	1.81932297967	-	2.24e-03	GO:0034375	high-density lipoprotein particle remodeling	BP
6	17	1.81932297967	-	3.28e-03	GO:0032479	regulation of type I interferon production	BP
26	74	1.81280967271	-	3.05e-11	GO:0007623	circadian rhythm	BP
21	60	1.80725014737	-	5.35e-08	GO:0070301	cellular response to hydrogen peroxide	BP
14	40	1.80725014737	-	8.99e-06	GO:0031648	protein destabilization	BP
10	29	1.78577041996	-	5.10e-05	GO:0001569	branching involved in blood vessel morphogenesis	BP
10	29	1.78577041996	-	1.66e-04	GO:1903146	regulation of autophagy of mitochondrion	BP
10	29	1.78577041996	-	1.15e-04	GO:0001103	RNA polymerase II repressing transcription factor binding	MF
11	32	1.78125493884	-	7.01e-06	GO:0048701	embryonic cranial skeleton morphogenesis	BP
11	32	1.78125493884	-	8.71e-05	GO:0043967	histone H4 acetylation	BP
11	32	1.78125493884	-	1.23e-04	GO:0051879	Hsp90 protein binding	MF
348	1041	1.74101246275	-	2.92e-10	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	BP
252	755	1.73877040949	-	3.25e-10	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	BP
10	30	1.73686081948	-	2.35e-04	GO:0090503	RNA phosphodiester bond hydrolysis, exonucleolytic	BP
5	15	1.73686081948	-	8.86e-04	GO:0010831	positive regulation of myotube differentiation	BP
5	15	1.73686081948	-	6.43e-03	GO:0007548	sex differentiation	BP
5	15	1.73686081948	-	9.20e-03	GO:0080182	histone H3-K4 trimethylation	BP
5	15	1.73686081948	-	9.20e-03	GO:0033146	regulation of intracellular estrogen receptor signaling pathway	BP
5	15	1.73686081948	-	9.20e-03	GO:0097067	cellular response to thyroid hormone stimulus	BP
5	15	1.73686081948	-	9.20e-03	GO:0014898	cardiac muscle hypertrophy in response to stress	BP
5	15	1.73686081948	-	9.20e-03	GO:0030330	DNA damage response, signal transduction by p53 class mediator	BP
5	15	1.73686081948	-	9.20e-03	GO:0051412	response to corticosterone	BP
5	15	1.73686081948	-	1.27e-02	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	BP
5	15	1.73686081948	-	1.27e-02	GO:0043982	histone H4-K8 acetylation	BP
5	15	1.73686081948	-	1.27e-02	GO:0043981	histone H4-K5 acetylation	BP
12	36	1.73686081948	-	6.44e-05	GO:0001837	epithelial to mesenchymal transition	BP
8	24	1.73686081948	-	8.69e-04	GO:0055007	cardiac muscle cell differentiation	BP
4	12	1.73686081948	-	1.27e-03	GO:0042738	exogenous drug catabolic process	BP
6	18	1.73686081948	-	1.46e-03	GO:0030279	negative regulation of ossification	BP
6	18	1.73686081948	-	2.24e-03	GO:0002076	osteoblast development	BP
6	18	1.73686081948	-	2.24e-03	GO:0032331	negative regulation of chondrocyte differentiation	BP
6	18	1.73686081948	-	4.64e-03	GO:0007250	activation of NF-kappaB-inducing kinase activity	BP
6	18	1.73686081948	-	4.64e-03	GO:0030225	macrophage differentiation	BP
6	18	1.73686081948	-	4.64e-03	GO:0009416	response to light stimulus	BP
4	12	1.73686081948	-	5.01e-03	GO:0045723	positive regulation of fatty acid biosynthetic process	BP
4	12	1.73686081948	-	5.01e-03	GO:0046889	positive regulation of lipid biosynthetic process	BP
6	18	1.73686081948	-	6.38e-03	GO:0010039	response to iron ion	BP
4	12	1.73686081948	-	1.28e-02	GO:0043616	keratinocyte proliferation	BP
4	12	1.73686081948	-	1.28e-02	GO:0042592	homeostatic process	BP
3	9	1.73686081948	-	1.58e-02	GO:0055091	phospholipid homeostasis	BP
3	9	1.73686081948	-	1.58e-02	GO:0070989	oxidative demethylation	BP
4	12	1.73686081948	-	1.85e-02	GO:0045651	positive regulation of macrophage differentiation	BP
4	12	1.73686081948	-	1.85e-02	GO:0043922	negative regulation by host of viral transcription	BP
4	12	1.73686081948	-	1.85e-02	GO:0060425	lung morphogenesis	BP
4	12	1.73686081948	-	1.85e-02	GO:0032495	response to muramyl dipeptide	BP
4	12	1.73686081948	-	1.85e-02	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling	BP
4	12	1.73686081948	-	1.85e-02	GO:0060218	hematopoietic stem cell differentiation	BP
4	12	1.73686081948	-	2.56e-02	GO:0021819	layer formation in cerebral cortex	BP
4	12	1.73686081948	-	2.56e-02	GO:0051457	maintenance of protein location in nucleus	BP
4	12	1.73686081948	-	2.56e-02	GO:0061014	positive regulation of mRNA catabolic process	BP
4	12	1.73686081948	-	2.56e-02	GO:0036499	PERK-mediated unfolded protein response	BP
4	12	1.73686081948	-	2.56e-02	GO:0048821	erythrocyte development	BP
4	12	1.73686081948	-	2.56e-02	GO:0035518	histone H2A monoubiquitination	BP
4	12	1.73686081948	-	2.56e-02	GO:0021954	central nervous system neuron development	BP
3	9	1.73686081948	-	2.57e-02	GO:0042118	endothelial cell activation	BP
3	9	1.73686081948	-	2.57e-02	GO:0030903	notochord development	BP
3	9	1.73686081948	-	2.57e-02	GO:0010907	positive regulation of glucose metabolic process	BP
3	9	1.73686081948	-	2.57e-02	GO:0097011	cellular response to granulocyte macrophage colony-stimulating factor stimulus	BP
2	6	1.73686081948	-	2.80e-02	GO:0042737	drug catabolic process	BP
2	6	1.73686081948	-	2.80e-02	GO:0007635	chemosensory behavior	BP
2	6	1.73686081948	-	2.80e-02	GO:0046483	heterocycle metabolic process	BP
3	9	1.73686081948	-	3.81e-02	GO:0019953	sexual reproduction	BP
3	9	1.73686081948	-	3.81e-02	GO:0032731	positive regulation of interleukin-1 beta production	BP
3	9	1.73686081948	-	3.81e-02	GO:0042473	outer ear morphogenesis	BP
3	9	1.73686081948	-	3.81e-02	GO:1990403	embryonic brain development	BP
3	9	1.73686081948	-	3.81e-02	GO:1990314	cellular response to insulin-like growth factor stimulus	BP
3	9	1.73686081948	-	3.81e-02	GO:0090073	positive regulation of protein homodimerization activity	BP
3	9	1.73686081948	-	3.81e-02	GO:0006353	DNA-templated transcription, termination	BP
3	9	1.73686081948	-	3.81e-02	GO:0042754	negative regulation of circadian rhythm	BP
3	9	1.73686081948	-	3.81e-02	GO:0007614	short-term memory	BP
3	9	1.73686081948	-	3.81e-02	GO:0042088	T-helper 1 type immune response	BP
2	6	1.73686081948	-	5.23e-02	GO:2001054	negative regulation of mesenchymal cell apoptotic process	BP
2	6	1.73686081948	-	5.23e-02	GO:0021930	cerebellar granule cell precursor proliferation	BP
2	6	1.73686081948	-	5.23e-02	GO:0030856	regulation of epithelial cell differentiation	BP
2	6	1.73686081948	-	5.23e-02	GO:0045743	positive regulation of fibroblast growth factor receptor signaling pathway	BP
2	6	1.73686081948	-	5.23e-02	GO:0002933	lipid hydroxylation	BP
3	9	1.73686081948	-	5.29e-02	GO:0060261	positive regulation of transcription initiation from RNA polymerase II promoter	BP
3	9	1.73686081948	-	5.29e-02	GO:0031053	primary miRNA processing	BP
3	9	1.73686081948	-	5.29e-02	GO:0050687	negative regulation of defense response to virus	BP
3	9	1.73686081948	-	5.29e-02	GO:0050880	regulation of blood vessel size	BP
3	9	1.73686081948	-	5.29e-02	GO:0050774	negative regulation of dendrite morphogenesis	BP
3	9	1.73686081948	-	5.29e-02	GO:1903827	regulation of cellular protein localization	BP
3	9	1.73686081948	-	5.29e-02	GO:0050807	regulation of synapse organization	BP
3	9	1.73686081948	-	5.29e-02	GO:0060670	branching involved in labyrinthine layer morphogenesis	BP
3	9	1.73686081948	-	5.29e-02	GO:0006265	DNA topological change	BP
3	9	1.73686081948	-	5.29e-02	GO:0043589	skin morphogenesis	BP
3	9	1.73686081948	-	5.29e-02	GO:0031497	chromatin assembly	BP
3	9	1.73686081948	-	5.29e-02	GO:0045080	positive regulation of chemokine biosynthetic process	BP
2	6	1.73686081948	-	8.14e-02	GO:0090344	negative regulation of cell aging	BP
2	6	1.73686081948	-	8.14e-02	GO:1902254	negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
2	6	1.73686081948	-	8.14e-02	GO:0030579	ubiquitin-dependent SMAD protein catabolic process	BP
2	6	1.73686081948	-	8.14e-02	GO:0003179	heart valve morphogenesis	BP
2	6	1.73686081948	-	8.14e-02	GO:0045953	negative regulation of natural killer cell mediated cytotoxicity	BP
2	6	1.73686081948	-	8.14e-02	GO:1901621	negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	BP
2	6	1.73686081948	-	8.14e-02	GO:0042536	negative regulation of tumor necrosis factor biosynthetic process	BP
2	6	1.73686081948	-	8.14e-02	GO:0048525	negative regulation of viral process	BP
2	6	1.73686081948	-	8.14e-02	GO:0060372	regulation of atrial cardiac muscle cell membrane repolarization	BP
2	6	1.73686081948	-	8.14e-02	GO:2000553	positive regulation of T-helper 2 cell cytokine production	BP
2	6	1.73686081948	-	8.14e-02	GO:0061180	mammary gland epithelium development	BP
2	6	1.73686081948	-	8.14e-02	GO:0072540	T-helper 17 cell lineage commitment	BP
2	6	1.73686081948	-	8.14e-02	GO:2000780	negative regulation of double-strand break repair	BP
2	6	1.73686081948	-	8.14e-02	GO:0021984	adenohypophysis development	BP
2	6	1.73686081948	-	8.14e-02	GO:0010631	epithelial cell migration	BP
2	6	1.73686081948	-	8.14e-02	GO:0032717	negative regulation of interleukin-8 production	BP
2	6	1.73686081948	-	8.14e-02	GO:0035315	hair cell differentiation	BP
2	6	1.73686081948	-	8.14e-02	GO:0033211	adiponectin-activated signaling pathway	BP
2	6	1.73686081948	-	8.14e-02	GO:0042415	norepinephrine metabolic process	BP
2	6	1.73686081948	-	8.14e-02	GO:0051150	regulation of smooth muscle cell differentiation	BP
2	6	1.73686081948	-	8.14e-02	GO:0045719	negative regulation of glycogen biosynthetic process	BP
1	3	1.73686081948	-	1.00e-01	GO:0070172	positive regulation of tooth mineralization	BP
1	3	1.73686081948	-	1.00e-01	GO:2000721	positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation	BP
1	3	1.73686081948	-	1.00e-01	GO:0006670	sphingosine metabolic process	BP
1	3	1.73686081948	-	1.00e-01	GO:0060980	cell migration involved in coronary vasculogenesis	BP
1	3	1.73686081948	-	1.00e-01	GO:0030858	positive regulation of epithelial cell differentiation	BP
1	3	1.73686081948	-	1.00e-01	GO:0036378	calcitriol biosynthetic process from calciol	BP
1	3	1.73686081948	-	1.00e-01	GO:0060005	vestibular reflex	BP
1	3	1.73686081948	-	1.00e-01	GO:0015917	aminophospholipid transport	BP
1	3	1.73686081948	-	1.00e-01	GO:0030886	negative regulation of myeloid dendritic cell activation	BP
1	3	1.73686081948	-	1.00e-01	GO:0006082	organic acid metabolic process	BP
2	6	1.73686081948	-	1.14e-01	GO:0042092	type 2 immune response	BP
2	6	1.73686081948	-	1.14e-01	GO:0000423	mitophagy	BP
2	6	1.73686081948	-	1.14e-01	GO:0046632	alpha-beta T cell differentiation	BP
2	6	1.73686081948	-	1.14e-01	GO:0098532	histone H3-K27 trimethylation	BP
2	6	1.73686081948	-	1.14e-01	GO:0010564	regulation of cell cycle process	BP
2	6	1.73686081948	-	1.14e-01	GO:1902533	positive regulation of intracellular signal transduction	BP
2	6	1.73686081948	-	1.14e-01	GO:0070816	phosphorylation of RNA polymerase II C-terminal domain	BP
2	6	1.73686081948	-	1.14e-01	GO:0071559	response to transforming growth factor beta	BP
2	6	1.73686081948	-	1.14e-01	GO:0038202	TORC1 signaling	BP
2	6	1.73686081948	-	1.14e-01	GO:1900272	negative regulation of long-term synaptic potentiation	BP
2	6	1.73686081948	-	1.14e-01	GO:1900271	regulation of long-term synaptic potentiation	BP
2	6	1.73686081948	-	1.14e-01	GO:0002740	negative regulation of cytokine secretion involved in immune response	BP
2	6	1.73686081948	-	1.14e-01	GO:0036465	synaptic vesicle recycling	BP
2	6	1.73686081948	-	1.14e-01	GO:0055013	cardiac muscle cell development	BP
2	6	1.73686081948	-	1.14e-01	GO:2000323	negative regulation of glucocorticoid receptor signaling pathway	BP
2	6	1.73686081948	-	1.14e-01	GO:0010835	regulation of protein ADP-ribosylation	BP
2	6	1.73686081948	-	1.14e-01	GO:0070734	histone H3-K27 methylation	BP
2	6	1.73686081948	-	1.14e-01	GO:0034620	cellular response to unfolded protein	BP
2	6	1.73686081948	-	1.14e-01	GO:0003309	type B pancreatic cell differentiation	BP
2	6	1.73686081948	-	1.14e-01	GO:1904417	positive regulation of xenophagy	BP
2	6	1.73686081948	-	1.14e-01	GO:0044794	positive regulation by host of viral process	BP
2	6	1.73686081948	-	1.14e-01	GO:0010216	maintenance of DNA methylation	BP
2	6	1.73686081948	-	1.14e-01	GO:0045639	positive regulation of myeloid cell differentiation	BP
2	6	1.73686081948	-	1.14e-01	GO:2000667	positive regulation of interleukin-13 secretion	BP
2	6	1.73686081948	-	1.14e-01	GO:0097084	vascular smooth muscle cell development	BP
2	6	1.73686081948	-	1.14e-01	GO:0003158	endothelium development	BP
2	6	1.73686081948	-	1.14e-01	GO:0051702	interaction with symbiont	BP
2	6	1.73686081948	-	1.14e-01	GO:0060363	cranial suture morphogenesis	BP
2	6	1.73686081948	-	1.14e-01	GO:0051932	synaptic transmission, GABAergic	BP
2	6	1.73686081948	-	1.14e-01	GO:0071470	cellular response to osmotic stress	BP
2	6	1.73686081948	-	1.14e-01	GO:0048668	collateral sprouting	BP
2	6	1.73686081948	-	1.14e-01	GO:0046929	negative regulation of neurotransmitter secretion	BP
2	6	1.73686081948	-	1.14e-01	GO:0001553	luteinization	BP
2	6	1.73686081948	-	1.14e-01	GO:0033210	leptin-mediated signaling pathway	BP
2	6	1.73686081948	-	1.14e-01	GO:0045661	regulation of myoblast differentiation	BP
2	6	1.73686081948	-	1.14e-01	GO:0007182	common-partner SMAD protein phosphorylation	BP
2	6	1.73686081948	-	1.14e-01	GO:0033194	response to hydroperoxide	BP
2	6	1.73686081948	-	1.14e-01	GO:0031087	deadenylation-independent decapping of nuclear-transcribed mRNA	BP
1	3	1.73686081948	-	1.90e-01	GO:0021524	visceral motor neuron differentiation	BP
1	3	1.73686081948	-	1.90e-01	GO:0070561	vitamin D receptor signaling pathway	BP
1	3	1.73686081948	-	1.90e-01	GO:0046639	negative regulation of alpha-beta T cell differentiation	BP
1	3	1.73686081948	-	1.90e-01	GO:1901078	negative regulation of relaxation of muscle	BP
1	3	1.73686081948	-	1.90e-01	GO:1905748	hard palate morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:1905747	negative regulation of saliva secretion	BP
1	3	1.73686081948	-	1.90e-01	GO:1900625	positive regulation of monocyte aggregation	BP
1	3	1.73686081948	-	1.90e-01	GO:0045959	negative regulation of complement activation, classical pathway	BP
1	3	1.73686081948	-	1.90e-01	GO:1901201	regulation of extracellular matrix assembly	BP
1	3	1.73686081948	-	1.90e-01	GO:0071224	cellular response to peptidoglycan	BP
1	3	1.73686081948	-	1.90e-01	GO:0060066	oviduct development	BP
1	3	1.73686081948	-	1.90e-01	GO:0045726	positive regulation of integrin biosynthetic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0072278	metanephric comma-shaped body morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0072102	glomerulus morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0010387	COP9 signalosome assembly	BP
1	3	1.73686081948	-	1.90e-01	GO:0001781	neutrophil apoptotic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0061031	endodermal digestive tract morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:2000078	positive regulation of type B pancreatic cell development	BP
1	3	1.73686081948	-	1.90e-01	GO:0046167	glycerol-3-phosphate biosynthetic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0070859	positive regulation of bile acid biosynthetic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0051246	regulation of protein metabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0010482	regulation of epidermal cell division	BP
1	3	1.73686081948	-	1.90e-01	GO:0045607	regulation of auditory receptor cell differentiation	BP
1	3	1.73686081948	-	1.90e-01	GO:0051797	regulation of hair follicle development	BP
1	3	1.73686081948	-	1.90e-01	GO:0003278	apoptotic process involved in heart morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0055014	atrial cardiac muscle cell development	BP
1	3	1.73686081948	-	1.90e-01	GO:0060916	mesenchymal cell proliferation involved in lung development	BP
1	3	1.73686081948	-	1.90e-01	GO:1900425	negative regulation of defense response to bacterium	BP
1	3	1.73686081948	-	1.90e-01	GO:0072050	S-shaped body morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0021533	cell differentiation in hindbrain	BP
1	3	1.73686081948	-	1.90e-01	GO:0009822	alkaloid catabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0071626	mastication	BP
1	3	1.73686081948	-	1.90e-01	GO:0035470	positive regulation of vascular wound healing	BP
1	3	1.73686081948	-	1.90e-01	GO:0044336	canonical Wnt signaling pathway involved in negative regulation of apoptotic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0032787	monocarboxylic acid metabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:1904000	positive regulation of eating behavior	BP
1	3	1.73686081948	-	1.90e-01	GO:0098583	learned vocalization behavior	BP
1	3	1.73686081948	-	1.90e-01	GO:0010573	vascular endothelial growth factor production	BP
1	3	1.73686081948	-	1.90e-01	GO:0034436	glycoprotein transport	BP
1	3	1.73686081948	-	1.90e-01	GO:0051490	negative regulation of filopodium assembly	BP
1	3	1.73686081948	-	1.90e-01	GO:1903426	regulation of reactive oxygen species biosynthetic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0019230	proprioception	BP
1	3	1.73686081948	-	1.90e-01	GO:0070633	transepithelial transport	BP
1	3	1.73686081948	-	1.90e-01	GO:0033076	isoquinoline alkaloid metabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0031344	regulation of cell projection organization	BP
1	3	1.73686081948	-	1.90e-01	GO:0010980	positive regulation of vitamin D 24-hydroxylase activity	BP
1	3	1.73686081948	-	1.90e-01	GO:0009957	epidermal cell fate specification	BP
1	3	1.73686081948	-	1.90e-01	GO:0021544	subpallium development	BP
1	3	1.73686081948	-	1.90e-01	GO:0014809	regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion	BP
1	3	1.73686081948	-	1.90e-01	GO:0003408	optic cup formation involved in camera-type eye development	BP
1	3	1.73686081948	-	1.90e-01	GO:0007418	ventral midline development	BP
1	3	1.73686081948	-	1.90e-01	GO:0044242	cellular lipid catabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0010909	positive regulation of heparan sulfate proteoglycan biosynthetic process	BP
1	3	1.73686081948	-	1.90e-01	GO:1905075	positive regulation of occluding junction disassembly	BP
1	3	1.73686081948	-	1.90e-01	GO:0021502	neural fold elevation formation	BP
1	3	1.73686081948	-	1.90e-01	GO:0035873	lactate transmembrane transport	BP
1	3	1.73686081948	-	1.90e-01	GO:0003192	mitral valve formation	BP
1	3	1.73686081948	-	1.90e-01	GO:0030104	water homeostasis	BP
1	3	1.73686081948	-	1.90e-01	GO:0032696	negative regulation of interleukin-13 production	BP
1	3	1.73686081948	-	1.90e-01	GO:0060947	cardiac vascular smooth muscle cell differentiation	BP
1	3	1.73686081948	-	1.90e-01	GO:0060940	epithelial to mesenchymal transition involved in cardiac fibroblast development	BP
1	3	1.73686081948	-	1.90e-01	GO:1900042	positive regulation of interleukin-2 secretion	BP
1	3	1.73686081948	-	1.90e-01	GO:1902990	mitotic telomere maintenance via semi-conservative replication	BP
1	3	1.73686081948	-	1.90e-01	GO:0061113	pancreas morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0006576	cellular biogenic amine metabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0002820	negative regulation of adaptive immune response	BP
1	3	1.73686081948	-	1.90e-01	GO:0010636	positive regulation of mitochondrial fusion	BP
1	3	1.73686081948	-	1.90e-01	GO:0070970	interleukin-2 secretion	BP
1	3	1.73686081948	-	1.90e-01	GO:0000305	response to oxygen radical	BP
1	3	1.73686081948	-	1.90e-01	GO:0003350	pulmonary myocardium development	BP
1	3	1.73686081948	-	1.90e-01	GO:0034766	negative regulation of ion transmembrane transport	BP
1	3	1.73686081948	-	1.90e-01	GO:0046340	diacylglycerol catabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0046885	regulation of hormone biosynthetic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0060486	Clara cell differentiation	BP
1	3	1.73686081948	-	1.90e-01	GO:0090271	positive regulation of fibroblast growth factor production	BP
1	3	1.73686081948	-	1.90e-01	GO:0072049	comma-shaped body morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0035411	catenin import into nucleus	BP
1	3	1.73686081948	-	1.90e-01	GO:0036023	embryonic skeletal limb joint morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:1902617	response to fluoride	BP
1	3	1.73686081948	-	1.90e-01	GO:0042668	auditory receptor cell fate determination	BP
1	3	1.73686081948	-	1.90e-01	GO:0072044	collecting duct development	BP
1	3	1.73686081948	-	1.90e-01	GO:0048634	regulation of muscle organ development	BP
1	3	1.73686081948	-	1.90e-01	GO:0072133	metanephric mesenchyme morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0072136	metanephric mesenchymal cell proliferation involved in metanephros development	BP
1	3	1.73686081948	-	1.90e-01	GO:1904339	negative regulation of dopaminergic neuron differentiation	BP
1	3	1.73686081948	-	1.90e-01	GO:0061009	common bile duct development	BP
1	3	1.73686081948	-	1.90e-01	GO:0050893	sensory processing	BP
1	3	1.73686081948	-	1.90e-01	GO:1900106	positive regulation of hyaluranon cable assembly	BP
1	3	1.73686081948	-	1.90e-01	GO:0072718	response to cisplatin	BP
1	3	1.73686081948	-	1.90e-01	GO:0050954	sensory perception of mechanical stimulus	BP
1	3	1.73686081948	-	1.90e-01	GO:0042461	photoreceptor cell development	BP
1	3	1.73686081948	-	1.90e-01	GO:0060523	prostate epithelial cord elongation	BP
1	3	1.73686081948	-	1.90e-01	GO:0042427	serotonin biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0034381	plasma lipoprotein particle clearance	BP
1	3	1.73686081948	-	2.71e-01	GO:2000819	regulation of nucleotide-excision repair	BP
1	3	1.73686081948	-	2.71e-01	GO:0033262	regulation of nuclear cell cycle DNA replication	BP
1	3	1.73686081948	-	2.71e-01	GO:0035993	deltoid tuberosity development	BP
1	3	1.73686081948	-	2.71e-01	GO:0043418	homocysteine catabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:1902255	positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	3	1.73686081948	-	2.71e-01	GO:0044346	fibroblast apoptotic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0060350	endochondral bone morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0060492	lung induction	BP
1	3	1.73686081948	-	2.71e-01	GO:0060491	regulation of cell projection assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	BP
1	3	1.73686081948	-	2.71e-01	GO:2001015	negative regulation of skeletal muscle cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0001773	myeloid dendritic cell activation	BP
1	3	1.73686081948	-	2.71e-01	GO:0044774	mitotic DNA integrity checkpoint	BP
1	3	1.73686081948	-	2.71e-01	GO:0090261	positive regulation of inclusion body assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0008218	bioluminescence	BP
1	3	1.73686081948	-	2.71e-01	GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:1903748	negative regulation of establishment of protein localization to mitochondrion	BP
1	3	1.73686081948	-	2.71e-01	GO:1904031	positive regulation of cyclin-dependent protein kinase activity	BP
1	3	1.73686081948	-	2.71e-01	GO:0099566	regulation of postsynaptic cytosolic calcium ion concentration	BP
1	3	1.73686081948	-	2.71e-01	GO:0007113	endomitotic cell cycle	BP
1	3	1.73686081948	-	2.71e-01	GO:0038091	positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0098908	regulation of neuronal action potential	BP
1	3	1.73686081948	-	2.71e-01	GO:0031587	positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	BP
1	3	1.73686081948	-	2.71e-01	GO:0002669	positive regulation of T cell anergy	BP
1	3	1.73686081948	-	2.71e-01	GO:1903208	negative regulation of hydrogen peroxide-induced neuron death	BP
1	3	1.73686081948	-	2.71e-01	GO:0014005	microglia development	BP
1	3	1.73686081948	-	2.71e-01	GO:0072331	signal transduction by p53 class mediator	BP
1	3	1.73686081948	-	2.71e-01	GO:0007500	mesodermal cell fate determination	BP
1	3	1.73686081948	-	2.71e-01	GO:0072277	metanephric glomerular capillary formation	BP
1	3	1.73686081948	-	2.71e-01	GO:1902803	regulation of synaptic vesicle transport	BP
1	3	1.73686081948	-	2.71e-01	GO:0060024	rhythmic synaptic transmission	BP
1	3	1.73686081948	-	2.71e-01	GO:0097187	dentinogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0071386	cellular response to corticosterone stimulus	BP
1	3	1.73686081948	-	2.71e-01	GO:0048871	multicellular organismal homeostasis	BP
1	3	1.73686081948	-	2.71e-01	GO:0070602	regulation of centromeric sister chromatid cohesion	BP
1	3	1.73686081948	-	2.71e-01	GO:1901897	regulation of relaxation of cardiac muscle	BP
1	3	1.73686081948	-	2.71e-01	GO:0070487	monocyte aggregation	BP
1	3	1.73686081948	-	2.71e-01	GO:0060743	epithelial cell maturation involved in prostate gland development	BP
1	3	1.73686081948	-	2.71e-01	GO:0060741	prostate gland stromal morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0051612	negative regulation of serotonin uptake	BP
1	3	1.73686081948	-	2.71e-01	GO:0022028	tangential migration from the subventricular zone to the olfactory bulb	BP
1	3	1.73686081948	-	2.71e-01	GO:0035284	brain segmentation	BP
1	3	1.73686081948	-	2.71e-01	GO:0018158	protein oxidation	BP
1	3	1.73686081948	-	2.71e-01	GO:2000366	positive regulation of STAT protein import into nucleus	BP
1	3	1.73686081948	-	2.71e-01	GO:0021885	forebrain cell migration	BP
1	3	1.73686081948	-	2.71e-01	GO:0010766	negative regulation of sodium ion transport	BP
1	3	1.73686081948	-	2.71e-01	GO:0071899	negative regulation of estrogen receptor binding	BP
1	3	1.73686081948	-	2.71e-01	GO:0071895	odontoblast differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:1990737	response to manganese-induced endoplasmic reticulum stress	BP
1	3	1.73686081948	-	2.71e-01	GO:1903542	negative regulation of exosomal secretion	BP
1	3	1.73686081948	-	2.71e-01	GO:0001704	formation of primary germ layer	BP
1	3	1.73686081948	-	2.71e-01	GO:0036123	histone H3-K9 dimethylation	BP
1	3	1.73686081948	-	2.71e-01	GO:2000286	receptor internalization involved in canonical Wnt signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0051795	positive regulation of timing of catagen	BP
1	3	1.73686081948	-	2.71e-01	GO:2000619	negative regulation of histone H4-K16 acetylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0060923	cardiac muscle cell fate commitment	BP
1	3	1.73686081948	-	2.71e-01	GO:0032911	negative regulation of transforming growth factor beta1 production	BP
1	3	1.73686081948	-	2.71e-01	GO:0014854	response to inactivity	BP
1	3	1.73686081948	-	2.71e-01	GO:1902263	apoptotic process involved in embryonic digit morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0045069	regulation of viral genome replication	BP
1	3	1.73686081948	-	2.71e-01	GO:0090435	protein localization to nuclear envelope	BP
1	3	1.73686081948	-	2.71e-01	GO:0050803	regulation of synapse structure or activity	BP
1	3	1.73686081948	-	2.71e-01	GO:2001212	regulation of vasculogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0007352	zygotic specification of dorsal/ventral axis	BP
1	3	1.73686081948	-	2.71e-01	GO:1904715	negative regulation of chaperone-mediated autophagy	BP
1	3	1.73686081948	-	2.71e-01	GO:0033273	response to vitamin	BP
1	3	1.73686081948	-	2.71e-01	GO:0090259	regulation of retinal ganglion cell axon guidance	BP
1	3	1.73686081948	-	2.71e-01	GO:0048295	positive regulation of isotype switching to IgE isotypes	BP
1	3	1.73686081948	-	2.71e-01	GO:0048294	negative regulation of isotype switching to IgE isotypes	BP
1	3	1.73686081948	-	2.71e-01	GO:0035984	cellular response to trichostatin A	BP
1	3	1.73686081948	-	2.71e-01	GO:0048742	regulation of skeletal muscle fiber development	BP
1	3	1.73686081948	-	2.71e-01	GO:0045351	type I interferon biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0042816	vitamin B6 metabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:2001258	negative regulation of cation channel activity	BP
1	3	1.73686081948	-	2.71e-01	GO:0038162	erythropoietin-mediated signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0060374	mast cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0051365	cellular response to potassium ion starvation	BP
1	3	1.73686081948	-	2.71e-01	GO:1902186	regulation of viral release from host cell	BP
1	3	1.73686081948	-	2.71e-01	GO:0072193	ureter smooth muscle cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0000472	endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	BP
1	3	1.73686081948	-	2.71e-01	GO:1902306	negative regulation of sodium ion transmembrane transport	BP
1	3	1.73686081948	-	2.71e-01	GO:0009451	RNA modification	BP
1	3	1.73686081948	-	2.71e-01	GO:0098910	regulation of atrial cardiac muscle cell action potential	BP
1	3	1.73686081948	-	2.71e-01	GO:0098912	membrane depolarization during atrial cardiac muscle cell action potential	BP
1	3	1.73686081948	-	2.71e-01	GO:0010572	positive regulation of platelet activation	BP
1	3	1.73686081948	-	2.71e-01	GO:0044778	meiotic DNA integrity checkpoint	BP
1	3	1.73686081948	-	2.71e-01	GO:0034435	cholesterol esterification	BP
1	3	1.73686081948	-	2.71e-01	GO:0006549	isoleucine metabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0000255	allantoin metabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0060672	epithelial cell morphogenesis involved in placental branching	BP
1	3	1.73686081948	-	2.71e-01	GO:0060675	ureteric bud morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0048807	female genitalia morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0070671	response to interleukin-12	BP
1	3	1.73686081948	-	2.71e-01	GO:1901491	negative regulation of lymphangiogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:1904044	response to aldosterone	BP
1	3	1.73686081948	-	2.71e-01	GO:0003157	endocardium development	BP
1	3	1.73686081948	-	2.71e-01	GO:1902856	negative regulation of non-motile cilium assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0070434	positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0000350	generation of catalytic spliceosome for second transesterification step	BP
1	3	1.73686081948	-	2.71e-01	GO:0031630	regulation of synaptic vesicle fusion to presynaptic active zone membrane	BP
1	3	1.73686081948	-	2.71e-01	GO:0039530	MDA-5 signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0070358	actin polymerization-dependent cell motility	BP
1	3	1.73686081948	-	2.71e-01	GO:0060638	mesenchymal-epithelial cell signaling	BP
1	3	1.73686081948	-	2.71e-01	GO:0060633	negative regulation of transcription initiation from RNA polymerase II promoter	BP
1	3	1.73686081948	-	2.71e-01	GO:0051987	positive regulation of attachment of spindle microtubules to kinetochore	BP
1	3	1.73686081948	-	2.71e-01	GO:0002638	negative regulation of immunoglobulin production	BP
1	3	1.73686081948	-	2.71e-01	GO:1902108	regulation of mitochondrial membrane permeability involved in apoptotic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0070966	nuclear-transcribed mRNA catabolic process, no-go decay	BP
1	3	1.73686081948	-	2.71e-01	GO:0090245	axis elongation involved in somitogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0010641	positive regulation of platelet-derived growth factor receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0021587	cerebellum morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0030917	midbrain-hindbrain boundary development	BP
1	3	1.73686081948	-	2.71e-01	GO:0015966	diadenosine tetraphosphate biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0072092	ureteric bud invasion	BP
1	3	1.73686081948	-	2.71e-01	GO:0007006	mitochondrial membrane organization	BP
1	3	1.73686081948	-	2.71e-01	GO:0060800	regulation of cell differentiation involved in embryonic placenta development	BP
1	3	1.73686081948	-	2.71e-01	GO:0021545	cranial nerve development	BP
1	3	1.73686081948	-	2.71e-01	GO:1902951	negative regulation of dendritic spine maintenance	BP
1	3	1.73686081948	-	2.71e-01	GO:0032613	interleukin-10 production	BP
1	3	1.73686081948	-	2.71e-01	GO:1902897	regulation of postsynaptic density protein 95 clustering	BP
1	3	1.73686081948	-	2.71e-01	GO:0023021	termination of signal transduction	BP
1	3	1.73686081948	-	2.71e-01	GO:0021747	cochlear nucleus development	BP
1	3	1.73686081948	-	2.71e-01	GO:0090204	protein localization to nuclear pore	BP
1	3	1.73686081948	-	2.71e-01	GO:1903551	regulation of extracellular exosome assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0018312	peptidyl-serine ADP-ribosylation	BP
1	3	1.73686081948	-	2.71e-01	GO:2000291	regulation of myoblast proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:0030859	polarized epithelial cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0051788	response to misfolded protein	BP
1	3	1.73686081948	-	2.71e-01	GO:0010903	negative regulation of very-low-density lipoprotein particle remodeling	BP
1	3	1.73686081948	-	2.71e-01	GO:0002291	T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	BP
1	3	1.73686081948	-	2.71e-01	GO:2001170	negative regulation of ATP biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0048388	endosomal lumen acidification	BP
1	3	1.73686081948	-	2.71e-01	GO:0048385	regulation of retinoic acid receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0043988	histone H3-S28 phosphorylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0002902	regulation of B cell apoptotic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0002904	positive regulation of B cell apoptotic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0035166	post-embryonic hemopoiesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0072017	distal tubule development	BP
1	3	1.73686081948	-	2.71e-01	GO:0090135	actin filament branching	BP
1	3	1.73686081948	-	2.71e-01	GO:0099074	mitochondrion to lysosome transport	BP
1	3	1.73686081948	-	2.71e-01	GO:0032387	negative regulation of intracellular transport	BP
1	3	1.73686081948	-	2.71e-01	GO:1902275	regulation of chromatin organization	BP
1	3	1.73686081948	-	2.71e-01	GO:0018125	peptidyl-cysteine methylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0003190	atrioventricular valve formation	BP
1	3	1.73686081948	-	2.71e-01	GO:0060126	somatotropin secreting cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0002317	plasma cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0001754	eye photoreceptor cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0003274	endocardial cushion fusion	BP
1	3	1.73686081948	-	2.71e-01	GO:2000504	positive regulation of blood vessel remodeling	BP
1	3	1.73686081948	-	2.71e-01	GO:0033128	negative regulation of histone phosphorylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0060168	positive regulation of adenosine receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0035246	peptidyl-arginine N-methylation	BP
1	3	1.73686081948	-	2.71e-01	GO:1902037	negative regulation of hematopoietic stem cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:1902991	regulation of amyloid precursor protein catabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:2000544	regulation of endothelial cell chemotaxis to fibroblast growth factor	BP
1	3	1.73686081948	-	2.71e-01	GO:0034465	response to carbon monoxide	BP
1	3	1.73686081948	-	2.71e-01	GO:1902174	positive regulation of keratinocyte apoptotic process	BP
1	3	1.73686081948	-	2.71e-01	GO:1903598	positive regulation of gap junction assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0071475	cellular hyperosmotic salinity response	BP
1	3	1.73686081948	-	2.71e-01	GO:0033363	secretory granule organization	BP
1	3	1.73686081948	-	2.71e-01	GO:0032800	receptor biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0000819	sister chromatid segregation	BP
1	3	1.73686081948	-	2.71e-01	GO:0048625	myoblast fate commitment	BP
1	3	1.73686081948	-	2.71e-01	GO:0048541	Peyer's patch development	BP
1	3	1.73686081948	-	2.71e-01	GO:1900212	negative regulation of mesenchymal cell apoptotic process involved in metanephros development	BP
1	3	1.73686081948	-	2.71e-01	GO:0045123	cellular extravasation	BP
1	3	1.73686081948	-	2.71e-01	GO:0048858	cell projection morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:1905144	response to acetylcholine	BP
1	3	1.73686081948	-	2.71e-01	GO:0031998	regulation of fatty acid beta-oxidation	BP
1	3	1.73686081948	-	2.71e-01	GO:0072125	negative regulation of glomerular mesangial cell proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:0045163	clustering of voltage-gated potassium channels	BP
1	3	1.73686081948	-	2.71e-01	GO:2000195	negative regulation of female gonad development	BP
1	3	1.73686081948	-	2.71e-01	GO:0071733	transcriptional activation by promoter-enhancer looping	BP
1	3	1.73686081948	-	2.71e-01	GO:0060763	mammary duct terminal end bud growth	BP
1	3	1.73686081948	-	2.71e-01	GO:0001555	oocyte growth	BP
1	3	1.73686081948	-	2.71e-01	GO:2000058	regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0034201	response to oleic acid	BP
1	3	1.73686081948	-	2.71e-01	GO:0045682	regulation of epidermis development	BP
1	3	1.73686081948	-	2.71e-01	GO:0030888	regulation of B cell proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:0033687	osteoblast proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:0021553	olfactory nerve development	BP
1	3	1.73686081948	-	2.71e-01	GO:0060399	positive regulation of growth hormone receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:1905232	cellular response to L-glutamate	BP
1	3	1.73686081948	-	2.71e-01	GO:0032608	interferon-beta production	BP
1	3	1.73686081948	-	2.71e-01	GO:0032602	chemokine production	BP
1	3	1.73686081948	-	2.71e-01	GO:0009648	photoperiodism	BP
1	3	1.73686081948	-	2.71e-01	GO:1901315	negative regulation of histone H2A K63-linked ubiquitination	BP
1	3	1.73686081948	-	2.71e-01	GO:0002118	aggressive behavior	BP
1	3	1.73686081948	-	2.71e-01	GO:2001180	negative regulation of interleukin-10 secretion	BP
1	3	1.73686081948	-	2.71e-01	GO:0045007	depurination	BP
1	3	1.73686081948	-	2.71e-01	GO:0051222	positive regulation of protein transport	BP
1	3	1.73686081948	-	2.71e-01	GO:0070168	negative regulation of biomineral tissue development	BP
1	3	1.73686081948	-	2.71e-01	GO:0061684	chaperone-mediated autophagy	BP
1	3	1.73686081948	-	2.71e-01	GO:0097286	iron ion import	BP
1	3	1.73686081948	-	2.71e-01	GO:0060480	lung goblet cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:2001027	negative regulation of endothelial cell chemotaxis	BP
1	3	1.73686081948	-	2.71e-01	GO:1900407	regulation of cellular response to oxidative stress	BP
1	3	1.73686081948	-	2.71e-01	GO:0051882	mitochondrial depolarization	BP
1	3	1.73686081948	-	2.71e-01	GO:0019060	intracellular transport of viral protein in host cell	BP
1	3	1.73686081948	-	2.71e-01	GO:0097676	histone H3-K36 dimethylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0051154	negative regulation of striated muscle cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0044313	protein K6-linked deubiquitination	BP
1	3	1.73686081948	-	2.71e-01	GO:0021869	forebrain ventricular zone progenitor cell division	BP
1	3	1.73686081948	-	2.71e-01	GO:0017085	response to insecticide	BP
1	3	1.73686081948	-	2.71e-01	GO:0060197	cloacal septation	BP
1	3	1.73686081948	-	2.71e-01	GO:1903378	positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0045408	regulation of interleukin-6 biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0043009	chordate embryonic development	BP
1	3	1.73686081948	-	2.71e-01	GO:2001271	negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis	BP
1	3	1.73686081948	-	2.71e-01	GO:0090230	regulation of centromere complex assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0090234	regulation of kinetochore assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:1903774	positive regulation of viral budding via host ESCRT complex	BP
1	3	1.73686081948	-	2.71e-01	GO:1903772	regulation of viral budding via host ESCRT complex	BP
1	3	1.73686081948	-	2.71e-01	GO:0032765	positive regulation of mast cell cytokine production	BP
1	3	1.73686081948	-	2.71e-01	GO:0071875	adrenergic receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0010817	regulation of hormone levels	BP
1	3	1.73686081948	-	2.71e-01	GO:0051306	mitotic sister chromatid separation	BP
1	3	1.73686081948	-	2.71e-01	GO:0009994	oocyte differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0060058	positive regulation of apoptotic process involved in mammary gland involution	BP
1	3	1.73686081948	-	2.71e-01	GO:0060979	vasculogenesis involved in coronary vascular morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0001560	regulation of cell growth by extracellular stimulus	BP
1	3	1.73686081948	-	2.71e-01	GO:0043987	histone H3-S10 phosphorylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0070370	cellular heat acclimation	BP
1	3	1.73686081948	-	2.71e-01	GO:0072282	metanephric nephron tubule morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0070495	negative regulation of thrombin-activated receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0061005	cell differentiation involved in kidney development	BP
1	3	1.73686081948	-	2.71e-01	GO:0003006	developmental process involved in reproduction	BP
1	3	1.73686081948	-	2.71e-01	GO:1990167	protein K27-linked deubiquitination	BP
1	3	1.73686081948	-	2.71e-01	GO:0016553	base conversion or substitution editing	BP
1	3	1.73686081948	-	2.71e-01	GO:1904640	response to methionine	BP
1	3	1.73686081948	-	2.71e-01	GO:0097680	double-strand break repair via classical nonhomologous end joining	BP
1	3	1.73686081948	-	2.71e-01	GO:0060221	retinal rod cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0072034	renal vesicle induction	BP
1	3	1.73686081948	-	2.71e-01	GO:0090118	receptor-mediated endocytosis involved in cholesterol transport	BP
8	24	1.73686081948	-	1.22e-03	GO:0032452	histone demethylase activity	MF
6	18	1.73686081948	-	2.24e-03	GO:0005319	lipid transporter activity	MF
4	12	1.73686081948	-	2.56e-02	GO:0048185	activin binding	MF
4	12	1.73686081948	-	2.56e-02	GO:0043422	protein kinase B binding	MF
4	12	1.73686081948	-	2.56e-02	GO:0050998	nitric-oxide synthase binding	MF
3	9	1.73686081948	-	2.57e-02	GO:0071933	Arp2/3 complex binding	MF
3	9	1.73686081948	-	3.81e-02	GO:0046790	virion binding	MF
2	6	1.73686081948	-	5.23e-02	GO:0016651	oxidoreductase activity, acting on NAD(P)H	MF
2	6	1.73686081948	-	5.23e-02	GO:0016174	NAD(P)H oxidase activity	MF
3	9	1.73686081948	-	5.29e-02	GO:0043995	histone acetyltransferase activity (H4-K5 specific)	MF
3	9	1.73686081948	-	5.29e-02	GO:0043996	histone acetyltransferase activity (H4-K8 specific)	MF
3	9	1.73686081948	-	5.29e-02	GO:0046972	histone acetyltransferase activity (H4-K16 specific)	MF
3	9	1.73686081948	-	5.29e-02	GO:0001075	transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly	MF
3	9	1.73686081948	-	5.29e-02	GO:0019887	protein kinase regulator activity	MF
3	9	1.73686081948	-	5.29e-02	GO:0004716	signal transducer, downstream of receptor, with protein tyrosine kinase activity	MF
3	9	1.73686081948	-	5.29e-02	GO:0061578	Lys63-specific deubiquitinase activity	MF
2	6	1.73686081948	-	8.14e-02	GO:0004468	lysine N-acetyltransferase activity, acting on acetyl phosphate as donor	MF
2	6	1.73686081948	-	8.14e-02	GO:0046935	1-phosphatidylinositol-3-kinase regulator activity	MF
2	6	1.73686081948	-	8.14e-02	GO:0030020	extracellular matrix structural constituent conferring tensile strength	MF
2	6	1.73686081948	-	8.14e-02	GO:0060228	phosphatidylcholine-sterol O-acyltransferase activator activity	MF
2	6	1.73686081948	-	8.14e-02	GO:0042500	aspartic endopeptidase activity, intramembrane cleaving	MF
1	3	1.73686081948	-	1.00e-01	GO:0047844	deoxycytidine deaminase activity	MF
1	3	1.73686081948	-	1.00e-01	GO:0033218	amide binding	MF
2	6	1.73686081948	-	1.14e-01	GO:0004704	NF-kappaB-inducing kinase activity	MF
2	6	1.73686081948	-	1.14e-01	GO:0055102	lipase inhibitor activity	MF
2	6	1.73686081948	-	1.14e-01	GO:0030275	LRR domain binding	MF
2	6	1.73686081948	-	1.14e-01	GO:0030911	TPR domain binding	MF
2	6	1.73686081948	-	1.14e-01	GO:0005168	neurotrophin TRKA receptor binding	MF
2	6	1.73686081948	-	1.14e-01	GO:0046975	histone methyltransferase activity (H3-K36 specific)	MF
2	6	1.73686081948	-	1.14e-01	GO:0035254	glutamate receptor binding	MF
2	6	1.73686081948	-	1.14e-01	GO:0010997	anaphase-promoting complex binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0035651	AP-3 adaptor complex binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0003918	DNA topoisomerase type II (ATP-hydrolyzing) activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0019958	C-X-C chemokine binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0102490	8-oxo-dGTP phosphohydrolase activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0048403	brain-derived neurotrophic factor binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0004370	glycerol kinase activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0016941	natriuretic peptide receptor activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0035276	ethanol binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0051120	hepoxilin A3 synthase activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0008332	low voltage-gated calcium channel activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0004809	tRNA (guanine-N2-)-methyltransferase activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0016807	cysteine-type carboxypeptidase activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0046625	sphingolipid binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0008427	calcium-dependent protein kinase inhibitor activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0001730	2'-5'-oligoadenylate synthetase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0016971	flavin-linked sulfhydryl oxidase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0001156	TFIIIC-class transcription factor binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0019959	interleukin-8 binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0004505	phenylalanine 4-monooxygenase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0004351	glutamate decarboxylase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0060230	lipoprotein lipase activator activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0010484	H3 histone acetyltransferase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0031531	thyrotropin-releasing hormone receptor binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0044729	hemi-methylated DNA-binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0030172	troponin C binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0016278	lysine N-methyltransferase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0055106	ubiquitin-protein transferase regulator activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0043812	phosphatidylinositol-4-phosphate phosphatase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0050508	glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0004948	calcitonin receptor activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0042954	lipoprotein transporter activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0035241	protein-arginine omega-N monomethyltransferase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0034190	apolipoprotein receptor binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0046404	ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0030348	syntaxin-3 binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0070325	lipoprotein particle receptor binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0004060	arylamine N-acetyltransferase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0001030	RNA polymerase III type 1 promoter DNA binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0001031	RNA polymerase III type 2 promoter DNA binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0099583	neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration	MF
1	3	1.73686081948	-	2.71e-01	GO:0004104	cholinesterase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0016314	phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0070051	fibrinogen binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0061649	ubiquitin modification-dependent histone binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0031493	nucleosomal histone binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0031826	type 2A serotonin receptor binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0004711	ribosomal protein S6 kinase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0042978	ornithine decarboxylase activator activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0070653	high-density lipoprotein particle receptor binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0004517	nitric-oxide synthase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0015093	ferrous iron transmembrane transporter activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0008426	protein kinase C inhibitor activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0070905	serine binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0043139	5'-3' DNA helicase activity	MF
9	27	1.73686081948	-	1.45e-04	GO:0010575	positive regulation of vascular endothelial growth factor production	BP
7	21	1.73686081948	-	1.16e-03	GO:0046697	decidualization	BP
7	21	1.73686081948	-	3.25e-03	GO:0045807	positive regulation of endocytosis	BP
16	49	1.70711347609	-	9.29e-06	GO:0032481	positive regulation of type I interferon production	BP
10	31	1.6895551047	-	5.10e-05	GO:0035115	embryonic forelimb morphogenesis	BP
10	31	1.6895551047	-	3.27e-04	GO:0006284	base-excision repair	BP
28	87	1.68623474641	-	9.29e-10	GO:0019216	regulation of lipid metabolic process	BP
154	479	1.68472801516	-	2.19e-10	GO:0045892	negative regulation of transcription, DNA-templated	BP
9	28	1.68439339959	-	1.16e-03	GO:0045739	positive regulation of DNA repair	BP
8	25	1.67796713043	-	1.71e-04	GO:1900745	positive regulation of p38MAPK cascade	BP
8	25	1.67796713043	-	1.22e-03	GO:0060612	adipose tissue development	BP
8	25	1.67796713043	-	1.67e-03	GO:0045737	positive regulation of cyclin-dependent protein serine/threonine kinase activity	BP
8	25	1.67796713043	-	2.24e-03	GO:0051149	positive regulation of muscle cell differentiation	BP
15	47	1.67412506413	-	3.17e-05	GO:0034644	cellular response to UV	BP
29	91	1.67200967513	-	9.53e-10	GO:0007179	transforming growth factor beta receptor signaling pathway	BP
35	110	1.66974662362	-	4.05e-11	GO:0016569	covalent chromatin modification	BP
7	22	1.66974662362	-	2.37e-03	GO:0043536	positive regulation of blood vessel endothelial cell migration	BP
7	22	1.66974662362	-	2.37e-03	GO:0035924	cellular response to vascular endothelial growth factor stimulus	BP
7	22	1.66974662362	-	3.25e-03	GO:0010165	response to X-ray	BP
7	22	1.66974662362	-	4.36e-03	GO:0000717	nucleotide-excision repair, DNA duplex unwinding	BP
7	22	1.66974662362	-	4.36e-03	GO:0004709	MAP kinase kinase kinase activity	MF
117	368	1.66862608373	-	1.56e-10	GO:0003682	chromatin binding	MF
6	19	1.65885830748	-	3.28e-03	GO:0032332	positive regulation of chondrocyte differentiation	BP
6	19	1.65885830748	-	4.64e-03	GO:0010613	positive regulation of cardiac muscle hypertrophy	BP
6	19	1.65885830748	-	6.38e-03	GO:0046827	positive regulation of protein export from nucleus	BP
6	19	1.65885830748	-	6.38e-03	GO:0010906	regulation of glucose metabolic process	BP
6	19	1.65885830748	-	8.55e-03	GO:1900182	positive regulation of protein localization to nucleus	BP
32	102	1.64939797823	-	2.69e-10	GO:0038111	interleukin-7-mediated signaling pathway	BP
10	32	1.64375141509	-	4.47e-04	GO:0070555	response to interleukin-1	BP
10	32	1.64375141509	-	6.01e-04	GO:0046677	response to antibiotic	BP
10	32	1.64375141509	-	6.01e-04	GO:0006513	protein monoubiquitination	BP
10	32	1.64375141509	-	6.01e-04	GO:0002755	MyD88-dependent toll-like receptor signaling pathway	BP
10	32	1.64375141509	-	7.96e-04	GO:0070911	global genome nucleotide-excision repair	BP
5	16	1.64375141509	-	4.31e-03	GO:0032924	activin receptor signaling pathway	BP
5	16	1.64375141509	-	9.20e-03	GO:0043508	negative regulation of JUN kinase activity	BP
5	16	1.64375141509	-	9.20e-03	GO:0035855	megakaryocyte development	BP
5	16	1.64375141509	-	1.27e-02	GO:0043968	histone H2A acetylation	BP
5	16	1.64375141509	-	1.69e-02	GO:0036503	ERAD pathway	BP
5	16	1.64375141509	-	1.69e-02	GO:0031396	regulation of protein ubiquitination	BP
5	16	1.64375141509	-	1.69e-02	GO:0032270	positive regulation of cellular protein metabolic process	BP
5	16	1.64375141509	-	1.69e-02	GO:0030889	negative regulation of B cell proliferation	BP
24	77	1.63999928023	-	1.15e-08	GO:0009952	anterior/posterior pattern specification	BP
13	42	1.62994561556	-	8.59e-05	GO:0030218	erythrocyte differentiation	BP
13	42	1.62994561556	-	1.14e-04	GO:0045429	positive regulation of nitric oxide biosynthetic process	BP
181	588	1.62199686245	-	2.47e-10	GO:0006366	transcription from RNA polymerase II promoter	BP
8	26	1.62138360206	-	6.05e-04	GO:0070328	triglyceride homeostasis	BP
8	26	1.62138360206	-	2.24e-03	GO:0071480	cellular response to gamma radiation	BP
4	13	1.62138360206	-	8.31e-03	GO:0010839	negative regulation of keratinocyte proliferation	BP
4	13	1.62138360206	-	8.31e-03	GO:0034374	low-density lipoprotein particle remodeling	BP
4	13	1.62138360206	-	1.28e-02	GO:0007398	ectoderm development	BP
4	13	1.62138360206	-	1.28e-02	GO:0031076	embryonic camera-type eye development	BP
4	13	1.62138360206	-	1.85e-02	GO:0090051	negative regulation of cell migration involved in sprouting angiogenesis	BP
4	13	1.62138360206	-	1.85e-02	GO:0006359	regulation of transcription from RNA polymerase III promoter	BP
4	13	1.62138360206	-	1.85e-02	GO:0046628	positive regulation of insulin receptor signaling pathway	BP
4	13	1.62138360206	-	1.85e-02	GO:2000737	negative regulation of stem cell differentiation	BP
4	13	1.62138360206	-	1.85e-02	GO:0045943	positive regulation of transcription from RNA polymerase I promoter	BP
4	13	1.62138360206	-	1.85e-02	GO:0055089	fatty acid homeostasis	BP
4	13	1.62138360206	-	2.56e-02	GO:0060413	atrial septum morphogenesis	BP
4	13	1.62138360206	-	2.56e-02	GO:2000059	negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
4	13	1.62138360206	-	2.56e-02	GO:0071285	cellular response to lithium ion	BP
4	13	1.62138360206	-	2.56e-02	GO:0010952	positive regulation of peptidase activity	BP
4	13	1.62138360206	-	2.56e-02	GO:0060317	cardiac epithelial to mesenchymal transition	BP
4	13	1.62138360206	-	2.56e-02	GO:0071872	cellular response to epinephrine stimulus	BP
4	13	1.62138360206	-	2.56e-02	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
4	13	1.62138360206	-	3.41e-02	GO:0070306	lens fiber cell differentiation	BP
4	13	1.62138360206	-	3.41e-02	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	BP
4	13	1.62138360206	-	3.41e-02	GO:0042176	regulation of protein catabolic process	BP
4	13	1.62138360206	-	3.41e-02	GO:0043984	histone H4-K16 acetylation	BP
32	104	1.62138360206	-	2.71e-09	GO:0047485	protein N-terminus binding	MF
4	13	1.62138360206	-	1.85e-02	GO:0003906	DNA-(apurinic or apyrimidinic site) lyase activity	MF
4	13	1.62138360206	-	1.85e-02	GO:0001191	transcriptional repressor activity, RNA polymerase II transcription factor binding	MF
4	13	1.62138360206	-	3.41e-02	GO:0035497	cAMP response element binding	MF
11	36	1.6113299374	-	1.70e-04	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	BP
77	252	1.6113299374	-	1.36e-10	GO:0019904	protein domain specific binding	MF
7	23	1.6056162862	-	2.37e-03	GO:0071398	cellular response to fatty acid	BP
7	23	1.6056162862	-	3.25e-03	GO:0071345	cellular response to cytokine stimulus	BP
7	23	1.6056162862	-	4.36e-03	GO:0090398	cellular senescence	BP
13	43	1.59599828364	-	1.17e-05	GO:0045599	negative regulation of fat cell differentiation	BP
48	160	1.58485772603	-	6.06e-11	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	BP
12	40	1.58485772603	-	2.18e-04	GO:0071364	cellular response to epidermal growth factor stimulus	BP
9	30	1.58485772603	-	4.51e-04	GO:0001707	mesoderm formation	BP
9	30	1.58485772603	-	1.16e-03	GO:0042177	negative regulation of protein catabolic process	BP
9	30	1.58485772603	-	1.99e-03	GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	BP
6	20	1.58485772603	-	3.28e-03	GO:0060716	labyrinthine layer blood vessel development	BP
3	10	1.58485772603	-	8.55e-03	GO:0046470	phosphatidylcholine metabolic process	BP
3	10	1.58485772603	-	8.55e-03	GO:0048387	negative regulation of retinoic acid receptor signaling pathway	BP
6	20	1.58485772603	-	1.12e-02	GO:0045663	positive regulation of myoblast differentiation	BP
3	10	1.58485772603	-	1.58e-02	GO:0005513	detection of calcium ion	BP
3	10	1.58485772603	-	2.57e-02	GO:0090009	primitive streak formation	BP
3	10	1.58485772603	-	2.57e-02	GO:0051006	positive regulation of lipoprotein lipase activity	BP
3	10	1.58485772603	-	2.57e-02	GO:0015909	long-chain fatty acid transport	BP
3	10	1.58485772603	-	3.81e-02	GO:0071168	protein localization to chromatin	BP
3	10	1.58485772603	-	3.81e-02	GO:0048048	embryonic eye morphogenesis	BP
3	10	1.58485772603	-	5.29e-02	GO:0033673	negative regulation of kinase activity	BP
3	10	1.58485772603	-	5.29e-02	GO:0002218	activation of innate immune response	BP
3	10	1.58485772603	-	5.29e-02	GO:0048711	positive regulation of astrocyte differentiation	BP
3	10	1.58485772603	-	5.29e-02	GO:0010739	positive regulation of protein kinase A signaling	BP
3	10	1.58485772603	-	5.29e-02	GO:0070544	histone H3-K36 demethylation	BP
3	10	1.58485772603	-	5.29e-02	GO:0016075	rRNA catabolic process	BP
3	10	1.58485772603	-	5.29e-02	GO:0003184	pulmonary valve morphogenesis	BP
3	10	1.58485772603	-	5.29e-02	GO:0010469	regulation of receptor activity	BP
3	10	1.58485772603	-	5.29e-02	GO:0045793	positive regulation of cell size	BP
3	10	1.58485772603	-	7.01e-02	GO:0002031	G-protein coupled receptor internalization	BP
3	10	1.58485772603	-	7.01e-02	GO:2000178	negative regulation of neural precursor cell proliferation	BP
3	10	1.58485772603	-	7.01e-02	GO:0050678	regulation of epithelial cell proliferation	BP
3	10	1.58485772603	-	7.01e-02	GO:0034145	positive regulation of toll-like receptor 4 signaling pathway	BP
3	10	1.58485772603	-	7.01e-02	GO:0051168	nuclear export	BP
3	10	1.58485772603	-	7.01e-02	GO:0044320	cellular response to leptin stimulus	BP
3	10	1.58485772603	-	7.01e-02	GO:0042053	regulation of dopamine metabolic process	BP
3	10	1.58485772603	-	7.01e-02	GO:2000637	positive regulation of gene silencing by miRNA	BP
3	10	1.58485772603	-	7.01e-02	GO:2001020	regulation of response to DNA damage stimulus	BP
6	20	1.58485772603	-	8.55e-03	GO:0030159	receptor signaling complex scaffold activity	MF
3	10	1.58485772603	-	3.81e-02	GO:0016176	superoxide-generating NADPH oxidase activator activity	MF
3	10	1.58485772603	-	5.29e-02	GO:0051864	histone demethylase activity (H3-K36 specific)	MF
3	10	1.58485772603	-	5.29e-02	GO:0051428	peptide hormone receptor binding	MF
3	10	1.58485772603	-	7.01e-02	GO:0030957	Tat protein binding	MF
3	10	1.58485772603	-	7.01e-02	GO:0017166	vinculin binding	MF
14	47	1.57458939058	-	2.46e-05	GO:0051591	response to cAMP	BP
14	47	1.57458939058	-	4.51e-05	GO:0005080	protein kinase C binding	MF
8	27	1.56693581804	-	3.83e-03	GO:0045070	positive regulation of viral genome replication	BP
8	27	1.56693581804	-	3.83e-03	GO:0051721	protein phosphatase 2A binding	MF
5	17	1.55628857384	-	6.43e-03	GO:0009948	anterior/posterior axis specification	BP
5	17	1.55628857384	-	6.43e-03	GO:0001708	cell fate specification	BP
5	17	1.55628857384	-	1.69e-02	GO:0034237	protein kinase A regulatory subunit binding	MF
5	17	1.55628857384	-	2.21e-02	GO:0071837	HMG box domain binding	MF
12	41	1.5492338163	-	2.18e-04	GO:0007595	lactation	BP
12	41	1.5492338163	-	2.86e-04	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	BP
19	65	1.54738302062	-	8.87e-08	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	BP
40	137	1.54571933213	-	1.46e-10	GO:0051092	positive regulation of NF-kappaB transcription factor activity	BP
21	72	1.54421574154	-	2.70e-06	GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
7	24	1.54421574154	-	5.73e-03	GO:2000778	positive regulation of interleukin-6 secretion	BP
120	413	1.53871594439	-	2.42e-10	GO:0006357	regulation of transcription from RNA polymerase II promoter	BP
9	31	1.53755201126	-	2.57e-03	GO:0097421	liver regeneration	BP
13	45	1.53040994201	-	4.67e-05	GO:1903507	negative regulation of nucleic acid-templated transcription	BP
42	146	1.5243161841	-	1.64e-10	GO:0018105	peptidyl-serine phosphorylation	BP
16	56	1.51446839814	-	6.82e-06	GO:0042475	odontogenesis of dentin-containing tooth	BP
12	42	1.51446839814	-	2.18e-04	GO:0045668	negative regulation of osteoblast differentiation	BP
12	42	1.51446839814	-	2.86e-04	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	BP
10	35	1.51446839814	-	4.47e-04	GO:0050808	synapse organization	BP
10	35	1.51446839814	-	1.04e-03	GO:0048536	spleen development	BP
8	28	1.51446839814	-	1.22e-03	GO:0003281	ventricular septum development	BP
8	28	1.51446839814	-	1.22e-03	GO:0048873	homeostasis of number of cells within a tissue	BP
8	28	1.51446839814	-	1.67e-03	GO:0071158	positive regulation of cell cycle arrest	BP
8	28	1.51446839814	-	3.83e-03	GO:0000060	protein import into nucleus, translocation	BP
6	21	1.51446839814	-	6.38e-03	GO:0045672	positive regulation of osteoclast differentiation	BP
4	14	1.51446839814	-	8.31e-03	GO:0021854	hypothalamus development	BP
4	14	1.51446839814	-	1.85e-02	GO:0043303	mast cell degranulation	BP
4	14	1.51446839814	-	1.85e-02	GO:0022011	myelination in peripheral nervous system	BP
4	14	1.51446839814	-	2.56e-02	GO:2000810	regulation of bicellular tight junction assembly	BP
4	14	1.51446839814	-	2.56e-02	GO:0060038	cardiac muscle cell proliferation	BP
4	14	1.51446839814	-	2.56e-02	GO:2001275	positive regulation of glucose import in response to insulin stimulus	BP
2	7	1.51446839814	-	2.80e-02	GO:0000160	phosphorelay signal transduction system	BP
2	7	1.51446839814	-	2.80e-02	GO:2000272	negative regulation of receptor activity	BP
4	14	1.51446839814	-	3.41e-02	GO:0045589	regulation of regulatory T cell differentiation	BP
4	14	1.51446839814	-	4.41e-02	GO:0007175	negative regulation of epidermal growth factor-activated receptor activity	BP
4	14	1.51446839814	-	4.41e-02	GO:0010243	response to organonitrogen compound	BP
4	14	1.51446839814	-	4.41e-02	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	BP
4	14	1.51446839814	-	4.41e-02	GO:2001234	negative regulation of apoptotic signaling pathway	BP
2	7	1.51446839814	-	5.23e-02	GO:0071467	cellular response to pH	BP
2	7	1.51446839814	-	5.23e-02	GO:1904628	cellular response to phorbol 13-acetate 12-myristate	BP
2	7	1.51446839814	-	5.23e-02	GO:0014807	regulation of somitogenesis	BP
2	7	1.51446839814	-	5.23e-02	GO:0021516	dorsal spinal cord development	BP
2	7	1.51446839814	-	8.14e-02	GO:0072643	interferon-gamma secretion	BP
2	7	1.51446839814	-	8.14e-02	GO:1904948	midbrain dopaminergic neuron differentiation	BP
2	7	1.51446839814	-	8.14e-02	GO:0015844	monoamine transport	BP
2	7	1.51446839814	-	8.14e-02	GO:0070431	nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
2	7	1.51446839814	-	8.14e-02	GO:0003344	pericardium morphogenesis	BP
2	7	1.51446839814	-	8.14e-02	GO:0032927	positive regulation of activin receptor signaling pathway	BP
2	7	1.51446839814	-	8.14e-02	GO:0090336	positive regulation of brown fat cell differentiation	BP
2	7	1.51446839814	-	8.14e-02	GO:0021559	trigeminal nerve development	BP
2	7	1.51446839814	-	8.14e-02	GO:0006657	CDP-choline pathway	BP
2	7	1.51446839814	-	8.14e-02	GO:0007530	sex determination	BP
2	7	1.51446839814	-	8.14e-02	GO:0030213	hyaluronan biosynthetic process	BP
2	7	1.51446839814	-	1.14e-01	GO:0045654	positive regulation of megakaryocyte differentiation	BP
2	7	1.51446839814	-	1.14e-01	GO:1902430	negative regulation of amyloid-beta formation	BP
2	7	1.51446839814	-	1.14e-01	GO:0019048	modulation by virus of host morphology or physiology	BP
2	7	1.51446839814	-	1.14e-01	GO:0010837	regulation of keratinocyte proliferation	BP
2	7	1.51446839814	-	1.14e-01	GO:0022612	gland morphogenesis	BP
2	7	1.51446839814	-	1.14e-01	GO:2000049	positive regulation of cell-cell adhesion mediated by cadherin	BP
2	7	1.51446839814	-	1.14e-01	GO:0032926	negative regulation of activin receptor signaling pathway	BP
2	7	1.51446839814	-	1.14e-01	GO:0032411	positive regulation of transporter activity	BP
2	7	1.51446839814	-	1.14e-01	GO:0060576	intestinal epithelial cell development	BP
2	7	1.51446839814	-	1.14e-01	GO:0055075	potassium ion homeostasis	BP
2	7	1.51446839814	-	1.14e-01	GO:1902004	positive regulation of amyloid-beta formation	BP
2	7	1.51446839814	-	1.14e-01	GO:0060972	left/right pattern formation	BP
2	7	1.51446839814	-	1.14e-01	GO:0061298	retina vasculature development in camera-type eye	BP
2	7	1.51446839814	-	1.14e-01	GO:0014902	myotube differentiation	BP
2	7	1.51446839814	-	1.14e-01	GO:0043620	regulation of DNA-templated transcription in response to stress	BP
2	7	1.51446839814	-	1.14e-01	GO:0008366	axon ensheathment	BP
2	7	1.51446839814	-	1.50e-01	GO:0055009	atrial cardiac muscle tissue morphogenesis	BP
2	7	1.51446839814	-	1.50e-01	GO:0046826	negative regulation of protein export from nucleus	BP
2	7	1.51446839814	-	1.50e-01	GO:0019896	axonal transport of mitochondrion	BP
2	7	1.51446839814	-	1.50e-01	GO:0034340	response to type I interferon	BP
2	7	1.51446839814	-	1.50e-01	GO:1902808	positive regulation of cell cycle G1/S phase transition	BP
2	7	1.51446839814	-	1.50e-01	GO:0001783	B cell apoptotic process	BP
2	7	1.51446839814	-	1.50e-01	GO:0010886	positive regulation of cholesterol storage	BP
2	7	1.51446839814	-	1.50e-01	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	BP
2	7	1.51446839814	-	1.50e-01	GO:0034141	positive regulation of toll-like receptor 3 signaling pathway	BP
2	7	1.51446839814	-	1.50e-01	GO:1903071	positive regulation of ER-associated ubiquitin-dependent protein catabolic process	BP
2	7	1.51446839814	-	1.50e-01	GO:0043405	regulation of MAP kinase activity	BP
2	7	1.51446839814	-	1.50e-01	GO:0045359	positive regulation of interferon-beta biosynthetic process	BP
2	7	1.51446839814	-	1.50e-01	GO:0048102	autophagic cell death	BP
2	7	1.51446839814	-	1.50e-01	GO:0031340	positive regulation of vesicle fusion	BP
2	7	1.51446839814	-	1.50e-01	GO:0010941	regulation of cell death	BP
2	7	1.51446839814	-	1.50e-01	GO:0048699	generation of neurons	BP
2	7	1.51446839814	-	1.50e-01	GO:2001171	positive regulation of ATP biosynthetic process	BP
2	7	1.51446839814	-	1.50e-01	GO:0006348	chromatin silencing at telomere	BP
2	7	1.51446839814	-	1.50e-01	GO:0071636	positive regulation of transforming growth factor beta production	BP
2	7	1.51446839814	-	1.50e-01	GO:2000394	positive regulation of lamellipodium morphogenesis	BP
2	7	1.51446839814	-	1.50e-01	GO:0003183	mitral valve morphogenesis	BP
2	7	1.51446839814	-	1.50e-01	GO:0060008	Sertoli cell differentiation	BP
2	7	1.51446839814	-	1.50e-01	GO:0060687	regulation of branching involved in prostate gland morphogenesis	BP
2	7	1.51446839814	-	1.50e-01	GO:0010669	epithelial structure maintenance	BP
2	7	1.51446839814	-	1.50e-01	GO:0000492	box C/D snoRNP assembly	BP
2	7	1.51446839814	-	1.50e-01	GO:2000347	positive regulation of hepatocyte proliferation	BP
2	7	1.51446839814	-	1.50e-01	GO:0048708	astrocyte differentiation	BP
2	7	1.51446839814	-	1.50e-01	GO:0071447	cellular response to hydroperoxide	BP
2	7	1.51446839814	-	1.50e-01	GO:0030050	vesicle transport along actin filament	BP
2	7	1.51446839814	-	1.50e-01	GO:0070417	cellular response to cold	BP
2	7	1.51446839814	-	1.50e-01	GO:0031659	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
2	7	1.51446839814	-	1.50e-01	GO:0048820	hair follicle maturation	BP
2	7	1.51446839814	-	1.50e-01	GO:0061002	negative regulation of dendritic spine morphogenesis	BP
2	7	1.51446839814	-	1.50e-01	GO:0050764	regulation of phagocytosis	BP
10	35	1.51446839814	-	1.04e-03	GO:0030544	Hsp70 protein binding	MF
6	21	1.51446839814	-	6.38e-03	GO:0008327	methyl-CpG binding	MF
4	14	1.51446839814	-	2.56e-02	GO:0043274	phospholipase binding	MF
4	14	1.51446839814	-	4.41e-02	GO:0034236	protein kinase A catalytic subunit binding	MF
2	7	1.51446839814	-	1.14e-01	GO:0008430	selenium binding	MF
2	7	1.51446839814	-	1.14e-01	GO:0042608	T cell receptor binding	MF
2	7	1.51446839814	-	1.14e-01	GO:0001848	complement binding	MF
2	7	1.51446839814	-	1.50e-01	GO:0004675	transmembrane receptor protein serine/threonine kinase activity	MF
2	7	1.51446839814	-	1.50e-01	GO:0042609	CD4 receptor binding	MF
2	7	1.51446839814	-	1.50e-01	GO:0032050	clathrin heavy chain binding	MF
2	7	1.51446839814	-	1.50e-01	GO:0097322	7SK snRNA binding	MF
2	7	1.51446839814	-	1.50e-01	GO:0019209	kinase activator activity	MF
2	7	1.51446839814	-	1.50e-01	GO:0009931	calcium-dependent protein serine/threonine kinase activity	MF
2	7	1.51446839814	-	1.50e-01	GO:0005078	MAP-kinase scaffold activity	MF
2	7	1.51446839814	-	1.50e-01	GO:0019784	NEDD8-specific protease activity	MF
13	46	1.49870108229	-	1.14e-04	GO:0007611	learning or memory	BP
53	188	1.49515492309	-	8.56e-11	GO:0004672	protein kinase activity	MF
106	376	1.49515492309	-	1.17e-10	GO:0043565	sequence-specific DNA binding	MF
9	32	1.49174832164	-	1.53e-03	GO:0042220	response to cocaine	BP
14	50	1.48532205248	-	4.28e-06	GO:0045600	positive regulation of fat cell differentiation	BP
14	50	1.48532205248	-	1.04e-04	GO:0071407	cellular response to organic cyclic compound	BP
7	25	1.48532205248	-	4.36e-03	GO:0021983	pituitary gland development	BP
7	25	1.48532205248	-	4.36e-03	GO:0034612	response to tumor necrosis factor	BP
7	25	1.48532205248	-	4.36e-03	GO:0048709	oligodendrocyte differentiation	BP
7	25	1.48532205248	-	5.73e-03	GO:0007569	cell aging	BP
7	25	1.48532205248	-	5.73e-03	GO:0002053	positive regulation of mesenchymal cell proliferation	BP
7	25	1.48532205248	-	7.40e-03	GO:0000083	regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
7	25	1.48532205248	-	9.41e-03	GO:0071353	cellular response to interleukin-4	BP
19	68	1.48228799239	-	3.28e-06	GO:0045444	fat cell differentiation	BP
10	36	1.47382641365	-	4.47e-04	GO:0001568	blood vessel development	BP
10	36	1.47382641365	-	1.04e-03	GO:0071392	cellular response to estradiol stimulus	BP
5	18	1.47382641365	-	2.74e-03	GO:0060044	negative regulation of cardiac muscle cell proliferation	BP
5	18	1.47382641365	-	9.20e-03	GO:1903861	positive regulation of dendrite extension	BP
5	18	1.47382641365	-	1.27e-02	GO:0030301	cholesterol transport	BP
5	18	1.47382641365	-	1.27e-02	GO:0030318	melanocyte differentiation	BP
5	18	1.47382641365	-	2.21e-02	GO:0030325	adrenal gland development	BP
5	18	1.47382641365	-	2.21e-02	GO:0001894	tissue homeostasis	BP
5	18	1.47382641365	-	2.21e-02	GO:0051000	positive regulation of nitric-oxide synthase activity	BP
5	18	1.47382641365	-	2.21e-02	GO:0000185	activation of MAPKKK activity	BP
5	18	1.47382641365	-	2.21e-02	GO:0048854	brain morphogenesis	BP
5	18	1.47382641365	-	2.81e-02	GO:0035904	aorta development	BP
5	18	1.47382641365	-	2.81e-02	GO:1904380	endoplasmic reticulum mannose trimming	BP
5	18	1.47382641365	-	9.20e-03	GO:0017127	cholesterol transporter activity	MF
5	18	1.47382641365	-	9.20e-03	GO:0016706	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors	MF
5	18	1.47382641365	-	1.27e-02	GO:0016279	protein-lysine N-methyltransferase activity	MF
13	47	1.46767418666	-	5.17e-04	GO:0000186	activation of MAPKK activity	BP
16	58	1.46384232507	-	1.00e-04	GO:0045732	positive regulation of protein catabolic process	BP
8	29	1.46384232507	-	1.22e-03	GO:0031047	gene silencing by RNA	BP
8	29	1.46384232507	-	2.24e-03	GO:2000379	positive regulation of reactive oxygen species metabolic process	BP
8	29	1.46384232507	-	3.83e-03	GO:0045765	regulation of angiogenesis	BP
8	29	1.46384232507	-	6.19e-03	GO:0006294	nucleotide-excision repair, preincision complex assembly	BP
8	29	1.46384232507	-	6.19e-03	GO:1900740	positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	BP
22	80	1.45932684395	-	8.52e-07	GO:0016301	kinase activity	MF
14	51	1.45675290029	-	1.78e-05	GO:0048666	neuron development	BP
14	51	1.45675290029	-	7.93e-05	GO:0048146	positive regulation of fibroblast proliferation	BP
14	51	1.45675290029	-	7.93e-05	GO:0097110	scaffold protein binding	MF
20	73	1.45392685621	-	1.67e-05	GO:0006283	transcription-coupled nucleotide-excision repair	BP
12	44	1.44735420229	-	2.86e-04	GO:0071363	cellular response to growth factor stimulus	BP
6	22	1.44735420229	-	6.38e-03	GO:0045671	negative regulation of osteoclast differentiation	BP
6	22	1.44735420229	-	1.12e-02	GO:0043623	cellular protein complex assembly	BP
6	22	1.44735420229	-	1.44e-02	GO:0045453	bone resorption	BP
6	22	1.44735420229	-	1.44e-02	GO:2000378	negative regulation of reactive oxygen species metabolic process	BP
3	11	1.44735420229	-	1.58e-02	GO:0070166	enamel mineralization	BP
3	11	1.44735420229	-	3.81e-02	GO:0006346	methylation-dependent chromatin silencing	BP
3	11	1.44735420229	-	5.29e-02	GO:0045670	regulation of osteoclast differentiation	BP
3	11	1.44735420229	-	5.29e-02	GO:0055078	sodium ion homeostasis	BP
3	11	1.44735420229	-	5.29e-02	GO:0022409	positive regulation of cell-cell adhesion	BP
3	11	1.44735420229	-	5.29e-02	GO:0019371	cyclooxygenase pathway	BP
3	11	1.44735420229	-	7.01e-02	GO:0045899	positive regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
3	11	1.44735420229	-	7.01e-02	GO:0071223	cellular response to lipoteichoic acid	BP
3	11	1.44735420229	-	7.01e-02	GO:0048484	enteric nervous system development	BP
3	11	1.44735420229	-	7.01e-02	GO:0001823	mesonephros development	BP
3	11	1.44735420229	-	7.01e-02	GO:0033234	negative regulation of protein sumoylation	BP
3	11	1.44735420229	-	7.01e-02	GO:0098911	regulation of ventricular cardiac muscle cell action potential	BP
3	11	1.44735420229	-	7.01e-02	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	BP
3	11	1.44735420229	-	7.01e-02	GO:0032930	positive regulation of superoxide anion generation	BP
3	11	1.44735420229	-	7.01e-02	GO:0050862	positive regulation of T cell receptor signaling pathway	BP
3	11	1.44735420229	-	7.01e-02	GO:0032688	negative regulation of interferon-beta production	BP
3	11	1.44735420229	-	7.01e-02	GO:0045792	negative regulation of cell size	BP
3	11	1.44735420229	-	8.95e-02	GO:0043249	erythrocyte maturation	BP
3	11	1.44735420229	-	8.95e-02	GO:0071383	cellular response to steroid hormone stimulus	BP
3	11	1.44735420229	-	8.95e-02	GO:0006983	ER overload response	BP
3	11	1.44735420229	-	8.95e-02	GO:0006266	DNA ligation	BP
3	11	1.44735420229	-	8.95e-02	GO:0033120	positive regulation of RNA splicing	BP
3	11	1.44735420229	-	8.95e-02	GO:0035563	positive regulation of chromatin binding	BP
3	11	1.44735420229	-	8.95e-02	GO:0060765	regulation of androgen receptor signaling pathway	BP
3	11	1.44735420229	-	8.95e-02	GO:0071481	cellular response to X-ray	BP
3	11	1.44735420229	-	2.57e-02	GO:0016175	superoxide-generating NADPH oxidase activity	MF
3	11	1.44735420229	-	3.81e-02	GO:0035925	mRNA 3'-UTR AU-rich region binding	MF
3	11	1.44735420229	-	7.01e-02	GO:0050786	RAGE receptor binding	MF
3	11	1.44735420229	-	7.01e-02	GO:0004526	ribonuclease P activity	MF
21	77	1.44735420229	-	7.18e-06	GO:0071260	cellular response to mechanical stimulus	BP
10	37	1.43429804946	-	1.72e-03	GO:0048469	cell maturation	BP
10	37	1.43429804946	-	2.17e-03	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	BP
89	330	1.43123453692	-	1.18e-10	GO:0019899	enzyme binding	MF
7	26	1.42873852412	-	7.40e-03	GO:0070371	ERK1 and ERK2 cascade	BP
46	171	1.42753276137	-	4.38e-11	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	MF
29	108	1.42491681317	-	5.02e-08	GO:0009615	response to virus	BP
11	41	1.42370293422	-	1.15e-03	GO:0045740	positive regulation of DNA replication	BP
220	820	1.42370293422	-	2.13e-10	GO:0003700	transcription factor activity, sequence-specific DNA binding	MF
8	30	1.41493272459	-	2.24e-03	GO:0031667	response to nutrient levels	BP
8	30	1.41493272459	-	3.83e-03	GO:0007281	germ cell development	BP
4	15	1.41493272459	-	2.56e-02	GO:0048485	sympathetic nervous system development	BP
4	15	1.41493272459	-	2.56e-02	GO:0035050	embryonic heart tube development	BP
4	15	1.41493272459	-	2.56e-02	GO:0086005	ventricular cardiac muscle cell action potential	BP
4	15	1.41493272459	-	3.41e-02	GO:0001824	blastocyst development	BP
4	15	1.41493272459	-	3.41e-02	GO:0034356	NAD biosynthesis via nicotinamide riboside salvage pathway	BP
4	15	1.41493272459	-	4.41e-02	GO:0031573	intra-S DNA damage checkpoint	BP
4	15	1.41493272459	-	4.41e-02	GO:0043277	apoptotic cell clearance	BP
4	15	1.41493272459	-	4.41e-02	GO:0000729	DNA double-strand break processing	BP
4	15	1.41493272459	-	4.41e-02	GO:0034162	toll-like receptor 9 signaling pathway	BP
4	15	1.41493272459	-	4.41e-02	GO:0035458	cellular response to interferon-beta	BP
4	15	1.41493272459	-	4.41e-02	GO:0043254	regulation of protein complex assembly	BP
4	15	1.41493272459	-	5.55e-02	GO:0031929	TOR signaling	BP
8	30	1.41493272459	-	1.67e-03	GO:0016874	ligase activity	MF
4	15	1.41493272459	-	5.55e-02	GO:0034185	apolipoprotein binding	MF
4	15	1.41493272459	-	5.55e-02	GO:0005123	death receptor binding	MF
17	64	1.40928616145	-	1.17e-05	GO:0043627	response to estrogen	BP
17	64	1.40928616145	-	8.47e-05	GO:0019903	protein phosphatase binding	MF
30	113	1.40853495339	-	7.27e-09	GO:0007219	Notch signaling pathway	BP
9	34	1.40428548039	-	1.45e-04	GO:0060045	positive regulation of cardiac muscle cell proliferation	BP
9	34	1.40428548039	-	1.99e-03	GO:0002931	response to ischemia	BP
9	34	1.40428548039	-	2.57e-03	GO:0032480	negative regulation of type I interferon production	BP
9	34	1.40428548039	-	3.26e-03	GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
9	34	1.40428548039	-	4.09e-03	GO:0051973	positive regulation of telomerase activity	BP
23	87	1.40244178041	-	2.61e-07	GO:0001227	transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
37	140	1.40199366889	-	9.39e-10	GO:0007050	cell cycle arrest	BP
5	19	1.39582390164	-	1.27e-02	GO:0007520	myoblast fusion	BP
5	19	1.39582390164	-	1.27e-02	GO:0001502	cartilage condensation	BP
5	19	1.39582390164	-	1.69e-02	GO:0045879	negative regulation of smoothened signaling pathway	BP
5	19	1.39582390164	-	2.21e-02	GO:0036120	cellular response to platelet-derived growth factor stimulus	BP
5	19	1.39582390164	-	2.81e-02	GO:0048169	regulation of long-term neuronal synaptic plasticity	BP
15	57	1.39582390164	-	1.86e-04	GO:0003684	damaged DNA binding	MF
5	19	1.39582390164	-	1.69e-02	GO:0051018	protein kinase A binding	MF
5	19	1.39582390164	-	3.51e-02	GO:0031491	nucleosome binding	MF
12	46	1.38322386487	-	2.18e-04	GO:0003151	outflow tract morphogenesis	BP
6	23	1.38322386487	-	1.12e-02	GO:0031018	endocrine pancreas development	BP
6	23	1.38322386487	-	1.81e-02	GO:0050999	regulation of nitric-oxide synthase activity	BP
6	23	1.38322386487	-	2.25e-02	GO:0017025	TBP-class protein binding	MF
13	50	1.37840684857	-	3.24e-04	GO:0034097	response to cytokine	BP
13	50	1.37840684857	-	7.98e-04	GO:0001540	amyloid-beta binding	MF
27	104	1.37627110422	-	2.82e-07	GO:0071456	cellular response to hypoxia	BP
14	54	1.3742907401	-	3.47e-04	GO:0071560	cellular response to transforming growth factor beta stimulus	BP
7	27	1.3742907401	-	5.73e-03	GO:0001958	endochondral ossification	BP
7	27	1.3742907401	-	1.46e-02	GO:0032728	positive regulation of interferon-beta production	BP
7	27	1.3742907401	-	7.40e-03	GO:0001106	RNA polymerase II transcription corepressor activity	MF
22	85	1.3718640027	-	4.89e-06	GO:0019900	kinase binding	MF
8	31	1.36762700981	-	4.91e-03	GO:0048662	negative regulation of smooth muscle cell proliferation	BP
8	31	1.36762700981	-	9.51e-03	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	BP
8	31	1.36762700981	-	7.72e-03	GO:0042169	SH2 domain binding	MF
9	35	1.3624653047	-	1.53e-03	GO:0048813	dendrite morphogenesis	BP
9	35	1.3624653047	-	3.26e-03	GO:0006641	triglyceride metabolic process	BP
9	35	1.3624653047	-	4.09e-03	GO:0045786	negative regulation of cell cycle	BP
9	35	1.3624653047	-	6.24e-03	GO:0070534	protein K63-linked ubiquitination	BP
9	35	1.3624653047	-	6.24e-03	GO:0008094	DNA-dependent ATPase activity	MF
19	74	1.36029746802	-	3.85e-05	GO:0001843	neural tube closure	BP
10	39	1.35834919623	-	3.35e-03	GO:0030890	positive regulation of B cell proliferation	BP
11	43	1.35499018414	-	2.22e-03	GO:0031397	negative regulation of protein ubiquitination	BP
12	47	1.35219696924	-	1.80e-03	GO:0070936	protein K48-linked ubiquitination	BP
13	51	1.34983769637	-	9.81e-04	GO:0051865	protein autoubiquitination	BP
16	63	1.3445433967	-	1.26e-04	GO:0032091	negative regulation of protein binding	BP
18	71	1.34200120214	-	3.65e-05	GO:0060333	interferon-gamma-mediated signaling pathway	BP
31	123	1.33350512525	-	4.87e-08	GO:0002223	stimulatory C-type lectin receptor signaling pathway	BP
25	100	1.3218233202	-	6.72e-06	GO:0000082	G1/S transition of mitotic cell cycle	BP
12	48	1.3218233202	-	7.70e-04	GO:0008542	visual learning	BP
6	24	1.3218233202	-	8.55e-03	GO:0048589	developmental growth	BP
6	24	1.3218233202	-	1.12e-02	GO:0031334	positive regulation of protein complex assembly	BP
6	24	1.3218233202	-	1.44e-02	GO:0033344	cholesterol efflux	BP
6	24	1.3218233202	-	2.25e-02	GO:0051966	regulation of synaptic transmission, glutamatergic	BP
6	24	1.3218233202	-	2.75e-02	GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	BP
3	12	1.3218233202	-	3.81e-02	GO:2000727	positive regulation of cardiac muscle cell differentiation	BP
3	12	1.3218233202	-	3.81e-02	GO:0032026	response to magnesium ion	BP
3	12	1.3218233202	-	5.29e-02	GO:0032963	collagen metabolic process	BP
3	12	1.3218233202	-	5.29e-02	GO:0060402	calcium ion transport into cytosol	BP
3	12	1.3218233202	-	7.01e-02	GO:0002437	inflammatory response to antigenic stimulus	BP
3	12	1.3218233202	-	7.01e-02	GO:0009888	tissue development	BP
3	12	1.3218233202	-	7.01e-02	GO:0060391	positive regulation of SMAD protein import into nucleus	BP
3	12	1.3218233202	-	7.01e-02	GO:0050868	negative regulation of T cell activation	BP
3	12	1.3218233202	-	8.95e-02	GO:0051764	actin crosslink formation	BP
3	12	1.3218233202	-	8.95e-02	GO:0021670	lateral ventricle development	BP
3	12	1.3218233202	-	8.95e-02	GO:0007512	adult heart development	BP
3	12	1.3218233202	-	8.95e-02	GO:2000505	regulation of energy homeostasis	BP
3	12	1.3218233202	-	8.95e-02	GO:0003016	respiratory system process	BP
3	12	1.3218233202	-	8.95e-02	GO:0001682	tRNA 5'-leader removal	BP
3	12	1.3218233202	-	8.95e-02	GO:0000002	mitochondrial genome maintenance	BP
3	12	1.3218233202	-	8.95e-02	GO:0030212	hyaluronan metabolic process	BP
3	12	1.3218233202	-	1.11e-01	GO:0046902	regulation of mitochondrial membrane permeability	BP
3	12	1.3218233202	-	1.11e-01	GO:0034329	cell junction assembly	BP
3	12	1.3218233202	-	1.11e-01	GO:0032801	receptor catabolic process	BP
3	12	1.3218233202	-	1.11e-01	GO:2000146	negative regulation of cell motility	BP
3	12	1.3218233202	-	1.11e-01	GO:0070528	protein kinase C signaling	BP
6	24	1.3218233202	-	2.75e-02	GO:0031593	polyubiquitin modification-dependent protein binding	MF
3	12	1.3218233202	-	7.01e-02	GO:0005548	phospholipid transporter activity	MF
3	12	1.3218233202	-	8.95e-02	GO:0050321	tau-protein kinase activity	MF
14	56	1.3218233202	-	1.04e-04	GO:0009612	response to mechanical stimulus	BP
10	40	1.3218233202	-	7.96e-04	GO:0032526	response to retinoic acid	BP
7	28	1.3218233202	-	3.25e-03	GO:0001755	neural crest cell migration	BP
7	28	1.3218233202	-	3.25e-03	GO:0045746	negative regulation of Notch signaling pathway	BP
8	32	1.3218233202	-	3.83e-03	GO:0048147	negative regulation of fibroblast proliferation	BP
4	16	1.3218233202	-	5.01e-03	GO:0050909	sensory perception of taste	BP
9	36	1.3218233202	-	5.08e-03	GO:0051402	neuron apoptotic process	BP
9	36	1.3218233202	-	7.60e-03	GO:0007257	activation of JUN kinase activity	BP
8	32	1.3218233202	-	1.16e-02	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	BP
7	28	1.3218233202	-	1.18e-02	GO:0001662	behavioral fear response	BP
5	20	1.3218233202	-	1.69e-02	GO:0006801	superoxide metabolic process	BP
5	20	1.3218233202	-	1.69e-02	GO:0045987	positive regulation of smooth muscle contraction	BP
4	16	1.3218233202	-	3.41e-02	GO:0070509	calcium ion import	BP
5	20	1.3218233202	-	4.31e-02	GO:0008361	regulation of cell size	BP
4	16	1.3218233202	-	4.41e-02	GO:0031293	membrane protein intracellular domain proteolysis	BP
4	16	1.3218233202	-	4.41e-02	GO:0042307	positive regulation of protein import into nucleus	BP
4	16	1.3218233202	-	4.41e-02	GO:0030502	negative regulation of bone mineralization	BP
2	8	1.3218233202	-	5.23e-02	GO:2000781	positive regulation of double-strand break repair	BP
4	16	1.3218233202	-	5.55e-02	GO:0021772	olfactory bulb development	BP
4	16	1.3218233202	-	5.55e-02	GO:2000179	positive regulation of neural precursor cell proliferation	BP
4	16	1.3218233202	-	5.55e-02	GO:0010608	posttranscriptional regulation of gene expression	BP
4	16	1.3218233202	-	5.55e-02	GO:0006349	regulation of gene expression by genetic imprinting	BP
4	16	1.3218233202	-	5.55e-02	GO:0071732	cellular response to nitric oxide	BP
4	16	1.3218233202	-	6.83e-02	GO:0034142	toll-like receptor 4 signaling pathway	BP
4	16	1.3218233202	-	6.83e-02	GO:0030224	monocyte differentiation	BP
2	8	1.3218233202	-	8.14e-02	GO:0031666	positive regulation of lipopolysaccharide-mediated signaling pathway	BP
2	8	1.3218233202	-	8.14e-02	GO:0051151	negative regulation of smooth muscle cell differentiation	BP
1	4	1.3218233202	-	1.00e-01	GO:1900239	regulation of phenotypic switching	BP
1	4	1.3218233202	-	1.00e-01	GO:1903609	negative regulation of inward rectifier potassium channel activity	BP
1	4	1.3218233202	-	1.00e-01	GO:0048859	formation of anatomical boundary	BP
2	8	1.3218233202	-	1.14e-01	GO:0060346	bone trabecula formation	BP
2	8	1.3218233202	-	1.14e-01	GO:0040016	embryonic cleavage	BP
2	8	1.3218233202	-	1.14e-01	GO:0009743	response to carbohydrate	BP
2	8	1.3218233202	-	1.14e-01	GO:0006029	proteoglycan metabolic process	BP
2	8	1.3218233202	-	1.14e-01	GO:0090140	regulation of mitochondrial fission	BP
2	8	1.3218233202	-	1.14e-01	GO:0043129	surfactant homeostasis	BP
2	8	1.3218233202	-	1.14e-01	GO:0042987	amyloid precursor protein catabolic process	BP
2	8	1.3218233202	-	1.14e-01	GO:0071313	cellular response to caffeine	BP
2	8	1.3218233202	-	1.50e-01	GO:0035265	organ growth	BP
2	8	1.3218233202	-	1.50e-01	GO:0000012	single strand break repair	BP
2	8	1.3218233202	-	1.50e-01	GO:0051103	DNA ligation involved in DNA repair	BP
2	8	1.3218233202	-	1.50e-01	GO:0009629	response to gravity	BP
2	8	1.3218233202	-	1.50e-01	GO:0045416	positive regulation of interleukin-8 biosynthetic process	BP
2	8	1.3218233202	-	1.50e-01	GO:0048312	intracellular distribution of mitochondria	BP
2	8	1.3218233202	-	1.50e-01	GO:0070102	interleukin-6-mediated signaling pathway	BP
2	8	1.3218233202	-	1.50e-01	GO:0033993	response to lipid	BP
2	8	1.3218233202	-	1.50e-01	GO:0005979	regulation of glycogen biosynthetic process	BP
2	8	1.3218233202	-	1.50e-01	GO:0007167	enzyme linked receptor protein signaling pathway	BP
2	8	1.3218233202	-	1.50e-01	GO:0050702	interleukin-1 beta secretion	BP
2	8	1.3218233202	-	1.50e-01	GO:0050663	cytokine secretion	BP
2	8	1.3218233202	-	1.50e-01	GO:0003254	regulation of membrane depolarization	BP
2	8	1.3218233202	-	1.50e-01	GO:0060155	platelet dense granule organization	BP
2	8	1.3218233202	-	1.50e-01	GO:0060059	embryonic retina morphogenesis in camera-type eye	BP
2	8	1.3218233202	-	1.50e-01	GO:0071394	cellular response to testosterone stimulus	BP
2	8	1.3218233202	-	1.50e-01	GO:0016584	nucleosome positioning	BP
2	8	1.3218233202	-	1.50e-01	GO:0030219	megakaryocyte differentiation	BP
2	8	1.3218233202	-	1.50e-01	GO:0015908	fatty acid transport	BP
2	8	1.3218233202	-	1.87e-01	GO:0060100	positive regulation of phagocytosis, engulfment	BP
2	8	1.3218233202	-	1.87e-01	GO:0071493	cellular response to UV-B	BP
2	8	1.3218233202	-	1.87e-01	GO:0070723	response to cholesterol	BP
2	8	1.3218233202	-	1.87e-01	GO:1901990	regulation of mitotic cell cycle phase transition	BP
2	8	1.3218233202	-	1.87e-01	GO:0010882	regulation of cardiac muscle contraction by calcium ion signaling	BP
2	8	1.3218233202	-	1.87e-01	GO:0050691	regulation of defense response to virus by host	BP
2	8	1.3218233202	-	1.87e-01	GO:0072577	endothelial cell apoptotic process	BP
2	8	1.3218233202	-	1.87e-01	GO:0010224	response to UV-B	BP
2	8	1.3218233202	-	1.87e-01	GO:2000177	regulation of neural precursor cell proliferation	BP
2	8	1.3218233202	-	1.87e-01	GO:0075713	establishment of integrated proviral latency	BP
2	8	1.3218233202	-	1.87e-01	GO:0002674	negative regulation of acute inflammatory response	BP
2	8	1.3218233202	-	1.87e-01	GO:0048762	mesenchymal cell differentiation	BP
2	8	1.3218233202	-	1.87e-01	GO:1901385	regulation of voltage-gated calcium channel activity	BP
2	8	1.3218233202	-	1.87e-01	GO:0051593	response to folic acid	BP
2	8	1.3218233202	-	1.87e-01	GO:0060732	positive regulation of inositol phosphate biosynthetic process	BP
2	8	1.3218233202	-	1.87e-01	GO:0030851	granulocyte differentiation	BP
2	8	1.3218233202	-	1.87e-01	GO:0006975	DNA damage induced protein phosphorylation	BP
2	8	1.3218233202	-	1.87e-01	GO:0002903	negative regulation of B cell apoptotic process	BP
2	8	1.3218233202	-	1.87e-01	GO:1900364	negative regulation of mRNA polyadenylation	BP
2	8	1.3218233202	-	1.87e-01	GO:1903265	positive regulation of tumor necrosis factor-mediated signaling pathway	BP
2	8	1.3218233202	-	1.87e-01	GO:0035093	spermatogenesis, exchange of chromosomal proteins	BP
2	8	1.3218233202	-	1.87e-01	GO:0019934	cGMP-mediated signaling	BP
2	8	1.3218233202	-	1.87e-01	GO:0007172	signal complex assembly	BP
2	8	1.3218233202	-	1.87e-01	GO:0016574	histone ubiquitination	BP
2	8	1.3218233202	-	1.87e-01	GO:0045830	positive regulation of isotype switching	BP
2	8	1.3218233202	-	1.87e-01	GO:1903800	positive regulation of production of miRNAs involved in gene silencing by miRNA	BP
2	8	1.3218233202	-	1.87e-01	GO:0048743	positive regulation of skeletal muscle fiber development	BP
2	8	1.3218233202	-	1.87e-01	GO:0070206	protein trimerization	BP
2	8	1.3218233202	-	1.87e-01	GO:0007184	SMAD protein import into nucleus	BP
2	8	1.3218233202	-	1.87e-01	GO:0045008	depyrimidination	BP
2	8	1.3218233202	-	1.87e-01	GO:0014732	skeletal muscle atrophy	BP
2	8	1.3218233202	-	1.87e-01	GO:0045630	positive regulation of T-helper 2 cell differentiation	BP
2	8	1.3218233202	-	1.87e-01	GO:0007270	neuron-neuron synaptic transmission	BP
2	8	1.3218233202	-	1.87e-01	GO:0071312	cellular response to alkaloid	BP
1	4	1.3218233202	-	1.90e-01	GO:2000105	positive regulation of DNA-dependent DNA replication	BP
1	4	1.3218233202	-	1.90e-01	GO:1904954	canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	BP
1	4	1.3218233202	-	1.90e-01	GO:0019918	peptidyl-arginine methylation, to symmetrical-dimethyl arginine	BP
1	4	1.3218233202	-	1.90e-01	GO:2000724	positive regulation of cardiac vascular smooth muscle cell differentiation	BP
1	4	1.3218233202	-	1.90e-01	GO:0043697	cell dedifferentiation	BP
1	4	1.3218233202	-	1.90e-01	GO:0021575	hindbrain morphogenesis	BP
1	4	1.3218233202	-	1.90e-01	GO:0046684	response to pyrethroid	BP
1	4	1.3218233202	-	1.90e-01	GO:0010868	negative regulation of triglyceride biosynthetic process	BP
1	4	1.3218233202	-	1.90e-01	GO:0043587	tongue morphogenesis	BP
1	4	1.3218233202	-	1.90e-01	GO:0060214	endocardium formation	BP
1	4	1.3218233202	-	1.90e-01	GO:0021555	midbrain-hindbrain boundary morphogenesis	BP
1	4	1.3218233202	-	1.90e-01	GO:0021759	globus pallidus development	BP
1	4	1.3218233202	-	1.90e-01	GO:0030311	poly-N-acetyllactosamine biosynthetic process	BP
1	4	1.3218233202	-	1.90e-01	GO:0030730	sequestering of triglyceride	BP
1	4	1.3218233202	-	1.90e-01	GO:0007386	compartment pattern specification	BP
1	4	1.3218233202	-	1.90e-01	GO:0051647	nucleus localization	BP
1	4	1.3218233202	-	2.71e-01	GO:0036438	maintenance of lens transparency	BP
1	4	1.3218233202	-	2.71e-01	GO:0086016	AV node cell action potential	BP
1	4	1.3218233202	-	2.71e-01	GO:0071494	cellular response to UV-C	BP
1	4	1.3218233202	-	2.71e-01	GO:0008211	glucocorticoid metabolic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0031547	brain-derived neurotrophic factor receptor signaling pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:1904037	positive regulation of epithelial cell apoptotic process	BP
1	4	1.3218233202	-	2.71e-01	GO:1903243	negative regulation of cardiac muscle hypertrophy in response to stress	BP
1	4	1.3218233202	-	2.71e-01	GO:0048368	lateral mesoderm development	BP
1	4	1.3218233202	-	2.71e-01	GO:0007442	hindgut morphogenesis	BP
1	4	1.3218233202	-	2.71e-01	GO:0032286	central nervous system myelin maintenance	BP
1	4	1.3218233202	-	2.71e-01	GO:1902806	regulation of cell cycle G1/S phase transition	BP
1	4	1.3218233202	-	2.71e-01	GO:0003338	metanephros morphogenesis	BP
1	4	1.3218233202	-	2.71e-01	GO:0035502	metanephric part of ureteric bud development	BP
1	4	1.3218233202	-	2.71e-01	GO:0061030	epithelial cell differentiation involved in mammary gland alveolus development	BP
1	4	1.3218233202	-	2.71e-01	GO:0072144	glomerular mesangial cell development	BP
1	4	1.3218233202	-	2.71e-01	GO:0072676	lymphocyte migration	BP
1	4	1.3218233202	-	2.71e-01	GO:0048808	male genitalia morphogenesis	BP
1	4	1.3218233202	-	2.71e-01	GO:0014819	regulation of skeletal muscle contraction	BP
1	4	1.3218233202	-	2.71e-01	GO:0003272	endocardial cushion formation	BP
1	4	1.3218233202	-	2.71e-01	GO:0003273	cell migration involved in endocardial cushion formation	BP
1	4	1.3218233202	-	2.71e-01	GO:1902261	positive regulation of delayed rectifier potassium channel activity	BP
1	4	1.3218233202	-	2.71e-01	GO:0035616	histone H2B conserved C-terminal lysine deubiquitination	BP
1	4	1.3218233202	-	2.71e-01	GO:2000653	regulation of genetic imprinting	BP
1	4	1.3218233202	-	2.71e-01	GO:0045920	negative regulation of exocytosis	BP
1	4	1.3218233202	-	2.71e-01	GO:0003231	cardiac ventricle development	BP
1	4	1.3218233202	-	2.71e-01	GO:0002360	T cell lineage commitment	BP
1	4	1.3218233202	-	2.71e-01	GO:0072600	establishment of protein localization to Golgi	BP
1	4	1.3218233202	-	2.71e-01	GO:0060429	epithelium development	BP
1	4	1.3218233202	-	2.71e-01	GO:0006779	porphyrin-containing compound biosynthetic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0032374	regulation of cholesterol transport	BP
1	4	1.3218233202	-	2.71e-01	GO:0070317	negative regulation of G0 to G1 transition	BP
1	4	1.3218233202	-	2.71e-01	GO:0031064	negative regulation of histone deacetylation	BP
1	4	1.3218233202	-	2.71e-01	GO:0015842	aminergic neurotransmitter loading into synaptic vesicle	BP
1	4	1.3218233202	-	2.71e-01	GO:0046726	positive regulation by virus of viral protein levels in host cell	BP
1	4	1.3218233202	-	2.71e-01	GO:1900738	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:0006835	dicarboxylic acid transport	BP
1	4	1.3218233202	-	2.71e-01	GO:0010644	cell communication by electrical coupling	BP
1	4	1.3218233202	-	2.71e-01	GO:0070212	protein poly-ADP-ribosylation	BP
1	4	1.3218233202	-	2.71e-01	GO:0032497	detection of lipopolysaccharide	BP
1	4	1.3218233202	-	2.71e-01	GO:0021938	smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation	BP
1	4	1.3218233202	-	2.71e-01	GO:1900127	positive regulation of hyaluronan biosynthetic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0021979	hypothalamus cell differentiation	BP
1	4	1.3218233202	-	2.71e-01	GO:0045759	negative regulation of action potential	BP
1	4	1.3218233202	-	2.71e-01	GO:0021782	glial cell development	BP
1	4	1.3218233202	-	2.71e-01	GO:0070741	response to interleukin-6	BP
1	4	1.3218233202	-	2.71e-01	GO:1902074	response to salt	BP
1	4	1.3218233202	-	2.71e-01	GO:0007320	insemination	BP
1	4	1.3218233202	-	2.71e-01	GO:0061156	pulmonary artery morphogenesis	BP
1	4	1.3218233202	-	2.71e-01	GO:0048133	male germ-line stem cell asymmetric division	BP
1	4	1.3218233202	-	2.71e-01	GO:0051294	establishment of spindle orientation	BP
1	4	1.3218233202	-	2.71e-01	GO:1902177	positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:0019695	choline metabolic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0033088	negative regulation of immature T cell proliferation in thymus	BP
1	4	1.3218233202	-	2.71e-01	GO:1904058	positive regulation of sensory perception of pain	BP
1	4	1.3218233202	-	2.71e-01	GO:0060043	regulation of cardiac muscle cell proliferation	BP
1	4	1.3218233202	-	2.71e-01	GO:0002768	immune response-regulating cell surface receptor signaling pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:0060393	regulation of pathway-restricted SMAD protein phosphorylation	BP
1	4	1.3218233202	-	2.71e-01	GO:1901165	positive regulation of trophoblast cell migration	BP
1	4	1.3218233202	-	2.71e-01	GO:0032392	DNA geometric change	BP
1	4	1.3218233202	-	2.71e-01	GO:0046596	regulation of viral entry into host cell	BP
1	4	1.3218233202	-	2.71e-01	GO:0046629	gamma-delta T cell activation	BP
1	4	1.3218233202	-	2.71e-01	GO:2000672	negative regulation of motor neuron apoptotic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0090184	positive regulation of kidney development	BP
1	4	1.3218233202	-	2.71e-01	GO:0060971	embryonic heart tube left/right pattern formation	BP
1	4	1.3218233202	-	2.71e-01	GO:0071442	positive regulation of histone H3-K14 acetylation	BP
1	4	1.3218233202	-	2.71e-01	GO:1900226	negative regulation of NLRP3 inflammasome complex assembly	BP
1	4	1.3218233202	-	2.71e-01	GO:0014827	intestine smooth muscle contraction	BP
1	4	1.3218233202	-	2.71e-01	GO:0048713	regulation of oligodendrocyte differentiation	BP
1	4	1.3218233202	-	2.71e-01	GO:0021891	olfactory bulb interneuron development	BP
1	4	1.3218233202	-	2.71e-01	GO:0071883	activation of MAPK activity by adrenergic receptor signaling pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:0016321	female meiosis chromosome segregation	BP
1	4	1.3218233202	-	3.44e-01	GO:0002455	humoral immune response mediated by circulating immunoglobulin	BP
1	4	1.3218233202	-	3.44e-01	GO:0031507	heterochromatin assembly	BP
1	4	1.3218233202	-	3.44e-01	GO:0071801	regulation of podosome assembly	BP
1	4	1.3218233202	-	3.44e-01	GO:2001013	epithelial cell proliferation involved in renal tubule morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0097411	hypoxia-inducible factor-1alpha signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0035791	platelet-derived growth factor receptor-beta signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0035799	ureter maturation	BP
1	4	1.3218233202	-	3.44e-01	GO:0051147	regulation of muscle cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0035655	interleukin-18-mediated signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0071459	protein localization to chromosome, centromeric region	BP
1	4	1.3218233202	-	3.44e-01	GO:1901509	regulation of endothelial tube morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0009048	dosage compensation by inactivation of X chromosome	BP
1	4	1.3218233202	-	3.44e-01	GO:0043242	negative regulation of protein complex disassembly	BP
1	4	1.3218233202	-	3.44e-01	GO:0016199	axon midline choice point recognition	BP
1	4	1.3218233202	-	3.44e-01	GO:0002070	epithelial cell maturation	BP
1	4	1.3218233202	-	3.44e-01	GO:0002074	extraocular skeletal muscle development	BP
1	4	1.3218233202	-	3.44e-01	GO:0051106	positive regulation of DNA ligation	BP
1	4	1.3218233202	-	3.44e-01	GO:0050689	negative regulation of defense response to virus by host	BP
1	4	1.3218233202	-	3.44e-01	GO:0010883	regulation of lipid storage	BP
1	4	1.3218233202	-	3.44e-01	GO:0072107	positive regulation of ureteric bud formation	BP
1	4	1.3218233202	-	3.44e-01	GO:0072108	positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0031296	B cell costimulation	BP
1	4	1.3218233202	-	3.44e-01	GO:0033625	positive regulation of integrin activation	BP
1	4	1.3218233202	-	3.44e-01	GO:0032507	maintenance of protein location in cell	BP
1	4	1.3218233202	-	3.44e-01	GO:2001137	positive regulation of endocytic recycling	BP
1	4	1.3218233202	-	3.44e-01	GO:0065002	intracellular protein transmembrane transport	BP
1	4	1.3218233202	-	3.44e-01	GO:1990966	ATP generation from poly-ADP-D-ribose	BP
1	4	1.3218233202	-	3.44e-01	GO:0060513	prostatic bud formation	BP
1	4	1.3218233202	-	3.44e-01	GO:0090168	Golgi reassembly	BP
1	4	1.3218233202	-	3.44e-01	GO:1903829	positive regulation of cellular protein localization	BP
1	4	1.3218233202	-	3.44e-01	GO:0090312	positive regulation of protein deacetylation	BP
1	4	1.3218233202	-	3.44e-01	GO:0060235	lens induction in camera-type eye	BP
1	4	1.3218233202	-	3.44e-01	GO:0016080	synaptic vesicle targeting	BP
1	4	1.3218233202	-	3.44e-01	GO:0003413	chondrocyte differentiation involved in endochondral bone morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0010155	regulation of proton transport	BP
1	4	1.3218233202	-	3.44e-01	GO:2000825	positive regulation of androgen receptor activity	BP
1	4	1.3218233202	-	3.44e-01	GO:2001168	positive regulation of histone H2B ubiquitination	BP
1	4	1.3218233202	-	3.44e-01	GO:0015722	canalicular bile acid transport	BP
1	4	1.3218233202	-	3.44e-01	GO:0031394	positive regulation of prostaglandin biosynthetic process	BP
1	4	1.3218233202	-	3.44e-01	GO:2000320	negative regulation of T-helper 17 cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0003186	tricuspid valve morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0002328	pro-B cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:1905907	negative regulation of amyloid fibril formation	BP
1	4	1.3218233202	-	3.44e-01	GO:0019086	late viral transcription	BP
1	4	1.3218233202	-	3.44e-01	GO:0038127	ERBB signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0061333	renal tubule morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0051712	positive regulation of killing of cells of other organism	BP
1	4	1.3218233202	-	3.44e-01	GO:0030174	regulation of DNA-dependent DNA replication initiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0048318	axial mesoderm development	BP
1	4	1.3218233202	-	3.44e-01	GO:0045964	positive regulation of dopamine metabolic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0090559	regulation of membrane permeability	BP
1	4	1.3218233202	-	3.44e-01	GO:0021631	optic nerve morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0003104	positive regulation of glomerular filtration	BP
1	4	1.3218233202	-	3.44e-01	GO:0060421	positive regulation of heart growth	BP
1	4	1.3218233202	-	3.44e-01	GO:2001044	regulation of integrin-mediated signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:1905323	telomerase holoenzyme complex assembly	BP
1	4	1.3218233202	-	3.44e-01	GO:0031670	cellular response to nutrient	BP
1	4	1.3218233202	-	3.44e-01	GO:0070318	positive regulation of G0 to G1 transition	BP
1	4	1.3218233202	-	3.44e-01	GO:0060676	ureteric bud formation	BP
1	4	1.3218233202	-	3.44e-01	GO:0051138	positive regulation of NK T cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0007089	traversing start control point of mitotic cell cycle	BP
1	4	1.3218233202	-	3.44e-01	GO:0007161	calcium-independent cell-matrix adhesion	BP
1	4	1.3218233202	-	3.44e-01	GO:2000491	positive regulation of hepatic stellate cell activation	BP
1	4	1.3218233202	-	3.44e-01	GO:0032510	endosome to lysosome transport via multivesicular body sorting pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:1904294	positive regulation of ERAD pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0006432	phenylalanyl-tRNA aminoacylation	BP
1	4	1.3218233202	-	3.44e-01	GO:1903347	negative regulation of bicellular tight junction assembly	BP
1	4	1.3218233202	-	3.44e-01	GO:1903690	negative regulation of wound healing, spreading of epidermal cells	BP
1	4	1.3218233202	-	3.44e-01	GO:0032611	interleukin-1 beta production	BP
1	4	1.3218233202	-	3.44e-01	GO:1901841	regulation of high voltage-gated calcium channel activity	BP
1	4	1.3218233202	-	3.44e-01	GO:0045191	regulation of isotype switching	BP
1	4	1.3218233202	-	3.44e-01	GO:0007621	negative regulation of female receptivity	BP
1	4	1.3218233202	-	3.44e-01	GO:0051660	establishment of centrosome localization	BP
1	4	1.3218233202	-	3.44e-01	GO:0072012	glomerulus vasculature development	BP
1	4	1.3218233202	-	3.44e-01	GO:1902916	positive regulation of protein polyubiquitination	BP
1	4	1.3218233202	-	3.44e-01	GO:0097623	potassium ion export across plasma membrane	BP
1	4	1.3218233202	-	3.44e-01	GO:0010735	positive regulation of transcription via serum response element binding	BP
1	4	1.3218233202	-	3.44e-01	GO:2001033	negative regulation of double-strand break repair via nonhomologous end joining	BP
1	4	1.3218233202	-	3.44e-01	GO:0032417	positive regulation of sodium:proton antiporter activity	BP
1	4	1.3218233202	-	3.44e-01	GO:2001200	positive regulation of dendritic cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:2000660	negative regulation of interleukin-1-mediated signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0046449	creatinine metabolic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0010044	response to aluminum ion	BP
1	4	1.3218233202	-	3.44e-01	GO:0060161	positive regulation of dopamine receptor signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0010988	regulation of low-density lipoprotein particle clearance	BP
1	4	1.3218233202	-	3.44e-01	GO:0048305	immunoglobulin secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:1900041	negative regulation of interleukin-2 secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:0051351	positive regulation of ligase activity	BP
1	4	1.3218233202	-	3.44e-01	GO:0006538	glutamate catabolic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0051169	nuclear transport	BP
1	4	1.3218233202	-	3.44e-01	GO:0071866	negative regulation of apoptotic process in bone marrow	BP
1	4	1.3218233202	-	3.44e-01	GO:0016071	mRNA metabolic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0035771	interleukin-4-mediated signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0006573	valine metabolic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0031077	post-embryonic camera-type eye development	BP
1	4	1.3218233202	-	3.44e-01	GO:2000741	positive regulation of mesenchymal stem cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0045876	positive regulation of sister chromatid cohesion	BP
1	4	1.3218233202	-	3.44e-01	GO:0035522	monoubiquitinated histone H2A deubiquitination	BP
1	4	1.3218233202	-	3.44e-01	GO:0031999	negative regulation of fatty acid beta-oxidation	BP
1	4	1.3218233202	-	3.44e-01	GO:0030223	neutrophil differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0034698	response to gonadotropin	BP
1	4	1.3218233202	-	3.44e-01	GO:0006273	lagging strand elongation	BP
1	4	1.3218233202	-	3.44e-01	GO:0072553	terminal button organization	BP
1	4	1.3218233202	-	3.44e-01	GO:0034205	amyloid-beta formation	BP
1	4	1.3218233202	-	3.44e-01	GO:0042490	mechanoreceptor differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0022009	central nervous system vasculogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0034088	maintenance of mitotic sister chromatid cohesion	BP
1	4	1.3218233202	-	3.44e-01	GO:0032226	positive regulation of synaptic transmission, dopaminergic	BP
1	4	1.3218233202	-	3.44e-01	GO:0033686	positive regulation of luteinizing hormone secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:0045629	negative regulation of T-helper 2 cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0072513	positive regulation of secondary heart field cardioblast proliferation	BP
1	4	1.3218233202	-	3.44e-01	GO:0060535	trachea cartilage morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0045986	negative regulation of smooth muscle contraction	BP
1	4	1.3218233202	-	3.44e-01	GO:1902949	positive regulation of tau-protein kinase activity	BP
1	4	1.3218233202	-	3.44e-01	GO:0042089	cytokine biosynthetic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0010916	negative regulation of very-low-density lipoprotein particle clearance	BP
1	4	1.3218233202	-	3.44e-01	GO:2001181	positive regulation of interleukin-10 secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:0045472	response to ether	BP
1	4	1.3218233202	-	3.44e-01	GO:0048549	positive regulation of pinocytosis	BP
1	4	1.3218233202	-	3.44e-01	GO:0032640	tumor necrosis factor production	BP
1	4	1.3218233202	-	3.44e-01	GO:0045006	DNA deamination	BP
1	4	1.3218233202	-	3.44e-01	GO:0070164	negative regulation of adiponectin secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:0006482	protein demethylation	BP
1	4	1.3218233202	-	3.44e-01	GO:0060485	mesenchyme development	BP
1	4	1.3218233202	-	3.44e-01	GO:0008088	axo-dendritic transport	BP
1	4	1.3218233202	-	3.44e-01	GO:0002159	desmosome assembly	BP
1	4	1.3218233202	-	3.44e-01	GO:0006924	activation-induced cell death of T cells	BP
1	4	1.3218233202	-	3.44e-01	GO:0090063	positive regulation of microtubule nucleation	BP
1	4	1.3218233202	-	3.44e-01	GO:2000676	positive regulation of type B pancreatic cell apoptotic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0048505	regulation of timing of cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0060192	negative regulation of lipase activity	BP
1	4	1.3218233202	-	3.44e-01	GO:2000736	regulation of stem cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:1903936	cellular response to sodium arsenite	BP
1	4	1.3218233202	-	3.44e-01	GO:0010992	ubiquitin recycling	BP
1	4	1.3218233202	-	3.44e-01	GO:1901984	negative regulation of protein acetylation	BP
1	4	1.3218233202	-	3.44e-01	GO:1901985	positive regulation of protein acetylation	BP
1	4	1.3218233202	-	3.44e-01	GO:0051345	positive regulation of hydrolase activity	BP
1	4	1.3218233202	-	3.44e-01	GO:0045085	negative regulation of interleukin-2 biosynthetic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0097201	negative regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	4	1.3218233202	-	3.44e-01	GO:0048633	positive regulation of skeletal muscle tissue growth	BP
1	4	1.3218233202	-	3.44e-01	GO:0035021	negative regulation of Rac protein signal transduction	BP
1	4	1.3218233202	-	3.44e-01	GO:1990869	cellular response to chemokine	BP
1	4	1.3218233202	-	3.44e-01	GO:0061041	regulation of wound healing	BP
1	4	1.3218233202	-	3.44e-01	GO:1990086	lens fiber cell apoptotic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0030260	entry into host cell	BP
1	4	1.3218233202	-	3.44e-01	GO:1902714	negative regulation of interferon-gamma secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:0038026	reelin-mediated signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0038028	insulin receptor signaling pathway via phosphatidylinositol 3-kinase	BP
1	4	1.3218233202	-	3.44e-01	GO:1901842	negative regulation of high voltage-gated calcium channel activity	BP
1	4	1.3218233202	-	3.44e-01	GO:1905342	positive regulation of protein localization to kinetochore	BP
1	4	1.3218233202	-	3.44e-01	GO:0097350	neutrophil clearance	BP
1	4	1.3218233202	-	3.44e-01	GO:0000904	cell morphogenesis involved in differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0021955	central nervous system neuron axonogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0031125	rRNA 3'-end processing	BP
1	4	1.3218233202	-	3.44e-01	GO:0097114	NMDA glutamate receptor clustering	BP
1	4	1.3218233202	-	3.44e-01	GO:0097113	AMPA glutamate receptor clustering	BP
1	4	1.3218233202	-	3.44e-01	GO:0034969	histone arginine methylation	BP
1	4	1.3218233202	-	3.44e-01	GO:0048570	notochord morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0043137	DNA replication, removal of RNA primer	BP
7	28	1.3218233202	-	1.78e-02	GO:0046875	ephrin receptor binding	MF
5	20	1.3218233202	-	4.31e-02	GO:0043548	phosphatidylinositol 3-kinase binding	MF
4	16	1.3218233202	-	4.41e-02	GO:0017091	AU-rich element binding	MF
4	16	1.3218233202	-	5.55e-02	GO:0097602	cullin family protein binding	MF
4	16	1.3218233202	-	6.83e-02	GO:0070182	DNA polymerase binding	MF
4	16	1.3218233202	-	6.83e-02	GO:0051393	alpha-actinin binding	MF
2	8	1.3218233202	-	1.14e-01	GO:0015271	outward rectifier potassium channel activity	MF
2	8	1.3218233202	-	1.14e-01	GO:0032052	bile acid binding	MF
2	8	1.3218233202	-	1.50e-01	GO:0019957	C-C chemokine binding	MF
2	8	1.3218233202	-	1.50e-01	GO:0004415	hyalurononglucosaminidase activity	MF
2	8	1.3218233202	-	1.87e-01	GO:0097157	pre-mRNA intronic binding	MF
2	8	1.3218233202	-	1.87e-01	GO:0001094	TFIID-class transcription factor binding	MF
2	8	1.3218233202	-	1.87e-01	GO:0001164	RNA polymerase I CORE element sequence-specific DNA binding	MF
2	8	1.3218233202	-	1.87e-01	GO:0031386	protein tag	MF
1	4	1.3218233202	-	1.90e-01	GO:0016614	oxidoreductase activity, acting on CH-OH group of donors	MF
1	4	1.3218233202	-	1.90e-01	GO:0050501	hyaluronan synthase activity	MF
1	4	1.3218233202	-	1.90e-01	GO:0035243	protein-arginine omega-N symmetric methyltransferase activity	MF
1	4	1.3218233202	-	1.90e-01	GO:0004522	ribonuclease A activity	MF
1	4	1.3218233202	-	1.90e-01	GO:0015252	hydrogen ion channel activity	MF
1	4	1.3218233202	-	1.90e-01	GO:0004515	nicotinate-nucleotide adenylyltransferase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0008509	anion transmembrane transporter activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0033265	choline binding	MF
1	4	1.3218233202	-	2.71e-01	GO:0005219	ryanodine-sensitive calcium-release channel activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0044736	acid-sensing ion channel activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0048763	calcium-induced calcium release activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0070891	lipoteichoic acid binding	MF
1	4	1.3218233202	-	2.71e-01	GO:0001851	complement component C3b binding	MF
1	4	1.3218233202	-	2.71e-01	GO:0050833	pyruvate transmembrane transporter activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0001032	RNA polymerase III type 3 promoter DNA binding	MF
1	4	1.3218233202	-	2.71e-01	GO:0042287	MHC protein binding	MF
1	4	1.3218233202	-	2.71e-01	GO:0005176	ErbB-2 class receptor binding	MF
1	4	1.3218233202	-	2.71e-01	GO:0090554	phosphatidylcholine-translocating ATPase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0004035	alkaline phosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0004305	ethanolamine kinase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0061676	importin-alpha family protein binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0005315	inorganic phosphate transmembrane transporter activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0043208	glycosphingolipid binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0097643	amylin receptor activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0003917	DNA topoisomerase type I activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0004706	JUN kinase kinase kinase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:1904288	BAT3 complex binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0048408	epidermal growth factor binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0005329	dopamine transmembrane transporter activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0038085	vascular endothelial growth factor binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0004945	angiotensin type II receptor activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0031852	mu-type opioid receptor binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0043199	sulfate binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0005087	Ran guanyl-nucleotide exchange factor activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0036033	mediator complex binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0004974	leukotriene receptor activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0034617	tetrahydrobiopterin binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0005497	androgen binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0070326	very-low-density lipoprotein particle receptor binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0003873	6-phosphofructo-2-kinase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0051425	PTB domain binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0035312	5'-3' exodeoxyribonuclease activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0001882	nucleoside binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0086089	voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization	MF
1	4	1.3218233202	-	3.44e-01	GO:0005172	vascular endothelial growth factor receptor binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0043121	neurotrophin binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0086007	voltage-gated calcium channel activity involved in cardiac muscle cell action potential	MF
1	4	1.3218233202	-	3.44e-01	GO:0033192	calmodulin-dependent protein phosphatase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0016505	peptidase activator activity involved in apoptotic process	MF
1	4	1.3218233202	-	3.44e-01	GO:0060090	binding, bridging	MF
1	4	1.3218233202	-	3.44e-01	GO:0031698	beta-2 adrenergic receptor binding	MF
17	69	1.30076170467	-	8.47e-05	GO:0001938	positive regulation of endothelial cell proliferation	BP
17	69	1.30076170467	-	2.38e-04	GO:0007265	Ras protein signal transduction	BP
16	65	1.29945550717	-	7.93e-05	GO:0031647	regulation of protein stability	BP
15	61	1.29797657825	-	5.33e-04	GO:0031398	positive regulation of protein ubiquitination	BP
14	57	1.29628822809	-	1.72e-04	GO:0045669	positive regulation of osteoblast differentiation	BP
14	57	1.29628822809	-	5.33e-04	GO:0007173	epidermal growth factor receptor signaling pathway	BP
13	53	1.29434258378	-	7.98e-04	GO:0035064	methylated histone binding	MF
11	45	1.28940184251	-	1.15e-03	GO:0030900	forebrain development	BP
11	45	1.28940184251	-	1.15e-03	GO:0034605	cellular response to heat	BP
39	160	1.28529744418	-	1.85e-08	GO:0001666	response to hypoxia	BP
19	78	1.28434861478	-	5.66e-06	GO:0030324	lung development	BP
9	37	1.28229495601	-	3.26e-03	GO:0032720	negative regulation of tumor necrosis factor production	BP
17	70	1.28000314451	-	1.30e-04	GO:0032088	negative regulation of NF-kappaB transcription factor activity	BP
16	66	1.27742920084	-	6.24e-05	GO:0060337	type I interferon signaling pathway	BP
8	33	1.27742920084	-	2.24e-03	GO:0001937	negative regulation of endothelial cell proliferation	BP
15	62	1.27451760542	-	7.11e-05	GO:0042632	cholesterol homeostasis	BP
29	120	1.27291371972	-	9.33e-07	GO:0071222	cellular response to lipopolysaccharide	BP
7	29	1.27119724713	-	1.18e-02	GO:0010033	response to organic substance	BP
7	29	1.27119724713	-	2.15e-02	GO:0000077	DNA damage checkpoint	BP
13	54	1.26737553618	-	7.98e-04	GO:0031072	heat shock protein binding	MF
50	208	1.26523979183	-	1.11e-10	GO:0006974	cellular response to DNA damage stimulus	BP
6	25	1.26292963115	-	2.25e-02	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	BP
6	25	1.26292963115	-	2.25e-02	GO:0043542	endothelial cell migration	BP
6	25	1.26292963115	-	2.75e-02	GO:0055010	ventricular cardiac muscle tissue morphogenesis	BP
6	25	1.26292963115	-	3.33e-02	GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	BP
15	63	1.25143399231	-	1.48e-04	GO:0008203	cholesterol metabolic process	BP
10	42	1.25143399231	-	3.35e-03	GO:0034198	cellular response to amino acid starvation	BP
10	42	1.25143399231	-	4.11e-03	GO:0014823	response to activity	BP
5	21	1.25143399231	-	1.69e-02	GO:0071542	dopaminergic neuron differentiation	BP
5	21	1.25143399231	-	3.51e-02	GO:0097150	neuronal stem cell population maintenance	BP
5	21	1.25143399231	-	3.51e-02	GO:0042346	positive regulation of NF-kappaB import into nucleus	BP
5	21	1.25143399231	-	3.51e-02	GO:0043113	receptor clustering	BP
5	21	1.25143399231	-	3.51e-02	GO:0050870	positive regulation of T cell activation	BP
5	21	1.25143399231	-	4.31e-02	GO:0030879	mammary gland development	BP
5	21	1.25143399231	-	4.31e-02	GO:0003148	outflow tract septum morphogenesis	BP
5	21	1.25143399231	-	1.69e-02	GO:0031210	phosphatidylcholine binding	MF
5	21	1.25143399231	-	1.69e-02	GO:0005112	Notch binding	MF
5	21	1.25143399231	-	4.31e-02	GO:0000175	3'-5'-exoribonuclease activity	MF
70	295	1.2465351929	-	1.00e-10	GO:0031625	ubiquitin protein ligase binding	MF
9	38	1.2438208082	-	3.26e-03	GO:0045597	positive regulation of cell differentiation	BP
9	38	1.2438208082	-	6.24e-03	GO:0010634	positive regulation of epithelial cell migration	BP
9	38	1.2438208082	-	1.10e-02	GO:0031623	receptor internalization	BP
94	398	1.23978755134	-	1.89e-10	GO:0019901	protein kinase binding	MF
8	34	1.23436047895	-	3.83e-03	GO:0030513	positive regulation of BMP signaling pathway	BP
4	17	1.23436047895	-	3.41e-02	GO:0014850	response to muscle activity	BP
4	17	1.23436047895	-	3.41e-02	GO:0045019	negative regulation of nitric oxide biosynthetic process	BP
4	17	1.23436047895	-	3.41e-02	GO:0048514	blood vessel morphogenesis	BP
4	17	1.23436047895	-	4.41e-02	GO:1903506	regulation of nucleic acid-templated transcription	BP
4	17	1.23436047895	-	4.41e-02	GO:0030193	regulation of blood coagulation	BP
4	17	1.23436047895	-	4.41e-02	GO:0050767	regulation of neurogenesis	BP
4	17	1.23436047895	-	5.55e-02	GO:0071354	cellular response to interleukin-6	BP
4	17	1.23436047895	-	5.55e-02	GO:0071380	cellular response to prostaglandin E stimulus	BP
4	17	1.23436047895	-	5.55e-02	GO:0045926	negative regulation of growth	BP
4	17	1.23436047895	-	5.55e-02	GO:0070935	3'-UTR-mediated mRNA stabilization	BP
4	17	1.23436047895	-	5.55e-02	GO:0071404	cellular response to low-density lipoprotein particle stimulus	BP
4	17	1.23436047895	-	6.83e-02	GO:2000249	regulation of actin cytoskeleton reorganization	BP
4	17	1.23436047895	-	6.83e-02	GO:1904355	positive regulation of telomere capping	BP
4	17	1.23436047895	-	6.83e-02	GO:0045638	negative regulation of myeloid cell differentiation	BP
4	17	1.23436047895	-	6.83e-02	GO:0048814	regulation of dendrite morphogenesis	BP
4	17	1.23436047895	-	8.25e-02	GO:0031668	cellular response to extracellular stimulus	BP
4	17	1.23436047895	-	1.28e-02	GO:0008392	arachidonic acid epoxygenase activity	MF
4	17	1.23436047895	-	2.56e-02	GO:0051213	dioxygenase activity	MF
4	17	1.23436047895	-	8.25e-02	GO:0003678	DNA helicase activity	MF
51	217	1.23269742973	-	5.97e-11	GO:0044267	cellular protein metabolic process	BP
69	294	1.23067543214	-	2.04e-10	GO:0010628	positive regulation of gene expression	BP
15	64	1.22871391581	-	4.37e-04	GO:0035019	somatic stem cell population maintenance	BP
18	77	1.22496178095	-	1.31e-04	GO:0003690	double-stranded DNA binding	MF
7	30	1.22228764665	-	7.40e-03	GO:0030901	midbrain development	BP
7	30	1.22228764665	-	9.41e-03	GO:0002027	regulation of heart rate	BP
7	30	1.22228764665	-	1.46e-02	GO:0007259	JAK-STAT cascade	BP
7	30	1.22228764665	-	1.46e-02	GO:0007616	long-term memory	BP
7	30	1.22228764665	-	2.15e-02	GO:0046627	negative regulation of insulin receptor signaling pathway	BP
10	43	1.21748666039	-	7.96e-04	GO:0045165	cell fate commitment	BP
10	43	1.21748666039	-	2.17e-03	GO:0030178	negative regulation of Wnt signaling pathway	BP
10	43	1.21748666039	-	2.71e-03	GO:0007566	embryo implantation	BP
23	99	1.21602865618	-	1.80e-05	GO:0051726	regulation of cell cycle	BP
38	164	1.21219882903	-	1.21e-08	GO:0007507	heart development	BP
19	82	1.21219882903	-	3.09e-05	GO:0060021	palate development	BP
9	39	1.20634610278	-	3.16e-04	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	BP
9	39	1.20634610278	-	2.57e-03	GO:0030326	embryonic limb morphogenesis	BP
6	26	1.20634610278	-	1.12e-02	GO:0010719	negative regulation of epithelial to mesenchymal transition	BP
6	26	1.20634610278	-	2.25e-02	GO:0033077	T cell differentiation in thymus	BP
6	26	1.20634610278	-	2.25e-02	GO:0032715	negative regulation of interleukin-6 production	BP
6	26	1.20634610278	-	2.25e-02	GO:0070372	regulation of ERK1 and ERK2 cascade	BP
6	26	1.20634610278	-	2.75e-02	GO:0010800	positive regulation of peptidyl-threonine phosphorylation	BP
3	13	1.20634610278	-	5.29e-02	GO:0001516	prostaglandin biosynthetic process	BP
3	13	1.20634610278	-	7.01e-02	GO:0002087	regulation of respiratory gaseous exchange by neurological system process	BP
3	13	1.20634610278	-	7.01e-02	GO:0042554	superoxide anion generation	BP
3	13	1.20634610278	-	7.01e-02	GO:0060389	pathway-restricted SMAD protein phosphorylation	BP
3	13	1.20634610278	-	8.95e-02	GO:0010717	regulation of epithelial to mesenchymal transition	BP
3	13	1.20634610278	-	8.95e-02	GO:0050872	white fat cell differentiation	BP
3	13	1.20634610278	-	8.95e-02	GO:0032228	regulation of synaptic transmission, GABAergic	BP
3	13	1.20634610278	-	1.11e-01	GO:1900181	negative regulation of protein localization to nucleus	BP
3	13	1.20634610278	-	1.11e-01	GO:0035909	aorta morphogenesis	BP
3	13	1.20634610278	-	1.11e-01	GO:0046685	response to arsenic-containing substance	BP
3	13	1.20634610278	-	1.11e-01	GO:0019725	cellular homeostasis	BP
3	13	1.20634610278	-	1.11e-01	GO:0019395	fatty acid oxidation	BP
3	13	1.20634610278	-	1.11e-01	GO:0071361	cellular response to ethanol	BP
3	13	1.20634610278	-	1.11e-01	GO:0002526	acute inflammatory response	BP
3	13	1.20634610278	-	1.34e-01	GO:0001774	microglial cell activation	BP
3	13	1.20634610278	-	1.34e-01	GO:0006809	nitric oxide biosynthetic process	BP
3	13	1.20634610278	-	1.34e-01	GO:0070986	left/right axis specification	BP
3	13	1.20634610278	-	1.34e-01	GO:0010498	proteasomal protein catabolic process	BP
40	175	1.19254030326	-	2.23e-08	GO:0001701	in utero embryonic development	BP
16	70	1.19254030326	-	4.32e-04	GO:0001889	liver development	BP
13	57	1.18937302418	-	2.10e-03	GO:0048661	positive regulation of smooth muscle cell proliferation	BP
112	492	1.18666373692	-	1.97e-10	GO:0046982	protein heterodimerization activity	MF
30	132	1.18431979645	-	1.67e-06	GO:0043524	negative regulation of neuron apoptotic process	BP
15	66	1.18431979645	-	7.79e-04	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	BP
10	44	1.18431979645	-	1.72e-03	GO:0032870	cellular response to hormone stimulus	BP
5	22	1.18431979645	-	2.21e-02	GO:0031016	pancreas development	BP
5	22	1.18431979645	-	2.81e-02	GO:0071157	negative regulation of cell cycle arrest	BP
5	22	1.18431979645	-	3.51e-02	GO:0042832	defense response to protozoan	BP
5	22	1.18431979645	-	4.31e-02	GO:1901224	positive regulation of NIK/NF-kappaB signaling	BP
5	22	1.18431979645	-	5.20e-02	GO:0045662	negative regulation of myoblast differentiation	BP
27	119	1.18189305906	-	7.86e-06	GO:0030308	negative regulation of cell growth	BP
47	208	1.17597245374	-	1.54e-08	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	BP
7	31	1.17498193187	-	1.46e-02	GO:0014065	phosphatidylinositol 3-kinase signaling	BP
7	31	1.17498193187	-	1.78e-02	GO:0030217	T cell differentiation	BP
7	31	1.17498193187	-	2.57e-02	GO:0045773	positive regulation of axon extension	BP
37	164	1.17372468121	-	1.54e-07	GO:0007568	aging	BP
16	71	1.1720762007	-	1.57e-04	GO:0009791	post-embryonic development	BP
16	71	1.1720762007	-	1.85e-03	GO:0048010	vascular endothelial growth factor receptor signaling pathway	BP
9	40	1.16982022676	-	4.09e-03	GO:0032570	response to progesterone	BP
20	89	1.16801798412	-	1.79e-04	GO:0034599	cellular response to oxidative stress	BP
40	179	1.15993563782	-	6.71e-07	GO:0008022	protein C-terminus binding	MF
60	269	1.15725155325	-	1.46e-10	GO:0016579	protein deubiquitination	BP
33	148	1.15676407393	-	1.62e-06	GO:0050852	T cell receptor signaling pathway	BP
18	81	1.15189831876	-	1.07e-04	GO:0060070	canonical Wnt signaling pathway	BP
14	63	1.15189831876	-	1.17e-03	GO:0032092	positive regulation of protein binding	BP
14	63	1.15189831876	-	1.40e-03	GO:0051384	response to glucocorticoid	BP
2	9	1.15189831876	-	9.99e-03	GO:1904685	positive regulation of metalloendopeptidase activity	BP
2	9	1.15189831876	-	2.80e-02	GO:1904753	negative regulation of vascular associated smooth muscle cell migration	BP
6	27	1.15189831876	-	4.69e-02	GO:0043278	response to morphine	BP
4	18	1.15189831876	-	5.55e-02	GO:0008585	female gonad development	BP
4	18	1.15189831876	-	6.83e-02	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	BP
2	9	1.15189831876	-	8.14e-02	GO:0043583	ear development	BP
4	18	1.15189831876	-	9.81e-02	GO:0043523	regulation of neuron apoptotic process	BP
4	18	1.15189831876	-	9.81e-02	GO:0045821	positive regulation of glycolytic process	BP
2	9	1.15189831876	-	1.14e-01	GO:0003073	regulation of systemic arterial blood pressure	BP
2	9	1.15189831876	-	1.14e-01	GO:0097267	omega-hydroxylase P450 pathway	BP
2	9	1.15189831876	-	1.14e-01	GO:0071435	potassium ion export	BP
2	9	1.15189831876	-	1.14e-01	GO:2000304	positive regulation of ceramide biosynthetic process	BP
2	9	1.15189831876	-	1.50e-01	GO:2000648	positive regulation of stem cell proliferation	BP
2	9	1.15189831876	-	1.50e-01	GO:0086014	atrial cardiac muscle cell action potential	BP
2	9	1.15189831876	-	1.50e-01	GO:2001223	negative regulation of neuron migration	BP
2	9	1.15189831876	-	1.50e-01	GO:0046548	retinal rod cell development	BP
2	9	1.15189831876	-	1.50e-01	GO:0048643	positive regulation of skeletal muscle tissue development	BP
2	9	1.15189831876	-	1.50e-01	GO:0003374	dynamin family protein polymerization involved in mitochondrial fission	BP
2	9	1.15189831876	-	1.50e-01	GO:0002281	macrophage activation involved in immune response	BP
2	9	1.15189831876	-	1.50e-01	GO:0010873	positive regulation of cholesterol esterification	BP
2	9	1.15189831876	-	1.50e-01	GO:0038166	angiotensin-activated signaling pathway	BP
2	9	1.15189831876	-	1.50e-01	GO:0048806	genitalia development	BP
2	9	1.15189831876	-	1.50e-01	GO:0007599	hemostasis	BP
2	9	1.15189831876	-	1.50e-01	GO:0072358	cardiovascular system development	BP
2	9	1.15189831876	-	1.50e-01	GO:0045124	regulation of bone resorption	BP
2	9	1.15189831876	-	1.50e-01	GO:0060253	negative regulation of glial cell proliferation	BP
2	9	1.15189831876	-	1.50e-01	GO:0035767	endothelial cell chemotaxis	BP
2	9	1.15189831876	-	1.87e-01	GO:0036500	ATF6-mediated unfolded protein response	BP
2	9	1.15189831876	-	1.87e-01	GO:0010762	regulation of fibroblast migration	BP
2	9	1.15189831876	-	1.87e-01	GO:0001818	negative regulation of cytokine production	BP
2	9	1.15189831876	-	1.87e-01	GO:0000733	DNA strand renaturation	BP
2	9	1.15189831876	-	1.87e-01	GO:0032886	regulation of microtubule-based process	BP
2	9	1.15189831876	-	1.87e-01	GO:0035562	negative regulation of chromatin binding	BP
2	9	1.15189831876	-	1.87e-01	GO:0050795	regulation of behavior	BP
2	9	1.15189831876	-	1.87e-01	GO:0032835	glomerulus development	BP
2	9	1.15189831876	-	1.87e-01	GO:0070493	thrombin-activated receptor signaling pathway	BP
2	9	1.15189831876	-	2.25e-01	GO:0043030	regulation of macrophage activation	BP
2	9	1.15189831876	-	2.25e-01	GO:1901030	positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	BP
2	9	1.15189831876	-	2.25e-01	GO:0010225	response to UV-C	BP
2	9	1.15189831876	-	2.25e-01	GO:0032463	negative regulation of protein homooligomerization	BP
2	9	1.15189831876	-	2.25e-01	GO:0010863	positive regulation of phospholipase C activity	BP
2	9	1.15189831876	-	2.25e-01	GO:0043268	positive regulation of potassium ion transport	BP
2	9	1.15189831876	-	2.25e-01	GO:0033689	negative regulation of osteoblast proliferation	BP
2	9	1.15189831876	-	2.25e-01	GO:0035456	response to interferon-beta	BP
2	9	1.15189831876	-	2.25e-01	GO:0034333	adherens junction assembly	BP
2	9	1.15189831876	-	2.25e-01	GO:0022407	regulation of cell-cell adhesion	BP
2	9	1.15189831876	-	2.25e-01	GO:0021895	cerebral cortex neuron differentiation	BP
2	9	1.15189831876	-	2.25e-01	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
4	18	1.15189831876	-	8.31e-03	GO:0001972	retinoic acid binding	MF
4	18	1.15189831876	-	9.81e-02	GO:0005234	extracellular-glutamate-gated ion channel activity	MF
2	9	1.15189831876	-	1.50e-01	GO:0031419	cobalamin binding	MF
2	9	1.15189831876	-	1.87e-01	GO:0070679	inositol 1,4,5 trisphosphate binding	MF
2	9	1.15189831876	-	2.25e-01	GO:0044389	ubiquitin-like protein ligase binding	MF
2	9	1.15189831876	-	2.25e-01	GO:0003691	double-stranded telomeric DNA binding	MF
2	9	1.15189831876	-	2.25e-01	GO:0034713	type I transforming growth factor beta receptor binding	MF
2	9	1.15189831876	-	2.25e-01	GO:0008179	adenylate cyclase binding	MF
2	9	1.15189831876	-	2.25e-01	GO:0017081	chloride channel regulator activity	MF
67	302	1.14950777133	-	9.98e-11	GO:0042493	response to drug	BP
17	77	1.14249962076	-	2.89e-04	GO:0042060	wound healing	BP
15	68	1.14125107456	-	6.46e-04	GO:0009749	response to glucose	BP
26	118	1.13961998898	-	1.61e-06	GO:0045766	positive regulation of angiogenesis	BP
24	109	1.13860149615	-	7.98e-05	GO:0000187	activation of MAPK activity	BP
7	32	1.12917824226	-	1.18e-02	GO:0071773	cellular response to BMP stimulus	BP
7	32	1.12917824226	-	2.57e-02	GO:0001932	regulation of protein phosphorylation	BP
7	32	1.12917824226	-	2.57e-02	GO:0001974	blood vessel remodeling	BP
7	32	1.12917824226	-	2.57e-02	GO:0032008	positive regulation of TOR signaling	BP
12	55	1.1254261074	-	1.80e-03	GO:0042733	embryonic digit morphogenesis	BP
12	55	1.1254261074	-	4.46e-03	GO:0043621	protein self-association	MF
10	46	1.12018945903	-	7.22e-03	GO:0007519	skeletal muscle tissue development	BP
10	46	1.12018945903	-	1.01e-02	GO:0031100	animal organ regeneration	BP
5	23	1.12018945903	-	5.20e-02	GO:0048870	cell motility	BP
5	23	1.12018945903	-	6.20e-02	GO:0005978	glycogen biosynthetic process	BP
5	23	1.12018945903	-	7.30e-02	GO:0001954	positive regulation of cell-matrix adhesion	BP
77	355	1.1169346465	-	1.00e-10	GO:0004674	protein serine/threonine kinase activity	MF
18	83	1.1167088903	-	8.75e-05	GO:0009887	animal organ morphogenesis	BP
101	467	1.11275606324	-	1.50e-10	GO:0043066	negative regulation of apoptotic process	BP
88	407	1.11236995457	-	2.28e-10	GO:0008285	negative regulation of cell proliferation	BP
16	74	1.11236995457	-	2.19e-03	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
8	37	1.11236995457	-	1.40e-02	GO:0009790	embryo development	BP
8	37	1.11236995457	-	1.40e-02	GO:0010507	negative regulation of autophagy	BP
11	51	1.10882959687	-	2.22e-03	GO:0008344	adult locomotory behavior	BP
17	79	1.10550541327	-	1.15e-03	GO:0032869	cellular response to insulin stimulus	BP
3	14	1.09943089886	-	2.57e-02	GO:0061049	cell growth involved in cardiac muscle cell development	BP
6	28	1.09943089886	-	2.75e-02	GO:0016358	dendrite development	BP
6	28	1.09943089886	-	4.69e-02	GO:0051603	proteolysis involved in cellular protein catabolic process	BP
3	14	1.09943089886	-	7.01e-02	GO:0031103	axon regeneration	BP
3	14	1.09943089886	-	7.01e-02	GO:0010666	positive regulation of cardiac muscle cell apoptotic process	BP
3	14	1.09943089886	-	1.11e-01	GO:1901185	negative regulation of ERBB signaling pathway	BP
3	14	1.09943089886	-	1.11e-01	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	BP
3	14	1.09943089886	-	1.11e-01	GO:1903078	positive regulation of protein localization to plasma membrane	BP
3	14	1.09943089886	-	1.11e-01	GO:0071425	hematopoietic stem cell proliferation	BP
3	14	1.09943089886	-	1.34e-01	GO:0044130	negative regulation of growth of symbiont in host	BP
3	14	1.09943089886	-	1.34e-01	GO:0001921	positive regulation of receptor recycling	BP
3	14	1.09943089886	-	1.34e-01	GO:2000060	positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
3	14	1.09943089886	-	1.34e-01	GO:0030818	negative regulation of cAMP biosynthetic process	BP
3	14	1.09943089886	-	1.34e-01	GO:0071360	cellular response to exogenous dsRNA	BP
3	14	1.09943089886	-	1.58e-01	GO:1902187	negative regulation of viral release from host cell	BP
3	14	1.09943089886	-	1.58e-01	GO:0043069	negative regulation of programmed cell death	BP
3	14	1.09943089886	-	1.58e-01	GO:1902043	positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
3	14	1.09943089886	-	5.29e-02	GO:0070403	NAD+ binding	MF
3	14	1.09943089886	-	1.11e-01	GO:0008528	G-protein coupled peptide receptor activity	MF
3	14	1.09943089886	-	1.34e-01	GO:0005095	GTPase inhibitor activity	MF
3	14	1.09943089886	-	1.58e-01	GO:0005041	low-density lipoprotein receptor activity	MF
3	14	1.09943089886	-	1.58e-01	GO:0005528	FK506 binding	MF
22	103	1.09475441166	-	9.56e-06	GO:0010468	regulation of gene expression	BP
39	183	1.09152570078	-	1.78e-07	GO:0007596	blood coagulation	BP
10	47	1.08916256341	-	2.03e-05	GO:0045596	negative regulation of cell differentiation	BP
10	47	1.08916256341	-	1.01e-02	GO:0032760	positive regulation of tumor necrosis factor production	BP
10	47	1.08916256341	-	1.19e-02	GO:0038083	peptidyl-tyrosine autophosphorylation	BP
17	80	1.08735806656	-	1.46e-03	GO:0033138	positive regulation of peptidyl-serine phosphorylation	BP
7	33	1.0847841229	-	4.36e-03	GO:0006656	phosphatidylcholine biosynthetic process	BP
7	33	1.0847841229	-	5.73e-03	GO:0042100	B cell proliferation	BP
7	33	1.0847841229	-	1.78e-02	GO:0003007	heart morphogenesis	BP
7	33	1.0847841229	-	3.57e-02	GO:0043491	protein kinase B signaling	BP
7	33	1.0847841229	-	4.15e-02	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	BP
24	114	1.07389580676	-	3.67e-05	GO:0071356	cellular response to tumor necrosis factor	BP
12	57	1.07389580676	-	1.47e-03	GO:0001947	heart looping	BP
12	57	1.07389580676	-	3.77e-03	GO:0071333	cellular response to glucose stimulus	BP
16	76	1.07389580676	-	2.19e-03	GO:0016925	protein sumoylation	BP
4	19	1.07389580676	-	3.41e-02	GO:0010881	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	BP
4	19	1.07389580676	-	3.41e-02	GO:0033280	response to vitamin D	BP
8	38	1.07389580676	-	4.98e-02	GO:0033683	nucleotide-excision repair, DNA incision	BP
4	19	1.07389580676	-	5.55e-02	GO:0048663	neuron fate commitment	BP
4	19	1.07389580676	-	9.81e-02	GO:0043153	entrainment of circadian clock by photoperiod	BP
4	19	1.07389580676	-	9.81e-02	GO:0098586	cellular response to virus	BP
4	19	1.07389580676	-	1.15e-01	GO:0031572	G2 DNA damage checkpoint	BP
4	19	1.07389580676	-	1.15e-01	GO:0070987	error-free translesion synthesis	BP
4	19	1.07389580676	-	8.25e-02	GO:0070530	K63-linked polyubiquitin modification-dependent protein binding	MF
14	67	1.0630890518	-	5.96e-03	GO:0038061	NIK/NF-kappaB signaling	BP
5	24	1.05878891437	-	1.69e-02	GO:0017144	drug metabolic process	BP
5	24	1.05878891437	-	3.51e-02	GO:0051899	membrane depolarization	BP
5	24	1.05878891437	-	3.51e-02	GO:0006182	cGMP biosynthetic process	BP
5	24	1.05878891437	-	8.49e-02	GO:0035235	ionotropic glutamate receptor signaling pathway	BP
16	77	1.05503677951	-	7.93e-05	GO:0045666	positive regulation of neuron differentiation	BP
12	58	1.04880482579	-	2.19e-03	GO:0050679	positive regulation of epithelial cell proliferation	BP
6	29	1.04880482579	-	2.25e-02	GO:0044344	cellular response to fibroblast growth factor stimulus	BP
6	29	1.04880482579	-	2.75e-02	GO:0050873	brown fat cell differentiation	BP
6	29	1.04880482579	-	3.33e-02	GO:2000145	regulation of cell motility	BP
6	29	1.04880482579	-	5.48e-02	GO:0004712	protein serine/threonine/tyrosine kinase activity	MF
31	150	1.04720094009	-	2.26e-05	GO:0050821	protein stabilization	BP
19	92	1.04618887759	-	8.82e-05	GO:0009636	response to toxic substance	BP
19	92	1.04618887759	-	5.46e-04	GO:0032355	response to estradiol	BP
28	136	1.04171540101	-	7.25e-05	GO:0042787	protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
90	438	1.03888935693	-	2.17e-10	GO:0006468	protein phosphorylation	BP
8	39	1.03642110134	-	4.91e-03	GO:0015459	potassium channel regulator activity	MF
66	322	1.03530056145	-	4.45e-09	GO:0016032	viral process	BP
10	49	1.02904157097	-	2.49e-02	GO:0042542	response to hydrogen peroxide	BP
28	138	1.02065378548	-	2.33e-05	GO:0001934	positive regulation of protein phosphorylation	BP
15	74	1.01926055018	-	4.46e-03	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
16	79	1.01804257202	-	2.19e-03	GO:0051117	ATPase binding	MF
19	94	1.01516198197	-	7.29e-04	GO:0008584	male gonad development	BP
65	322	1.01327425512	-	1.37e-10	GO:0043065	positive regulation of apoptotic process	BP
26	129	1.01103578292	-	1.30e-06	GO:0009653	anatomical structure morphogenesis	BP
12	60	0.999895225314	-	4.46e-03	GO:0050727	regulation of inflammatory response	BP
6	30	0.999895225314	-	1.44e-02	GO:0045930	negative regulation of mitotic cell cycle	BP
3	15	0.999895225314	-	7.01e-02	GO:0008209	androgen metabolic process	BP
3	15	0.999895225314	-	1.11e-01	GO:0010759	positive regulation of macrophage chemotaxis	BP
3	15	0.999895225314	-	1.11e-01	GO:1901379	regulation of potassium ion transmembrane transport	BP
3	15	0.999895225314	-	1.11e-01	GO:0048665	neuron fate specification	BP
3	15	0.999895225314	-	1.11e-01	GO:1900017	positive regulation of cytokine production involved in inflammatory response	BP
6	30	0.999895225314	-	1.15e-01	GO:0009314	response to radiation	BP
3	15	0.999895225314	-	1.34e-01	GO:0060347	heart trabecula formation	BP
3	15	0.999895225314	-	1.34e-01	GO:2000310	regulation of NMDA receptor activity	BP
3	15	0.999895225314	-	1.34e-01	GO:0006309	apoptotic DNA fragmentation	BP
3	15	0.999895225314	-	1.34e-01	GO:0032793	positive regulation of CREB transcription factor activity	BP
3	15	0.999895225314	-	1.34e-01	GO:0044849	estrous cycle	BP
3	15	0.999895225314	-	1.58e-01	GO:0007095	mitotic G2 DNA damage checkpoint	BP
3	15	0.999895225314	-	1.58e-01	GO:0032469	endoplasmic reticulum calcium ion homeostasis	BP
3	15	0.999895225314	-	1.58e-01	GO:0071850	mitotic cell cycle arrest	BP
3	15	0.999895225314	-	1.58e-01	GO:0070848	response to growth factor	BP
3	15	0.999895225314	-	1.58e-01	GO:0051044	positive regulation of membrane protein ectodomain proteolysis	BP
3	15	0.999895225314	-	1.58e-01	GO:0007076	mitotic chromosome condensation	BP
3	15	0.999895225314	-	1.58e-01	GO:0043162	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	BP
3	15	0.999895225314	-	1.84e-01	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
3	15	0.999895225314	-	1.84e-01	GO:0044257	cellular protein catabolic process	BP
3	15	0.999895225314	-	1.84e-01	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	BP
3	15	0.999895225314	-	1.84e-01	GO:0048168	regulation of neuronal synaptic plasticity	BP
3	15	0.999895225314	-	1.84e-01	GO:0007215	glutamate receptor signaling pathway	BP
3	15	0.999895225314	-	1.58e-01	GO:0004702	signal transducer, downstream of receptor, with serine/threonine kinase activity	MF
3	15	0.999895225314	-	1.58e-01	GO:0004438	phosphatidylinositol-3-phosphatase activity	MF
7	35	0.999895225314	-	1.46e-02	GO:0035094	response to nicotine	BP
7	35	0.999895225314	-	1.78e-02	GO:0002062	chondrocyte differentiation	BP
5	25	0.999895225314	-	3.51e-02	GO:0060349	bone morphogenesis	BP
5	25	0.999895225314	-	3.51e-02	GO:0032689	negative regulation of interferon-gamma production	BP
5	25	0.999895225314	-	4.31e-02	GO:0050715	positive regulation of cytokine secretion	BP
5	25	0.999895225314	-	6.20e-02	GO:0050772	positive regulation of axonogenesis	BP
5	25	0.999895225314	-	7.30e-02	GO:0051602	response to electrical stimulus	BP
5	25	0.999895225314	-	8.49e-02	GO:0032757	positive regulation of interleukin-8 production	BP
5	25	0.999895225314	-	8.49e-02	GO:0060976	coronary vasculature development	BP
5	25	0.999895225314	-	9.78e-02	GO:0000188	inactivation of MAPK activity	BP
5	25	0.999895225314	-	4.31e-02	GO:0019838	growth factor binding	MF
8	40	0.999895225314	-	2.73e-02	GO:0032024	positive regulation of insulin secretion	BP
8	40	0.999895225314	-	2.73e-02	GO:0009411	response to UV	BP
2	10	0.999895225314	-	2.80e-02	GO:0002430	complement receptor mediated signaling pathway	BP
2	10	0.999895225314	-	5.23e-02	GO:0030728	ovulation	BP
4	20	0.999895225314	-	6.83e-02	GO:0032753	positive regulation of interleukin-4 production	BP
4	20	0.999895225314	-	8.25e-02	GO:0010804	negative regulation of tumor necrosis factor-mediated signaling pathway	BP
4	20	0.999895225314	-	8.25e-02	GO:0061436	establishment of skin barrier	BP
4	20	0.999895225314	-	9.81e-02	GO:0071310	cellular response to organic substance	BP
2	10	0.999895225314	-	1.14e-01	GO:0060174	limb bud formation	BP
2	10	0.999895225314	-	1.14e-01	GO:0007168	receptor guanylyl cyclase signaling pathway	BP
2	10	0.999895225314	-	1.14e-01	GO:0002021	response to dietary excess	BP
4	20	0.999895225314	-	1.15e-01	GO:0045861	negative regulation of proteolysis	BP
4	20	0.999895225314	-	1.33e-01	GO:0042326	negative regulation of phosphorylation	BP
2	10	0.999895225314	-	1.50e-01	GO:0060306	regulation of membrane repolarization	BP
2	10	0.999895225314	-	1.50e-01	GO:0060452	positive regulation of cardiac muscle contraction	BP
2	10	0.999895225314	-	1.50e-01	GO:0030261	chromosome condensation	BP
2	10	0.999895225314	-	1.50e-01	GO:0032525	somite rostral/caudal axis specification	BP
2	10	0.999895225314	-	1.87e-01	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	BP
2	10	0.999895225314	-	1.87e-01	GO:0050966	detection of mechanical stimulus involved in sensory perception of pain	BP
2	10	0.999895225314	-	1.87e-01	GO:0035136	forelimb morphogenesis	BP
2	10	0.999895225314	-	1.87e-01	GO:0007216	G-protein coupled glutamate receptor signaling pathway	BP
2	10	0.999895225314	-	1.87e-01	GO:0071639	positive regulation of monocyte chemotactic protein-1 production	BP
2	10	0.999895225314	-	1.87e-01	GO:0021904	dorsal/ventral neural tube patterning	BP
2	10	0.999895225314	-	1.87e-01	GO:0002237	response to molecule of bacterial origin	BP
2	10	0.999895225314	-	1.87e-01	GO:0016322	neuron remodeling	BP
2	10	0.999895225314	-	1.87e-01	GO:0048853	forebrain morphogenesis	BP
1	5	0.999895225314	-	1.90e-01	GO:0006706	steroid catabolic process	BP
1	5	0.999895225314	-	1.90e-01	GO:0070309	lens fiber cell morphogenesis	BP
1	5	0.999895225314	-	1.90e-01	GO:0000320	re-entry into mitotic cell cycle	BP
1	5	0.999895225314	-	1.90e-01	GO:0097070	ductus arteriosus closure	BP
1	5	0.999895225314	-	1.90e-01	GO:1905064	negative regulation of vascular smooth muscle cell differentiation	BP
1	5	0.999895225314	-	1.90e-01	GO:0003357	noradrenergic neuron differentiation	BP
1	5	0.999895225314	-	1.90e-01	GO:0021797	forebrain anterior/posterior pattern specification	BP
1	5	0.999895225314	-	1.90e-01	GO:0042743	hydrogen peroxide metabolic process	BP
2	10	0.999895225314	-	2.25e-01	GO:0050855	regulation of B cell receptor signaling pathway	BP
2	10	0.999895225314	-	2.25e-01	GO:0060340	positive regulation of type I interferon-mediated signaling pathway	BP
2	10	0.999895225314	-	2.25e-01	GO:0014894	response to denervation involved in regulation of muscle adaptation	BP
2	10	0.999895225314	-	2.25e-01	GO:0071548	response to dexamethasone	BP
2	10	0.999895225314	-	2.25e-01	GO:0000290	deadenylation-dependent decapping of nuclear-transcribed mRNA	BP
2	10	0.999895225314	-	2.25e-01	GO:0060081	membrane hyperpolarization	BP
2	10	0.999895225314	-	2.25e-01	GO:0003014	renal system process	BP
2	10	0.999895225314	-	2.25e-01	GO:0045475	locomotor rhythm	BP
2	10	0.999895225314	-	2.25e-01	GO:0060484	lung-associated mesenchyme development	BP
2	10	0.999895225314	-	2.25e-01	GO:0046626	regulation of insulin receptor signaling pathway	BP
2	10	0.999895225314	-	2.64e-01	GO:0001771	immunological synapse formation	BP
2	10	0.999895225314	-	2.64e-01	GO:0031115	negative regulation of microtubule polymerization	BP
2	10	0.999895225314	-	2.64e-01	GO:1902188	positive regulation of viral release from host cell	BP
2	10	0.999895225314	-	2.64e-01	GO:0060546	negative regulation of necroptotic process	BP
2	10	0.999895225314	-	2.64e-01	GO:0043114	regulation of vascular permeability	BP
2	10	0.999895225314	-	2.64e-01	GO:0001759	organ induction	BP
2	10	0.999895225314	-	2.64e-01	GO:0048304	positive regulation of isotype switching to IgG isotypes	BP
2	10	0.999895225314	-	2.64e-01	GO:0071985	multivesicular body sorting pathway	BP
2	10	0.999895225314	-	2.64e-01	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	BP
2	10	0.999895225314	-	2.64e-01	GO:0042982	amyloid precursor protein metabolic process	BP
2	10	0.999895225314	-	2.64e-01	GO:0060252	positive regulation of glial cell proliferation	BP
1	5	0.999895225314	-	2.71e-01	GO:0060414	aorta smooth muscle tissue morphogenesis	BP
1	5	0.999895225314	-	2.71e-01	GO:0048645	animal organ formation	BP
1	5	0.999895225314	-	2.71e-01	GO:0021889	olfactory bulb interneuron differentiation	BP
1	5	0.999895225314	-	2.71e-01	GO:0060335	positive regulation of interferon-gamma-mediated signaling pathway	BP
1	5	0.999895225314	-	2.71e-01	GO:0003105	negative regulation of glomerular filtration	BP
1	5	0.999895225314	-	2.71e-01	GO:0046219	indolalkylamine biosynthetic process	BP
1	5	0.999895225314	-	2.71e-01	GO:0055069	zinc ion homeostasis	BP
1	5	0.999895225314	-	2.71e-01	GO:0046618	drug export	BP
1	5	0.999895225314	-	2.71e-01	GO:0048513	animal organ development	BP
1	5	0.999895225314	-	2.71e-01	GO:0021879	forebrain neuron differentiation	BP
1	5	0.999895225314	-	2.71e-01	GO:0002829	negative regulation of type 2 immune response	BP
1	5	0.999895225314	-	2.71e-01	GO:0032714	negative regulation of interleukin-5 production	BP
1	5	0.999895225314	-	2.71e-01	GO:0003211	cardiac ventricle formation	BP
1	5	0.999895225314	-	3.44e-01	GO:0048730	epidermis morphogenesis	BP
1	5	0.999895225314	-	3.44e-01	GO:1900180	regulation of protein localization to nucleus	BP
1	5	0.999895225314	-	3.44e-01	GO:0007341	penetration of zona pellucida	BP
1	5	0.999895225314	-	3.44e-01	GO:0086011	membrane repolarization during action potential	BP
1	5	0.999895225314	-	3.44e-01	GO:0050851	antigen receptor-mediated signaling pathway	BP
1	5	0.999895225314	-	3.44e-01	GO:0050856	regulation of T cell receptor signaling pathway	BP
1	5	0.999895225314	-	3.44e-01	GO:1900020	positive regulation of protein kinase C activity	BP
1	5	0.999895225314	-	3.44e-01	GO:0003283	atrial septum development	BP
1	5	0.999895225314	-	3.44e-01	GO:0060666	dichotomous subdivision of terminal units involved in salivary gland branching	BP
1	5	0.999895225314	-	3.44e-01	GO:0050688	regulation of defense response to virus	BP
1	5	0.999895225314	-	3.44e-01	GO:0060591	chondroblast differentiation	BP
1	5	0.999895225314	-	3.44e-01	GO:0006824	cobalt ion transport	BP
1	5	0.999895225314	-	3.44e-01	GO:1902514	regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	BP
1	5	0.999895225314	-	3.44e-01	GO:0021960	anterior commissure morphogenesis	BP
1	5	0.999895225314	-	3.44e-01	GO:0072162	metanephric mesenchymal cell differentiation	BP
1	5	0.999895225314	-	3.44e-01	GO:0046600	negative regulation of centriole replication	BP
1	5	0.999895225314	-	3.44e-01	GO:0007356	thorax and anterior abdomen determination	BP
1	5	0.999895225314	-	3.44e-01	GO:0032460	negative regulation of protein oligomerization	BP
1	5	0.999895225314	-	3.44e-01	GO:1903232	melanosome assembly	BP
1	5	0.999895225314	-	3.44e-01	GO:0072734	cellular response to staurosporine	BP
1	5	0.999895225314	-	3.44e-01	GO:0033033	negative regulation of myeloid cell apoptotic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0045636	positive regulation of melanocyte differentiation	BP
1	5	0.999895225314	-	3.44e-01	GO:0071502	cellular response to temperature stimulus	BP
1	5	0.999895225314	-	3.44e-01	GO:1901844	regulation of cell communication by electrical coupling involved in cardiac conduction	BP
1	5	0.999895225314	-	3.44e-01	GO:0072284	metanephric S-shaped body morphogenesis	BP
1	5	0.999895225314	-	3.44e-01	GO:0017038	protein import	BP
1	5	0.999895225314	-	3.44e-01	GO:0001302	replicative cell aging	BP
1	5	0.999895225314	-	3.44e-01	GO:0090036	regulation of protein kinase C signaling	BP
1	5	0.999895225314	-	3.44e-01	GO:0030300	regulation of intestinal cholesterol absorption	BP
1	5	0.999895225314	-	3.44e-01	GO:0031914	negative regulation of synaptic plasticity	BP
1	5	0.999895225314	-	3.44e-01	GO:0019563	glycerol catabolic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0071205	protein localization to juxtaparanode region of axon	BP
1	5	0.999895225314	-	3.44e-01	GO:0010632	regulation of epithelial cell migration	BP
1	5	0.999895225314	-	3.44e-01	GO:0016101	diterpenoid metabolic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0050716	positive regulation of interleukin-1 secretion	BP
1	5	0.999895225314	-	3.44e-01	GO:0009414	response to water deprivation	BP
1	5	0.999895225314	-	3.44e-01	GO:0032224	positive regulation of synaptic transmission, cholinergic	BP
1	5	0.999895225314	-	3.44e-01	GO:0007406	negative regulation of neuroblast proliferation	BP
1	5	0.999895225314	-	3.44e-01	GO:0021517	ventral spinal cord development	BP
1	5	0.999895225314	-	3.44e-01	GO:1904888	cranial skeletal system development	BP
1	5	0.999895225314	-	3.44e-01	GO:0021650	vestibulocochlear nerve formation	BP
1	5	0.999895225314	-	3.44e-01	GO:0021798	forebrain dorsal/ventral pattern formation	BP
1	5	0.999895225314	-	3.44e-01	GO:0086046	membrane depolarization during SA node cell action potential	BP
1	5	0.999895225314	-	3.44e-01	GO:0072207	metanephric epithelium development	BP
1	5	0.999895225314	-	3.44e-01	GO:0043043	peptide biosynthetic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0021696	cerebellar cortex morphogenesis	BP
1	5	0.999895225314	-	3.44e-01	GO:0071219	cellular response to molecule of bacterial origin	BP
1	5	0.999895225314	-	3.44e-01	GO:0014050	negative regulation of glutamate secretion	BP
1	5	0.999895225314	-	3.44e-01	GO:0090650	cellular response to oxygen-glucose deprivation	BP
1	5	0.999895225314	-	3.44e-01	GO:1900227	positive regulation of NLRP3 inflammasome complex assembly	BP
1	5	0.999895225314	-	3.44e-01	GO:0050915	sensory perception of sour taste	BP
1	5	0.999895225314	-	3.44e-01	GO:0048864	stem cell development	BP
1	5	0.999895225314	-	3.44e-01	GO:0038027	apolipoprotein A-I-mediated signaling pathway	BP
1	5	0.999895225314	-	3.44e-01	GO:0060019	radial glial cell differentiation	BP
1	5	0.999895225314	-	3.44e-01	GO:0045823	positive regulation of heart contraction	BP
1	5	0.999895225314	-	3.44e-01	GO:0070231	T cell apoptotic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0006089	lactate metabolic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0072178	nephric duct morphogenesis	BP
1	5	0.999895225314	-	3.44e-01	GO:0060718	chorionic trophoblast cell differentiation	BP
1	5	0.999895225314	-	4.10e-01	GO:0006623	protein targeting to vacuole	BP
1	5	0.999895225314	-	4.10e-01	GO:0006360	transcription from RNA polymerase I promoter	BP
1	5	0.999895225314	-	4.10e-01	GO:0072656	maintenance of protein location in mitochondrion	BP
1	5	0.999895225314	-	4.10e-01	GO:0016191	synaptic vesicle uncoating	BP
1	5	0.999895225314	-	4.10e-01	GO:0002551	mast cell chemotaxis	BP
1	5	0.999895225314	-	4.10e-01	GO:0034134	toll-like receptor 2 signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:0034137	positive regulation of toll-like receptor 2 signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:0061737	leukotriene signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:0006896	Golgi to vacuole transport	BP
1	5	0.999895225314	-	4.10e-01	GO:1902474	positive regulation of protein localization to synapse	BP
1	5	0.999895225314	-	4.10e-01	GO:2000481	positive regulation of cAMP-dependent protein kinase activity	BP
1	5	0.999895225314	-	4.10e-01	GO:0060028	convergent extension involved in axis elongation	BP
1	5	0.999895225314	-	4.10e-01	GO:0035509	negative regulation of myosin-light-chain-phosphatase activity	BP
1	5	0.999895225314	-	4.10e-01	GO:0010193	response to ozone	BP
1	5	0.999895225314	-	4.10e-01	GO:0036124	histone H3-K9 trimethylation	BP
1	5	0.999895225314	-	4.10e-01	GO:0098735	positive regulation of the force of heart contraction	BP
1	5	0.999895225314	-	4.10e-01	GO:0019640	glucuronate catabolic process to xylulose 5-phosphate	BP
1	5	0.999895225314	-	4.10e-01	GO:0010936	negative regulation of macrophage cytokine production	BP
1	5	0.999895225314	-	4.10e-01	GO:0046602	regulation of mitotic centrosome separation	BP
1	5	0.999895225314	-	4.10e-01	GO:0045927	positive regulation of growth	BP
1	5	0.999895225314	-	4.10e-01	GO:0034109	homotypic cell-cell adhesion	BP
1	5	0.999895225314	-	4.10e-01	GO:0034316	negative regulation of Arp2/3 complex-mediated actin nucleation	BP
1	5	0.999895225314	-	4.10e-01	GO:0008063	Toll signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:0038084	vascular endothelial growth factor signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:1903912	negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation	BP
1	5	0.999895225314	-	4.10e-01	GO:0098914	membrane repolarization during atrial cardiac muscle cell action potential	BP
1	5	0.999895225314	-	4.10e-01	GO:0001661	conditioned taste aversion	BP
1	5	0.999895225314	-	4.10e-01	GO:0001660	fever generation	BP
1	5	0.999895225314	-	4.10e-01	GO:1903898	negative regulation of PERK-mediated unfolded protein response	BP
1	5	0.999895225314	-	4.10e-01	GO:0003150	muscular septum morphogenesis	BP
1	5	0.999895225314	-	4.10e-01	GO:0019530	taurine metabolic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0038001	paracrine signaling	BP
1	5	0.999895225314	-	4.10e-01	GO:0044791	positive regulation by host of viral release from host cell	BP
1	5	0.999895225314	-	4.10e-01	GO:0018401	peptidyl-proline hydroxylation to 4-hydroxy-L-proline	BP
1	5	0.999895225314	-	4.10e-01	GO:0048755	branching morphogenesis of a nerve	BP
1	5	0.999895225314	-	4.10e-01	GO:0032232	negative regulation of actin filament bundle assembly	BP
1	5	0.999895225314	-	4.10e-01	GO:0001714	endodermal cell fate specification	BP
1	5	0.999895225314	-	4.10e-01	GO:0032410	negative regulation of transporter activity	BP
1	5	0.999895225314	-	4.10e-01	GO:0070296	sarcoplasmic reticulum calcium ion transport	BP
1	5	0.999895225314	-	4.10e-01	GO:0090074	negative regulation of protein homodimerization activity	BP
1	5	0.999895225314	-	4.10e-01	GO:0070242	thymocyte apoptotic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0036035	osteoclast development	BP
1	5	0.999895225314	-	4.10e-01	GO:0098780	response to mitochondrial depolarisation	BP
1	5	0.999895225314	-	4.10e-01	GO:0051354	negative regulation of oxidoreductase activity	BP
1	5	0.999895225314	-	4.10e-01	GO:0010040	response to iron(II) ion	BP
1	5	0.999895225314	-	4.10e-01	GO:0030263	apoptotic chromosome condensation	BP
1	5	0.999895225314	-	4.10e-01	GO:0002821	positive regulation of adaptive immune response	BP
1	5	0.999895225314	-	4.10e-01	GO:2000467	positive regulation of glycogen (starch) synthase activity	BP
1	5	0.999895225314	-	4.10e-01	GO:0032713	negative regulation of interleukin-4 production	BP
1	5	0.999895225314	-	4.10e-01	GO:0045836	positive regulation of meiotic nuclear division	BP
1	5	0.999895225314	-	4.10e-01	GO:0045838	positive regulation of membrane potential	BP
1	5	0.999895225314	-	4.10e-01	GO:0060762	regulation of branching involved in mammary gland duct morphogenesis	BP
1	5	0.999895225314	-	4.10e-01	GO:0036336	dendritic cell migration	BP
1	5	0.999895225314	-	4.10e-01	GO:0001887	selenium compound metabolic process	BP
1	5	0.999895225314	-	4.10e-01	GO:2000052	positive regulation of non-canonical Wnt signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:0071051	polyadenylation-dependent snoRNA 3'-end processing	BP
1	5	0.999895225314	-	4.10e-01	GO:0090330	regulation of platelet aggregation	BP
1	5	0.999895225314	-	4.10e-01	GO:0070201	regulation of establishment of protein localization	BP
1	5	0.999895225314	-	4.10e-01	GO:0021942	radial glia guided migration of Purkinje cell	BP
1	5	0.999895225314	-	4.10e-01	GO:0098887	neurotransmitter receptor transport, endosome to postsynaptic membrane	BP
1	5	0.999895225314	-	4.10e-01	GO:0031133	regulation of axon diameter	BP
1	5	0.999895225314	-	4.10e-01	GO:0002725	negative regulation of T cell cytokine production	BP
1	5	0.999895225314	-	4.10e-01	GO:0045040	protein import into mitochondrial outer membrane	BP
1	5	0.999895225314	-	4.10e-01	GO:0070245	positive regulation of thymocyte apoptotic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0033133	positive regulation of glucokinase activity	BP
1	5	0.999895225314	-	4.10e-01	GO:0051220	cytoplasmic sequestering of protein	BP
1	5	0.999895225314	-	4.10e-01	GO:0090188	negative regulation of pancreatic juice secretion	BP
1	5	0.999895225314	-	4.10e-01	GO:0001504	neurotransmitter uptake	BP
1	5	0.999895225314	-	4.10e-01	GO:0045541	negative regulation of cholesterol biosynthetic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0060351	cartilage development involved in endochondral bone morphogenesis	BP
1	5	0.999895225314	-	4.10e-01	GO:0051344	negative regulation of cyclic-nucleotide phosphodiesterase activity	BP
1	5	0.999895225314	-	4.10e-01	GO:1900015	regulation of cytokine production involved in inflammatory response	BP
1	5	0.999895225314	-	4.10e-01	GO:0048639	positive regulation of developmental growth	BP
1	5	0.999895225314	-	4.10e-01	GO:0051302	regulation of cell division	BP
1	5	0.999895225314	-	4.10e-01	GO:0006003	fructose 2,6-bisphosphate metabolic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0010452	histone H3-K36 methylation	BP
1	5	0.999895225314	-	4.10e-01	GO:0051383	kinetochore organization	BP
1	5	0.999895225314	-	4.10e-01	GO:1904504	positive regulation of lipophagy	BP
1	5	0.999895225314	-	4.10e-01	GO:0032534	regulation of microvillus assembly	BP
1	5	0.999895225314	-	4.10e-01	GO:0030098	lymphocyte differentiation	BP
1	5	0.999895225314	-	4.10e-01	GO:0042509	regulation of tyrosine phosphorylation of STAT protein	BP
1	5	0.999895225314	-	4.10e-01	GO:0021952	central nervous system projection neuron axonogenesis	BP
1	5	0.999895225314	-	4.10e-01	GO:1903361	protein localization to basolateral plasma membrane	BP
1	5	0.999895225314	-	4.10e-01	GO:0060385	axonogenesis involved in innervation	BP
2	10	0.999895225314	-	1.87e-01	GO:0019911	structural constituent of myelin sheath	MF
2	10	0.999895225314	-	1.87e-01	GO:0017111	nucleoside-triphosphatase activity	MF
1	5	0.999895225314	-	1.90e-01	GO:0005499	vitamin D binding	MF
2	10	0.999895225314	-	2.25e-01	GO:1990380	Lys48-specific deubiquitinase activity	MF
2	10	0.999895225314	-	2.25e-01	GO:0036312	phosphatidylinositol 3-kinase regulatory subunit binding	MF
2	10	0.999895225314	-	2.25e-01	GO:0008276	protein methyltransferase activity	MF
2	10	0.999895225314	-	2.25e-01	GO:0019104	DNA N-glycosylase activity	MF
2	10	0.999895225314	-	2.25e-01	GO:0008080	N-acetyltransferase activity	MF
2	10	0.999895225314	-	2.64e-01	GO:0042805	actinin binding	MF
2	10	0.999895225314	-	2.64e-01	GO:0031702	type 1 angiotensin receptor binding	MF
2	10	0.999895225314	-	2.64e-01	GO:0045294	alpha-catenin binding	MF
2	10	0.999895225314	-	2.64e-01	GO:0034452	dynactin binding	MF
2	10	0.999895225314	-	2.64e-01	GO:0097200	cysteine-type endopeptidase activity involved in execution phase of apoptosis	MF
1	5	0.999895225314	-	2.71e-01	GO:0042392	sphingosine-1-phosphate phosphatase activity	MF
1	5	0.999895225314	-	2.71e-01	GO:0043141	ATP-dependent 5'-3' DNA helicase activity	MF
1	5	0.999895225314	-	2.71e-01	GO:0032190	acrosin binding	MF
1	5	0.999895225314	-	2.71e-01	GO:0008532	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity	MF
1	5	0.999895225314	-	2.71e-01	GO:0032027	myosin light chain binding	MF
1	5	0.999895225314	-	2.71e-01	GO:0004528	phosphodiesterase I activity	MF
1	5	0.999895225314	-	2.71e-01	GO:0035529	NADH pyrophosphatase activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0003747	translation release factor activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0031545	peptidyl-proline 4-dioxygenase activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0015129	lactate transmembrane transporter activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0070290	N-acylphosphatidylethanolamine-specific phospholipase D activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0098519	nucleotide phosphatase activity, acting on free nucleotides	MF
1	5	0.999895225314	-	3.44e-01	GO:0032451	demethylase activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0004028	3-chloroallyl aldehyde dehydrogenase activity	MF
1	5	0.999895225314	-	3.44e-01	GO:1990254	keratin filament binding	MF
1	5	0.999895225314	-	3.44e-01	GO:0034596	phosphatidylinositol phosphate 4-phosphatase activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0051434	BH3 domain binding	MF
1	5	0.999895225314	-	3.44e-01	GO:0016462	pyrophosphatase activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0051373	FATZ binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0031013	troponin I binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0004331	fructose-2,6-bisphosphate 2-phosphatase activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0004826	phenylalanine-tRNA ligase activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0031802	type 5 metabotropic glutamate receptor binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0005324	long-chain fatty acid transporter activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0050544	arachidonic acid binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0015277	kainate selective glutamate receptor activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0005134	interleukin-2 receptor binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0005131	growth hormone receptor binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0034711	inhibin binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0044547	DNA topoisomerase binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0008379	thioredoxin peroxidase activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0042289	MHC class II protein binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0034046	poly(G) binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0001875	lipopolysaccharide receptor activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0015057	thrombin-activated receptor activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0005143	interleukin-12 receptor binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0019788	NEDD8 transferase activity	MF
35	176	0.991674718509	-	6.64e-09	GO:0038095	Fc-epsilon receptor signaling pathway	BP
14	71	0.979431122754	-	9.68e-04	GO:0071300	cellular response to retinoic acid	BP
11	56	0.973900016781	-	7.90e-03	GO:0060041	retina development in camera-type eye	BP
9	46	0.968186365586	-	1.53e-03	GO:0030514	negative regulation of BMP signaling pathway	BP
8	41	0.964271315583	-	1.67e-02	GO:0009725	response to hormone	BP
8	41	0.964271315583	-	1.99e-02	GO:0045071	negative regulation of viral genome replication	BP
8	41	0.964271315583	-	4.98e-02	GO:0097191	extrinsic apoptotic signaling pathway	BP
31	159	0.963136675304	-	3.94e-06	GO:0010629	negative regulation of gene expression	BP
7	36	0.959253240816	-	3.04e-02	GO:0051209	release of sequestered calcium ion into cytosol	BP
7	36	0.959253240816	-	7.56e-02	GO:0007223	Wnt signaling pathway, calcium modulating pathway	BP
19	98	0.95504098953	-	6.56e-04	GO:0001764	neuron migration	BP
6	31	0.952589510535	-	2.75e-02	GO:0045907	positive regulation of vasoconstriction	BP
6	31	0.952589510535	-	5.48e-02	GO:0046326	positive regulation of glucose import	BP
16	83	0.946783888854	-	3.56e-04	GO:0050728	negative regulation of inflammatory response	BP
15	78	0.943311696947	-	9.59e-03	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	BP
5	26	0.943311696947	-	3.51e-02	GO:0090102	cochlea development	BP
5	26	0.943311696947	-	4.31e-02	GO:0031069	hair follicle morphogenesis	BP
5	26	0.943311696947	-	5.20e-02	GO:0007202	activation of phospholipase C activity	BP
5	26	0.943311696947	-	6.20e-02	GO:0060173	limb development	BP
5	26	0.943311696947	-	1.76e-01	GO:0016239	positive regulation of macroautophagy	BP
19	99	0.940394213565	-	5.46e-04	GO:0030182	neuron differentiation	BP
33	172	0.939952684858	-	1.04e-05	GO:0042127	regulation of cell proliferation	BP
12	63	0.929505897422	-	1.02e-02	GO:0009611	response to wounding	BP
12	63	0.929505897422	-	1.46e-02	GO:0001933	negative regulation of protein phosphorylation	BP
4	21	0.929505897422	-	3.41e-02	GO:0019373	epoxygenase P450 pathway	BP
4	21	0.929505897422	-	9.81e-02	GO:0035902	response to immobilization stress	BP
4	21	0.929505897422	-	1.15e-01	GO:0001782	B cell homeostasis	BP
4	21	0.929505897422	-	1.33e-01	GO:0051443	positive regulation of ubiquitin-protein transferase activity	BP
4	21	0.929505897422	-	1.33e-01	GO:0071901	negative regulation of protein serine/threonine kinase activity	BP
4	21	0.929505897422	-	1.52e-01	GO:0006295	nucleotide-excision repair, DNA incision, 3'-to lesion	BP
4	21	0.929505897422	-	1.52e-01	GO:0006293	nucleotide-excision repair, preincision complex stabilization	BP
12	63	0.929505897422	-	2.98e-02	GO:0043130	ubiquitin binding	MF
8	42	0.929505897422	-	5.64e-02	GO:0032947	protein complex scaffold activity	MF
4	21	0.929505897422	-	1.52e-01	GO:0050750	low-density lipoprotein particle receptor binding	MF
4	21	0.929505897422	-	1.52e-01	GO:0051019	mitogen-activated protein kinase binding	MF
15	79	0.924933167633	-	2.61e-03	GO:0031295	T cell costimulation	BP
15	79	0.924933167633	-	3.61e-03	GO:0007005	mitochondrion organization	BP
11	58	0.923273943711	-	6.72e-03	GO:0051216	cartilage development	BP
7	37	0.91972487663	-	4.15e-02	GO:0042149	cellular response to glucose starvation	BP
7	37	0.91972487663	-	9.10e-02	GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion	BP
7	37	0.91972487663	-	9.10e-02	GO:0042769	DNA damage response, detection of DNA damage	BP
13	69	0.913738581564	-	2.05e-02	GO:0097190	apoptotic signaling pathway	BP
12	64	0.906785820922	-	1.02e-02	GO:0032868	response to insulin	BP
15	80	0.906785820922	-	1.14e-02	GO:0007346	regulation of mitotic cell cycle	BP
6	32	0.906785820922	-	4.69e-02	GO:0001654	eye development	BP
6	32	0.906785820922	-	6.35e-02	GO:0007585	respiratory gaseous exchange	BP
3	16	0.906785820922	-	8.95e-02	GO:0086002	cardiac muscle cell action potential involved in contraction	BP
3	16	0.906785820922	-	1.11e-01	GO:0043409	negative regulation of MAPK cascade	BP
3	16	0.906785820922	-	1.11e-01	GO:0019372	lipoxygenase pathway	BP
6	32	0.906785820922	-	1.21e-01	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	BP
6	32	0.906785820922	-	1.21e-01	GO:0071549	cellular response to dexamethasone stimulus	BP
6	32	0.906785820922	-	1.21e-01	GO:0042594	response to starvation	BP
3	16	0.906785820922	-	1.34e-01	GO:0007220	Notch receptor processing	BP
3	16	0.906785820922	-	1.34e-01	GO:0045616	regulation of keratinocyte differentiation	BP
3	16	0.906785820922	-	1.58e-01	GO:0043032	positive regulation of macrophage activation	BP
3	16	0.906785820922	-	1.58e-01	GO:0061036	positive regulation of cartilage development	BP
3	16	0.906785820922	-	1.58e-01	GO:0001709	cell fate determination	BP
3	16	0.906785820922	-	1.58e-01	GO:0060216	definitive hemopoiesis	BP
3	16	0.906785820922	-	1.58e-01	GO:0048593	camera-type eye morphogenesis	BP
3	16	0.906785820922	-	1.58e-01	GO:0060292	long term synaptic depression	BP
3	16	0.906785820922	-	1.58e-01	GO:0055117	regulation of cardiac muscle contraction	BP
3	16	0.906785820922	-	1.84e-01	GO:0051131	chaperone-mediated protein complex assembly	BP
3	16	0.906785820922	-	1.84e-01	GO:0010259	multicellular organism aging	BP
3	16	0.906785820922	-	1.84e-01	GO:0010744	positive regulation of macrophage derived foam cell differentiation	BP
3	16	0.906785820922	-	1.84e-01	GO:0007026	negative regulation of microtubule depolymerization	BP
3	16	0.906785820922	-	2.11e-01	GO:0014002	astrocyte development	BP
3	16	0.906785820922	-	2.11e-01	GO:1900273	positive regulation of long-term synaptic potentiation	BP
3	16	0.906785820922	-	2.11e-01	GO:0046328	regulation of JNK cascade	BP
3	16	0.906785820922	-	2.11e-01	GO:0007212	dopamine receptor signaling pathway	BP
3	16	0.906785820922	-	2.11e-01	GO:0001935	endothelial cell proliferation	BP
3	16	0.906785820922	-	5.29e-02	GO:0005216	ion channel activity	MF
3	16	0.906785820922	-	1.58e-01	GO:0008408	3'-5' exonuclease activity	MF
3	16	0.906785820922	-	1.84e-01	GO:0005159	insulin-like growth factor receptor binding	MF
3	16	0.906785820922	-	2.11e-01	GO:0000400	four-way junction DNA binding	MF
31	166	0.900980199241	-	5.62e-04	GO:0046777	protein autophosphorylation	BP
41	220	0.898015611295	-	2.19e-05	GO:0032403	protein complex binding	MF
8	43	0.895558565499	-	1.40e-02	GO:0001756	somitogenesis	BP
8	43	0.895558565499	-	5.27e-02	GO:0032508	DNA duplex unwinding	BP
38	205	0.890270734139	-	1.58e-05	GO:0004871	signal transducer activity	MF
10	54	0.888863912925	-	2.70e-02	GO:0030097	hemopoiesis	BP
5	27	0.888863912925	-	5.20e-02	GO:0007628	adult walking behavior	BP
5	27	0.888863912925	-	8.49e-02	GO:2000352	negative regulation of endothelial cell apoptotic process	BP
5	27	0.888863912925	-	9.78e-02	GO:0040014	regulation of multicellular organism growth	BP
5	27	0.888863912925	-	1.76e-01	GO:0090314	positive regulation of protein targeting to membrane	BP
5	27	0.888863912925	-	4.31e-02	GO:0017046	peptide hormone binding	MF
7	38	0.881250728815	-	3.04e-02	GO:0001657	ureteric bud development	BP
15	82	0.871161911192	-	4.46e-03	GO:0035264	multicellular organism growth	BP
44	241	0.868365602609	-	2.20e-06	GO:0042981	regulation of apoptotic process	BP
12	66	0.862391701564	-	2.98e-02	GO:0046330	positive regulation of JNK cascade	BP
12	66	0.862391701564	-	3.28e-02	GO:0032147	activation of protein kinase activity	BP
6	33	0.862391701564	-	2.25e-02	GO:0017080	sodium channel regulator activity	MF
10	55	0.862391701564	-	2.31e-02	GO:0001570	vasculogenesis	BP
4	22	0.862391701564	-	9.81e-02	GO:0048488	synaptic vesicle endocytosis	BP
4	22	0.862391701564	-	9.81e-02	GO:0097755	positive regulation of blood vessel diameter	BP
4	22	0.862391701564	-	1.15e-01	GO:0030111	regulation of Wnt signaling pathway	BP
4	22	0.862391701564	-	1.33e-01	GO:0060999	positive regulation of dendritic spine development	BP
4	22	0.862391701564	-	1.33e-01	GO:1904886	beta-catenin destruction complex disassembly	BP
2	11	0.862391701564	-	1.50e-01	GO:0002064	epithelial cell development	BP
2	11	0.862391701564	-	1.50e-01	GO:1903672	positive regulation of sprouting angiogenesis	BP
2	11	0.862391701564	-	1.50e-01	GO:0022010	central nervous system myelination	BP
2	11	0.862391701564	-	1.87e-01	GO:0006707	cholesterol catabolic process	BP
2	11	0.862391701564	-	1.87e-01	GO:0002089	lens morphogenesis in camera-type eye	BP
2	11	0.862391701564	-	1.87e-01	GO:0009268	response to pH	BP
2	11	0.862391701564	-	1.87e-01	GO:0033690	positive regulation of osteoblast proliferation	BP
2	11	0.862391701564	-	2.25e-01	GO:0070365	hepatocyte differentiation	BP
2	11	0.862391701564	-	2.25e-01	GO:0048745	smooth muscle tissue development	BP
2	11	0.862391701564	-	2.25e-01	GO:0060055	angiogenesis involved in wound healing	BP
2	11	0.862391701564	-	2.64e-01	GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
2	11	0.862391701564	-	2.64e-01	GO:1903204	negative regulation of oxidative stress-induced neuron death	BP
2	11	0.862391701564	-	2.64e-01	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	BP
2	11	0.862391701564	-	2.64e-01	GO:0032204	regulation of telomere maintenance	BP
2	11	0.862391701564	-	2.64e-01	GO:0001952	regulation of cell-matrix adhesion	BP
2	11	0.862391701564	-	2.64e-01	GO:2000009	negative regulation of protein localization to cell surface	BP
2	11	0.862391701564	-	2.64e-01	GO:0007260	tyrosine phosphorylation of STAT protein	BP
2	11	0.862391701564	-	2.64e-01	GO:0030816	positive regulation of cAMP metabolic process	BP
2	11	0.862391701564	-	2.64e-01	GO:0035413	positive regulation of catenin import into nucleus	BP
2	11	0.862391701564	-	2.64e-01	GO:0043517	positive regulation of DNA damage response, signal transduction by p53 class mediator	BP
4	22	0.862391701564	-	2.70e-01	GO:0016050	vesicle organization	BP
4	22	0.862391701564	-	2.70e-01	GO:0030316	osteoclast differentiation	BP
2	11	0.862391701564	-	3.03e-01	GO:0042347	negative regulation of NF-kappaB import into nucleus	BP
2	11	0.862391701564	-	3.03e-01	GO:0045762	positive regulation of adenylate cyclase activity	BP
2	11	0.862391701564	-	3.03e-01	GO:0042535	positive regulation of tumor necrosis factor biosynthetic process	BP
2	11	0.862391701564	-	3.03e-01	GO:0070914	UV-damage excision repair	BP
2	11	0.862391701564	-	3.03e-01	GO:0032700	negative regulation of interleukin-17 production	BP
2	11	0.862391701564	-	3.03e-01	GO:0045806	negative regulation of endocytosis	BP
2	11	0.862391701564	-	3.03e-01	GO:0030238	male sex determination	BP
2	11	0.862391701564	-	3.03e-01	GO:0043306	positive regulation of mast cell degranulation	BP
2	11	0.862391701564	-	3.03e-01	GO:0006600	creatine metabolic process	BP
2	11	0.862391701564	-	3.03e-01	GO:0071372	cellular response to follicle-stimulating hormone stimulus	BP
2	11	0.862391701564	-	3.03e-01	GO:0090331	negative regulation of platelet aggregation	BP
2	11	0.862391701564	-	3.03e-01	GO:0042417	dopamine metabolic process	BP
2	11	0.862391701564	-	3.03e-01	GO:0033197	response to vitamin E	BP
2	11	0.862391701564	-	3.03e-01	GO:0034379	very-low-density lipoprotein particle assembly	BP
2	11	0.862391701564	-	1.14e-01	GO:0051378	serotonin binding	MF
2	11	0.862391701564	-	1.87e-01	GO:0042301	phosphate ion binding	MF
2	11	0.862391701564	-	2.64e-01	GO:0048407	platelet-derived growth factor binding	MF
2	11	0.862391701564	-	2.64e-01	GO:0008349	MAP kinase kinase kinase kinase activity	MF
2	11	0.862391701564	-	3.03e-01	GO:0043522	leucine zipper domain binding	MF
2	11	0.862391701564	-	3.03e-01	GO:0031432	titin binding	MF
2	11	0.862391701564	-	3.03e-01	GO:0031996	thioesterase binding	MF
317	1744	0.861978025564	-	3.15e-10	GO:0006351	transcription, DNA-templated	BP
32	177	0.854217770118	-	7.40e-06	GO:0051607	defense response to virus	BP
146	809	0.851651986651	-	1.99e-10	GO:0008270	zinc ion binding	MF
48	266	0.851503385421	-	1.05e-05	GO:0000165	MAPK cascade	BP
11	61	0.850517601276	-	1.43e-02	GO:0006879	cellular iron ion homeostasis	BP
38	211	0.848651644938	-	1.11e-04	GO:0061630	ubiquitin protein ligase activity	MF
266	1479	0.846699418603	-	2.27e-10	GO:0003677	DNA binding	MF
16	89	0.846089889235	-	8.38e-03	GO:1990830	cellular response to leukemia inhibitory factor	BP
7	39	0.843776023397	-	3.57e-02	GO:0048704	embryonic skeletal system morphogenesis	BP
7	39	0.843776023397	-	7.56e-02	GO:0060291	long-term synaptic potentiation	BP
5	28	0.836396493031	-	1.69e-02	GO:0015721	bile acid and bile salt transport	BP
10	56	0.836396493031	-	3.22e-02	GO:0009267	cellular response to starvation	BP
5	28	0.836396493031	-	8.49e-02	GO:0045595	regulation of cell differentiation	BP
5	28	0.836396493031	-	1.76e-01	GO:0007528	neuromuscular junction development	BP
5	28	0.836396493031	-	1.94e-01	GO:0004714	transmembrane receptor protein tyrosine kinase activity	MF
13	73	0.832438479462	-	8.87e-03	GO:0008144	drug binding	MF
22	124	0.827058628452	-	4.75e-03	GO:0006461	protein complex assembly	BP
3	17	0.819322979672	-	5.29e-02	GO:1904706	negative regulation of vascular smooth muscle cell proliferation	BP
3	17	0.819322979672	-	8.95e-02	GO:0042310	vasoconstriction	BP
3	17	0.819322979672	-	1.11e-01	GO:0043537	negative regulation of blood vessel endothelial cell migration	BP
6	34	0.819322979672	-	1.46e-01	GO:0000731	DNA synthesis involved in DNA repair	BP
3	17	0.819322979672	-	1.58e-01	GO:0006970	response to osmotic stress	BP
3	17	0.819322979672	-	1.58e-01	GO:0043651	linoleic acid metabolic process	BP
3	17	0.819322979672	-	1.58e-01	GO:0010975	regulation of neuron projection development	BP
3	17	0.819322979672	-	1.58e-01	GO:0050804	modulation of chemical synaptic transmission	BP
3	17	0.819322979672	-	1.58e-01	GO:0042462	eye photoreceptor cell development	BP
3	17	0.819322979672	-	1.84e-01	GO:0045956	positive regulation of calcium ion-dependent exocytosis	BP
3	17	0.819322979672	-	1.84e-01	GO:0048255	mRNA stabilization	BP
3	17	0.819322979672	-	1.84e-01	GO:1901800	positive regulation of proteasomal protein catabolic process	BP
3	17	0.819322979672	-	2.11e-01	GO:0090201	negative regulation of release of cytochrome c from mitochondria	BP
3	17	0.819322979672	-	2.11e-01	GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
3	17	0.819322979672	-	1.34e-01	GO:0017049	GTP-Rho binding	MF
3	17	0.819322979672	-	1.84e-01	GO:0031489	myosin V binding	MF
3	17	0.819322979672	-	2.38e-01	GO:0008266	poly(U) RNA binding	MF
19	108	0.814863331481	-	5.78e-03	GO:0048015	phosphatidylinositol-mediated signaling	BP
10	57	0.810861400924	-	7.22e-03	GO:0006959	humoral immune response	BP
7	40	0.807250147371	-	8.50e-02	GO:0071902	positive regulation of protein serine/threonine kinase activity	BP
7	40	0.807250147371	-	9.10e-02	GO:0021549	cerebellum development	BP
7	40	0.807250147371	-	9.78e-02	GO:0070527	platelet aggregation	BP
15	86	0.802449161108	-	3.57e-04	GO:0006805	xenobiotic metabolic process	BP
4	23	0.798261364144	-	5.55e-02	GO:0006694	steroid biosynthetic process	BP
4	23	0.798261364144	-	6.83e-02	GO:1904707	positive regulation of vascular smooth muscle cell proliferation	BP
4	23	0.798261364144	-	1.15e-01	GO:0048741	skeletal muscle fiber development	BP
4	23	0.798261364144	-	2.70e-01	GO:0007088	regulation of mitotic nuclear division	BP
4	23	0.798261364144	-	2.70e-01	GO:0003009	skeletal muscle contraction	BP
4	23	0.798261364144	-	2.81e-01	GO:2001235	positive regulation of apoptotic signaling pathway	BP
4	23	0.798261364144	-	2.81e-01	GO:0051439	regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	BP
19	110	0.78839112012	-	5.78e-03	GO:0030168	platelet activation	BP
10	58	0.785770419961	-	2.70e-02	GO:0021766	hippocampus development	BP
5	29	0.785770419961	-	5.20e-02	GO:0030163	protein catabolic process	BP
21	122	0.783403405417	-	6.97e-03	GO:0004713	protein tyrosine kinase activity	MF
11	64	0.781254938838	-	2.17e-02	GO:0070373	negative regulation of ERK1 and ERK2 cascade	BP
30	175	0.777502803977	-	1.27e-04	GO:0016055	Wnt signaling pathway	BP
6	35	0.777502803977	-	1.37e-01	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
6	35	0.777502803977	-	4.64e-03	GO:0004497	monooxygenase activity	MF
13	76	0.774335524899	-	4.98e-02	GO:1900034	regulation of cellular response to heat	BP
14	82	0.771626237641	-	1.77e-02	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	BP
7	41	0.771626237641	-	7.99e-02	GO:0043010	camera-type eye development	BP
15	88	0.769282297172	-	5.58e-03	GO:0007517	muscle organ development	BP
8	47	0.767234468524	-	6.06e-02	GO:0023014	signal transduction by protein phosphorylation	BP
10	59	0.761108365727	-	1.19e-02	GO:0050660	flavin adenine dinucleotide binding	MF
11	65	0.75888712581	-	1.80e-02	GO:0030183	B cell differentiation	BP
27	160	0.754782727477	-	8.57e-04	GO:0032496	response to lipopolysaccharide	BP
80	480	0.73686081948	-	6.50e-10	GO:0008284	positive regulation of cell proliferation	BP
5	30	0.73686081948	-	7.30e-02	GO:0002088	lens development in camera-type eye	BP
5	30	0.73686081948	-	9.78e-02	GO:0060325	face morphogenesis	BP
5	30	0.73686081948	-	9.78e-02	GO:0048167	regulation of synaptic plasticity	BP
5	30	0.73686081948	-	1.84e-01	GO:0021915	neural tube development	BP
13	78	0.73686081948	-	2.75e-02	GO:0008286	insulin receptor signaling pathway	BP
6	36	0.73686081948	-	5.48e-02	GO:0045859	regulation of protein kinase activity	BP
1	6	0.73686081948	-	1.00e-01	GO:1902110	positive regulation of mitochondrial membrane permeability involved in apoptotic process	BP
3	18	0.73686081948	-	1.34e-01	GO:0042157	lipoprotein metabolic process	BP
6	36	0.73686081948	-	1.37e-01	GO:0043507	positive regulation of JUN kinase activity	BP
2	12	0.73686081948	-	1.50e-01	GO:0032966	negative regulation of collagen biosynthetic process	BP
2	12	0.73686081948	-	1.50e-01	GO:0001964	startle response	BP
6	36	0.73686081948	-	1.56e-01	GO:0006953	acute-phase response	BP
3	18	0.73686081948	-	1.58e-01	GO:0060037	pharyngeal system development	BP
3	18	0.73686081948	-	1.58e-01	GO:2000377	regulation of reactive oxygen species metabolic process	BP
3	18	0.73686081948	-	1.84e-01	GO:0046427	positive regulation of JAK-STAT cascade	BP
1	6	0.73686081948	-	1.90e-01	GO:0030540	female genitalia development	BP
1	6	0.73686081948	-	1.90e-01	GO:2000253	positive regulation of feeding behavior	BP
1	6	0.73686081948	-	1.90e-01	GO:0034755	iron ion transmembrane transport	BP
2	12	0.73686081948	-	2.25e-01	GO:1901381	positive regulation of potassium ion transmembrane transport	BP
2	12	0.73686081948	-	2.25e-01	GO:0001655	urogenital system development	BP
2	12	0.73686081948	-	2.25e-01	GO:1900016	negative regulation of cytokine production involved in inflammatory response	BP
3	18	0.73686081948	-	2.38e-01	GO:0035024	negative regulation of Rho protein signal transduction	BP
3	18	0.73686081948	-	2.38e-01	GO:1902236	negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
3	18	0.73686081948	-	2.38e-01	GO:0045445	myoblast differentiation	BP
3	18	0.73686081948	-	2.38e-01	GO:0035307	positive regulation of protein dephosphorylation	BP
2	12	0.73686081948	-	2.64e-01	GO:0006554	lysine catabolic process	BP
2	12	0.73686081948	-	2.64e-01	GO:0097028	dendritic cell differentiation	BP
2	12	0.73686081948	-	2.64e-01	GO:0010447	response to acidic pH	BP
2	12	0.73686081948	-	2.64e-01	GO:0019430	removal of superoxide radicals	BP
2	12	0.73686081948	-	2.64e-01	GO:0061158	3'-UTR-mediated mRNA destabilization	BP
2	12	0.73686081948	-	2.64e-01	GO:0001706	endoderm formation	BP
2	12	0.73686081948	-	2.64e-01	GO:0032695	negative regulation of interleukin-12 production	BP
2	12	0.73686081948	-	2.64e-01	GO:0034116	positive regulation of heterotypic cell-cell adhesion	BP
2	12	0.73686081948	-	2.64e-01	GO:0030516	regulation of axon extension	BP
2	12	0.73686081948	-	2.64e-01	GO:0008206	bile acid metabolic process	BP
2	12	0.73686081948	-	2.64e-01	GO:0048333	mesodermal cell differentiation	BP
2	12	0.73686081948	-	2.64e-01	GO:0090399	replicative senescence	BP
2	12	0.73686081948	-	2.64e-01	GO:0072520	seminiferous tubule development	BP
4	24	0.73686081948	-	2.70e-01	GO:0042113	B cell activation	BP
4	24	0.73686081948	-	2.70e-01	GO:0033137	negative regulation of peptidyl-serine phosphorylation	BP
1	6	0.73686081948	-	2.71e-01	GO:1903202	negative regulation of oxidative stress-induced cell death	BP
1	6	0.73686081948	-	2.71e-01	GO:1904996	positive regulation of leukocyte adhesion to vascular endothelial cell	BP
1	6	0.73686081948	-	2.71e-01	GO:0070383	DNA cytosine deamination	BP
1	6	0.73686081948	-	2.71e-01	GO:0045590	negative regulation of regulatory T cell differentiation	BP
1	6	0.73686081948	-	2.71e-01	GO:0045143	homologous chromosome segregation	BP
1	6	0.73686081948	-	2.71e-01	GO:0051552	flavone metabolic process	BP
1	6	0.73686081948	-	2.71e-01	GO:0032964	collagen biosynthetic process	BP
1	6	0.73686081948	-	2.71e-01	GO:0048512	circadian behavior	BP
1	6	0.73686081948	-	2.71e-01	GO:0006880	intracellular sequestering of iron ion	BP
1	6	0.73686081948	-	2.71e-01	GO:0090370	negative regulation of cholesterol efflux	BP
2	12	0.73686081948	-	3.03e-01	GO:0001736	establishment of planar polarity	BP
2	12	0.73686081948	-	3.03e-01	GO:0030833	regulation of actin filament polymerization	BP
2	12	0.73686081948	-	3.03e-01	GO:0050435	amyloid-beta metabolic process	BP
2	12	0.73686081948	-	3.03e-01	GO:0045060	negative thymic T cell selection	BP
2	12	0.73686081948	-	3.03e-01	GO:0086004	regulation of cardiac muscle cell contraction	BP
2	12	0.73686081948	-	3.41e-01	GO:0055003	cardiac myofibril assembly	BP
2	12	0.73686081948	-	3.41e-01	GO:0055008	cardiac muscle tissue morphogenesis	BP
2	12	0.73686081948	-	3.41e-01	GO:0047496	vesicle transport along microtubule	BP
2	12	0.73686081948	-	3.41e-01	GO:0010801	negative regulation of peptidyl-threonine phosphorylation	BP
2	12	0.73686081948	-	3.41e-01	GO:0032897	negative regulation of viral transcription	BP
2	12	0.73686081948	-	3.41e-01	GO:0046688	response to copper ion	BP
2	12	0.73686081948	-	3.41e-01	GO:0010955	negative regulation of protein processing	BP
2	12	0.73686081948	-	3.41e-01	GO:0035970	peptidyl-threonine dephosphorylation	BP
2	12	0.73686081948	-	3.41e-01	GO:0046710	GDP metabolic process	BP
2	12	0.73686081948	-	3.41e-01	GO:0048747	muscle fiber development	BP
2	12	0.73686081948	-	3.41e-01	GO:0045086	positive regulation of interleukin-2 biosynthetic process	BP
2	12	0.73686081948	-	3.41e-01	GO:0040007	growth	BP
1	6	0.73686081948	-	3.44e-01	GO:2000647	negative regulation of stem cell proliferation	BP
1	6	0.73686081948	-	3.44e-01	GO:0086015	SA node cell action potential	BP
1	6	0.73686081948	-	3.44e-01	GO:0045345	positive regulation of MHC class I biosynthetic process	BP
1	6	0.73686081948	-	3.44e-01	GO:0021853	cerebral cortex GABAergic interneuron migration	BP
1	6	0.73686081948	-	3.44e-01	GO:0032367	intracellular cholesterol transport	BP
1	6	0.73686081948	-	3.44e-01	GO:0018230	peptidyl-L-cysteine S-palmitoylation	BP
1	6	0.73686081948	-	3.44e-01	GO:0040012	regulation of locomotion	BP
1	6	0.73686081948	-	3.44e-01	GO:0061038	uterus morphogenesis	BP
1	6	0.73686081948	-	3.44e-01	GO:0031223	auditory behavior	BP
1	6	0.73686081948	-	3.44e-01	GO:0003100	regulation of systemic arterial blood pressure by endothelin	BP
1	6	0.73686081948	-	3.44e-01	GO:0060426	lung vasculature development	BP
1	6	0.73686081948	-	3.44e-01	GO:1990845	adaptive thermogenesis	BP
1	6	0.73686081948	-	3.44e-01	GO:0000480	endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	BP
1	6	0.73686081948	-	3.44e-01	GO:0042403	thyroid hormone metabolic process	BP
1	6	0.73686081948	-	3.44e-01	GO:0070508	cholesterol import	BP
1	6	0.73686081948	-	3.44e-01	GO:0010172	embryonic body morphogenesis	BP
1	6	0.73686081948	-	3.44e-01	GO:2000507	positive regulation of energy homeostasis	BP
1	6	0.73686081948	-	3.44e-01	GO:0048793	pronephros development	BP
1	6	0.73686081948	-	3.44e-01	GO:1904468	negative regulation of tumor necrosis factor secretion	BP
1	6	0.73686081948	-	3.44e-01	GO:0060298	positive regulation of sarcomere organization	BP
1	6	0.73686081948	-	3.44e-01	GO:0071774	response to fibroblast growth factor	BP
1	6	0.73686081948	-	3.44e-01	GO:1900116	extracellular negative regulation of signal transduction	BP
1	6	0.73686081948	-	3.44e-01	GO:0018206	peptidyl-methionine modification	BP
1	6	0.73686081948	-	3.44e-01	GO:0061000	negative regulation of dendritic spine development	BP
1	6	0.73686081948	-	4.10e-01	GO:2001269	positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
1	6	0.73686081948	-	4.10e-01	GO:0032364	oxygen homeostasis	BP
1	6	0.73686081948	-	4.10e-01	GO:0035864	response to potassium ion	BP
1	6	0.73686081948	-	4.10e-01	GO:0061037	negative regulation of cartilage development	BP
1	6	0.73686081948	-	4.10e-01	GO:0033555	multicellular organismal response to stress	BP
1	6	0.73686081948	-	4.10e-01	GO:0060136	embryonic process involved in female pregnancy	BP
1	6	0.73686081948	-	4.10e-01	GO:0048524	positive regulation of viral process	BP
1	6	0.73686081948	-	4.10e-01	GO:0031960	response to corticosteroid	BP
1	6	0.73686081948	-	4.10e-01	GO:0060074	synapse maturation	BP
1	6	0.73686081948	-	4.10e-01	GO:0048845	venous blood vessel morphogenesis	BP
1	6	0.73686081948	-	4.10e-01	GO:0021707	cerebellar granule cell differentiation	BP
1	6	0.73686081948	-	4.10e-01	GO:0002639	positive regulation of immunoglobulin production	BP
1	6	0.73686081948	-	4.10e-01	GO:0042693	muscle cell fate commitment	BP
1	6	0.73686081948	-	4.10e-01	GO:0070257	positive regulation of mucus secretion	BP
1	6	0.73686081948	-	4.10e-01	GO:0050667	homocysteine metabolic process	BP
1	6	0.73686081948	-	4.10e-01	GO:0042796	snRNA transcription from RNA polymerase III promoter	BP
1	6	0.73686081948	-	4.10e-01	GO:0043584	nose development	BP
1	6	0.73686081948	-	4.10e-01	GO:0060836	lymphatic endothelial cell differentiation	BP
1	6	0.73686081948	-	4.10e-01	GO:0010637	negative regulation of mitochondrial fusion	BP
1	6	0.73686081948	-	4.10e-01	GO:0051099	positive regulation of binding	BP
1	6	0.73686081948	-	4.10e-01	GO:0021902	commitment of neuronal cell to specific neuron type in forebrain	BP
1	6	0.73686081948	-	4.10e-01	GO:0071287	cellular response to manganese ion	BP
1	6	0.73686081948	-	4.10e-01	GO:0021796	cerebral cortex regionalization	BP
1	6	0.73686081948	-	4.10e-01	GO:1904385	cellular response to angiotensin	BP
1	6	0.73686081948	-	4.10e-01	GO:0001878	response to yeast	BP
1	6	0.73686081948	-	4.10e-01	GO:0042048	olfactory behavior	BP
1	6	0.73686081948	-	4.10e-01	GO:0044806	G-quadruplex DNA unwinding	BP
1	6	0.73686081948	-	4.10e-01	GO:0060056	mammary gland involution	BP
1	6	0.73686081948	-	4.10e-01	GO:0031987	locomotion involved in locomotory behavior	BP
1	6	0.73686081948	-	4.10e-01	GO:0072719	cellular response to cisplatin	BP
1	6	0.73686081948	-	4.10e-01	GO:0010960	magnesium ion homeostasis	BP
1	6	0.73686081948	-	4.10e-01	GO:0042421	norepinephrine biosynthetic process	BP
3	18	0.73686081948	-	4.16e-01	GO:1901741	positive regulation of myoblast fusion	BP
3	18	0.73686081948	-	4.16e-01	GO:0031333	negative regulation of protein complex assembly	BP
1	6	0.73686081948	-	4.69e-01	GO:0006323	DNA packaging	BP
1	6	0.73686081948	-	4.69e-01	GO:2001014	regulation of skeletal muscle cell differentiation	BP
1	6	0.73686081948	-	4.69e-01	GO:0097647	amylin receptor signaling pathway	BP
1	6	0.73686081948	-	4.69e-01	GO:0031584	activation of phospholipase D activity	BP
1	6	0.73686081948	-	4.69e-01	GO:0014910	regulation of smooth muscle cell migration	BP
1	6	0.73686081948	-	4.69e-01	GO:0012501	programmed cell death	BP
1	6	0.73686081948	-	4.69e-01	GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	BP
1	6	0.73686081948	-	4.69e-01	GO:0030240	skeletal muscle thin filament assembly	BP
1	6	0.73686081948	-	4.69e-01	GO:0048642	negative regulation of skeletal muscle tissue development	BP
1	6	0.73686081948	-	4.69e-01	GO:0097062	dendritic spine maintenance	BP
1	6	0.73686081948	-	4.69e-01	GO:0090166	Golgi disassembly	BP
1	6	0.73686081948	-	4.69e-01	GO:0035900	response to isolation stress	BP
1	6	0.73686081948	-	4.69e-01	GO:0050671	positive regulation of lymphocyte proliferation	BP
1	6	0.73686081948	-	4.69e-01	GO:0018344	protein geranylgeranylation	BP
1	6	0.73686081948	-	4.69e-01	GO:1902065	response to L-glutamate	BP
1	6	0.73686081948	-	4.69e-01	GO:2000651	positive regulation of sodium ion transmembrane transporter activity	BP
1	6	0.73686081948	-	4.69e-01	GO:0001956	positive regulation of neurotransmitter secretion	BP
1	6	0.73686081948	-	4.69e-01	GO:0072307	regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	6	0.73686081948	-	4.69e-01	GO:0034315	regulation of Arp2/3 complex-mediated actin nucleation	BP
1	6	0.73686081948	-	4.69e-01	GO:2001046	positive regulation of integrin-mediated signaling pathway	BP
1	6	0.73686081948	-	4.69e-01	GO:0045842	positive regulation of mitotic metaphase/anaphase transition	BP
1	6	0.73686081948	-	4.69e-01	GO:0030031	cell projection assembly	BP
1	6	0.73686081948	-	4.69e-01	GO:0060770	negative regulation of epithelial cell proliferation involved in prostate gland development	BP
1	6	0.73686081948	-	4.69e-01	GO:0042487	regulation of odontogenesis of dentin-containing tooth	BP
1	6	0.73686081948	-	4.69e-01	GO:0032025	response to cobalt ion	BP
1	6	0.73686081948	-	4.69e-01	GO:0043535	regulation of blood vessel endothelial cell migration	BP
1	6	0.73686081948	-	4.69e-01	GO:0048598	embryonic morphogenesis	BP
1	6	0.73686081948	-	4.69e-01	GO:0007044	cell-substrate junction assembly	BP
1	6	0.73686081948	-	4.69e-01	GO:0036289	peptidyl-serine autophosphorylation	BP
1	6	0.73686081948	-	4.69e-01	GO:0001711	endodermal cell fate commitment	BP
1	6	0.73686081948	-	4.69e-01	GO:0030853	negative regulation of granulocyte differentiation	BP
1	6	0.73686081948	-	4.69e-01	GO:0006101	citrate metabolic process	BP
1	6	0.73686081948	-	4.69e-01	GO:0014842	regulation of skeletal muscle satellite cell proliferation	BP
1	6	0.73686081948	-	4.69e-01	GO:0072673	lamellipodium morphogenesis	BP
1	6	0.73686081948	-	4.69e-01	GO:0071371	cellular response to gonadotropin stimulus	BP
1	6	0.73686081948	-	4.69e-01	GO:0006531	aspartate metabolic process	BP
1	6	0.73686081948	-	4.69e-01	GO:0003223	ventricular compact myocardium morphogenesis	BP
1	6	0.73686081948	-	4.69e-01	GO:0071638	negative regulation of monocyte chemotactic protein-1 production	BP
1	6	0.73686081948	-	4.69e-01	GO:0070585	protein localization to mitochondrion	BP
1	6	0.73686081948	-	4.69e-01	GO:0051353	positive regulation of oxidoreductase activity	BP
1	6	0.73686081948	-	4.69e-01	GO:0010042	response to manganese ion	BP
1	6	0.73686081948	-	4.69e-01	GO:0046755	viral budding	BP
1	6	0.73686081948	-	4.69e-01	GO:0000018	regulation of DNA recombination	BP
1	6	0.73686081948	-	4.69e-01	GO:1901018	positive regulation of potassium ion transmembrane transporter activity	BP
1	6	0.73686081948	-	4.69e-01	GO:0046881	positive regulation of follicle-stimulating hormone secretion	BP
1	6	0.73686081948	-	4.69e-01	GO:1901222	regulation of NIK/NF-kappaB signaling	BP
1	6	0.73686081948	-	4.69e-01	GO:0032754	positive regulation of interleukin-5 production	BP
1	6	0.73686081948	-	4.69e-01	GO:0060760	positive regulation of response to cytokine stimulus	BP
1	6	0.73686081948	-	4.69e-01	GO:0070244	negative regulation of thymocyte apoptotic process	BP
1	6	0.73686081948	-	4.69e-01	GO:2000675	negative regulation of type B pancreatic cell apoptotic process	BP
1	6	0.73686081948	-	4.69e-01	GO:0090279	regulation of calcium ion import	BP
1	6	0.73686081948	-	4.69e-01	GO:0007100	mitotic centrosome separation	BP
1	6	0.73686081948	-	4.69e-01	GO:0061299	retina vasculature morphogenesis in camera-type eye	BP
1	6	0.73686081948	-	4.69e-01	GO:0071870	cellular response to catecholamine stimulus	BP
1	6	0.73686081948	-	4.69e-01	GO:0032680	regulation of tumor necrosis factor production	BP
1	6	0.73686081948	-	4.69e-01	GO:0006282	regulation of DNA repair	BP
1	6	0.73686081948	-	4.69e-01	GO:0035020	regulation of Rac protein signal transduction	BP
1	6	0.73686081948	-	4.69e-01	GO:0097527	necroptotic signaling pathway	BP
1	6	0.73686081948	-	4.69e-01	GO:0006207	'de novo' pyrimidine nucleobase biosynthetic process	BP
1	6	0.73686081948	-	4.69e-01	GO:0060561	apoptotic process involved in morphogenesis	BP
1	6	0.73686081948	-	4.69e-01	GO:0007435	salivary gland morphogenesis	BP
1	6	0.73686081948	-	4.69e-01	GO:0060527	prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	BP
1	6	0.73686081948	-	4.69e-01	GO:0042423	catecholamine biosynthetic process	BP
4	24	0.73686081948	-	5.01e-03	GO:0008395	steroid hydroxylase activity	MF
3	18	0.73686081948	-	1.58e-01	GO:0016209	antioxidant activity	MF
2	12	0.73686081948	-	1.87e-01	GO:0042043	neurexin family protein binding	MF
1	6	0.73686081948	-	1.90e-01	GO:0000155	phosphorelay sensor kinase activity	MF
2	12	0.73686081948	-	2.25e-01	GO:0016829	lyase activity	MF
2	12	0.73686081948	-	2.64e-01	GO:0008331	high voltage-gated calcium channel activity	MF
2	12	0.73686081948	-	2.64e-01	GO:0043495	protein membrane anchor	MF
1	6	0.73686081948	-	2.71e-01	GO:0004322	ferroxidase activity	MF
1	6	0.73686081948	-	2.71e-01	GO:0045545	syndecan binding	MF
1	6	0.73686081948	-	2.71e-01	GO:0005381	iron ion transmembrane transporter activity	MF
4	24	0.73686081948	-	2.94e-01	GO:0030295	protein kinase activator activity	MF
1	6	0.73686081948	-	3.44e-01	GO:0008504	monoamine transmembrane transporter activity	MF
1	6	0.73686081948	-	3.44e-01	GO:0004630	phospholipase D activity	MF
1	6	0.73686081948	-	3.44e-01	GO:0004983	neuropeptide Y receptor activity	MF
1	6	0.73686081948	-	3.44e-01	GO:0043546	molybdopterin cofactor binding	MF
1	6	0.73686081948	-	3.44e-01	GO:0004969	histamine receptor activity	MF
1	6	0.73686081948	-	3.44e-01	GO:0004030	aldehyde dehydrogenase [NAD(P)+] activity	MF
1	6	0.73686081948	-	3.44e-01	GO:0048019	receptor antagonist activity	MF
1	6	0.73686081948	-	4.10e-01	GO:0036435	K48-linked polyubiquitin modification-dependent protein binding	MF
1	6	0.73686081948	-	4.10e-01	GO:0004985	opioid receptor activity	MF
1	6	0.73686081948	-	4.10e-01	GO:0035473	lipase binding	MF
1	6	0.73686081948	-	4.10e-01	GO:0004430	1-phosphatidylinositol 4-kinase activity	MF
1	6	0.73686081948	-	4.10e-01	GO:0072341	modified amino acid binding	MF
1	6	0.73686081948	-	4.10e-01	GO:0001042	RNA polymerase I core binding	MF
1	6	0.73686081948	-	4.69e-01	GO:0003958	NADPH-hemoprotein reductase activity	MF
1	6	0.73686081948	-	4.69e-01	GO:0003910	DNA ligase (ATP) activity	MF
1	6	0.73686081948	-	4.69e-01	GO:1990239	steroid hormone binding	MF
1	6	0.73686081948	-	4.69e-01	GO:0005024	transforming growth factor beta-activated receptor activity	MF
1	6	0.73686081948	-	4.69e-01	GO:1903136	cuprous ion binding	MF
1	6	0.73686081948	-	4.69e-01	GO:0045182	translation regulator activity	MF
1	6	0.73686081948	-	4.69e-01	GO:0070087	chromo shadow domain binding	MF
1	6	0.73686081948	-	4.69e-01	GO:0016004	phospholipase activator activity	MF
1	6	0.73686081948	-	4.69e-01	GO:0017108	5'-flap endonuclease activity	MF
1	6	0.73686081948	-	4.69e-01	GO:0031730	CCR5 chemokine receptor binding	MF
1	6	0.73686081948	-	4.69e-01	GO:0000403	Y-form DNA binding	MF
1	6	0.73686081948	-	4.69e-01	GO:0055131	C3HC4-type RING finger domain binding	MF
1	6	0.73686081948	-	4.69e-01	GO:0036402	proteasome-activating ATPase activity	MF
1	6	0.73686081948	-	4.69e-01	GO:0032357	oxidized purine DNA binding	MF
1	6	0.73686081948	-	4.69e-01	GO:0019239	deaminase activity	MF
1	6	0.73686081948	-	4.69e-01	GO:0043559	insulin binding	MF
17	102	0.73686081948	-	1.18e-02	GO:0001649	osteoblast differentiation	BP
7	42	0.73686081948	-	4.15e-02	GO:0001658	branching involved in ureteric bud morphogenesis	BP
11	66	0.73686081948	-	4.53e-02	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	MF
26	157	0.727642289451	-	6.69e-05	GO:0046983	protein dimerization activity	MF
87	528	0.720372696691	-	1.28e-08	GO:0006915	apoptotic process	BP
27	164	0.719158817747	-	1.92e-03	GO:0090090	negative regulation of canonical Wnt signaling pathway	BP
13	79	0.718482290165	-	2.05e-02	GO:0005543	phospholipid binding	MF
25	152	0.717751996532	-	4.84e-03	GO:0018108	peptidyl-tyrosine phosphorylation	BP
12	73	0.716961262042	-	1.79e-02	GO:0006816	calcium ion transport	BP
10	61	0.713014077526	-	7.65e-02	GO:0021987	cerebral cortex development	BP
9	55	0.710388608119	-	4.04e-02	GO:0000902	cell morphogenesis	BP
9	55	0.710388608119	-	4.79e-02	GO:0071277	cellular response to calcium ion	BP
9	55	0.710388608119	-	9.47e-02	GO:0006417	regulation of translation	BP
8	49	0.707113476086	-	7.73e-02	GO:0071230	cellular response to amino acid stimulus	BP
7	43	0.702913487557	-	4.15e-02	GO:0050885	neuromuscular process controlling balance	BP
33	203	0.700881522374	-	1.23e-03	GO:0006281	DNA repair	BP
6	37	0.697332455293	-	1.56e-01	GO:0006605	protein targeting	BP
35	216	0.696218834983	-	3.10e-04	GO:0001525	angiogenesis	BP
5	31	0.689555104702	-	1.27e-02	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	BP
10	62	0.689555104702	-	6.56e-02	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	BP
5	31	0.689555104702	-	1.84e-01	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	BP
5	31	0.689555104702	-	1.94e-01	GO:0021510	spinal cord development	BP
5	31	0.689555104702	-	2.18e-01	GO:0019058	viral life cycle	BP
5	31	0.689555104702	-	1.76e-01	GO:0050699	WW domain binding	MF
17	106	0.681365706888	-	1.29e-02	GO:0002020	protease binding	MF
8	50	0.677967130426	-	1.36e-01	GO:0019827	stem cell population maintenance	BP
4	25	0.677967130426	-	2.70e-01	GO:0005246	calcium channel regulator activity	MF
14	88	0.669746623621	-	5.96e-03	GO:0030509	BMP signaling pathway	BP
7	44	0.669746623621	-	7.99e-02	GO:0006342	chromatin silencing	BP
10	63	0.666471491589	-	3.54e-02	GO:0007613	memory	BP
10	63	0.666471491589	-	1.32e-01	GO:0007059	chromosome segregation	BP
13	82	0.664711033724	-	5.20e-02	GO:0030307	positive regulation of cell growth	BP
56	354	0.661572692176	-	5.03e-05	GO:0008283	cell proliferation	BP
196	1240	0.660408759042	-	2.29e-10	GO:0006355	regulation of transcription, DNA-templated	BP
30	190	0.658858307479	-	3.74e-04	GO:0070374	positive regulation of ERK1 and ERK2 cascade	BP
6	38	0.658858307479	-	2.75e-02	GO:0009409	response to cold	BP
3	19	0.658858307479	-	8.95e-02	GO:2000649	regulation of sodium ion transmembrane transporter activity	BP
3	19	0.658858307479	-	1.58e-01	GO:0033198	response to ATP	BP
3	19	0.658858307479	-	1.84e-01	GO:0014032	neural crest cell development	BP
3	19	0.658858307479	-	1.84e-01	GO:0048557	embryonic digestive tract morphogenesis	BP
3	19	0.658858307479	-	2.11e-01	GO:0007263	nitric oxide mediated signal transduction	BP
3	19	0.658858307479	-	2.38e-01	GO:0008589	regulation of smoothened signaling pathway	BP
3	19	0.658858307479	-	2.38e-01	GO:0051968	positive regulation of synaptic transmission, glutamatergic	BP
6	38	0.658858307479	-	2.63e-01	GO:0006289	nucleotide-excision repair	BP
3	19	0.658858307479	-	4.16e-01	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	BP
3	19	0.658858307479	-	4.16e-01	GO:0046716	muscle cell cellular homeostasis	BP
3	19	0.658858307479	-	4.16e-01	GO:0046597	negative regulation of viral entry into host cell	BP
3	19	0.658858307479	-	4.29e-01	GO:0006509	membrane protein ectodomain proteolysis	BP
3	19	0.658858307479	-	4.29e-01	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	BP
3	19	0.658858307479	-	7.01e-02	GO:0004190	aspartic-type endopeptidase activity	MF
3	19	0.658858307479	-	1.58e-01	GO:0043395	heparan sulfate proteoglycan binding	MF
3	19	0.658858307479	-	4.16e-01	GO:0001965	G-protein alpha-subunit binding	MF
3	19	0.658858307479	-	4.29e-01	GO:0070064	proline-rich region binding	MF
9	57	0.658858307479	-	3.28e-02	GO:0060395	SMAD protein signal transduction	BP
9	57	0.658858307479	-	5.23e-02	GO:0043087	regulation of GTPase activity	BP
11	70	0.651971921894	-	1.06e-01	GO:0042795	snRNA transcription from RNA polymerase II promoter	BP
8	51	0.64939797823	-	1.27e-01	GO:0010506	regulation of autophagy	BP
8	51	0.64939797823	-	1.42e-01	GO:0010977	negative regulation of neuron projection development	BP
8	51	0.64939797823	-	1.42e-01	GO:0004715	non-membrane spanning protein tyrosine kinase activity	MF
18	115	0.646258270699	-	1.92e-02	GO:0005088	Ras guanyl-nucleotide exchange factor activity	MF
10	64	0.643751415089	-	6.30e-02	GO:0006310	DNA recombination	BP
10	64	0.643751415089	-	8.11e-02	GO:0035690	cellular response to drug	BP
5	32	0.643751415089	-	1.94e-01	GO:0040018	positive regulation of multicellular organism growth	BP
5	32	0.643751415089	-	2.05e-01	GO:0043200	response to amino acid	BP
19	122	0.639013496082	-	2.74e-02	GO:0017124	SH3 domain binding	MF
7	45	0.637325145929	-	7.99e-02	GO:0048839	inner ear development	BP
7	45	0.637325145929	-	8.50e-02	GO:0008015	blood circulation	BP
7	45	0.637325145929	-	8.50e-02	GO:0042552	myelination	BP
7	45	0.637325145929	-	1.14e-01	GO:0032956	regulation of actin cytoskeleton organization	BP
9	58	0.633767326516	-	5.23e-02	GO:0050680	negative regulation of epithelial cell proliferation	BP
9	58	0.633767326516	-	1.04e-01	GO:0050729	positive regulation of inflammatory response	BP
10	65	0.62138360206	-	6.87e-02	GO:0050796	regulation of insulin secretion	BP
6	39	0.62138360206	-	2.69e-01	GO:0030155	regulation of cell adhesion	BP
6	39	0.62138360206	-	6.35e-02	GO:0042626	ATPase activity, coupled to transmembrane movement of substances	MF
4	26	0.62138360206	-	6.83e-02	GO:0009880	embryonic pattern specification	BP
4	26	0.62138360206	-	1.33e-01	GO:0030534	adult behavior	BP
2	13	0.62138360206	-	1.50e-01	GO:0021527	spinal cord association neuron differentiation	BP
2	13	0.62138360206	-	1.50e-01	GO:0061051	positive regulation of cell growth involved in cardiac muscle cell development	BP
2	13	0.62138360206	-	1.87e-01	GO:0048599	oocyte development	BP
2	13	0.62138360206	-	2.25e-01	GO:0001775	cell activation	BP
2	13	0.62138360206	-	2.25e-01	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	BP
2	13	0.62138360206	-	2.25e-01	GO:0071318	cellular response to ATP	BP
2	13	0.62138360206	-	2.64e-01	GO:0090501	RNA phosphodiester bond hydrolysis	BP
2	13	0.62138360206	-	2.64e-01	GO:0097435	supramolecular fiber organization	BP
4	26	0.62138360206	-	2.70e-01	GO:0001656	metanephros development	BP
4	26	0.62138360206	-	2.81e-01	GO:0015758	glucose transport	BP
2	13	0.62138360206	-	3.03e-01	GO:0060996	dendritic spine development	BP
2	13	0.62138360206	-	3.03e-01	GO:0010763	positive regulation of fibroblast migration	BP
2	13	0.62138360206	-	3.03e-01	GO:0050806	positive regulation of synaptic transmission	BP
2	13	0.62138360206	-	3.03e-01	GO:0008610	lipid biosynthetic process	BP
2	13	0.62138360206	-	3.03e-01	GO:0001967	suckling behavior	BP
2	13	0.62138360206	-	3.03e-01	GO:0099133	ATP hydrolysis coupled anion transmembrane transport	BP
2	13	0.62138360206	-	3.03e-01	GO:0071280	cellular response to copper ion	BP
2	13	0.62138360206	-	3.03e-01	GO:0097320	plasma membrane tubulation	BP
2	13	0.62138360206	-	3.03e-01	GO:0051926	negative regulation of calcium ion transport	BP
2	13	0.62138360206	-	3.03e-01	GO:0045995	regulation of embryonic development	BP
4	26	0.62138360206	-	3.08e-01	GO:0000732	strand displacement	BP
2	13	0.62138360206	-	3.41e-01	GO:0007096	regulation of exit from mitosis	BP
2	13	0.62138360206	-	3.41e-01	GO:0051085	chaperone mediated protein folding requiring cofactor	BP
2	13	0.62138360206	-	3.41e-01	GO:0006883	cellular sodium ion homeostasis	BP
2	13	0.62138360206	-	3.41e-01	GO:0010821	regulation of mitochondrion organization	BP
2	13	0.62138360206	-	3.41e-01	GO:2000010	positive regulation of protein localization to cell surface	BP
2	13	0.62138360206	-	3.41e-01	GO:0045780	positive regulation of bone resorption	BP
2	13	0.62138360206	-	3.41e-01	GO:0030194	positive regulation of blood coagulation	BP
2	13	0.62138360206	-	3.79e-01	GO:0016242	negative regulation of macroautophagy	BP
2	13	0.62138360206	-	3.79e-01	GO:0048024	regulation of mRNA splicing, via spliceosome	BP
2	13	0.62138360206	-	3.79e-01	GO:0060134	prepulse inhibition	BP
2	13	0.62138360206	-	3.79e-01	GO:0033630	positive regulation of cell adhesion mediated by integrin	BP
2	13	0.62138360206	-	3.79e-01	GO:1904668	positive regulation of ubiquitin protein ligase activity	BP
2	13	0.62138360206	-	3.79e-01	GO:0045579	positive regulation of B cell differentiation	BP
2	13	0.62138360206	-	2.64e-01	GO:0004518	nuclease activity	MF
2	13	0.62138360206	-	3.41e-01	GO:0043024	ribosomal small subunit binding	MF
2	13	0.62138360206	-	3.79e-01	GO:0051787	misfolded protein binding	MF
2	13	0.62138360206	-	3.79e-01	GO:0004385	guanylate kinase activity	MF
2	13	0.62138360206	-	3.79e-01	GO:0017160	Ral GTPase binding	MF
17	111	0.614870295101	-	1.54e-02	GO:0044325	ion channel binding	MF
13	85	0.612872102205	-	9.83e-03	GO:1903955	positive regulation of protein targeting to mitochondrion	BP
16	105	0.607577802535	-	6.85e-02	GO:0043488	regulation of mRNA stability	BP
7	46	0.605616286202	-	1.83e-01	GO:0030968	endoplasmic reticulum unfolded protein response	BP
17	112	0.601931239394	-	6.24e-03	GO:0007417	central nervous system development	BP
10	66	0.59935729573	-	7.23e-02	GO:0051291	protein heterooligomerization	BP
5	33	0.59935729573	-	3.74e-01	GO:0006361	transcription initiation from RNA polymerase I promoter	BP
5	33	0.59935729573	-	3.74e-01	GO:0043928	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	BP
28	186	0.590019431151	-	1.90e-03	GO:0007420	brain development	BP
27	180	0.584857726035	-	7.13e-03	GO:0016477	cell migration	BP
3	20	0.584857726035	-	1.11e-01	GO:0010460	positive regulation of heart rate	BP
3	20	0.584857726035	-	1.11e-01	GO:0043046	DNA methylation involved in gamete generation	BP
3	20	0.584857726035	-	1.58e-01	GO:0001659	temperature homeostasis	BP
6	40	0.584857726035	-	1.68e-01	GO:0043434	response to peptide hormone	BP
3	20	0.584857726035	-	2.11e-01	GO:0034314	Arp2/3 complex-mediated actin nucleation	BP
3	20	0.584857726035	-	2.38e-01	GO:0035584	calcium-mediated signaling using intracellular calcium source	BP
3	20	0.584857726035	-	4.16e-01	GO:0019882	antigen processing and presentation	BP
3	20	0.584857726035	-	4.16e-01	GO:0045862	positive regulation of proteolysis	BP
3	20	0.584857726035	-	4.16e-01	GO:0002230	positive regulation of defense response to virus by host	BP
3	20	0.584857726035	-	4.29e-01	GO:0042276	error-prone translesion synthesis	BP
3	20	0.584857726035	-	4.44e-01	GO:0071526	semaphorin-plexin signaling pathway	BP
3	20	0.584857726035	-	1.84e-01	GO:0005251	delayed rectifier potassium channel activity	MF
10	67	0.577662224631	-	1.36e-01	GO:0051259	protein oligomerization	BP
7	47	0.574589390581	-	8.50e-02	GO:0065009	regulation of molecular function	BP
7	47	0.574589390581	-	2.02e-01	GO:0010595	positive regulation of endothelial cell migration	BP
8	54	0.566935818038	-	1.31e-01	GO:0045665	negative regulation of neuron differentiation	BP
4	27	0.566935818038	-	3.08e-01	GO:0051281	positive regulation of release of sequestered calcium ion into cytosol	BP
4	27	0.566935818038	-	3.40e-01	GO:0050690	regulation of defense response to virus by virus	BP
8	54	0.566935818038	-	1.63e-01	GO:0004386	helicase activity	MF
4	27	0.566935818038	-	3.40e-01	GO:0017048	Rho GTPase binding	MF
48	325	0.562489913007	-	2.81e-04	GO:0004842	ubiquitin-protein transferase activity	MF
9	61	0.561010984081	-	1.15e-01	GO:0006302	double-strand break repair	BP
14	95	0.559322633928	-	1.13e-01	GO:0006368	transcription elongation from RNA polymerase II promoter	BP
5	34	0.556288573838	-	1.84e-01	GO:0001890	placenta development	BP
5	34	0.556288573838	-	2.05e-01	GO:0042130	negative regulation of T cell proliferation	BP
5	34	0.556288573838	-	2.05e-01	GO:0045540	regulation of cholesterol biosynthetic process	BP
5	34	0.556288573838	-	2.31e-01	GO:0031098	stress-activated protein kinase signaling cascade	BP
5	34	0.556288573838	-	3.74e-01	GO:0097194	execution phase of apoptosis	BP
5	34	0.556288573838	-	3.82e-01	GO:0032212	positive regulation of telomere maintenance via telomerase	BP
5	34	0.556288573838	-	2.46e-01	GO:0031624	ubiquitin conjugating enzyme binding	MF
12	82	0.549233816304	-	1.23e-01	GO:0008543	fibroblast growth factor receptor signaling pathway	BP
15	103	0.542213388626	-	8.26e-02	GO:0045471	response to ethanol	BP
8	55	0.540463606677	-	1.42e-01	GO:0060548	negative regulation of cell death	BP
8	55	0.540463606677	-	1.48e-01	GO:0006950	response to stress	BP
11	76	0.533327425395	-	2.39e-02	GO:0016525	negative regulation of angiogenesis	BP
37	256	0.53127668583	-	3.93e-03	GO:0007049	cell cycle	BP
115	801	0.521654938737	-	2.36e-06	GO:0042802	identical protein binding	MF
3	21	0.514468398144	-	1.34e-01	GO:0007369	gastrulation	BP
3	21	0.514468398144	-	1.34e-01	GO:0032094	response to food	BP
12	84	0.514468398144	-	1.40e-01	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	BP
6	42	0.514468398144	-	1.46e-01	GO:0001541	ovarian follicle development	BP
3	21	0.514468398144	-	1.58e-01	GO:0014059	regulation of dopamine secretion	BP
5	35	0.514468398144	-	1.76e-01	GO:0051480	regulation of cytosolic calcium ion concentration	BP
10	70	0.514468398144	-	2.29e-01	GO:0016241	regulation of macroautophagy	BP
5	35	0.514468398144	-	2.31e-01	GO:0033574	response to testosterone	BP
3	21	0.514468398144	-	2.38e-01	GO:0009235	cobalamin metabolic process	BP
3	21	0.514468398144	-	2.38e-01	GO:0000266	mitochondrial fission	BP
3	21	0.514468398144	-	4.44e-01	GO:0045921	positive regulation of exocytosis	BP
3	21	0.514468398144	-	4.61e-01	GO:0060828	regulation of canonical Wnt signaling pathway	BP
3	21	0.514468398144	-	4.61e-01	GO:0001836	release of cytochrome c from mitochondria	BP
5	35	0.514468398144	-	2.46e-01	GO:0051219	phosphoprotein binding	MF
18	126	0.514468398144	-	8.63e-03	GO:0006629	lipid metabolic process	BP
8	56	0.514468398144	-	2.34e-02	GO:0042472	inner ear morphogenesis	BP
14	98	0.514468398144	-	3.69e-02	GO:0016310	phosphorylation	BP
11	77	0.514468398144	-	6.06e-02	GO:0043085	positive regulation of catalytic activity	BP
7	49	0.514468398144	-	7.56e-02	GO:0051898	negative regulation of protein kinase B signaling	BP
18	126	0.514468398144	-	9.00e-02	GO:0033209	tumor necrosis factor-mediated signaling pathway	BP
1	7	0.514468398144	-	1.00e-01	GO:0006766	vitamin metabolic process	BP
2	14	0.514468398144	-	1.50e-01	GO:0051481	negative regulation of cytosolic calcium ion concentration	BP
2	14	0.514468398144	-	1.87e-01	GO:0006693	prostaglandin metabolic process	BP
2	14	0.514468398144	-	2.25e-01	GO:1901223	negative regulation of NIK/NF-kappaB signaling	BP
2	14	0.514468398144	-	2.64e-01	GO:0048172	regulation of short-term neuronal synaptic plasticity	BP
2	14	0.514468398144	-	2.64e-01	GO:0002063	chondrocyte development	BP
1	7	0.514468398144	-	2.71e-01	GO:0006776	vitamin A metabolic process	BP
4	28	0.514468398144	-	2.81e-01	GO:0097193	intrinsic apoptotic signaling pathway	BP
2	14	0.514468398144	-	3.03e-01	GO:0030207	chondroitin sulfate catabolic process	BP
2	14	0.514468398144	-	3.03e-01	GO:0022408	negative regulation of cell-cell adhesion	BP
4	28	0.514468398144	-	3.23e-01	GO:0070207	protein homotrimerization	BP
4	28	0.514468398144	-	3.23e-01	GO:0048008	platelet-derived growth factor receptor signaling pathway	BP
2	14	0.514468398144	-	3.41e-01	GO:0045056	transcytosis	BP
2	14	0.514468398144	-	3.41e-01	GO:1900006	positive regulation of dendrite development	BP
1	7	0.514468398144	-	3.44e-01	GO:0001945	lymph vessel development	BP
1	7	0.514468398144	-	3.44e-01	GO:2000543	positive regulation of gastrulation	BP
1	7	0.514468398144	-	3.44e-01	GO:0095500	acetylcholine receptor signaling pathway	BP
1	7	0.514468398144	-	3.44e-01	GO:0060831	smoothened signaling pathway involved in dorsal/ventral neural tube patterning	BP
1	7	0.514468398144	-	3.44e-01	GO:0048771	tissue remodeling	BP
2	14	0.514468398144	-	3.79e-01	GO:0072657	protein localization to membrane	BP
2	14	0.514468398144	-	3.79e-01	GO:0035640	exploration behavior	BP
2	14	0.514468398144	-	3.79e-01	GO:1901673	regulation of mitotic spindle assembly	BP
2	14	0.514468398144	-	3.79e-01	GO:0050892	intestinal absorption	BP
2	14	0.514468398144	-	3.79e-01	GO:0050768	negative regulation of neurogenesis	BP
1	7	0.514468398144	-	4.10e-01	GO:0003209	cardiac atrium morphogenesis	BP
1	7	0.514468398144	-	4.10e-01	GO:0009620	response to fungus	BP
1	7	0.514468398144	-	4.10e-01	GO:0003416	endochondral bone growth	BP
1	7	0.514468398144	-	4.10e-01	GO:0051798	positive regulation of hair follicle development	BP
1	7	0.514468398144	-	4.10e-01	GO:0034144	negative regulation of toll-like receptor 4 signaling pathway	BP
1	7	0.514468398144	-	4.10e-01	GO:0033135	regulation of peptidyl-serine phosphorylation	BP
1	7	0.514468398144	-	4.10e-01	GO:2001259	positive regulation of cation channel activity	BP
1	7	0.514468398144	-	4.10e-01	GO:0060463	lung lobe morphogenesis	BP
1	7	0.514468398144	-	4.10e-01	GO:0044828	negative regulation by host of viral genome replication	BP
1	7	0.514468398144	-	4.10e-01	GO:2000252	negative regulation of feeding behavior	BP
1	7	0.514468398144	-	4.10e-01	GO:0031346	positive regulation of cell projection organization	BP
1	7	0.514468398144	-	4.10e-01	GO:0035878	nail development	BP
1	7	0.514468398144	-	4.10e-01	GO:0009950	dorsal/ventral axis specification	BP
1	7	0.514468398144	-	4.10e-01	GO:0051045	negative regulation of membrane protein ectodomain proteolysis	BP
1	7	0.514468398144	-	4.10e-01	GO:0045577	regulation of B cell differentiation	BP
1	7	0.514468398144	-	4.10e-01	GO:0045576	mast cell activation	BP
1	7	0.514468398144	-	4.10e-01	GO:0019227	neuronal action potential propagation	BP
1	7	0.514468398144	-	4.10e-01	GO:0042756	drinking behavior	BP
1	7	0.514468398144	-	4.10e-01	GO:0010518	positive regulation of phospholipase activity	BP
1	7	0.514468398144	-	4.10e-01	GO:0070613	regulation of protein processing	BP
1	7	0.514468398144	-	4.10e-01	GO:0003360	brainstem development	BP
1	7	0.514468398144	-	4.10e-01	GO:0060710	chorio-allantoic fusion	BP
1	7	0.514468398144	-	4.69e-01	GO:0048539	bone marrow development	BP
1	7	0.514468398144	-	4.69e-01	GO:0034138	toll-like receptor 3 signaling pathway	BP
1	7	0.514468398144	-	4.69e-01	GO:1902018	negative regulation of cilium assembly	BP
1	7	0.514468398144	-	4.69e-01	GO:0090281	negative regulation of calcium ion import	BP
1	7	0.514468398144	-	4.69e-01	GO:0072205	metanephric collecting duct development	BP
1	7	0.514468398144	-	4.69e-01	GO:0015872	dopamine transport	BP
1	7	0.514468398144	-	4.69e-01	GO:0032287	peripheral nervous system myelin maintenance	BP
1	7	0.514468398144	-	4.69e-01	GO:0060998	regulation of dendritic spine development	BP
1	7	0.514468398144	-	4.69e-01	GO:1903077	negative regulation of protein localization to plasma membrane	BP
1	7	0.514468398144	-	4.69e-01	GO:0007256	activation of JNKK activity	BP
1	7	0.514468398144	-	4.69e-01	GO:0032466	negative regulation of cytokinesis	BP
1	7	0.514468398144	-	4.69e-01	GO:0014037	Schwann cell differentiation	BP
1	7	0.514468398144	-	4.69e-01	GO:0097756	negative regulation of blood vessel diameter	BP
1	7	0.514468398144	-	4.69e-01	GO:0060075	regulation of resting membrane potential	BP
1	7	0.514468398144	-	4.69e-01	GO:0000578	embryonic axis specification	BP
1	7	0.514468398144	-	4.69e-01	GO:0043576	regulation of respiratory gaseous exchange	BP
1	7	0.514468398144	-	4.69e-01	GO:0006475	internal protein amino acid acetylation	BP
1	7	0.514468398144	-	4.69e-01	GO:0061384	heart trabecula morphogenesis	BP
1	7	0.514468398144	-	4.69e-01	GO:0051001	negative regulation of nitric-oxide synthase activity	BP
1	7	0.514468398144	-	4.69e-01	GO:0031102	neuron projection regeneration	BP
1	7	0.514468398144	-	4.69e-01	GO:0006972	hyperosmotic response	BP
1	7	0.514468398144	-	4.69e-01	GO:1900246	positive regulation of RIG-I signaling pathway	BP
1	7	0.514468398144	-	4.69e-01	GO:2000318	positive regulation of T-helper 17 type immune response	BP
1	7	0.514468398144	-	4.69e-01	GO:2000121	regulation of removal of superoxide radicals	BP
1	7	0.514468398144	-	4.69e-01	GO:0044539	long-chain fatty acid import	BP
1	7	0.514468398144	-	4.69e-01	GO:0035095	behavioral response to nicotine	BP
1	7	0.514468398144	-	4.69e-01	GO:0019054	modulation by virus of host process	BP
1	7	0.514468398144	-	4.69e-01	GO:0097237	cellular response to toxic substance	BP
1	7	0.514468398144	-	4.69e-01	GO:0060042	retina morphogenesis in camera-type eye	BP
1	7	0.514468398144	-	4.69e-01	GO:0071281	cellular response to iron ion	BP
1	7	0.514468398144	-	4.69e-01	GO:0007617	mating behavior	BP
1	7	0.514468398144	-	4.69e-01	GO:0070050	neuron cellular homeostasis	BP
1	7	0.514468398144	-	4.69e-01	GO:0007379	segment specification	BP
1	7	0.514468398144	-	4.69e-01	GO:0021799	cerebral cortex radially oriented cell migration	BP
1	7	0.514468398144	-	4.69e-01	GO:0051057	positive regulation of small GTPase mediated signal transduction	BP
1	7	0.514468398144	-	4.69e-01	GO:0050861	positive regulation of B cell receptor signaling pathway	BP
1	7	0.514468398144	-	4.69e-01	GO:0017121	phospholipid scrambling	BP
1	7	0.514468398144	-	4.69e-01	GO:0006527	arginine catabolic process	BP
1	7	0.514468398144	-	4.69e-01	GO:0060840	artery development	BP
1	7	0.514468398144	-	4.69e-01	GO:0003084	positive regulation of systemic arterial blood pressure	BP
1	7	0.514468398144	-	4.69e-01	GO:2000271	positive regulation of fibroblast apoptotic process	BP
1	7	0.514468398144	-	4.69e-01	GO:0042297	vocal learning	BP
1	7	0.514468398144	-	4.69e-01	GO:0035726	common myeloid progenitor cell proliferation	BP
1	7	0.514468398144	-	4.69e-01	GO:0045822	negative regulation of heart contraction	BP
1	7	0.514468398144	-	4.69e-01	GO:0042129	regulation of T cell proliferation	BP
1	7	0.514468398144	-	4.69e-01	GO:0060563	neuroepithelial cell differentiation	BP
1	7	0.514468398144	-	4.69e-01	GO:0014824	artery smooth muscle contraction	BP
4	28	0.514468398144	-	5.20e-01	GO:0014047	glutamate secretion	BP
1	7	0.514468398144	-	5.22e-01	GO:0045650	negative regulation of macrophage differentiation	BP
1	7	0.514468398144	-	5.22e-01	GO:0050810	regulation of steroid biosynthetic process	BP
1	7	0.514468398144	-	5.22e-01	GO:0006516	glycoprotein catabolic process	BP
1	7	0.514468398144	-	5.22e-01	GO:0045955	negative regulation of calcium ion-dependent exocytosis	BP
1	7	0.514468398144	-	5.22e-01	GO:0032736	positive regulation of interleukin-13 production	BP
1	7	0.514468398144	-	5.22e-01	GO:0003337	mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	7	0.514468398144	-	5.22e-01	GO:0070389	chaperone cofactor-dependent protein refolding	BP
1	7	0.514468398144	-	5.22e-01	GO:0010269	response to selenium ion	BP
1	7	0.514468398144	-	5.22e-01	GO:0031848	protection from non-homologous end joining at telomere	BP
1	7	0.514468398144	-	5.22e-01	GO:1902741	positive regulation of interferon-alpha secretion	BP
1	7	0.514468398144	-	5.22e-01	GO:0090160	Golgi to lysosome transport	BP
1	7	0.514468398144	-	5.22e-01	GO:0061626	pharyngeal arch artery morphogenesis	BP
1	7	0.514468398144	-	5.22e-01	GO:0060706	cell differentiation involved in embryonic placenta development	BP
1	7	0.514468398144	-	5.22e-01	GO:1903715	regulation of aerobic respiration	BP
1	7	0.514468398144	-	5.22e-01	GO:0071233	cellular response to leucine	BP
1	7	0.514468398144	-	5.22e-01	GO:0006020	inositol metabolic process	BP
1	7	0.514468398144	-	5.22e-01	GO:0048261	negative regulation of receptor-mediated endocytosis	BP
1	7	0.514468398144	-	5.22e-01	GO:0051988	regulation of attachment of spindle microtubules to kinetochore	BP
1	7	0.514468398144	-	5.22e-01	GO:2000210	positive regulation of anoikis	BP
1	7	0.514468398144	-	5.22e-01	GO:0006264	mitochondrial DNA replication	BP
1	7	0.514468398144	-	5.22e-01	GO:0002819	regulation of adaptive immune response	BP
1	7	0.514468398144	-	5.22e-01	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	BP
1	7	0.514468398144	-	5.22e-01	GO:0030916	otic vesicle formation	BP
1	7	0.514468398144	-	5.22e-01	GO:0002438	acute inflammatory response to antigenic stimulus	BP
1	7	0.514468398144	-	5.22e-01	GO:0014808	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	BP
1	7	0.514468398144	-	5.22e-01	GO:0060907	positive regulation of macrophage cytokine production	BP
1	7	0.514468398144	-	5.22e-01	GO:0071169	establishment of protein localization to chromatin	BP
1	7	0.514468398144	-	5.22e-01	GO:0042035	regulation of cytokine biosynthetic process	BP
1	7	0.514468398144	-	5.22e-01	GO:0032308	positive regulation of prostaglandin secretion	BP
1	7	0.514468398144	-	5.22e-01	GO:0015813	L-glutamate transport	BP
1	7	0.514468398144	-	5.22e-01	GO:0071474	cellular hyperosmotic response	BP
1	7	0.514468398144	-	5.22e-01	GO:0042178	xenobiotic catabolic process	BP
1	7	0.514468398144	-	5.22e-01	GO:0035194	posttranscriptional gene silencing by RNA	BP
1	7	0.514468398144	-	5.22e-01	GO:0032057	negative regulation of translational initiation in response to stress	BP
1	7	0.514468398144	-	5.22e-01	GO:0060575	intestinal epithelial cell differentiation	BP
1	7	0.514468398144	-	5.22e-01	GO:0032609	interferon-gamma production	BP
1	7	0.514468398144	-	5.22e-01	GO:0048702	embryonic neurocranium morphogenesis	BP
1	7	0.514468398144	-	5.22e-01	GO:0010918	positive regulation of mitochondrial membrane potential	BP
1	7	0.514468398144	-	5.22e-01	GO:0034128	negative regulation of MyD88-independent toll-like receptor signaling pathway	BP
1	7	0.514468398144	-	5.22e-01	GO:0019064	fusion of virus membrane with host plasma membrane	BP
1	7	0.514468398144	-	5.22e-01	GO:0043496	regulation of protein homodimerization activity	BP
2	14	0.514468398144	-	6.44e-01	GO:0045088	regulation of innate immune response	BP
2	14	0.514468398144	-	6.44e-01	GO:0051492	regulation of stress fiber assembly	BP
2	14	0.514468398144	-	6.44e-01	GO:0048009	insulin-like growth factor receptor signaling pathway	BP
18	126	0.514468398144	-	9.80e-04	GO:0020037	heme binding	MF
1	7	0.514468398144	-	1.90e-01	GO:0004875	complement receptor activity	MF
1	7	0.514468398144	-	2.71e-01	GO:0015645	fatty acid ligase activity	MF
1	7	0.514468398144	-	2.71e-01	GO:0004321	fatty-acyl-CoA synthase activity	MF
2	14	0.514468398144	-	3.03e-01	GO:0005523	tropomyosin binding	MF
1	7	0.514468398144	-	4.10e-01	GO:0005501	retinoid binding	MF
1	7	0.514468398144	-	4.10e-01	GO:0016494	C-X-C chemokine receptor activity	MF
1	7	0.514468398144	-	4.69e-01	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	MF
1	7	0.514468398144	-	4.69e-01	GO:0004128	cytochrome-b5 reductase activity, acting on NAD(P)H	MF
1	7	0.514468398144	-	4.69e-01	GO:0010485	H4 histone acetyltransferase activity	MF
1	7	0.514468398144	-	4.69e-01	GO:0046870	cadmium ion binding	MF
1	7	0.514468398144	-	4.69e-01	GO:0035612	AP-2 adaptor complex binding	MF
1	7	0.514468398144	-	4.69e-01	GO:0000405	bubble DNA binding	MF
1	7	0.514468398144	-	4.69e-01	GO:0016853	isomerase activity	MF
1	7	0.514468398144	-	4.69e-01	GO:0086008	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	MF
1	7	0.514468398144	-	4.69e-01	GO:1901981	phosphatidylinositol phosphate binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0005314	high-affinity glutamate transmembrane transporter activity	MF
1	7	0.514468398144	-	5.22e-01	GO:0005021	vascular endothelial growth factor-activated receptor activity	MF
1	7	0.514468398144	-	5.22e-01	GO:0043140	ATP-dependent 3'-5' DNA helicase activity	MF
1	7	0.514468398144	-	5.22e-01	GO:0005114	type II transforming growth factor beta receptor binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0030274	LIM domain binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0030346	protein phosphatase 2B binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0034618	arginine binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0051880	G-quadruplex DNA binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0019787	ubiquitin-like protein transferase activity	MF
2	14	0.514468398144	-	6.44e-01	GO:0032794	GTPase activating protein binding	MF
2	14	0.514468398144	-	6.44e-01	GO:0035198	miRNA binding	MF
109	766	0.508807063053	-	1.33e-07	GO:0042803	protein homodimerization activity	MF
9	64	0.491748321643	-	1.15e-01	GO:0008217	regulation of blood pressure	BP
26	185	0.490881577826	-	1.02e-02	GO:0007411	axon guidance	BP
8	57	0.488933306036	-	1.42e-01	GO:0007612	learning	BP
8	57	0.488933306036	-	2.51e-01	GO:0005070	SH3/SH2 adaptor activity	MF
6	43	0.48052106622	-	2.86e-01	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
6	43	0.48052106622	-	3.07e-01	GO:0051496	positive regulation of stress fiber assembly	BP
6	43	0.48052106622	-	1.46e-01	GO:0015485	cholesterol binding	MF
11	79	0.477474190661	-	9.46e-02	GO:0007626	locomotory behavior	BP
10	72	0.473826413646	-	1.46e-01	GO:0071347	cellular response to interleukin-1	BP
5	36	0.473826413646	-	1.84e-01	GO:0086091	regulation of heart rate by cardiac conduction	BP
5	36	0.473826413646	-	3.91e-01	GO:0043407	negative regulation of MAP kinase activity	BP
19	137	0.471718750684	-	1.04e-01	GO:0006260	DNA replication	BP
4	29	0.463842325074	-	3.08e-01	GO:0007205	protein kinase C-activating G-protein coupled receptor signaling pathway	BP
4	29	0.463842325074	-	5.20e-01	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	BP
4	29	0.463842325074	-	3.40e-01	GO:0004003	ATP-dependent DNA helicase activity	MF
4	29	0.463842325074	-	5.27e-01	GO:0043021	ribonucleoprotein complex binding	MF
11	80	0.459326843951	-	1.67e-01	GO:0030674	protein binding, bridging	MF
7	51	0.456752900287	-	2.19e-01	GO:0045860	positive regulation of protein kinase activity	BP
7	51	0.456752900287	-	2.29e-01	GO:0040008	regulation of growth	BP
7	51	0.456752900287	-	2.19e-01	GO:0048365	Rac GTPase binding	MF
6	44	0.447354202285	-	1.28e-01	GO:0061337	cardiac conduction	BP
3	22	0.447354202285	-	1.84e-01	GO:0017158	regulation of calcium ion-dependent exocytosis	BP
3	22	0.447354202285	-	1.84e-01	GO:0045333	cellular respiration	BP
6	44	0.447354202285	-	3.07e-01	GO:0002224	toll-like receptor signaling pathway	BP
3	22	0.447354202285	-	4.16e-01	GO:0010842	retina layer formation	BP
3	22	0.447354202285	-	4.29e-01	GO:0001816	cytokine production	BP
3	22	0.447354202285	-	4.44e-01	GO:0090103	cochlea morphogenesis	BP
3	22	0.447354202285	-	4.61e-01	GO:0006607	NLS-bearing protein import into nucleus	BP
3	22	0.447354202285	-	4.61e-01	GO:0002092	positive regulation of receptor internalization	BP
3	22	0.447354202285	-	4.61e-01	GO:0050769	positive regulation of neurogenesis	BP
3	22	0.447354202285	-	4.61e-01	GO:0004683	calmodulin-dependent protein kinase activity	MF
3	22	0.447354202285	-	4.78e-01	GO:0003899	DNA-directed 5'-3' RNA polymerase activity	MF
58	426	0.445094695103	-	8.41e-04	GO:0016567	protein ubiquitination	BP
14	103	0.442677715076	-	1.16e-01	GO:0031175	neuron projection development	BP
52	383	0.441062456417	-	1.08e-03	GO:0035556	intracellular signal transduction	BP
8	59	0.439180270839	-	1.63e-01	GO:0042102	positive regulation of T cell proliferation	BP
13	96	0.437300537621	-	9.95e-02	GO:0042593	glucose homeostasis	BP
5	37	0.43429804946	-	1.84e-01	GO:0008202	steroid metabolic process	BP
5	37	0.43429804946	-	2.05e-01	GO:0001942	hair follicle development	BP
5	37	0.43429804946	-	3.91e-01	GO:0007098	centrosome cycle	BP
25	187	0.418785050088	-	2.41e-02	GO:0030335	positive regulation of cell migration	BP
2	15	0.414932724593	-	1.87e-01	GO:0045603	positive regulation of endothelial cell differentiation	BP
2	15	0.414932724593	-	2.25e-01	GO:1903206	negative regulation of hydrogen peroxide-induced cell death	BP
2	15	0.414932724593	-	2.25e-01	GO:0046928	regulation of neurotransmitter secretion	BP
2	15	0.414932724593	-	2.25e-01	GO:0080111	DNA demethylation	BP
2	15	0.414932724593	-	2.64e-01	GO:0003382	epithelial cell morphogenesis	BP
2	15	0.414932724593	-	2.64e-01	GO:0051604	protein maturation	BP
8	60	0.414932724593	-	2.73e-01	GO:0010972	negative regulation of G2/M transition of mitotic cell cycle	BP
4	30	0.414932724593	-	2.81e-01	GO:0042476	odontogenesis	BP
2	15	0.414932724593	-	3.03e-01	GO:0006112	energy reserve metabolic process	BP
2	15	0.414932724593	-	3.03e-01	GO:0060314	regulation of ryanodine-sensitive calcium-release channel activity	BP
2	15	0.414932724593	-	3.03e-01	GO:0010812	negative regulation of cell-substrate adhesion	BP
2	15	0.414932724593	-	3.41e-01	GO:0051276	chromosome organization	BP
2	15	0.414932724593	-	3.79e-01	GO:0050965	detection of temperature stimulus involved in sensory perception of pain	BP
2	15	0.414932724593	-	3.79e-01	GO:0002042	cell migration involved in sprouting angiogenesis	BP
2	15	0.414932724593	-	3.79e-01	GO:0050995	negative regulation of lipid catabolic process	BP
2	15	0.414932724593	-	3.79e-01	GO:0090303	positive regulation of wound healing	BP
4	30	0.414932724593	-	5.36e-01	GO:0006362	transcription elongation from RNA polymerase I promoter	BP
2	15	0.414932724593	-	6.44e-01	GO:0006622	protein targeting to lysosome	BP
2	15	0.414932724593	-	6.44e-01	GO:0048872	homeostasis of number of cells	BP
2	15	0.414932724593	-	6.44e-01	GO:2000251	positive regulation of actin cytoskeleton reorganization	BP
2	15	0.414932724593	-	6.44e-01	GO:2000353	positive regulation of endothelial cell apoptotic process	BP
2	15	0.414932724593	-	6.44e-01	GO:0010288	response to lead ion	BP
2	15	0.414932724593	-	6.57e-01	GO:0051895	negative regulation of focal adhesion assembly	BP
2	15	0.414932724593	-	6.57e-01	GO:2000484	positive regulation of interleukin-8 secretion	BP
2	15	0.414932724593	-	6.57e-01	GO:0060997	dendritic spine morphogenesis	BP
2	15	0.414932724593	-	6.57e-01	GO:1903543	positive regulation of exosomal secretion	BP
2	15	0.414932724593	-	6.57e-01	GO:0006376	mRNA splice site selection	BP
2	15	0.414932724593	-	6.57e-01	GO:0048011	neurotrophin TRK receptor signaling pathway	BP
2	15	0.414932724593	-	1.14e-01	GO:0008188	neuropeptide receptor activity	MF
2	15	0.414932724593	-	3.79e-01	GO:0030676	Rac guanyl-nucleotide exchange factor activity	MF
2	15	0.414932724593	-	3.79e-01	GO:0017016	Ras GTPase binding	MF
2	15	0.414932724593	-	3.79e-01	GO:0005504	fatty acid binding	MF
4	30	0.414932724593	-	5.27e-01	GO:0005164	tumor necrosis factor receptor binding	MF
2	15	0.414932724593	-	6.44e-01	GO:0005161	platelet-derived growth factor receptor binding	MF
2	15	0.414932724593	-	6.57e-01	GO:0005521	lamin binding	MF
10	75	0.414932724593	-	6.56e-02	GO:0001503	ossification	BP
6	45	0.414932724593	-	2.77e-01	GO:0060048	cardiac muscle contraction	BP
6	45	0.414932724593	-	2.96e-01	GO:0030971	receptor tyrosine kinase binding	MF
9	68	0.404285480393	-	2.83e-01	GO:0034976	response to endoplasmic reticulum stress	BP
7	53	0.401257787696	-	2.29e-01	GO:0043406	positive regulation of MAP kinase activity	BP
26	197	0.400211218886	-	3.98e-02	GO:0000287	magnesium ion binding	MF
29	220	0.398444601804	-	6.09e-02	GO:0000209	protein polyubiquitination	BP
17	129	0.398058906028	-	2.79e-02	GO:0008289	lipid binding	MF
10	76	0.395823901645	-	2.35e-01	GO:0043410	positive regulation of MAPK cascade	BP
10	76	0.395823901645	-	3.32e-01	GO:0051437	positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition	BP
5	38	0.395823901645	-	3.74e-01	GO:0045184	establishment of protein localization	BP
5	38	0.395823901645	-	4.25e-01	GO:0030049	muscle filament sliding	BP
5	38	0.395823901645	-	8.49e-02	GO:0004519	endonuclease activity	MF
8	61	0.391085982638	-	2.73e-01	GO:0009967	positive regulation of signal transduction	BP
17	130	0.386918348423	-	2.36e-01	GO:0000086	G2/M transition of mitotic cell cycle	BP
9	69	0.383223864865	-	1.09e-01	GO:0060079	excitatory postsynaptic potential	BP
3	23	0.383223864865	-	1.58e-01	GO:0007140	male meiotic nuclear division	BP
3	23	0.383223864865	-	2.11e-01	GO:0046856	phosphatidylinositol dephosphorylation	BP
3	23	0.383223864865	-	4.16e-01	GO:0001819	positive regulation of cytokine production	BP
3	23	0.383223864865	-	4.44e-01	GO:0008306	associative learning	BP
3	23	0.383223864865	-	4.44e-01	GO:0051928	positive regulation of calcium ion transport	BP
3	23	0.383223864865	-	4.61e-01	GO:0034394	protein localization to cell surface	BP
3	23	0.383223864865	-	4.61e-01	GO:2000463	positive regulation of excitatory postsynaptic potential	BP
3	23	0.383223864865	-	4.61e-01	GO:0048675	axon extension	BP
3	23	0.383223864865	-	4.78e-01	GO:0007422	peripheral nervous system development	BP
3	23	0.383223864865	-	4.97e-01	GO:0006297	nucleotide-excision repair, DNA gap filling	BP
3	23	0.383223864865	-	4.97e-01	GO:0030866	cortical actin cytoskeleton organization	BP
3	23	0.383223864865	-	5.29e-02	GO:0070330	aromatase activity	MF
3	23	0.383223864865	-	4.44e-01	GO:0017134	fibroblast growth factor binding	MF
13	100	0.378406848568	-	1.47e-01	GO:0006979	response to oxidative stress	BP
7	54	0.374290740095	-	3.34e-01	GO:0008104	protein localization	BP
8	62	0.367627009814	-	2.57e-01	GO:0045727	positive regulation of translation	BP
4	31	0.367627009814	-	2.94e-01	GO:0030073	insulin secretion	BP
4	31	0.367627009814	-	3.23e-01	GO:0048286	lung alveolus development	BP
4	31	0.367627009814	-	5.27e-01	GO:0034504	protein localization to nucleus	BP
4	31	0.367627009814	-	5.45e-01	GO:0006363	termination of RNA polymerase I transcription	BP
9	70	0.362465304699	-	1.74e-01	GO:0001558	regulation of cell growth	BP
5	39	0.358349196226	-	7.30e-02	GO:0007631	feeding behavior	BP
5	39	0.358349196226	-	2.46e-01	GO:0030819	positive regulation of cAMP biosynthetic process	BP
11	86	0.354990184136	-	5.68e-02	GO:0036459	thiol-dependent ubiquitinyl hydrolase activity	MF
6	47	0.352196969245	-	3.07e-01	GO:0051781	positive regulation of cell division	BP
12	95	0.336930212591	-	3.83e-01	GO:0016236	macroautophagy	BP
12	95	0.336930212591	-	3.86e-01	GO:0000278	mitotic cell cycle	BP
55	436	0.334998708949	-	8.00e-06	GO:0045087	innate immune response	BP
17	135	0.332470564401	-	5.27e-02	GO:0001501	skeletal system development	BP
3	24	0.321823320201	-	2.11e-01	GO:0019369	arachidonic acid metabolic process	BP
3	24	0.321823320201	-	4.29e-01	GO:0032967	positive regulation of collagen biosynthetic process	BP
3	24	0.321823320201	-	4.61e-01	GO:0032435	negative regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
3	24	0.321823320201	-	4.78e-01	GO:0002040	sprouting angiogenesis	BP
3	24	0.321823320201	-	4.78e-01	GO:0042327	positive regulation of phosphorylation	BP
3	24	0.321823320201	-	4.97e-01	GO:0048041	focal adhesion assembly	BP
3	24	0.321823320201	-	7.28e-01	GO:0070536	protein K63-linked deubiquitination	BP
3	24	0.321823320201	-	3.81e-02	GO:0004993	G-protein coupled serotonin receptor activity	MF
6	48	0.321823320201	-	3.97e-02	GO:0008168	methyltransferase activity	MF
3	24	0.321823320201	-	4.97e-01	GO:0005031	tumor necrosis factor-activated receptor activity	MF
46	368	0.321823320201	-	2.30e-03	GO:0006954	inflammatory response	BP
2	16	0.321823320201	-	1.50e-01	GO:0030500	regulation of bone mineralization	BP
1	8	0.321823320201	-	1.90e-01	GO:2000818	negative regulation of myoblast proliferation	BP
1	8	0.321823320201	-	1.90e-01	GO:0061303	cornea development in camera-type eye	BP
8	64	0.321823320201	-	2.51e-01	GO:0072659	protein localization to plasma membrane	BP
4	32	0.321823320201	-	2.70e-01	GO:1900087	positive regulation of G1/S transition of mitotic cell cycle	BP
9	72	0.321823320201	-	2.92e-01	GO:0045454	cell redox homeostasis	BP
2	16	0.321823320201	-	3.03e-01	GO:0048566	embryonic digestive tract development	BP
4	32	0.321823320201	-	3.08e-01	GO:0007498	mesoderm development	BP
10	80	0.321823320201	-	3.37e-01	GO:0006928	movement of cell or subcellular component	BP
4	32	0.321823320201	-	3.40e-01	GO:0032007	negative regulation of TOR signaling	BP
1	8	0.321823320201	-	3.44e-01	GO:2000042	negative regulation of double-strand break repair via homologous recombination	BP
1	8	0.321823320201	-	3.44e-01	GO:0015871	choline transport	BP
1	8	0.321823320201	-	3.44e-01	GO:0006690	icosanoid metabolic process	BP
1	8	0.321823320201	-	3.44e-01	GO:0051601	exocyst localization	BP
2	16	0.321823320201	-	3.79e-01	GO:0006402	mRNA catabolic process	BP
5	40	0.321823320201	-	3.82e-01	GO:0030199	collagen fibril organization	BP
1	8	0.321823320201	-	4.10e-01	GO:0090286	cytoskeletal anchoring at nuclear membrane	BP
1	8	0.321823320201	-	4.10e-01	GO:0031017	exocrine pancreas development	BP
1	8	0.321823320201	-	4.10e-01	GO:0035865	cellular response to potassium ion	BP
1	8	0.321823320201	-	4.10e-01	GO:0045602	negative regulation of endothelial cell differentiation	BP
1	8	0.321823320201	-	4.10e-01	GO:0034392	negative regulation of smooth muscle cell apoptotic process	BP
1	8	0.321823320201	-	4.10e-01	GO:0060373	regulation of ventricular cardiac muscle cell membrane depolarization	BP
1	8	0.321823320201	-	4.10e-01	GO:0010940	positive regulation of necrotic cell death	BP
1	8	0.321823320201	-	4.10e-01	GO:0051782	negative regulation of cell division	BP
1	8	0.321823320201	-	4.10e-01	GO:0006108	malate metabolic process	BP
1	8	0.321823320201	-	4.10e-01	GO:0061052	negative regulation of cell growth involved in cardiac muscle cell development	BP
1	8	0.321823320201	-	4.10e-01	GO:0044255	cellular lipid metabolic process	BP
1	8	0.321823320201	-	4.10e-01	GO:0046512	sphingosine biosynthetic process	BP
1	8	0.321823320201	-	4.10e-01	GO:0003085	negative regulation of systemic arterial blood pressure	BP
9	72	0.321823320201	-	4.21e-01	GO:0031146	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	BP
1	8	0.321823320201	-	4.69e-01	GO:0044342	type B pancreatic cell proliferation	BP
1	8	0.321823320201	-	4.69e-01	GO:0071800	podosome assembly	BP
1	8	0.321823320201	-	4.69e-01	GO:0043031	negative regulation of macrophage activation	BP
1	8	0.321823320201	-	4.69e-01	GO:0006704	glucocorticoid biosynthetic process	BP
1	8	0.321823320201	-	4.69e-01	GO:0046324	regulation of glucose import	BP
1	8	0.321823320201	-	4.69e-01	GO:0035137	hindlimb morphogenesis	BP
1	8	0.321823320201	-	4.69e-01	GO:0060137	maternal process involved in parturition	BP
1	8	0.321823320201	-	4.69e-01	GO:0098915	membrane repolarization during ventricular cardiac muscle cell action potential	BP
1	8	0.321823320201	-	4.69e-01	GO:0042698	ovulation cycle	BP
1	8	0.321823320201	-	4.69e-01	GO:0007494	midgut development	BP
1	8	0.321823320201	-	4.69e-01	GO:0060087	relaxation of vascular smooth muscle	BP
1	8	0.321823320201	-	4.69e-01	GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	BP
1	8	0.321823320201	-	4.69e-01	GO:0002827	positive regulation of T-helper 1 type immune response	BP
1	8	0.321823320201	-	4.69e-01	GO:0060339	negative regulation of type I interferon-mediated signaling pathway	BP
1	8	0.321823320201	-	4.69e-01	GO:0060259	regulation of feeding behavior	BP
1	8	0.321823320201	-	4.69e-01	GO:0010917	negative regulation of mitochondrial membrane potential	BP
1	8	0.321823320201	-	4.69e-01	GO:0048339	paraxial mesoderm development	BP
1	8	0.321823320201	-	4.69e-01	GO:0010898	positive regulation of triglyceride catabolic process	BP
1	8	0.321823320201	-	4.69e-01	GO:0061635	regulation of protein complex stability	BP
1	8	0.321823320201	-	4.69e-01	GO:0042420	dopamine catabolic process	BP
1	8	0.321823320201	-	5.22e-01	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	BP
1	8	0.321823320201	-	5.22e-01	GO:0040019	positive regulation of embryonic development	BP
1	8	0.321823320201	-	5.22e-01	GO:0033629	negative regulation of cell adhesion mediated by integrin	BP
1	8	0.321823320201	-	5.22e-01	GO:0006356	regulation of transcription from RNA polymerase I promoter	BP
1	8	0.321823320201	-	5.22e-01	GO:0048103	somatic stem cell division	BP
1	8	0.321823320201	-	5.22e-01	GO:0038003	opioid receptor signaling pathway	BP
1	8	0.321823320201	-	5.22e-01	GO:0045059	positive thymic T cell selection	BP
1	8	0.321823320201	-	5.22e-01	GO:0016264	gap junction assembly	BP
1	8	0.321823320201	-	5.22e-01	GO:0032691	negative regulation of interleukin-1 beta production	BP
1	8	0.321823320201	-	5.22e-01	GO:0006729	tetrahydrobiopterin biosynthetic process	BP
1	8	0.321823320201	-	5.22e-01	GO:0051549	positive regulation of keratinocyte migration	BP
1	8	0.321823320201	-	5.22e-01	GO:0016188	synaptic vesicle maturation	BP
1	8	0.321823320201	-	5.22e-01	GO:0001766	membrane raft polarization	BP
1	8	0.321823320201	-	5.22e-01	GO:0001959	regulation of cytokine-mediated signaling pathway	BP
1	8	0.321823320201	-	5.22e-01	GO:0051963	regulation of synapse assembly	BP
1	8	0.321823320201	-	5.22e-01	GO:1902715	positive regulation of interferon-gamma secretion	BP
1	8	0.321823320201	-	5.22e-01	GO:0009651	response to salt stress	BP
4	32	0.321823320201	-	5.56e-01	GO:0000281	mitotic cytokinesis	BP
1	8	0.321823320201	-	5.70e-01	GO:0048739	cardiac muscle fiber development	BP
1	8	0.321823320201	-	5.70e-01	GO:1990416	cellular response to brain-derived neurotrophic factor stimulus	BP
1	8	0.321823320201	-	5.70e-01	GO:1901799	negative regulation of proteasomal protein catabolic process	BP
1	8	0.321823320201	-	5.70e-01	GO:0047497	mitochondrion transport along microtubule	BP
1	8	0.321823320201	-	5.70e-01	GO:0007097	nuclear migration	BP
1	8	0.321823320201	-	5.70e-01	GO:0001825	blastocyst formation	BP
1	8	0.321823320201	-	5.70e-01	GO:0006012	galactose metabolic process	BP
1	8	0.321823320201	-	5.70e-01	GO:0042775	mitochondrial ATP synthesis coupled electron transport	BP
1	8	0.321823320201	-	5.70e-01	GO:0035148	tube formation	BP
1	8	0.321823320201	-	5.70e-01	GO:0033622	integrin activation	BP
1	8	0.321823320201	-	5.70e-01	GO:0006782	protoporphyrinogen IX biosynthetic process	BP
1	8	0.321823320201	-	5.70e-01	GO:0010888	negative regulation of lipid storage	BP
1	8	0.321823320201	-	5.70e-01	GO:0072321	chaperone-mediated protein transport	BP
1	8	0.321823320201	-	5.70e-01	GO:0050805	negative regulation of synaptic transmission	BP
1	8	0.321823320201	-	5.70e-01	GO:0061462	protein localization to lysosome	BP
1	8	0.321823320201	-	5.70e-01	GO:0001955	blood vessel maturation	BP
1	8	0.321823320201	-	5.70e-01	GO:0034475	U4 snRNA 3'-end processing	BP
1	8	0.321823320201	-	5.70e-01	GO:0034629	cellular protein complex localization	BP
1	8	0.321823320201	-	5.70e-01	GO:1902305	regulation of sodium ion transmembrane transport	BP
1	8	0.321823320201	-	5.70e-01	GO:0006268	DNA unwinding involved in DNA replication	BP
1	8	0.321823320201	-	5.70e-01	GO:0001960	negative regulation of cytokine-mediated signaling pathway	BP
1	8	0.321823320201	-	5.70e-01	GO:0000075	cell cycle checkpoint	BP
1	8	0.321823320201	-	5.70e-01	GO:2000096	positive regulation of Wnt signaling pathway, planar cell polarity pathway	BP
1	8	0.321823320201	-	5.70e-01	GO:0007289	spermatid nucleus differentiation	BP
1	8	0.321823320201	-	5.70e-01	GO:0002011	morphogenesis of an epithelial sheet	BP
1	8	0.321823320201	-	5.70e-01	GO:1990253	cellular response to leucine starvation	BP
1	8	0.321823320201	-	5.70e-01	GO:0010467	gene expression	BP
1	8	0.321823320201	-	5.70e-01	GO:0033151	V(D)J recombination	BP
1	8	0.321823320201	-	5.70e-01	GO:0014909	smooth muscle cell migration	BP
1	8	0.321823320201	-	5.70e-01	GO:0051683	establishment of Golgi localization	BP
1	8	0.321823320201	-	5.70e-01	GO:0060711	labyrinthine layer development	BP
1	8	0.321823320201	-	5.70e-01	GO:0060712	spongiotrophoblast layer development	BP
1	8	0.321823320201	-	5.70e-01	GO:0051646	mitochondrion localization	BP
2	16	0.321823320201	-	6.57e-01	GO:0046037	GMP metabolic process	BP
2	16	0.321823320201	-	6.57e-01	GO:0061136	regulation of proteasomal protein catabolic process	BP
2	16	0.321823320201	-	6.71e-01	GO:0045725	positive regulation of glycogen biosynthetic process	BP
2	16	0.321823320201	-	6.71e-01	GO:0000380	alternative mRNA splicing, via spliceosome	BP
1	8	0.321823320201	-	1.90e-01	GO:0016712	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	MF
7	56	0.321823320201	-	3.41e-01	GO:0004722	protein serine/threonine phosphatase activity	MF
1	8	0.321823320201	-	3.44e-01	GO:0003996	acyl-CoA ligase activity	MF
1	8	0.321823320201	-	3.44e-01	GO:0005243	gap junction channel activity	MF
1	8	0.321823320201	-	3.44e-01	GO:0047760	butyrate-CoA ligase activity	MF
1	8	0.321823320201	-	3.44e-01	GO:0042562	hormone binding	MF
1	8	0.321823320201	-	3.44e-01	GO:0038036	sphingosine-1-phosphate receptor activity	MF
1	8	0.321823320201	-	4.10e-01	GO:0004126	cytidine deaminase activity	MF
1	8	0.321823320201	-	4.69e-01	GO:0001162	RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding	MF
1	8	0.321823320201	-	4.69e-01	GO:1902282	voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization	MF
1	8	0.321823320201	-	5.22e-01	GO:0017110	nucleoside-diphosphatase activity	MF
1	8	0.321823320201	-	5.22e-01	GO:0036310	annealing helicase activity	MF
1	8	0.321823320201	-	5.22e-01	GO:0005113	patched binding	MF
1	8	0.321823320201	-	5.22e-01	GO:0003954	NADH dehydrogenase activity	MF
1	8	0.321823320201	-	5.22e-01	GO:0102391	decanoate--CoA ligase activity	MF
1	8	0.321823320201	-	5.22e-01	GO:0008429	phosphatidylethanolamine binding	MF
1	8	0.321823320201	-	5.70e-01	GO:0030983	mismatched DNA binding	MF
1	8	0.321823320201	-	5.70e-01	GO:0003857	3-hydroxyacyl-CoA dehydrogenase activity	MF
1	8	0.321823320201	-	5.70e-01	GO:0000150	recombinase activity	MF
1	8	0.321823320201	-	5.70e-01	GO:0008432	JUN kinase binding	MF
1	8	0.321823320201	-	5.70e-01	GO:0032036	myosin heavy chain binding	MF
1	8	0.321823320201	-	5.70e-01	GO:0031748	D1 dopamine receptor binding	MF
1	8	0.321823320201	-	5.70e-01	GO:0031406	carboxylic acid binding	MF
1	8	0.321823320201	-	5.70e-01	GO:0001849	complement component C1q binding	MF
1	8	0.321823320201	-	5.70e-01	GO:0031995	insulin-like growth factor II binding	MF
1	8	0.321823320201	-	5.70e-01	GO:0035591	signaling adaptor activity	MF
2	16	0.321823320201	-	6.71e-01	GO:0001056	RNA polymerase III activity	MF
2	16	0.321823320201	-	6.71e-01	GO:0008656	cysteine-type endopeptidase activator activity involved in apoptotic process	MF
9	73	0.301923762763	-	4.04e-02	GO:0030216	keratinocyte differentiation	BP
7	57	0.296288228094	-	1.95e-01	GO:1903779	regulation of cardiac conduction	BP
62	505	0.295880052949	-	2.34e-05	GO:0030154	cell differentiation	BP
6	49	0.292075976807	-	4.66e-01	GO:0010212	response to ionizing radiation	BP
6	49	0.292075976807	-	4.75e-01	GO:0036297	interstrand cross-link repair	BP
5	41	0.28619941047	-	1.94e-01	GO:0022008	neurogenesis	BP
10	82	0.28619941047	-	2.41e-01	GO:0007229	integrin-mediated signaling pathway	BP
19	156	0.284348614783	-	1.04e-01	GO:0006511	ubiquitin-dependent protein catabolic process	BP
4	33	0.277429200843	-	1.52e-01	GO:0043330	response to exogenous dsRNA	BP
12	99	0.277429200843	-	2.03e-01	GO:0046854	phosphatidylinositol phosphorylation	BP
4	33	0.277429200843	-	5.20e-01	GO:0006298	mismatch repair	BP
4	33	0.277429200843	-	5.27e-01	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	BP
4	33	0.277429200843	-	5.27e-01	GO:0070830	bicellular tight junction assembly	BP
4	33	0.277429200843	-	5.56e-01	GO:0008219	cell death	BP
4	33	0.277429200843	-	5.45e-01	GO:0005154	epidermal growth factor receptor binding	MF
3	25	0.262929631148	-	4.44e-01	GO:0019433	triglyceride catabolic process	BP
3	25	0.262929631148	-	4.44e-01	GO:0015914	phospholipid transport	BP
3	25	0.262929631148	-	4.78e-01	GO:0043473	pigmentation	BP
3	25	0.262929631148	-	4.78e-01	GO:0051924	regulation of calcium ion transport	BP
3	25	0.262929631148	-	7.28e-01	GO:0048678	response to axon injury	BP
3	25	0.262929631148	-	7.34e-01	GO:0032735	positive regulation of interleukin-12 production	BP
3	25	0.262929631148	-	3.81e-02	GO:0030594	neurotransmitter receptor activity	MF
6	50	0.262929631148	-	1.46e-01	GO:0005044	scavenger receptor activity	MF
3	25	0.262929631148	-	7.34e-01	GO:0043027	cysteine-type endopeptidase inhibitor activity involved in apoptotic process	MF
5	42	0.25143399231	-	3.74e-01	GO:0050890	cognition	BP
5	42	0.25143399231	-	5.93e-01	GO:0006986	response to unfolded protein	BP
5	42	0.25143399231	-	9.78e-02	GO:0019825	oxygen binding	MF
4	34	0.234360478951	-	2.70e-01	GO:0045747	positive regulation of Notch signaling pathway	BP
2	17	0.234360478951	-	3.03e-01	GO:0007276	gamete generation	BP
4	34	0.234360478951	-	3.23e-01	GO:0008016	regulation of heart contraction	BP
2	17	0.234360478951	-	3.41e-01	GO:0097009	energy homeostasis	BP
2	17	0.234360478951	-	3.79e-01	GO:0010880	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	BP
6	51	0.234360478951	-	4.66e-01	GO:0051592	response to calcium ion	BP
4	34	0.234360478951	-	5.20e-01	GO:0030501	positive regulation of bone mineralization	BP
4	34	0.234360478951	-	5.67e-01	GO:0006383	transcription from RNA polymerase III promoter	BP
2	17	0.234360478951	-	6.44e-01	GO:0030902	hindbrain development	BP
2	17	0.234360478951	-	6.44e-01	GO:0021537	telencephalon development	BP
2	17	0.234360478951	-	6.44e-01	GO:0006471	protein ADP-ribosylation	BP
2	17	0.234360478951	-	6.44e-01	GO:0007043	cell-cell junction assembly	BP
2	17	0.234360478951	-	6.44e-01	GO:0045582	positive regulation of T cell differentiation	BP
2	17	0.234360478951	-	6.57e-01	GO:0034199	activation of protein kinase A activity	BP
2	17	0.234360478951	-	6.57e-01	GO:0002407	dendritic cell chemotaxis	BP
2	17	0.234360478951	-	6.57e-01	GO:0032722	positive regulation of chemokine production	BP
2	17	0.234360478951	-	6.71e-01	GO:1990138	neuron projection extension	BP
2	17	0.234360478951	-	6.71e-01	GO:0008045	motor neuron axon guidance	BP
2	17	0.234360478951	-	6.85e-01	GO:0007094	mitotic spindle assembly checkpoint	BP
2	17	0.234360478951	-	6.85e-01	GO:0070266	necroptotic process	BP
2	17	0.234360478951	-	6.85e-01	GO:0000920	cell separation after cytokinesis	BP
6	51	0.234360478951	-	2.96e-01	GO:0030145	manganese ion binding	MF
4	34	0.234360478951	-	5.67e-01	GO:0048487	beta-tubulin binding	MF
2	17	0.234360478951	-	6.44e-01	GO:0004540	ribonuclease activity	MF
2	17	0.234360478951	-	6.44e-01	GO:0004383	guanylate cyclase activity	MF
2	17	0.234360478951	-	6.57e-01	GO:0016597	amino acid binding	MF
2	17	0.234360478951	-	6.57e-01	GO:0048037	cofactor binding	MF
2	17	0.234360478951	-	6.71e-01	GO:0050431	transforming growth factor beta binding	MF
7	60	0.22228764665	-	5.01e-01	GO:0030334	regulation of cell migration	BP
7	60	0.22228764665	-	2.10e-01	GO:0008237	metallopeptidase activity	MF
22	189	0.219012514617	-	1.92e-01	GO:0005516	calmodulin binding	MF
5	43	0.217486660386	-	4.25e-01	GO:0042110	T cell activation	BP
10	86	0.217486660386	-	4.66e-01	GO:0048013	ephrin receptor signaling pathway	BP
5	43	0.217486660386	-	4.25e-01	GO:0016303	1-phosphatidylinositol-3-kinase activity	MF
5	43	0.217486660386	-	5.93e-01	GO:0003727	single-stranded RNA binding	MF
8	69	0.213298863423	-	6.06e-02	GO:0042391	regulation of membrane potential	BP
1045	9019	0.212358781911	-	6.13e-10	GO:0005515	protein binding	MF
15	130	0.206346102781	-	9.59e-03	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	BP
15	130	0.206346102781	-	5.56e-02	GO:0007605	sensory perception of sound	BP
9	78	0.206346102781	-	1.88e-01	GO:0008544	epidermis development	BP
3	26	0.206346102781	-	2.11e-01	GO:0035025	positive regulation of Rho protein signal transduction	BP
3	26	0.206346102781	-	7.34e-01	GO:0071108	protein K48-linked deubiquitination	BP
3	26	0.206346102781	-	7.41e-01	GO:0051225	spindle assembly	BP
3	26	0.206346102781	-	7.28e-01	GO:0043014	alpha-tubulin binding	MF
7	61	0.198440904696	-	3.41e-01	GO:0005518	collagen binding	MF
4	35	0.192540303256	-	5.36e-01	GO:0006479	protein methylation	BP
4	35	0.192540303256	-	5.67e-01	GO:0000723	telomere maintenance	BP
4	35	0.192540303256	-	7.71e-01	GO:0019985	translesion synthesis	BP
4	35	0.192540303256	-	7.71e-01	GO:0005057	signal transducer activity, downstream of receptor	MF
14	123	0.18666373692	-	3.37e-01	GO:0002576	platelet degranulation	BP
10	88	0.184319796451	-	2.41e-01	GO:0007565	female pregnancy	BP
5	44	0.184319796451	-	6.00e-01	GO:0034260	negative regulation of GTPase activity	BP
26	229	0.183059250245	-	2.99e-01	GO:0061024	membrane organization	BP
12	106	0.178865366359	-	1.99e-01	GO:0005178	integrin binding	MF
10	89	0.168017984122	-	4.66e-01	GO:0051087	chaperone binding	MF
124	1114	0.154486113248	-	2.30e-05	GO:0007165	signal transduction	BP
2	18	0.151898318759	-	5.23e-02	GO:0098664	G-protein coupled serotonin receptor signaling pathway	BP
3	27	0.151898318759	-	2.11e-01	GO:0007154	cell communication	BP
2	18	0.151898318759	-	3.03e-01	GO:0030539	male genitalia development	BP
9	81	0.151898318759	-	3.10e-01	GO:0006874	cellular calcium ion homeostasis	BP
2	18	0.151898318759	-	3.41e-01	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	BP
2	18	0.151898318759	-	3.41e-01	GO:0036342	post-anal tail morphogenesis	BP
1	9	0.151898318759	-	3.44e-01	GO:0060371	regulation of atrial cardiac muscle cell membrane depolarization	BP
1	9	0.151898318759	-	3.44e-01	GO:0043266	regulation of potassium ion transport	BP
1	9	0.151898318759	-	3.44e-01	GO:0090181	regulation of cholesterol metabolic process	BP
1	9	0.151898318759	-	4.10e-01	GO:0046549	retinal cone cell development	BP
1	9	0.151898318759	-	4.10e-01	GO:0097186	amelogenesis	BP
1	9	0.151898318759	-	4.10e-01	GO:0051205	protein insertion into membrane	BP
1	9	0.151898318759	-	4.10e-01	GO:0007567	parturition	BP
1	9	0.151898318759	-	4.10e-01	GO:0070286	axonemal dynein complex assembly	BP
1	9	0.151898318759	-	4.10e-01	GO:0045580	regulation of T cell differentiation	BP
3	27	0.151898318759	-	4.29e-01	GO:0009755	hormone-mediated signaling pathway	BP
3	27	0.151898318759	-	4.44e-01	GO:0048791	calcium ion-regulated exocytosis of neurotransmitter	BP
6	54	0.151898318759	-	4.58e-01	GO:0019233	sensory perception of pain	BP
1	9	0.151898318759	-	4.69e-01	GO:0051896	regulation of protein kinase B signaling	BP
1	9	0.151898318759	-	4.69e-01	GO:0035988	chondrocyte proliferation	BP
1	9	0.151898318759	-	4.69e-01	GO:2001256	regulation of store-operated calcium entry	BP
1	9	0.151898318759	-	4.69e-01	GO:0060287	epithelial cilium movement involved in determination of left/right asymmetry	BP
1	9	0.151898318759	-	4.69e-01	GO:0060586	multicellular organismal iron ion homeostasis	BP
1	9	0.151898318759	-	4.69e-01	GO:0002315	marginal zone B cell differentiation	BP
1	9	0.151898318759	-	4.69e-01	GO:0097746	regulation of blood vessel diameter	BP
1	9	0.151898318759	-	4.69e-01	GO:0070327	thyroid hormone transport	BP
1	9	0.151898318759	-	4.69e-01	GO:0046887	positive regulation of hormone secretion	BP
1	9	0.151898318759	-	4.69e-01	GO:0032099	negative regulation of appetite	BP
1	9	0.151898318759	-	4.69e-01	GO:0009972	cytidine deamination	BP
3	27	0.151898318759	-	4.78e-01	GO:0035774	positive regulation of insulin secretion involved in cellular response to glucose stimulus	BP
3	27	0.151898318759	-	4.78e-01	GO:0008033	tRNA processing	BP
7	63	0.151898318759	-	5.15e-01	GO:0017148	negative regulation of translation	BP
1	9	0.151898318759	-	5.22e-01	GO:0061549	sympathetic ganglion development	BP
1	9	0.151898318759	-	5.22e-01	GO:0007589	body fluid secretion	BP
1	9	0.151898318759	-	5.22e-01	GO:0097105	presynaptic membrane assembly	BP
1	9	0.151898318759	-	5.22e-01	GO:0021702	cerebellar Purkinje cell differentiation	BP
1	9	0.151898318759	-	5.22e-01	GO:0014883	transition between fast and slow fiber	BP
1	9	0.151898318759	-	5.22e-01	GO:0000447	endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	BP
1	9	0.151898318759	-	5.22e-01	GO:0035313	wound healing, spreading of epidermal cells	BP
1	9	0.151898318759	-	5.22e-01	GO:0050713	negative regulation of interleukin-1 beta secretion	BP
1	9	0.151898318759	-	5.22e-01	GO:0046620	regulation of organ growth	BP
1	9	0.151898318759	-	5.22e-01	GO:0097094	craniofacial suture morphogenesis	BP
1	9	0.151898318759	-	5.22e-01	GO:2000270	negative regulation of fibroblast apoptotic process	BP
4	36	0.151898318759	-	5.45e-01	GO:0010942	positive regulation of cell death	BP
4	36	0.151898318759	-	5.67e-01	GO:0030177	positive regulation of Wnt signaling pathway	BP
1	9	0.151898318759	-	5.70e-01	GO:1900027	regulation of ruffle assembly	BP
1	9	0.151898318759	-	5.70e-01	GO:0060068	vagina development	BP
1	9	0.151898318759	-	5.70e-01	GO:0048193	Golgi vesicle transport	BP
1	9	0.151898318759	-	5.70e-01	GO:0042119	neutrophil activation	BP
1	9	0.151898318759	-	5.70e-01	GO:0045591	positive regulation of regulatory T cell differentiation	BP
1	9	0.151898318759	-	5.70e-01	GO:0032206	positive regulation of telomere maintenance	BP
1	9	0.151898318759	-	5.70e-01	GO:0060231	mesenchymal to epithelial transition	BP
1	9	0.151898318759	-	5.70e-01	GO:0031110	regulation of microtubule polymerization or depolymerization	BP
1	9	0.151898318759	-	5.70e-01	GO:0002544	chronic inflammatory response	BP
1	9	0.151898318759	-	5.70e-01	GO:0071236	cellular response to antibiotic	BP
1	9	0.151898318759	-	5.70e-01	GO:0051451	myoblast migration	BP
1	9	0.151898318759	-	5.70e-01	GO:0006105	succinate metabolic process	BP
1	9	0.151898318759	-	5.70e-01	GO:0070886	positive regulation of calcineurin-NFAT signaling cascade	BP
1	9	0.151898318759	-	5.70e-01	GO:0006930	substrate-dependent cell migration, cell extension	BP
1	9	0.151898318759	-	5.70e-01	GO:0098789	pre-mRNA cleavage required for polyadenylation	BP
1	9	0.151898318759	-	5.70e-01	GO:0042908	xenobiotic transport	BP
1	9	0.151898318759	-	5.70e-01	GO:0009410	response to xenobiotic stimulus	BP
1	9	0.151898318759	-	5.70e-01	GO:0072089	stem cell proliferation	BP
1	9	0.151898318759	-	5.70e-01	GO:0046855	inositol phosphate dephosphorylation	BP
1	9	0.151898318759	-	5.70e-01	GO:0030299	intestinal cholesterol absorption	BP
5	45	0.151898318759	-	5.93e-01	GO:0030838	positive regulation of actin filament polymerization	BP
5	45	0.151898318759	-	6.07e-01	GO:0006094	gluconeogenesis	BP
2	18	0.151898318759	-	6.44e-01	GO:0035249	synaptic transmission, glutamatergic	BP
2	18	0.151898318759	-	6.44e-01	GO:0071294	cellular response to zinc ion	BP
2	18	0.151898318759	-	6.57e-01	GO:0016079	synaptic vesicle exocytosis	BP
2	18	0.151898318759	-	6.57e-01	GO:0090026	positive regulation of monocyte chemotaxis	BP
2	18	0.151898318759	-	6.57e-01	GO:1901214	regulation of neuron death	BP
2	18	0.151898318759	-	6.71e-01	GO:0032418	lysosome localization	BP
2	18	0.151898318759	-	6.85e-01	GO:0046579	positive regulation of Ras protein signal transduction	BP
2	18	0.151898318759	-	6.85e-01	GO:0048260	positive regulation of receptor-mediated endocytosis	BP
2	18	0.151898318759	-	6.85e-01	GO:0030490	maturation of SSU-rRNA	BP
2	18	0.151898318759	-	6.85e-01	GO:0045948	positive regulation of translational initiation	BP
2	18	0.151898318759	-	7.00e-01	GO:0031116	positive regulation of microtubule polymerization	BP
2	18	0.151898318759	-	7.00e-01	GO:0002026	regulation of the force of heart contraction	BP
3	27	0.151898318759	-	7.28e-01	GO:0046580	negative regulation of Ras protein signal transduction	BP
3	27	0.151898318759	-	7.28e-01	GO:0035987	endodermal cell differentiation	BP
3	27	0.151898318759	-	7.48e-01	GO:0050718	positive regulation of interleukin-1 beta secretion	BP
1	9	0.151898318759	-	1.00e+00	GO:0045657	positive regulation of monocyte differentiation	BP
1	9	0.151898318759	-	1.00e+00	GO:0043653	mitochondrial fragmentation involved in apoptotic process	BP
1	9	0.151898318759	-	1.00e+00	GO:0048489	synaptic vesicle transport	BP
1	9	0.151898318759	-	1.00e+00	GO:0010761	fibroblast migration	BP
1	9	0.151898318759	-	1.00e+00	GO:0006390	transcription from mitochondrial promoter	BP
1	9	0.151898318759	-	1.00e+00	GO:0008635	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	BP
1	9	0.151898318759	-	1.00e+00	GO:0006903	vesicle targeting	BP
1	9	0.151898318759	-	1.00e+00	GO:1903076	regulation of protein localization to plasma membrane	BP
1	9	0.151898318759	-	1.00e+00	GO:0061157	mRNA destabilization	BP
1	9	0.151898318759	-	1.00e+00	GO:0030071	regulation of mitotic metaphase/anaphase transition	BP
1	9	0.151898318759	-	1.00e+00	GO:0006000	fructose metabolic process	BP
1	9	0.151898318759	-	1.00e+00	GO:2000008	regulation of protein localization to cell surface	BP
1	9	0.151898318759	-	1.00e+00	GO:0043534	blood vessel endothelial cell migration	BP
1	9	0.151898318759	-	1.00e+00	GO:0051315	attachment of mitotic spindle microtubules to kinetochore	BP
1	9	0.151898318759	-	1.00e+00	GO:0034427	nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'	BP
1	9	0.151898318759	-	1.00e+00	GO:0008608	attachment of spindle microtubules to kinetochore	BP
1	9	0.151898318759	-	1.00e+00	GO:0046621	negative regulation of organ growth	BP
1	9	0.151898318759	-	1.00e+00	GO:0033314	mitotic DNA replication checkpoint	BP
1	9	0.151898318759	-	1.00e+00	GO:0071028	nuclear mRNA surveillance	BP
1	9	0.151898318759	-	1.00e+00	GO:0043497	regulation of protein heterodimerization activity	BP
3	27	0.151898318759	-	1.84e-01	GO:0019706	protein-cysteine S-palmitoyltransferase activity	MF
2	18	0.151898318759	-	2.64e-01	GO:0016409	palmitoyltransferase activity	MF
2	18	0.151898318759	-	2.64e-01	GO:0005520	insulin-like growth factor binding	MF
2	18	0.151898318759	-	3.41e-01	GO:0016746	transferase activity, transferring acyl groups	MF
1	9	0.151898318759	-	4.10e-01	GO:0055056	D-glucose transmembrane transporter activity	MF
3	27	0.151898318759	-	4.29e-01	GO:0001530	lipopolysaccharide binding	MF
3	27	0.151898318759	-	4.61e-01	GO:0003785	actin monomer binding	MF
3	27	0.151898318759	-	4.61e-01	GO:0004435	phosphatidylinositol phospholipase C activity	MF
3	27	0.151898318759	-	4.61e-01	GO:0005244	voltage-gated ion channel activity	MF
1	9	0.151898318759	-	4.69e-01	GO:0016702	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen	MF
3	27	0.151898318759	-	4.97e-01	GO:0004857	enzyme inhibitor activity	MF
1	9	0.151898318759	-	5.22e-01	GO:0031404	chloride ion binding	MF
1	9	0.151898318759	-	5.22e-01	GO:0016918	retinal binding	MF
1	9	0.151898318759	-	5.22e-01	GO:0008035	high-density lipoprotein particle binding	MF
1	9	0.151898318759	-	5.22e-01	GO:0016709	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen	MF
1	9	0.151898318759	-	5.70e-01	GO:0030291	protein serine/threonine kinase inhibitor activity	MF
1	9	0.151898318759	-	5.70e-01	GO:0052659	inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity	MF
1	9	0.151898318759	-	5.70e-01	GO:0045236	CXCR chemokine receptor binding	MF
3	27	0.151898318759	-	7.41e-01	GO:0061631	ubiquitin conjugating enzyme activity	MF
1	9	0.151898318759	-	1.00e+00	GO:0019869	chloride channel inhibitor activity	MF
1	9	0.151898318759	-	1.00e+00	GO:0016595	glutamate binding	MF
1	9	0.151898318759	-	1.00e+00	GO:0019215	intermediate filament binding	MF
1	9	0.151898318759	-	1.00e+00	GO:0002162	dystroglycan binding	MF
1	9	0.151898318759	-	1.00e+00	GO:0035197	siRNA binding	MF
1	9	0.151898318759	-	1.00e+00	GO:0005522	profilin binding	MF
1	9	0.151898318759	-	1.00e+00	GO:0031681	G-protein beta-subunit binding	MF
39	355	0.135550324671	-	1.25e-01	GO:0043687	post-translational protein modification	BP
8	73	0.131998761321	-	5.27e-01	GO:0001618	virus receptor activity	MF
6	55	0.125426107398	-	2.86e-01	GO:0007368	determination of left/right symmetry	BP
5	46	0.120189459032	-	6.00e-01	GO:0009408	response to heat	BP
5	46	0.120189459032	-	6.07e-01	GO:0019902	phosphatase binding	MF
9	83	0.116708890297	-	4.27e-01	GO:0001822	kidney development	BP
9	83	0.116708890297	-	5.57e-01	GO:0046718	viral entry into host cell	BP
31	286	0.11614829381	-	5.48e-01	GO:0045296	cadherin binding	MF
4	37	0.112369954572	-	5.20e-01	GO:0007588	excretion	BP
8	74	0.112369954572	-	2.73e-01	GO:0005089	Rho guanyl-nucleotide exchange factor activity	MF
3	28	0.0994308988647	-	4.16e-01	GO:0086010	membrane depolarization during action potential	BP
3	28	0.0994308988647	-	4.61e-01	GO:0060338	regulation of type I interferon-mediated signaling pathway	BP
3	28	0.0994308988647	-	7.28e-01	GO:0032148	activation of protein kinase B activity	BP
3	28	0.0994308988647	-	7.48e-01	GO:0050434	positive regulation of viral transcription	BP
3	28	0.0994308988647	-	7.56e-01	GO:0070979	protein K11-linked ubiquitination	BP
3	28	0.0994308988647	-	4.97e-01	GO:0008139	nuclear localization sequence binding	MF
6	56	0.0994308988647	-	6.49e-01	GO:0004197	cysteine-type endopeptidase activity	MF
10	94	0.0891625634109	-	3.37e-01	GO:0051897	positive regulation of protein kinase B signaling	BP
5	47	0.0891625634109	-	4.01e-01	GO:0006631	fatty acid metabolic process	BP
5	47	0.0891625634109	-	6.15e-01	GO:0006909	phagocytosis	BP
34	320	0.0873580665641	-	2.64e-02	GO:0007399	nervous system development	BP
7	66	0.0847841229003	-	8.33e-01	GO:0016197	endosomal transport	BP
21	198	0.0847841229003	-	1.31e-01	GO:0004872	receptor activity	MF
156	1472	0.0836635830064	-	7.08e-03	GO:0005524	ATP binding	MF
6	57	0.0738958067576	-	8.19e-01	GO:0035722	interleukin-12-mediated signaling pathway	BP
6	57	0.0738958067576	-	3.07e-01	GO:0001664	G-protein coupled receptor binding	MF
4	38	0.0738958067576	-	2.81e-01	GO:0048468	cell development	BP
2	19	0.0738958067576	-	3.03e-01	GO:0018345	protein palmitoylation	BP
2	19	0.0738958067576	-	3.79e-01	GO:0007141	male meiosis I	BP
2	19	0.0738958067576	-	6.44e-01	GO:0048148	behavioral response to cocaine	BP
2	19	0.0738958067576	-	6.57e-01	GO:0045216	cell-cell junction organization	BP
2	19	0.0738958067576	-	6.57e-01	GO:0048545	response to steroid hormone	BP
2	19	0.0738958067576	-	6.57e-01	GO:0002028	regulation of sodium ion transport	BP
2	19	0.0738958067576	-	6.57e-01	GO:0060384	innervation	BP
2	19	0.0738958067576	-	6.71e-01	GO:0010592	positive regulation of lamellipodium assembly	BP
2	19	0.0738958067576	-	6.85e-01	GO:0071385	cellular response to glucocorticoid stimulus	BP
2	19	0.0738958067576	-	7.00e-01	GO:0031954	positive regulation of protein autophosphorylation	BP
2	19	0.0738958067576	-	7.00e-01	GO:0042311	vasodilation	BP
2	19	0.0738958067576	-	1.00e+00	GO:0008637	apoptotic mitochondrial changes	BP
2	19	0.0738958067576	-	3.41e-01	GO:0046914	transition metal ion binding	MF
41	393	0.0609898225606	-	2.29e-02	GO:0007283	spermatogenesis	BP
5	48	0.0587889143674	-	3.91e-01	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	BP
3	29	0.0488048257948	-	2.38e-01	GO:0060078	regulation of postsynaptic membrane potential	BP
3	29	0.0488048257948	-	4.61e-01	GO:0030203	glycosaminoglycan metabolic process	BP
3	29	0.0488048257948	-	7.34e-01	GO:0006378	mRNA polyadenylation	BP
3	29	0.0488048257948	-	7.48e-01	GO:0051491	positive regulation of filopodium assembly	BP
6	58	0.0488048257948	-	8.19e-01	GO:0036498	IRE1-mediated unfolded protein response	BP
3	29	0.0488048257948	-	7.41e-01	GO:0008234	cysteine-type peptidase activity	MF
4	39	0.0364211013389	-	5.56e-01	GO:0006633	fatty acid biosynthetic process	BP
5	49	0.0290415709733	-	4.13e-01	GO:0016485	protein processing	BP
5	49	0.0290415709733	-	5.88e-01	GO:0035176	social behavior	BP
5	49	0.0290415709733	-	6.00e-01	GO:0071320	cellular response to cAMP	BP
6	59	0.0241427715605	-	2.96e-01	GO:0007338	single fertilization	BP
6	59	0.0241427715605	-	4.66e-01	GO:0042277	peptide binding	MF
8	79	0.0180425720241	-	6.94e-01	GO:0004843	thiol-dependent ubiquitin-specific protease activity	MF
